[go: up one dir, main page]

HK1201329B - Method of predicting breast cancer prognosis - Google Patents

Method of predicting breast cancer prognosis Download PDF

Info

Publication number
HK1201329B
HK1201329B HK15101891.1A HK15101891A HK1201329B HK 1201329 B HK1201329 B HK 1201329B HK 15101891 A HK15101891 A HK 15101891A HK 1201329 B HK1201329 B HK 1201329B
Authority
HK
Hong Kong
Prior art keywords
breast cancer
rna
recurrence
likelihood
patient
Prior art date
Application number
HK15101891.1A
Other languages
German (de)
French (fr)
Chinese (zh)
Other versions
HK1201329A1 (en
Inventor
Joffre B. Baker
Dominick V. Sinicropi
Robert J. Pelham
Michael Crager
Francois Collin
James C. STEPHANS
Mei-lan LIU
John Morlan
Kunbin Qu
Original Assignee
Genomic Health, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomic Health, Inc. filed Critical Genomic Health, Inc.
Priority claimed from PCT/US2012/063313 external-priority patent/WO2013070521A1/en
Publication of HK1201329A1 publication Critical patent/HK1201329A1/en
Publication of HK1201329B publication Critical patent/HK1201329B/en

Links

Description

FIELD OF THE INVENTION
The present invention relates to biomarkers associated with breast cancer prognosis. These biomarkers include coding transcripts and their expression products, as well as non-coding transcripts, and are useful for predicting the likelihood of breast cancer recurrence in a breast cancer patient.
INTRODUCTION
For over a decade, technologies such as DNA microarray and reverse transcription polymerase chain reaction (RT-PCR) have demonstrated that levels of certain RNA transcripts ("gene expression profiles") relate to patient stratification and disease outcomes, especially in a variety of cancers. Several validated and now widely used clinical tests make use of gene expression profiling, such as the Oncotype DX® RT-PCR test, which measures the levels of 21 biomarker RNAs in archival formalin-fixed paraffin-embedded (FFPE) tissue. The Oncotype DX® RT-PCR test predicts the risk of recurrence of early estrogen receptor (ER)-positive breast cancer, as well as the likelihood of response to chemotherapy, and is now used to guide treatment decisions for about half of ER+ breast cancer patients in the U.S.
However, RT-PCR is constrained by the number of transcripts and sequence complexity that can be interrogated, especially given the limited amount of patient FFPE RNA available from many tumor specimens. Recent major advances in DNA sequencing ("next generation sequencing") provide massively parallel throughput and data volumes that eclipse the nucleic acid information content possible with other technologies, such as RT-PCR. Next generation sequencing makes feasible unprecedented extensive genome analysis of groups of individuals, including analyses of sequence differences, polymorphisms, mutations, copy number variations, epigenetic variations and transcript abundance (RNA-Seq).
SUMMARY
A multiplexed, whole genome sequencing methodology was developed to enable whole transcriptome-wide breast cancer biomarker discovery using low amounts of FFPE tissue. The present invention provides biomarkers that associate, positively or negatively, with a particular clinical outcome in breast cancer. These biomarkers are listed in Tables 1-5 and 15. For example, the clinical outcome could be no cancer recurrence or cancer recurrence. The clinical outcome may be defined by clinical endpoints, such as disease or recurrence free survival, metastasis free survival, overall survival, etc.
The present invention accommodates the use of archived paraffin-embedded biopsy material for assay of all markers in the set, and therefore is compatible with the most widely available type of biopsy material. It is also compatible with other different methods of tumor tissue harvest, for example, via core biopsy or fine needle aspiration.
In one aspect, the present invention provides a method of predicting a likelihood of long-term survival without recurrence of breast cancer in a breast cancer patient. The method comprises determining a level of one or more RNA transcripts, or its expression product, in a breast cancer tumor sample obtained from the patient. The RNA transcript or its expression product may be selected from Tables 1 and 15. The likelihood of long-term survival without breast cancer recurrence is then predicted based on the negative or positive correlation of the RNA transcript or its expression product with increased likelihood of long-term survival without breast cancer recurrence. An RNA transcript is negatively correlated with increased long-term survival without recurrence of breast cancer if its direction of association is marked 1 in Tables 1 and 15, and is positively correlated with increased long-term survival without recurrence of breast cancer if its direction of association is marked -lin Tables 1 and 15.
In another aspect, the present invention provides a method of predicting a likelihood of long-term survival without recurrence of breast cancer in an estrogen receptor (ER)-positive breast cancer patient. The method comprises determining a level of one or more RNA transcripts, or its expression product, in a breast cancer tumor sample obtained from the patient. The RNA transcript or its expression product may be selected from Table 2. The likelihood of long-term survival without breast cancer recurrence is then predicted based on the negative or positive correlation of the RNA transcript or its expression product with increased likelihood of long-term survival without breast cancer recurrence. An RNA transcript is negatively correlated with increased long-term survival without recurrence of breast cancer if its direction of association is marked 1 in Table 2, and is positively correlated with increased long-term survival without recurrence of breast cancer if its direction of association is marked -1 in Table 2.
The RNA transcripts, or the expression products, may be grouped into gene networks based on the current understanding of their cellular function. For example, the gene networks include a cell cycle network, ESR1 network, Chr9q22network, Chr17q23-24 network, Chr8q21-24 network, olfactory receptor network, and metabolic-like networks. The present invention therefore also provides a method of predicting a likelihood of long-term survival without breast cancer recurrence in a breast cancer patient by determining a quantitative value, such as a likelihood score, for one or more gene networks based on the level of at least one RNA transcript, or expression product thereof, within the gene network, in a breast cancer tumor sample obtained from the patient. The quantitative value for the gene network may be determined by weighting the contribution of one or more RNA transcripts, or their expression products, to clinical outcome, such as risk of recurrence.
In yet another aspect, the present invention provides a method of predicting a likelihood of long-term survival without recurrence of breast cancer in a breast cancer patient by determining a level of one or more non-coding sequences in a breast cancer tissue sample obtained from the patient. In one embodiment, the non-coding sequence is one or more intronic RNAs selected from Table 3. In another embodiment, the non-coding sequence is one or more long intergenic non-coding regions (lincRNAs) selected from Table 4. In a further embodiment, the non-coding sequence is one or more intergenic sequences selected from Table 5. In yet another embodiment, the non-coding sequence is one or more intergenic regions 1-69 selected from Table 5. The intergenic region may be comprised of one or more intergenic sequences according to Table 5. The likelihood of long-term survival without breast cancer recurrence is predicted based on the negative or positive correlation of the non-coding sequence with increased likelihood of long-term survival without breast cancer recurrence. A non-coding sequence is negatively correlated with increased long-term survival without recurrence of breast cancer if its direction of association is marked 1 in Tables 3-5, and is positively correlated with increased long-term survival without recurrence of breast cancer if its direction of association is marked -1 in Tables 3-5.
In a further aspect, the present invention provides a method of predicting a likelihood of long-term survival without recurrence of breast cancer in a breast cancer patient by determining a level of an RNA transcript, or an expression product thereof, from a metabolic-like network in a breast cancer tumor sample obtained from the patient. The metabolic-like networks include a five-gene set comprising ENO1, IDH2, TMSB10, PGK1, and G6PD, and a fourteen-gene set comprising PGD, TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, ACO2, and FBP1. In one aspect, levels of at least three RNA transcripts, or expression products thereof, selected from ENO1, IDH2, TMSB10, PGK1, and G6PD, are determined. In a specific embodiment, the levels of at least IDH2, PGK1, and G6PD are determined. In yet another embodiment, the levels of ENO1, IDH2, TMSB10, PGK1, and G6PD are determined. In another aspect, levels of at least five RNA transcripts, or expression products thereof, selected from PGD, TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, ACO2, and FBP1, are determined. In a specific embodiment, the levels of the RNA transcripts, or expression products thereof, of PGD, TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, ACO2, and FBP1, are determined. The likelihood of long-term survival without breast cancer recurrence is predicted based on the negative or positive correlation of the RNA transcripts, or expression products thereof, with increased likelihood of long-term survival without breast cancer recurrence. Levels of ENO1, IDH2, TMSB10, PGK1, G6PD, PGD, TKT, TALDO1, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, and ACO2 are all negatively correlated with an increased likelihood of long-term survival without recurrence of breast cancer, while the level of FBP1 is positively correlated with an increased likelihood of long-term survival without recurrence of breast cancer.
Any of the above methods may utilize a combination of coding and non-coding RNA transcripts for predicting breast cancer prognosis. Moreover, any of the above methods may be performed by whole transcriptome sequencing, reverse transcription polymerase chain reaction (RT-PCR), or by array. Other methods known in the art may be used. In an embodiment of the invention, the breast cancer tumor sample is a fixed, wax-embedded tissue sample or a fine needle biopsy sample. In another embodiment, the level of the RNA transcript, or its expression product, or the level of the non-coding sequence may be normalized.
In an embodiment of the invention, a likelihood score (e.g., a score predicting a likelihood of long-term survival without breast cancer recurrence) can be calculated based on the level or normalized level of the coding RNA transcript, or an expression product thereof, and/or non-coding RNA transcript. A score may be calculated using weighted values based on the level or normalized level of the coding RNA transcript (or expression product thereof) and/or the non-coding RNA transcript, and its contribution to clinical outcome, such as long-term survival without breast cancer recurrence.
BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows the relationship of increased RNA expression to risk of breast cancer recurrence in 136 breast cancer patients. Each point represents a distinct RNA sequence. The magnitude of the effect size is given by the hazard ratio from Cox proportional hazard analysis and statistical significance by P-Value. Fig. 1A shows an analysis of 192 genes measured by RT-PCR. Tested Oncotype Dx® genes are indicated. Fig. 1B shows an analysis of assembled RefSeq transcripts as measured by whole transcriptome sequencing.
  • FIG. 2 are boxplots of normalized expression values of RNAs in breast cancer patients, stratified by recurrence status. Each point represents a patient tumor. The bottom and top of the box are the 25th and 75th percentiles and the band within the box is the 50th percentile (the median) of the points in the group. The ends of the whiskers represent the lowest datum still within 1.5 interquartile range (IQR) of the lower quartile, and the highest datum still within 1.5 IQR of the upper quartile. Values from RNA-Seq (left panel) and RT-PCR (right panel) are shown: Fig. 2A: BCL2; Fig. 2B: GSTM1; Fig. 2C: AURKA; Fig. 2D: MKI67.
  • FIG. 3 is a scatter plot of the breast cancer recurrence risk hazard ratios of 192 RNA sequences comparing the RT-PCR results (x-axis) versus RNA-Seq (assembled RefSeq) results (y axis). Each point represents a distinct RNA.
  • FIG. 4 is a comparison of the genes identified using publicly available microarray data and the NGS ("next generation sequencing") data of the present invention. Fig. 4A shows that there is substantial agreement in the genes identified as prognostic between the two platforms (11,659 genes in common, odds ratio = 2.99). Fig. 4B shows that at the low end of RNA-Seq expression (RNAs with mean counts <10.25), the level of agreement among the two platforms is not statistically significant (1620 genes in common, odds ratio = 0.89).
  • FIG. 5 is a 2D visualization of the network of gene co-expression (with a Pearson correlation coefficient cutoff of ≥0.6) amongst the 1307 identified prognostic RefSeqs generated using Cytoscape 2.8.
DETAILED DESCRIPTION
Before the present invention and specific exemplary embodiments of the invention are described, it is to be understood that this invention is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges is also encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either both of those included limits are also included in the invention.
As used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "an RNA transcript" includes a plurality of such RNA transcripts.
Unless defined otherwise, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. For example, Singleton et al., Dictionary of Microbiology and Molecular Biology 2nd ed., J. Wiley & Sons (New York, NY 1994), provide one skilled in the art with a general guide to many of the terms used in the present application.
Additionally, the practice of the present invention will employ, unless otherwise indicated, conventional techniques of molecular biology (including recombinant techniques), microbiology, cell biology, and biochemistry, which are within the skill of the art. Such techniques are explained fully in the literature, such as, "Molecular Cloning: A Laboratory Manual", 2nd edition (Sambrook et al., 1989); "Oligonucleotide Synthesis" (M.J. Gait, ed., 1984); "Animal Cell Culture" (R.I. Freshney, ed., 1987); "Methods in Enzymology" (Academic Press, Inc.); "Handbook of Experimental Immunology", 4th edition (D.M. Weir & C.C. Blackwell, eds., Blackwell Science Inc., 1987); "Gene Transfer Vectors for Mammalian Cells" (J.M. Miller & M.P. Calos, eds., 1987); "Current Protocols in Molecular Biology" (F.M. Ausubel et al., eds., 1987); and "PCR: The Polymerase Chain Reaction", (Mullis et al., eds., 1994).
The terms "cancer" and "cancerous" refer to or describe the physiological condition in mammals that is typically characterized by unregulated cell growth. An example of a cancer is breast cancer.
The term "co-expressed" as used herein refers to a statistical correlation between the expression level of one sequence and the expression level of another sequence. Pairwise co-expression may be calculated by various methods known in the art, e.g., by calculating a Pearson correlation coefficient or Spearman correlation coefficient. Co-expressed gene cliques or gene networks may also be identified using a graph theory. An analysis of co-expression may be calculated using normalized data.
The term "correlates" or "correlating" as used herein refers to a statistical association between instances of two events, where events may include numbers, data sets, and the like. For example, when the events involve numbers, a positive correlation (also referred to herein as a "direct correlation") means that as one increases, the other increases as well. A negative correlation (also referred to herein as an "inverse correlation") means that as one increases, the other decreases. The present invention provides coding and non-coding RNA transcripts, or expression products thereof, the levels of which are correlated with a particular outcome measure, such as between the level of an RNA transcript and the likelihood of long-term survival without breast cancer recurrence. For example, the increased level of an RNA transcript may be positively correlated with a likelihood of a good clinical outcome for the patient, such as an increased likelihood of long-term survival without recurrence and/or a positive response to a chemotherapy, and the like. Such a positive correlation may be demonstrated statistically in various ways, e.g. by a low hazard ratio. In another example, the increased level of an RNA transcript may be negatively correlated with a likelihood of good clinical outcome for the patient. In this case, for example, the patient may have a decreased likelihood of long-term survival without recurrence of the cancer and/or a positive response to a chemotherapy, and the like. Such a negative correlation indicates that the patient likely has a poor prognosis or will respond poorly to a chemotherapy, and this may be demonstrated statistically in various ways, e.g., by a high hazard ratio.
As used herein, the term "exon" refers to any segment of an interrupted gene that is represented in the mature RNA product (B. Lewin. Genes IV Cell Press, Cambridge Mass. 1990). As used herein, the terms "intron" and "intronic sequence" refer to any non-coding region found within genes.
The term "expression product" as used herein refers to an expression product of a coding RNA transcript. Thus, the term refers to a polypeptide or protein.
As used herein, the term "intergenic region" refers to a stretch of DNA or RNA sequences located between clusters of genes that contain few or no genes. Intergenic regions are different from intragenic regions (or "introns"), which are non-coding regions that are found between exons within genes. An intergenic region may be comprised of one or more "intergenic sequences." As shown in the Examples below, 69 intergenic regions were found to correlate to long-term survival without breast cancer recurrence, and each intergenic region comprises one or more intergenic sequences. The intergenic sequences are readily available from publicly available information. For example, the UCSC Genome Browser available at http://genome.ucsc.edu/cgi-bin/hgGateway allows inputting of the coordinates, such as the chromosome number and the start/stop positions on the chromosome shown in Tables 4 and 5, to produce an output comprising that sequence.
As used herein, the terms "long intergenic non-coding RNAs" and "lincRNAs" are used interchangeably and refer to non-coding transcripts that are typically longer than 200 nucleotides. As shown in the Examples below, 22 lincRNAs were found to correlate to long-term survival without breast cancer recurrence. The coordinates of these lincRNAs are publicly available and are also listed in Table 4. The sequences of the lincRNAs may also be obtained from publicly available information, such as the UCSC Genome Browser discussed above.
As used herein, the term "level" as used herein refers to qualitative or quantitative determination of the number of copies of a coding or non-coding RNA transcript or a polypeptide/protein. An RNA transcript or a polypeptide/protein exhibits an "increased level" when the level of the RNA transcript or polypeptide/protein is higher in a first sample, such as in a clinically relevant subpopulation of patients (e.g., patients who have experienced cancer recurrence), than in a second sample, such as in a related subpopulation (e.g., patients who did not experience cancer recurrence). In the context of an analysis of a level of an RNA transcript or a polypeptide/protein in a tumor sample obtained from an individual patient, an RNA transcript or polypeptide/protein exhibits "increased level" when the level of the RNA transcript or polypeptide/protein in the subject trends toward, or more closely approximates, the level characteristic of a clinically relevant subpopulation of patients.
Thus, for example, when the RNA transcript analyzed is an RNA transcript that shows an increased level in subjects that experienced long-term survival without cancer recurrence as compared to subjects that did not experience long-term survival without cancer recurrence, then an "increased" level of a given RNA transcript can be described as being positively correlated with a likelihood of long-term survival without cancer recurrence. If the level of the RNA transcript in an individual patient being assessed trends toward a level characteristic of a subject who experienced long-term survival without cancer recurrence, the level of the RNA transcript supports a determination that the individual patient is more likely to experience long-term survival without cancer recurrence. If the level of the RNA transcript in the individual patient trends toward a level characteristic of a subject who experienced cancer recurrence, then the level of the RNA transcript supports a determination that the individual patient is more likely to experience cancer recurrence.
The term "likelihood score" is an arithmetically or mathematically calculated numerical value for aiding in simplifying or disclosing or informing the analysis of more complex quantitative information, such as the correlation of certain levels of the disclosed RNA transcripts, their expression products, or gene networks to a likelihood of a certain clinical outcome in a breast cancer patient, such as likelihood of long-term survival without breast cancer recurrence. A likelihood score may be determined by the application of a specific algorithm. The algorithm used to calculate the likelihood score may group the RNA transcripts, or their expression products, into gene networks. A likelihood score may be determined for a gene network by determining the level of one or more RNA transcripts, or an expression product thereof, and weighting their contributions to a certain clinical outcome such as recurrence. A likelihood score may also be determined for a patient. In an embodiment, a likelihood score is a recurrence score, wherein an increase in the recurrence score negatively correlates with an increased likelihood of long-term survival without breast cancer recurrence. In other words, an increase in the recurrence score correlates with bad prognosis. Examples of methods for determining the likelihood score or recurrence score are disclosed in U.S. Patent No. 7,526,387 .
The term "long-term" survival as used herein refers to survival for at least 3 years. In other embodiments, it may refer to survival for at least 5 years, or for at least 10 years following surgery or other treatment.
As used herein, the term "normalized" with regard to a coding or non-coding RNA transcript, or an expression product of the coding RNA transcript, refers to the level of the RNA transcript, or its expression product, relative to the mean levels of transcript/product of a set of reference RNA transcripts, or their expression products. The reference RNA transcripts, or their expression products, are based on their minimal variation across patients, tissues, or treatments. Alternatively, the coding or non-coding RNA transcript, or its expression product, may be normalized to the totality of tested RNA transcripts, or a subset of such tested RNA transcripts.
As used herein, the term "pathology" of cancer includes all phenomena that comprise the well-being of the patient. This includes, without limitation, abnormal or uncontrollable cell growth, metastasis, interference with the normal functioning of neighboring cells, release of cytokines or other secretory products at abnormal levels, suppression or aggravation of inflammatory or immunological response, neoplasia, premalignancy, malignancy, invasion of surrounding or distant tissues or organs, such as lymph nodes.
A "patient response" may be assessed using any endpoint indicating a benefit to the patient, including, without limitation, (1) inhibition, to some extent, of tumor growth, including slowing down and complete growth arrest; (2) reduction in the number of tumor cells; (3) reduction in tumor size; (4) inhibition (i.e., reduction, slowing down or complete stopping) of tumor cell infiltration into adjacent peripheral organs and/or tissues; (5) inhibition (i.e. reduction, slowing down or complete stopping) of metastasis; (6) enhancement of anti-tumor immune response, which may, but does not have to, result in the regression or rejection of the tumor; (7) relief, to some extent, of one or more symptoms associated with the cancer; (8) increase in the length of survival following treatment; and/or (9) decreased mortality at a given point of time following treatment.
The term "prognosis" as used herein, refers to the prediction of the likelihood of cancer-attributable death or progression, including recurrence, metastatic spread, and drug resistance, of neoplastic disease, such as breast cancer. The term "prediction" is used herein to refer to the likelihood that a patient will respond either favorably or unfavorably to a drug or set of drugs, and also the extent of those responses, or that a patient will survive, following surgical removal of the primary tumor and/or chemotherapy for a certain period of time without cancer recurrence. The methods of the present invention can be used clinically to make treatment decisions by choosing the most appropriate treatment modalities for any particular patient. The methods of the present invention are tools in predicting if a patient is likely to respond favorably to a treatment regimen, such as surgical intervention, chemotherapy with a given drug or drug combination, and/or radiation therapy, or whether long-term survival of the patient without cancer recurrence is likely, following surgery and/or termination of chemotherapy or other treatment modalities.
The term "breast cancer prognostic biomarker" refers to an RNA transcript, or an expression product thereof, intronic RNA, lincRNA, intergenic sequence, and/or intergenic region found to be associated with long term survival without breast cancer recurrence as disclosed herein.
The term "reference" RNA transcript or an expression product thereof, as used herein, refers to an RNA transcript or an expression product thereof, whose level can be used to compare the level of an RNA transcript or its expression product in a test sample. In an embodiment of the invention, reference RNA transcripts include housekeeping genes, such as beta-globin, alcohol dehydrogenase, or any other RNA transcript, the level or expression of which does not vary depending on the disease status of the cell containing the RNA transcript or its expression product. In another embodiment, all of the assayed RNA transcripts, or their expression products, or a subset thereof, may serve as reference RNA transcripts or reference RNA expression products.
As used herein, the term "RefSeq RNA" refers to an RNA that can be found in the Reference Sequence (RefSeq) database, a collection of publicly available nucleotide sequences and their protein products built by the National Center for Biotechnology Information (NCBI). The RefSeq database provides an annotated, non-redundant record for each natural biological molecule (i.e. DNA, RNA or protein) included in the database. Thus, a sequence of a RefSeq RNA is well-known and can be found in the RefSeq database at http://www.ncbi.nlm.nih.gov/RefSeq/. See also Pruitt et al., Nucl. Acids Res. 33(Supp 1):D501-D504 (2005). Accession numbers for each RefSeq, which include accession numbers for any alternative splice forms, are provided in Tables 1 and 2 and in Table B. The intronic sequences for a RefSeq are also publicly available. Nonetheless, the coordinates for each intronic sequence listed in Table 3 are provided in Table A. Therefore, the sequence of each RNA sequence in Tables 1-3 and 15 are readily available from publicly available sources.
As used herein, the term "RNA transcript" refers to the RNA transcription product of DNA and includes coding and non-coding RNA transcripts. RNA transcripts include, for example, mRNA, an unspliced RNA, a splice variant mRNA, a microRNA, fragmented RNA, long intergenic non-coding RNAs (lincRNAs), intergenic RNA sequences or regions, and intronic RNAs.
The terms "subject," "individual," and "patient" are used interchangeably herein to refer to a mammal being assessed for treatment and/or being treated. In an embodiment, the mammal is a human. The terms "subject," "individual," and "patient" thus encompass individuals having cancer (e.g., breast cancer), including those who have undergone or are candidates for resection (surgery) to remove cancerous tissue.
As used herein, the term "surgery" applies to surgical methods undertaken for removal of cancerous tissue, including mastectomy, lumpectomy, lymph node removal, sentinel lymph node dissection, prophylactic mastectomy, prophylactic ovary removal, cryotherapy, and tumor biopsy. The tumor samples used for the methods of the present invention may have been obtained from any of these methods.
The term "tumor" as used herein, refers to all neoplastic cell growth and proliferation, whether malignant or benign, and all pre-cancerous and cancerous cells and tissues.:
The term "tumor sample" as used herein refers to a sample comprising tumor material obtained from a cancer patient. The term encompasses tumor tissue samples, for example, tissue obtained by surgical resection and tissue obtained by biopsy, such as for example, a core biopsy or a fine needle biopsy. In a particular embodiment, the tumor sample is a fixed, wax-embedded tissue sample, such as a formalin-fixed, paraffin-embedded tissue sample. Additionally, the term "tumor sample" encompasses a sample comprising tumor cells obtained from sites other than the primary tumor, e.g., circulating tumor cells. The term also encompasses cells that are the progeny of the patient's tumor cells, e.g. cell culture samples derived from primary tumor cells or circulating tumor cells. The term further encompasses samples that may comprise protein or nucleic acid material shed from tumor cells in vivo, e.g., bone marrow, blood, plasma, serum, and the like. The term also encompasses samples that have been enriched for tumor cells or otherwise manipulated after their procurement and samples comprising polynucleotides and/or polypeptides that are obtained from a patient's tumor material.
As used herein, "whole transcriptome sequencing" refers to the use of high throughput sequencing technologies to sequence the entire transcriptome in order to get information about a sample's RNA content. Whole transcriptome sequencing can be done with a variety of platforms for example, the Genome Analyzer (Illumina, Inc., San Diego, CA) and the SOLiD™ Sequencing System (Life Tehcnologies, Carlsbad, CA). However, any platform useful for whole transcriptome sequencing may be used.
The term "RNA-Seq" or "transcriptome sequencing" refers to sequencing performed on RNA (or cDNA) instead of DNA, where typically, the primary goal is to measure expression levels, detect fusion transcripts, alternative splicing, and other genomic alterations that can be better assessed from RNA. RNA-Seq includes whole transcriptome sequencing as well as target specific sequencing.
The term "computer-based system," as used herein, refers to the hardware means, software means, and data storage means used to analyze information. The minimum hardware of a patient computer-based system comprises a central processing unit (CPU), input means, output means, and data storage means. A skilled artisan can readily appreciate that many of the currently available computer-based system are suitable for use in the present invention and may be programmed to perform the specific measurement and/or calculation functions of the present invention.
To "record" data, programming or other information on a computer readable medium refers to a process for storing information, using any such methods as known in the art. Any convenient data storage structure may be chosen, based on the means used to access the stored information. A variety of data processor programs and formats can be used for storage, e.g. word processing text file, database format, etc.
A "processor" or "computing means" references any hardware and/or software combination that will perform the functions required of it. For example, any processor herein may be a programmable digital microprocessor such as available in the form of an electronic controller, mainframe, server or personal computer (desktop or portable). Where the processor is programmable, suitable programming can be communicated from a remote location to the processor, or previously saved in a computer program product (such as a portable or fixed computer readable storage medium, whether magnetic, optical or solid state device based). For example, a magnetic medium or optical disk may carry the programming, and can be read by a suitable reader communicating with each processor at its corresponding station.
The present invention provides RNA transcripts that are prognostic for breast cancer. These RNA transcripts are listed in Tables 1-5 and 15 and include coding and non-coding RNA transcripts. A subset of the RNA transcripts of Table 1 may be further grouped into gene networks, depending on their known function. For example, the gene networks may include a cell cycle network, ESR1 network, Chr9q22 network, Chr17q23-24 network, Chr8q21-24 network, olfactory receptor network, and metabolic-like networks. The cell cycle network comprises the genes listed in Table 6. The ESR1 network comprises BCL2, SCUBE2, CPEB2, IL6ST, DNALI1, PGR, SLC7A8, C6orf97, RSPH1, EVL, BCL2, NXNL2, GATA3, GFRA1, GFRA1, ZNF740, MKL2, AFF3, ERBB4, RABEP1, KDM4B, ESR1, C4orf32, and CPLX1 as shown in Table 7. The Chr9q22 network comprises ASPN, CENPP, ECM2, OGN, and OMD as shown in Table 8. The Chr17q23-24 network comprises CCDC45, POLG2, SMURF2, CCDC47, CLTC, DCAF7, DDX42, FTSJ3, PSMC5, RPS6KB1, SMARCD2, and TEX2 as shown in Table 9. The Chr8q21-24 network comprises CYC1, DGAT1, GPAA1, GRINA, PUF60, PYCRL, RPL8, SQLE, TSTA3, ESRP1, GRHL2, INTS8, MTDH, and UQCRB as shown in Table 10. The olfactory receptor network comprises 134 genes listed in Table 11. OR10H3, OR14J1, OR2J2, OR2W5, OR5T2, OR7E24, OR7G3, OR8S1, and OR9K2 code for olfactory receptors, and MIR1208, MIR1266, MIR1297, MIR133A1, MIR195, MIR196A1, MIR3170, MIR3183, MIR4267, MIR4275, MIR4318, MIR501, MIR501, MIR539, and MIR542 are microRNA precursors. The metabolic-like network comprises a five gene set of ENO1, IDH2, TMSB10, PGK1, and G6PD, or a fourteen gene set of PGD, TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, ACO2, and FBP1. An RNA transcript, or an expression product thereof, is negatively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the RNA transcript is marked 1 in Tables 1-5 and 15, and is positively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the RNA transcript is marked -1 in Tables 1-5 and 15. Co-expressed RNA transcripts within a gene network may be substituted for other the RNA transcripts within the same gene network.
The present invention provides methods that utilize the RNA transcripts and associated information. For example, the present invention provides a method of predicting a likelihood that a breast cancer patient will exhibit long-term survival without breast cancer recurrence. The methods of the invention comprise determining the level of at least one RNA transcript, or an expression product thereof, in a tumor sample, and determining the likelihood of long-term survival without breast cancer recurrence based on the correlation between the level of the RNA transcript, or its expression product, and long-term survival without breast cancer recurrence.
For all aspects of the present invention, the methods may further include determining the level of at least two RNA transcripts, or their expression products. It is further contemplated that the methods of the present invention may further include determining the level of at least three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, or at least fifteen of the RNA transcripts, or their expression products. For example, the levels of at least three RNA transcripts, or their expression products, selected from ENO1, IDH2, TMSB10, PGK1, and G6PD may be determined. In another aspect, the levels of all five of ENO1, IDH2, TMSB10, PGK1, and G6PD RNA transcripts, or their expression products, may be determined. In another example, at least five RNA transcripts, or expression products thereof, selected from PGD, TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, ACO2, and FBP1 may be determined. In yet another example, the levels of all fourteen of PGD, TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, ACO2, and FBP1 may be determined. Coding and non-coding RNA transcripts may be combined in any of the methods described herein.
The RNA transcripts and associated information provided by the present invention also have utility in the development of therapies to treat cancers and screening patients for inclusion in clinical trials. The RNA transcripts and associated information may further be used to design or produce a reagent that modulates the level or activity of the RNA transcript or its expression product. Such reagents may include, but are not limited to, a drug, an antisense RNA, a small inhibitory RNA (siRNA), a ribozyme, a small molecule, a monoclonal antibody, and a polyclonal antibody.
In various embodiments of the methods of the present invention, various technological approaches are available for determining the levels of the RNA transcripts, including, without limitation, whole transcriptome sequencing, RT-PCR, microarrays, and serial analysis of gene expression (SAGE), which are described in more detail below.
CORRELATING LEVEL OF AN RNA TRANSCRIPT OR AN EXPRESSION PRODUCT TO A CLINICAL OUTCOME
One skilled in the art will recognize that there are many statistical methods that may be used to determine whether there is a correlation between an outcome of interest (e.g., likelihood of survival) and levels of RNA transcripts or their expression products as described here. This relationship can be presented as a continuous recurrence score (RS), or patients may be stratified into risk groups (e.g., low, intermediate, high). For example, a Cox proportional hazards regression model may fit to a particular clinical endpoint (e.g., RFI, DFS, OS). One assumption of the Cox proportional hazards regression model is the proportional hazards assumption, i.e. the assumption that effect parameters multiply the underlying hazard. Assessments of model adequacy may be performed including, but not limited to, examination of the cumulative sum of martingale residuals. One skilled in the art would recognize that there are numerous statistical methods that may be used (e.g., Royston and Parmer (2002), smoothing spline, etc.) to fit a flexible parametric model using the hazard scale and the Weibull distribution with natural spline smoothing of the log cumulative hazards function, with effects for treatment (chemotherapy or observation) and RS allowed to be time-dependent. (See, e.g., P. Royston, M. Parmer, Statistics in Medicine 21(15:2175-2197 (2002).)
In an exemplary embodiment, power calculations are carried out for the Cox proportional hazards model with a single non-binary covariate using the method proposed by F. Hsieh and P. Lavori, Control Clin Trials 21:552-560 (2000) as implemented in PASS 2008.
Any of the methods described may group the levels of RNA transcripts or their expression products. The grouping of the RNA transcripts or expression products may be performed at least in part based on knowledge of the contribution of the RNA transcripts or their expression products according to physiologic functions or component cellular characteristics, such as in the gene networks described herein. The formation of groups, in addition, can facilitate the mathematical weighting of the contribution of various expression levels to the recurrence/likelihood score. The weighting of a gene network representing a physiological process or component cellular characteristic can reflect the contribution of that process or characteristic to the pathology of the cancer and clinical outcome. Accordingly, the present invention provides gene networks of the RNA transcripts, or their expression products, identified herein for use in the methods disclosed herein.
The coding and non-coding RNA transcripts, and any expression products thereof, of the present invention are listed in Tables 1-5 and 15. In an embodiment of the invention, a level of one or more RNA transcripts, or an expression product thereof, listed in Tables 1 and 15, is negatively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the RNA transcript is marked 1 in Tables 1 and 15, and is positively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the RNA transcript is marked -1 in Tables 1 and 15.
In another embodiment of the invention, a level of one or more RNA transcript, or an expression product thereof, listed in Table 2, is negatively correlated with an increased likelihood of long-term survival without recurrence of breast cancer in an ER-positive breast cancer patient if the direction of association of the RNA transcript is marked 1 in Table 2, and is positively correlated with an increased likelihood of long-term survival without recurrence of breast cancer in an ER-positive breast cancer patient if the direction of association of the RNA transcript is marked -1 in Table 2.
In a further embodiment of the invention, a level of an intronic RNA selected from Table 3 is negatively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the intronic RNA is marked 1 in Table 3, and is positively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the intronic RNA is marked -1 in Table 3.
In a specific embodiment, a level of one or more long intergenic non-coding region (lincRNA) selected from Table 4 is negatively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the lincRNA is marked 1 in Table 4, and is positively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the lincRNA is marked -1 in Table 4.
In another embodiment, a level of one or more intergenic sequence or intergenic region selected from intergenic regions 1-69 listed in Table 5 is negatively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the intergenic sequence or intergenic region is marked 1 in Table 5, and is positively correlated with an increased likelihood of long-term survival without recurrence of breast cancer if the direction of association of the intergenic sequence or intergenic region is marked -1 in Table 5.
In yet another embodiment, a likelihood score is determined for assessing the likelihood of a certain clinical outcome in a breast cancer patient, such as likelihood of long-term survival without breast cancer recurrence. A likelihood score may be calculated by determining the level of one or more RNA transcripts, or its expression product, selected from Tables 1-5 and 15, and mathematically weighting its contribution to the clinical outcome. In a specific embodiment, a likelihood score is determined for a gene network selected from a cell cycle network, ESR1 network, Chr9q22 network, Chr17q23-24 network, Chr8q21-24 network, olfactory receptor network, and metabolic-like networks by determining the level of one or more RNA transcripts, or an expression product thereof, within a gene network. The level of the one or more RNA transcripts, or its expression product, may be weighted by its contribution to a certain clinical outcome, such as recurrence. A likelihood score may also be determined for a gene network based on the likelihood score of one or more RNA transcripts, or an expression product thereof, within the gene network. In another embodiment, a likelihood score may be determined for a patient, based on the likelihood score of one or more RNA transcripts, or an expression product thereof, and/or the likelihood score of one or more gene networks.
METHODS TO PREDICT LIKELIHOOD OF LONG-TERM SURVIVAL WITHOUT BREAST CANCER RECURRENCE
As described above, a number of coding and non-coding RNA transcripts that correlate with breast cancer prognosis were identified. The levels of these RNA transcripts, or their expression products, can be determined in a tumor sample obtained from an individual patient who has breast cancer and for whom treatment is being contemplated. Depending on the outcome of the assessment, treatment with chemotherapy may be indicated, or an alternative treatment regimen may be indicated.
In carrying out the method of the present invention, a tumor sample is assayed or measured for a level of an RNA transcript, or its expression product. The tumor sample can be obtained from a solid tumor, e.g., via biopsy, or from a surgical procedure carried out to remove a tumor; or from a tissue or bodily fluid that contains cancer cells. In an embodiment of the invention, the tumor sample is obtained from a patient with breast cancer, such as ER-positive breast cancer. In another embodiment, the level of an RNA transcript, or its expression product, is normalized relative to the level of one or more reference RNA transcripts, or its expression product.
In an embodiment of the invention, the likelihood of long-term survival without breast cancer recurrence in an individual patient is predicted by comparing, directly or indirectly, the level or normalized level of the RNA transcript, or its expression product, in the tumor sample from the individual patient to the level or normalized level of the RNA transcript, or its expression product, in a clinically relevant subpopulation of patients. Thus, as explained above, when the RNA transcript, or its expression product, analyzed is an RNA transcript, or an expression product, that shows increased level in subjects that experienced long-term survival without breast cancer recurrence as compared to subjects that experienced breast cancer recurrence, then if the level of the RNA transcript, or its expression product in an individual patient being assessed trends toward a level characteristic of a subject with long-term survival without breast cancer recurrence, then the RNA transcript or its expression product level supports a determination that the individual patient is more likely to experience long-term survival without breast cancer recurrence. Similarly, where the RNA transcript or its expression product analyzed is an RNA transcript or expression product that is increased in subjects who have experienced breast cancer recurrence as compared subjects who have experienced long-term survival without breast cancer recurrence, then if the level of the RNA transcript, or its expression product, in an individual patient being assessed trends toward a level characteristic of a subject with breast cancer recurrence, then RNA transcript or expression product level supports a determination that the individual patient will more likely experience breast cancer recurrence. Thus, the level of a given RNA transcript, or its expression product, can be described as being positively correlated with a likelihood of long-term survival without breast cancer recurrence, or as being negatively correlated with a likelihood of long-term survival without breast cancer recurrence.
It is understood that the level or normalized level of an RNA transcript, or its expression product, from an individual patient can be compared, directly or indirectly, to the level or normalized level of the RNA transcript, or its expression product, in a clinically relevant subpopulation of patients. For example, when compared indirectly, the level or normalized level of the RNA transcript, or its expression product, from the individual patient may be used to calculate a likelihood of long-term survival without breast cancer recurrence, such as a likelihood/recurrence score (RS) as described above, and compared to a calculated score in the clinically relevant subpopulation of patients.
METHODS OF ASSAYING LEVELS OF RNA TRANSCRIPTS OR THEIR EXPRESSION PRODUCTS
Methods of expression profiling include methods based on sequencing of polynucleotides, methods based on hybridization analysis of polynucleotides, and proteomics-based methods. Representative methods for sequencing-based analysis include Massively Parallel Sequencing (see e.g., Tucker et al., The American J. Human Genetics 85:142-154, 2009) and Serial Analysis of Gene Expression (SAGE). Exemplary methods known in the art for the quantification of mRNA expression in a sample include northern blotting and in situ hybridization (Parker & Barnes, Methods in Molecular Biology 106:247-283 (1999)); RNAse protection assays (Hod, Biotechniques 13:852-854 (1992)); and PCR-based methods, such as reverse transcription polymerase chain reaction (RT-PCR) (Weis et al., Trends in Genetics 8:263-264 (1992)). Antibodies may be employed that can recognize sequence-specific duplexes, including DNA duplexes, RNA duplexes, and DNA-RNA hybrid duplexes or DNA-protein duplexes.
Nucleic Acid Sequencing-Based Methods
Nucleic acid sequencing technologies are suitable methods for expression analysis. The principle underlying these methods is that the number of times a cDNA sequence is detected in a sample is directly related to the relative RNA levels corresponding to that sequence. These methods are sometimes referred to by the term Digital Gene Expression (DGE) to reflect the discrete numeric property of the resulting data. Early methods applying this principle were Serial Analysis of Gene Expression (SAGE) and Massively Parallel Signature Sequencing (MPSS). See, e.g., S. Brenner, et al., Nature Biotechnology 18(6):630-634 (2000).
More recently, the advent of "next-generation" sequencing technologies has made DGE simpler, higher throughput, and more affordable. As a result, more laboratories are able to utilize DGE to screen the expression of more nucleic acids in more individual patient samples than previously possible. See, e.g., J. Marioni, Genome Research 18(9):1509-1517 (2008); R. Morin, Genome Research 18(4):610-621 (2008); A. Mortazavi, Nature Methods 5(7):621-628 (2008); N. Cloonan, Nature Methods 5(7):613-619 (2008). Massively parallel sequencing methods have also enabled whole genome or transcriptome sequencing, allowing the analysis of not only coding but also non-coding sequencees. As reviewed in Tucker et al., The American J. Human Genetics 85:142-154 (2009), there are several commercially available massively parallel sequencing platforms, such as the Illumina Genome Analyzer (Illumina, Inc., San Diego, CA), Applied Biosystems SOLiD™ Sequencer (Life Technologies, Carlsbad, CA), Roche GS-FLX 454 Genome Sequencer (Roche Applied Science, Germany), and the Helicos® Genetic Analysis Platform (Helicos Biosciences Corp., Cambridge, MA). Other developing technologies may be used.
Reverse Transcription PCR (RT-PCR)
The starting material is typically total RNA isolated from a human tumor, usually from a primary tumor. Optionally, normal tissues from the same patient can be used as an internal control. RNA can be extracted from a tissue sample, e.g., from a sample that is fresh, frozen (e.g. fresh frozen), or paraffin-embedded and fixed (e.g. formalin-fixed).
General methods for RNA extraction are well known in the art and are disclosed in standard textbooks of molecular biology, including Ausubel et al., Current Protocols of Molecular Biology, John Wiley and Sons (1997). Methods for RNA extraction from paraffin embedded tissues are disclosed, for example, in Rupp and Locker, Lab Invest. 56:A67 (1987), and De Andrés et al., BioTechniques 18:42044 (1995). In particular, RNA isolation can be performed using a purification kit, buffer set and protease from commercial manufacturers, such as Qiagen, according to the manufacturer's instructions. For example, total RNA from cells in culture can be isolated using Qiagen RNeasy mini-columns. Other commercially available RNA isolation kits include MasterPure™ Complete DNA and RNA Purification Kit (EPICENTRE®, Madison, WI), and Paraffin Block RNA Isolation Kit (Ambion, Inc.). Total RNA from tissue samples can be isolated using RNA Stat-60 (Tel-Test). RNA prepared from a tumor sample can be isolated, for example, by cesium chloride density gradient centrifugation. The isolated RNA may then be depleted of ribosomal RNA as described in U.S. Pub. No. 2011/0111409 .
The sample containing the RNA is then subjected to reverse transcription to produce cDNA from the RNA template, followed by exponential amplification in a PCR reaction. The two most commonly used reverse transcriptases are avian myeloblastosis virus reverse transcriptase (AMV-RT) and Moloney murine leukemia virus reverse transcriptase (MMLV-RT). The reverse transcription step is typically primed using specific primers, random hexamers, or oligo-dT primers, depending on the circumstances and the goal of expression profiling. For example, extracted RNA can be reverse-transcribed using a GeneAmp RNA PCR kit (Perkin Elmer, CA, USA), following the manufacturer's instructions. The derived cDNA can then be used as a template in the subsequent PCR reaction.
PCR-based methods use a thermostable DNA-dependent DNA polymerase, such as a Taq DNA polymerase. For example, TaqMan® PCR typically utilizes the 5'-nuclease activity of Taq or Tth polymerase to hydrolyze a hybridization probe bound to its target amplicon, but any enzyme with equivalent 5' nuclease activity can be used. Two oligonucleotide primers are used to generate an amplicon typical of a PCR reaction product. A third oligonucleotide, or probe, can be designed to facilitate detection of a nucleotide sequence of the amplicon located between the hybridization sites of the two PCR primers. The probe can be detectably labeled, e.g., with a reporter dye, and can further be provided with both a fluorescent dye, and a quencher fluorescent dye, as in a Taqman® probe configuration. Where a Taqman® probe is used, during the amplification reaction, the Taq DNA polymerase enzyme cleaves the probe in a template-dependent manner. The resultant probe fragments disassociate in solution, and signal from the released reporter dye is free from the quenching effect of the second fluorophore. One molecule of reporter dye is liberated for each new molecule synthesized, and detection of the unquenched reporter dye provides the basis for quantitative interpretation of the data.
TaqMan® RT-PCR can be performed using commercially available equipment, such as, for example, ABI PRISM 7700™ Sequence Detection System™ (Perkin-Elmer-Applied Biosystems, Foster City, CA, USA), or Lightcycler (Roche Molecular Biochemicals, Mannheim, Germany). In a preferred embodiment, the 5' nuclease procedure is run on a real-time quantitative PCR device such as the ABI PRISM 7700™ Sequence Detection System™. The system consists of a thermocycler, laser, charge-coupled device (CCD), camera and computer. The system amplifies samples in a 384-well format on a thermocycler. The RT-PCR may be performed in triplicate wells with an equivalent of 2ng RNA input per 10 µL-reaction volume. During amplification, laser-induced fluorescent signal is collected in real-time through fiber optics cables for all wells, and detected at the CCD. The system includes software for running the instrument and for analyzing the data.
5'-Nuclease assay data are generally initially expressed as a threshold cycle ("Ct"). Fluorescence values are recorded during every cycle and represent the amount of product amplified to that point in the amplification reaction. The threshold cycle (Ct) is generally described as the point when the fluorescent signal is first recorded as statistically significant.
To minimize errors and the effect of sample-to-sample variation, RT-PCR is usually performed using an internal standard. The ideal internal standard gene (also referred to as a reference gene) is expressed at a constant level among cancerous and non-cancerous tissue of the same origin (i.e., a level that is not significantly different among normal and cancerous tissues), and is not significantly affected by the experimental treatment (i.e., does not exhibit a significant difference in expression level in the relevant tissue as a result of exposure to chemotherapy). RNAs most frequently used to normalize patterns of gene expression are mRNAs for the housekeeping genes glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) and β-actin. Gene expression measurements can be normalized relative to the mean of one or more (e.g., 2, 3, 4, 5, or more) reference genes. Reference-normalized expression measurements can range from 0 to 15, where a one unit increase generally reflects a 2-fold increase in RNA quantity.
Real time PCR is compatible both with quantitative competitive PCR, where an internal competitor for each target sequence is used for normalization, and with quantitative comparative PCR using a normalization gene contained within the sample, or a housekeeping gene for RT-PCR. For further details see, e.g. Held et al., Genome Research 6:986-994 (1996).
Design of PCR Primers and Probes
PCR primers and probes can be designed based upon exon, intron, or intergenic sequences present in the RNA transcript of interest. Primer/probe design can be performed using publicly available software, such as the DNA BLAT software developed by Kent, W.J., Genome Res. 12(4):656-64 (2002), or by the BLAST software including its variations.
Where necessary or desired, repetitive sequences of the target sequence can be masked to mitigate non-specific signals. Exemplary tools to accomplish this include the Repeat Masker program available on-line through the Baylor College of Medicine, which screens DNA sequences against a library of repetitive elements and returns a query sequence in which the repetitive elements are masked. The masked sequences can then be used to design primer and probe sequences using any commercially or otherwise publicly available primer/probe design packages, such as Primer Express (Applied Biosystems); MGB assay-by-design (Applied Biosystems); Primer3 (Steve Rozen and Helen J. Skaletsky (2000) Primer3 on the WWW for general users and for biologist programmers. In: Rrawetz S, Misener S (eds) Bioinformatics Methods and Protocols: Methods in Molecular Biology. Humana Press, Totowa, NJ, pp 365-386).
Other factors that can influence PCR primer design include primer length, melting temperature (Tm), and G/C content, specificity, complementary primer sequences, and 3 '-end sequence. In general, optimal PCR primers are generally 17-30 bases in length, and contain about 20-80%, such as, for example, about 50-60% G+C bases, and exhibit Tm's between 50 and 80 °C, e.g. about 50 to 70 °C.
For further guidelines for PCR primer and probe design see, e.g. Dieffenbach, CW. et al, "General Concepts for PCR Primer Design" in: PCR Primer, A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, 1995, pp. 133-155; Innis and Gelfand, "Optimization of PCRs" in: PCR Protocols, A Guide to Methods and Applications, CRC Press, London, 1994, pp. 5-11; and Plasterer, T.N. Primerselect: Primer and probe design. Methods Mol. Biol. 70:520-527 (1997).
MassARRAY® System
In MassARRAY-based methods, such as the exemplary method developed by Sequenom, Inc. (San Diego, CA) following the isolation of RNA and reverse transcription, the obtained cDNA is spiked with a synthetic DNA molecule (competitor), which matches the targeted cDNA region in all positions, except a single base, and serves as an internal standard. The cDNA/competitor mixture is PCR amplified and is subjected to a post-PCR shrimp alkaline phosphatase (SAP) enzyme treatment, which results in the dephosphorylation of the remaining nucleotides. After inactivation of the alkaline phosphatase, the PCR products from the competitor and cDNA are subjected to primer extension, which generates distinct mass signals for the competitor- and cDNA-derived PCR products. After purification, these products are dispensed on a chip array, which is pre-loaded with components needed for analysis with matrix- assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) analysis. The cDNA present in the reaction is then quantified by analyzing the ratios of the peak areas in the mass spectrum generated. For further details see, e.g. Ding and Cantor, Proc. Natl. Acad Sci. USA 100:3059-3064 (2003).
Other PCR-based Methods
Further PCR-based techniques that can find use in the methods disclosed herein include, for example, BeadArray® technology (Illumina, San Diego, CA; Oliphant et al., Discovery of Markers for Disease (Supplement to Biotechniques), June 2002; Ferguson et al., Analytical Chemistry 72:5618 (2000)); BeadsArray for Detection of Gene Expression® (BADGE), using the commercially available LuminexlOO LabMAP® system and multiple color-coded microspheres (Luminex Corp., Austin, TX) in a rapid assay for gene expression (Yang et al., Genome Res. 11:1888-1898 (2001)); and high coverage expression profiling (HiCEP) analysis (Fukumura et al., Nucl. Acids. Res. 31(16) e94 (2003).
Microarrays
In this method, polynucleotide sequences of interest (including cDNAs and oligonucleotides) are arrayed on a substrate. The arrayed sequences are then contacted under conditions suitable for specific hybridization with detectably labeled cDNA generated from RNA of a sample. The source of RNA typically is total RNA isolated from a tumor sample, and optionally from normal tissue of the same patient as an internal control or cell lines. RNA can be extracted, for example, from frozen or archived paraffin-embedded and fixed (e.g. formalin-fixed) tissue samples.
For example, PCR amplified inserts of cDNA clones of a gene to be assayed are applied to a substrate in a dense array. Usually at least 10,000 nucleotide sequences are applied to the substrate. For example, the microarrayed genes, immobilized on the microchip at 10,000 elements each, are suitable for hybridization under stringent conditions. Fluorescently labeled cDNA probes may be generated through incorporation of fluorescent nucleotides by reverse transcription of RNA extracted from tissues of interest. Labeled cDNA probes applied to the chip hybridize with specificity to each spot of DNA on the array. After washing under stringent conditions to remove non-specifically bound probes, the chip is scanned by confocal laser microscopy or by another detection method, such as a CCD camera. Quantitation of hybridization of each arrayed element allows for assessment of corresponding mRNA abundance.
With dual color fluorescence, separately labeled cDNA probes generated from two sources of RNA are hybridized pair wise to the array. The relative abundance of the transcripts from the two sources corresponding to each specified gene is thus determined simultaneously. The miniaturized scale of the hybridization affords a convenient and rapid evaluation of the expression pattern for large numbers of genes. Such methods have been shown to have the sensitivity required to detect rare transcripts, which are expressed at a few copies per cell, and to reproducibly detect at least approximately two-fold differences in the expression levels (Schena et at, Proc. Natl. Acad. Sci. USA 93(2): 106-149 (1996)). Microarray analysis can be performed on commercially available equipment, following the manufacturer's protocols, such as by using the Affymetrix GenChip® technology, or Incyte's microarray technology.
Isolating RNA from Body Fluids
Methods of isolating RNA for expression analysis from blood, plasma and serum (see for example, Tsui NB et al. (2002) Clin. Chem. 48,1647-53 and references cited therein) and from urine (see for example, Boom R et al. (1990) J Clin Microbiol. 28, 495-503 and reference cited therein) have been described.
Immunohistochemistry
Immunohistochemistry methods are also suitable for detecting the expression levels of genes and applied to the method disclosed herein. Antibodies (e.g., monoclonal antibodies) that specifically bind a gene product of a gene of interest can be used in such methods. The antibodies can be detected by direct labeling of the antibodies themselves, for example, with radioactive labels, fluorescent labels, hapten labels such as biotin, or an enzyme such as horse radish peroxidase or alkaline phosphatase. Alternatively, unlabeled primary antibody can be used in conjunction with a labeled secondary antibody specific for the primary antibody. Immunohistochemistry protocols and kits are well known in the art and are commercially available.
Proteomics
The term "proteome" is defined as the totality of the proteins present in a sample (e.g. tissue, organism, or cell culture) at a certain point of time. Proteomics includes, among other things, study of the global changes of protein expression in a sample (also referred to as "expression proteomics"). Proteomics typically includes the following steps: (1) separation of individual proteins in a sample by 2-D gel electrophoresis (2-D PAGE); (2) identification of the individual proteins recovered from the gel, e.g. my mass spectrometry or N- terminal sequencing, and (3) analysis of the data using bioinformatics.
GENERAL DESCRIPTION OF THE RNA ISOLATION AND PREPARATION FROM FIXED, PARAFFIN-EMBEDDED SAMPLES FOR WHOLE TRANSCRIPTOME SEQUENCING
The steps of a representative protocol for profiling gene expression levels using fixed, paraffin-embedded tissues as the RNA source are provided in various published journal articles. (See, e.g., T.E. Godfrey et al,. J. Molec. Diagnostics 2: 84-91 (2000); K. Specht et al., Am. J. Pathol. 158: 419-29 (2001), M. Cronin, et al., Am J Pathol 164:35-42 (2004)). Modified methods can used for whole transcriptome sequencing as described in the Examples section. Briefly, a representative process starts with cutting a tissue sample section (e.g. about 10 µm thick sections of a paraffin-embedded tumor tissue sample). The RNA is then extracted, and ribosomal RNA may be deleted as described in U.S. Pub. No. 2011/0111409 . cDNA sequencing libraries may be prepared that are directional and single or paired-end using commercially available kits such as the ScriptSeq™ mRNA-Seq Library Preparation Kit (Epicenter Biotechnologies, Madison, WI). The libraries may also be barcoded for multiplex sequencing using commercially available barcode primers such as the RNA-Seq Barcode Primers from Epicenter Biotechnologies (Madison, WI). PCR is then carried out to generate the second strand of cDNA to incorporate the barcodes and to amplify the libraries. After the libraries are quantified, the sequencing libraries may be sequenced as described herein.
COEXPRESSION ANALYSIS
To perform particular biological processes, genes often work together in a concerted way, i.e. they are co-expressed. Co-expressed gene networks identified for a disease process like cancer can also serve as prognostic biomarkers. Such co-expressed genes can be assayed in lieu of, or in addition to, assaying the biomarker with which they co-express.
One skilled in the art will recognize that many co-expression analysis methods now known or later developed will fall within the scope and spirit of the present invention. These methods may incorporate, for example, correlation coefficients, co-expression network analysis, clique analysis, etc., and may be based on expression data from RT-PCR, microarrays, sequencing, and other similar technologies. For example, gene expression clusters can be identified using pairwise analysis of correlation based on Pearson or Spearman correlation coefficients. (See e.g, Pearson K. and Lee A., Biometrika 2:357 (1902); C. Spearman, Amer. J. Psychol. 15:72-101 (1904); J. Myers, A. Well, Research Design and Statistical Analysis, p. 508 (2nd Ed., 2003).) In general, a correlation coefficient of equal to or greater than 0.3 is considered to be statistically significant in a sample size of at least 20. (See e.g., G. Norman, D. Streiner, Biostatistics: The Bare Essentials, 137-138 (3rd Ed. 2007).)
REFERENCE NORMALIZATION
In order to minimize expression measurement variations due to non-biological variations in samples, e.g., the amount and quality of product to be measured, the level of an RNA transcript or its expression product may be normalized relative to the mean levels obtained for one or more reference RNA transcripts or their expression products. Examples of reference RNA transcripts or expression products include housekeeping genes, such as GAPDH. Alternatively, all of the assayed RNA transcripts or expression products, or a subset thereof, may also serve as reference. On a transcript (or protein)-by-transcript (or protein) basis, measured normalized amount of a patient tumor RNA or protein may be compared to the amount found in a cancer tissue reference set. See e.g., Cronin, M. et al., Am. Soc. Investigative Pathology 164:35-42 (2004). The normalization may be carried out such that a one unit increase in normalized level of an RNA transcript or expression product generally reflects a 2-fold increase in quantity present in the sample.
KITS OF THE INVENTION
The materials for use in the methods of the present invention are suited for preparation of kits produced in accordance with well known procedures. The present invention thus provides kits comprising agents, which may include primers and/or probes, for quantitating the level of the disclosed RNA transcripts or their expression products via methods such as whole transcriptome sequencing or RT-PCR for predicting prognostic outcome. Such kits may optionally contain reagents for the extraction of RNA from tumor samples, in particular, fixed paraffin-embedded tissue samples and/or reagents for whole transcriptome sequencing. In addition, the kits may optionally comprise the reagent(s) with an identifying description or label or instructions relating to their use in the methods of the present invention. The kits may comprise containers (including microliter plates suitable for use in an automated implementation of the method), each with one or more of the various reagents (typically in concentrated form) utilized in the methods, including, for example, pre-fabricated microarrays, buffers, the appropriate nucleotide triphosphates (e.g., dATP, dCTP, dGTP and dTTP; or rATP, rCTP, rGTP and UTP), reverse transcriptase, DNA polymerase, RNA polymerase, and one or more probes and primers of the present invention (e.g., appropriate length poly(T) or random primers linked to a promoter reactive with the RNA polymerase). Mathematical algorithms used to estimate or quantify prognostic information are also potential components of kits.
REPORTS
The methods of this invention are suited for the preparation of reports summarizing the predictions resulting from the methods of the present invention. A "report" as described herein, is an electronic or tangible document that includes elements that provide information of interest relating to a likelihood assessment and its results. A subject report includes at least a likelihood assessment, e.g., an indication as to the likelihood that a cancer patient will exhibit long-term survival without breast cancer recurrence. A subject report can be completely or partially electronically generated, e.g., presented on an electronic display (e.g., computer monitor). A report can further include one or more of: 1) information regarding the testing facility; 2) service provider information; 3) patient data; 4) sample data; 5) an interpretive report, which can include various information including: a) indication; b) test data, where test data can include a normalized level of one or more RNA transcripts of interest, and 6) other features.
The present invention therefore provides methods of creating reports and the reports resulting therefrom. The report may include a summary of the levels of the RNA transcripts, or the expression products of such RNA transcripts, in the cells obtained from the patient's tumor sample. The report may include a prediction that the patient has an increased likelihood of long-term survival without breast cancer recurrence or the report may include a prediction that the subject has a decreased likelihood of long-term survival without breast cancer recurrence. The report may include a recommendation for a treatment modality such as surgery alone or surgery in combination with chemotherapy. The report may be presented in electronic format or on paper.
Thus, in some embodiments, the methods of the present invention further include generating a report that includes information regarding the patient's likelihood of long-term survival without breast cancer recurrence. For example, the methods of the present invention can further include a step of generating or outputting a report providing the results of a patient response likelihood assessment, which can be provided in the form of an electronic medium (e.g., an electronic display on a computer monitor), or in the form of a tangible medium (e.g., a report printed on paper or other tangible medium).
A report that includes information regarding the likelihood that a patient will exhibit long-term survival without breast cancer recurrence, is provided to a user. An assessment as to the likelihood that a cancer patient will exhibit long-term survival without breast cancer reucrrence, is referred to as a "likelihood assessment." A person or entity who prepares a report ("report generator") may also perform the likelihood assessment. The report generator may also perform one or more of sample gathering, sample processing, and data generation, e.g., the report generator may also perform one or more of: a) sample gathering; b) sample processing; c) measuring a level of an RNA transcript or its expression product; d) measuring a level of a reference RNA transcript or its expression product; and e) determining a normalized level of an RNA transcript or its expression product. Alternatively, an entity other than the report generator can perform one or more sample gathering, sample processing, and data generation.
The term "user" or "client" refers to a person or entity to whom a report is transmitted, and may be the same person or entity who does one or more of the following: a) collects a sample; b) processes a sample; c) provides a sample or a processed sample; and d) generates data for use in the likelihood assessment. In some cases, the person or entity who provides sample collection and/or sample processing and/or data generation, and the person who receives the results and/or report may be different persons, but are both referred to as "users" or "clients." In certain embodiments, e.g., where the methods are completely executed on a single computer, the user or client provides for data input and review of data output. A "user" can be a health professional (e.g., a clinician, a laboratory technician, a physician (e.g., an oncologist, surgeon, pathologist), etc.).
In embodiments where the user only executes a portion of the method, the individual who, after computerized data processing according to the methods of the invention, reviews data output (e.g., results prior to release to provide a complete report, a complete, or reviews an "incomplete" report and provides for manual intervention and completion of an interpretive report) is referred to herein as a "reviewer." The reviewer may be located at a location remote to the user (e.g., at a service provided separate from a healthcare facility where a user may be located).
Where government regulations or other restrictions apply (e.g., requirements by health, malpractice, or liability insurance), all results, whether generated wholly or partially electronically, are subjected to a quality control routine prior to release to the user.
COMPUTER -BASED SYSTEMS AND METHODS
The methods and systems described herein can be implemented in numerous ways. In one embodiment of the invention, the methods involve use of a communications infrastructure, for example, the internet. Several embodiments of the invention are discussed below. The present invention may also be implemented in various forms of hardware, software, firmware, processors, or a combination thereof. The methods and systems described herein can be implemented as a combination of hardware and software. The software can be implemented as an application program tangibly embodied on a program storage device, or different portions of the software implemented in the user's computing environment (e.g., as an applet) and on the reviewer's computing environment, where the reviewer may be located at a remote site (e.g., at a service provider's facility).
In an embodiment of the invention, during or after data input by the user, portions of the data processing can be performed in the user-side computing environment. For example, the user-side computing environment can be programmed to provide for defined test codes to denote a likelihood "score," where the score is transmitted as processed or partially processed responses to the reviewer's computing environment in the form of test code for subsequent execution of one or more algorithms to provide a result and/or generate a report in the reviewer's computing environment. The score can be a numerical score (representative of a numerical value) or a non-numerical score representative of a numerical value or range of numerical values (e.g., "A": representative of a 90-95% likelihood of a positive response; "High": representative of a greater than 50% chance of a positive response (or some other selected threshold of likelihood); "Low": representative of a less than 50% chance of a positive response (or some other selected threshold of likelihood), and the like.
As a computer system, the system generally includes a processor unit. The processor unit operates to receive information, which can include test data (e.g., level of an RNA transcript or its expression product; level of a reference RNA transcript or its expression product; normalized level of an RNA transcript or its expression product) and may also include other data such as patient data. This information received can be stored at least temporarily in a database, and data analyzed to generate a report as described above.
Part or all of the input and output data can also be sent electronically. Certain output data (e.g., reports) can be sent electronically or telephonically (e.g., by facsimile, using devices such as fax back). Exemplary output receiving devices can include a display element, a printer, a facsimile device and the like. Electronic forms of transmission and/or display can include email, interactive television, and the like. In an embodiment of the invention, all or a portion of the input data and/or output data (e.g., usually at least the final report) are maintained on a web server for access, preferably confidential access, with typical browsers. The data may be accessed or sent to health professionals as desired. The input and output data, including all or a portion of the final report, can be used to populate a patient's medical record that may exist in a confidential database as the healthcare facility.
The present invention also contemplates a computer-readable storage medium (e.g., CD-ROM, memory key, flash memory card, diskette, etc.) having stored thereon a program which, when executed in a computing environment, provides for implementation of algorithms to carry out all or a portion of the results of a likelihood assessment as described herein. Where the computer-readable medium contains a complete program for carrying out the methods described herein, the program includes program instructions for collecting, analyzing and generating output, and generally includes computer readable code devices for interacting with a user as described herein, processing that data in conjunction with analytical information, and generating unique printed or electronic media for that user.
Where the storage medium includes a program that provides for implementation of a portion of the methods described herein (e.g., the user-side aspect of the methods (e.g., data input, report receipt capabilities, etc.)), the program provides for transmission of data input by the user (e.g., via the internet, via an intranet, etc.) to a computing environment at a remote site. Processing or completion of processing of the data is carried out at the remote site to generate a report. After review of the report, and completion of any needed manual intervention, to provide a complete report, the complete report is then transmitted back to the user as an electronic document or printed document (e.g., fax or mailed paper report). The storage medium containing a program according to the invention can be packaged with instructions (e.g., for program installation, use, etc.) recorded on a suitable substrate or a web address where such instructions may be obtained. The computer-readable storage medium can also be provided in combination with one or more reagents for carrying out a likelihood assessment (e.g., primers, probes, arrays, or such other kit components).
EXAMPLE 1 Materials and Methods Patients
One hundred and thirty-six primary breast cancer FFPE tumor specimens with clinical outcomes were provided by Providence St. Joseph Medical Center (Burbank, CA), with institutional review board approval. The time to first recurrence of breast cancer or death due to breast cancer (including death due to unknown cause) was determined from these records. Patients who were still alive without breast cancer recurrence or who died due to known other causes were considered censored at the time of last follow-up or death. These tumor specimens were used for biomarker discovery in the development of the Oncotype DX® assay. See e.g., U.S. Patent No. 7,081,340 ; S. Paik et al., The New England Journal of Medicine 351, 2817 (2004). For the present study, 136 specimens had adequate RNA remaining. Among the 136 patients, 26 experienced breast cancer recurrence or death due to breast cancer.
RNA-Seq Sample Preparation and Sequencing
Total RNA was prepared from three 10-µm-thick sections of FFPE tumor tissue as previously described using the MasterPure™ Purification Kit (Epicentre® Biotechnologies, Madison, WI). M. Cronin et al., The American Journal of Pathology 164, 35 (Jan, 2004). One hundred nanograms of the isolated RNA were depleted of ribosomal RNA as described. See U.S. Pub. No. 2011/0111409 . Sequencing libraries for whole transcriptome analysis were prepared using ScriptSeq™ mRNA-Seq Library Preparation Kits (Epicentre® Biotechnologies, Madison, WI). During the cDNA synthesis step, additional incubation for 90 minutes at 37°C was implemented in the reverse transcription step to increase library yield. After 3'-terminal tagging, the di-tagged cDNA was purified using MinElute® PCR Purification Kits (Qiagen, Valencia, CA). Two 6 base index sequences were used to prepare barcoded libraries for duplex sequencing (RNA-Seq Barcode Primers; Epicentre® Biotechnologies, Madison, WI). PCR was carried out through 16 cycles to generate the second strand of cDNA, incorporate barcodes, and amplify libraries. The amplified libraries were size-selected by a solid phase reversible immobilization, paramagnetic bead-based process (Agencourt® AMPure® XP System; Beckman Coulter Genomics, Danvers, MA). Libraries were quantified by PicoGreen® assay (Life Technologies, Carlsbad, CA) and visualized with an Agilent Bioanalyzer using a DNA 1000 kit (Agilent Technologies, Waldbronn, Germany).
TruSeq™ SR Cluster Kits v2 (Illumina Inc.; San Diego, CA) were used for cluster generation in an Illumina cBOT™ instrument following the manufacturer's protocol. Two indexed libraries were loaded into each lane of flow cells. Sequencing was performed on an Illumina HiSeq®2000 instrument (Illumina, Inc.) by the manufacturer's protocol. Multiplexed single-read runs were carried out with a total of 57 cycles per run (including 7 cycles for the index sequences).
Data Quality Assessment
Each sequencing lane was duplexed with two patient sample libraries using a 6 base barcode to differentiate between them. The mean read ratio +/-SD between the two samples in each lane was 1.05±0.38 and the mean +/-SD percentage of un-discerned barcodes was 2.08%±1.63%. Using principal components analysis and other exploratory data analysis methods, no systematic differences were found among samples associated with flow cell or barcode.
In a run-in phase of the study, duplicate libraries were prepared for 8 samples selected at random from the study set of 136. RefSeq RNA coverage for these libraries ranged between 3.1M and 6.7M uniquely mapped reads. Log count Pearson correlations among duplicate libraries ranged between 0.947 and 0.985. Single libraries were prepared for the remaining 128 samples and distributed in duplex mode among the lanes of 8 flow-cells. Sequencing in 3 lanes failed. Two libraries had low yield, resulting in low coverage. Three lanes were flagged by various Illumina process monitoring indices: low Q30 (coverage = 2.8M and 4.2M), high cluster density (coverage = 1.6M and 1.8M), or inadequate imaging (coverage = 3.3M and 3.1M). For the remaining lanes, sample coverage ranged between 2.5M and 7.3M reads. New libraries for the samples that had low yield were prepared and sequenced. Libraries in the failed and flagged lanes, as well as some of the low coverage samples, were re-sequenced. Replicate correlations among all sequenced samples were very high, 0.985 for the samples with the high cluster density in the original run, and over 0.990 for all others. For the analysis data set, data for one of each of the duplicate libraries from the run-in experiment were kept. For the samples for which new libraries were prepared and for the samples in the failed and flagged lanes, the reads from the subsequent run were used. For the samples with low coverage for which the library was reprocessed, reads from the two runs were pooled. For the rest of the samples, the reads from the single lane were used. Results differed little when other data analysis procedures were used, for example, using only the second run when libraries were reprocessed.
Statistics and Bioinformatics
With the exception noted below, all primary analysis of sequence data was performed in CASAVA 1.7, the standard data processing package from Illumina. De-multiplexing of sample indices was set with 1 mismatch tolerance to separate the two samples within each lane. Raw FASTQ sequences were trimmed from both ends before mapping to the human genome (UCSC release, version 19), to address 3' end adapter contamination and random RT primer artifacts, and 5' end terminal-tagging oligonucleotide artifacts. The libraries as prepared contain strand-of-origin (directional) sequence information. Annotated RNA counts (defined by refFlat.txt from UCSC) were calculated by CASAVA 1.7 both with and without consideration of strand-of-origin information. Although retained in the mapping process, CASAVA does not provide directional counts by default. These counts were obtained by splitting the mapped (export.txt) file into two parts, one with sense strand counts, the other with antisense strand counts, and processing them independently. Raw FASTQ sequence was mapped with Bowtie (B. Langmead et al., Genome Biology 10, R25 (2009)) in parallel with CASAVA to count ribosomal RNA transcripts.
Data were analyzed in 3 categories: first, RefSeq RNAs, about 80% of which are exon sequences, consolidated for each gene; second, intronic RNA sequences, consolidated for each gene; third, intergenic sequences. RNAs with maximum counts less than 5 among the 136 patients were excluded from analysis. Of 21,283 total RefSeq transcripts counted by CASAVA, 821 had a maximum count less than 5, leaving 20,462 RefSeq transcripts for analysis. Similar to a recently published procedure described by Bullard et al. (BMC Bioinformatics 11, 94 (2010)), log2 raw RNA counts (setting the log2 for a 0 count to 0) were normalized by subtracting the 3rd quartile of the log2 RefSeq RNA counts and adding the cohort mean 3rd quartile ("Q3 normalization"). For analysis of RefSeq and intergenic RNAs normalization, RefSeq RNA data were used. For analysis of intronic RNAs normalization, intronic RNA data were used.
Standardized hazard ratios for breast cancer recurrence for each RNA, that is, the proportional change in the hazard with a 1-standard deviation increase in the normalized level of the RNA, were calculated using univariate Cox proportional hazard regression analyses (Cox, Journal of the Royal Statistical Society: Series B (Methodological) 34, 187 (1972)). The robust standard error estimate of Lin and Wei (Journal of the American Statistical Society, 84, 1074 (1989)) was used to accommodate possible departures from the assumptions of Cox regression, including nonlinearity of the relationship of gene expression with log hazard and nonproportional hazards. False discovery rates (FDR, q-values) were assessed using the method of Storey ( Journal of the Royal Statistical Society, Series B 64, 479 (2002)) with a "tuning parameter" of λ=0.5. Analyses were conducted to identify true discovery degree of association (TDRDA) sets of RNAs with absolute standardized hazard ratio greater than a specified lower bound while controlling the FDR at 10% (Crager, Statistics in Medicine 29, 33 (2010). Taking individual RNAs identified at this FDR, the analysis finds the maximum lower bound for which the RNA is included in a TDRDA set. Also computed was an estimate of each RNA's actual standardized hazard ratio corrected for regression to the mean. Id.
Expression of 192 transcripts in the same tumor RNAs was measured using previously described RT-PCR methods (Cronin et al., The American Journal of Pathology 164, 35 (Jan, 2004); Cronin et al., Clinical Chemistry 50, 1464 (Aug, 2004)). Standardized hazard ratios associating the expression of each gene (normalized by subtracting each gene's crossing threshold (CT) from the cohort median CT) with cancer recurrence were computed using the same methods used for evaluation of the RNA-Seq data.
Identifying Intergenic Sequences
Intergenic regions were identified by a novel program that evaluates genomic regions that vary widely in length and on a population basis. This program was developed to evaluate intergenic regions having wide variations in length, and to use data from a population of subjects rather than an individual subject. The uniquely mapped reads from all 136 patients were analyzed to identify clusters of reads that might arise from intergenic transcripts. Genomic regions containing less than 2 mapped reads of genomic sequence were not counted to eliminate potential noise from mis-mapping orgenomic DNA contamination. The remaining reads were clustered into individual read "islands" based on the overlap of their mapped coordinates to the hg 19 reference human genome, which resulted in 12,750,071 islands in all 136 patient samples. Any islands within 30 base pairs (bp) of each other were grouped together as regions of interest (ROI) producing a total of 6,633,258 ROIs. The number of ROIs were further reduced by the following criteria: 1) The average number of reads mapped to the ROI was ≥ 5 across all 136 patients, 2) the length of the ROI was at least 100 bp, and 3) the read depth (average read number divided by the length of the ROI) was ≥ 0.075. Applying these criteria reduced the number of ROIs to 23,024 . ROIs were classified as intergenic regions if they did not overlap with the transcripts (including non-coding ones) annotated in the refFlat.txt file obtained from UCSC, thereby eliminating overlap with known exons and introns of protein-coding genes and well annotated non-protein coding transcripts. A total of 2,101 intergenic regions were identified by this computational procedure.
EXAMPLE 2 Evaluation of whole transcriptome RNA-Seq as a platform for biomarker discovery
Patient clinical characteristics are shown in Table 12. One-hundred and ten patients (81 %) had no involved nodes. There was a mixture of chemotherapy and hormonal therapy usage. Estrogen receptor (ER) status was not included in patient records. Therefore, normalized ESR1 mRNA levels obtained in the present RNA-Seq study were used to identify 111 tumors as estrogen-receptor positive and 25 as estrogen-receptor negative. Use of RT-PCR rather than RNA-Seq for this purpose yielded similar but not identical results, identifying as ER+ two more patients, for a total of 113. Archive ages of FFPE tumor blocks ranged from 5 to 12.4 years (median 8.5 years).
RNA-Seq results were successfully generated for all 136 patients, with an average of 43 million median reads per patient (86 million median reads per Illumina Hiseq 2000 flow cell lane). Sixty-nine percent of these uniquely mapped to the human genome: 19.2% to exons, 64.9 % to introns, and 15.9% to intergenic regions. Ribosomal RNA accounted for less than 0.3% of the total reads. On average, 17,248 Refseq transcripts were detected per patient, 66% with greater than 10 counts, and 47% with greater than 100 counts.
Use of third quartile normalization effectively mitigated trends in overall coverage related to sample age and produced stable estimates of expression with relative log expression (RLE, individual gene log2 count minus within-patient median log2 count) values that were centered on zero and relatively tightly distributed around 0, an indicator of effective normalization.
Figure 1A displays results from the historical RT-PCR 192 candidate gene screen of the Providence 136 patient cohort, relating increasing mRNA expression to recurrence risk hazard ratios and statistical significance. As shown, fourteen of the sixteen cancer-related genes in the Oncotype DX® panel were assayed, and most were identified with Hazard Ratios greater than 1.2 or less than 0.8 and P values <0.05.
The effect sizes and statistical significance of Oncotype DX® genes were similar when screening was carried out by whole transcriptome RNA-Seq rather than RT-PCR (compare Figures 1A and 1B). This is shown in detail on a gene by gene basis in box plots (Figure 2). A scatter plot of log hazard ratios demonstrates overall concordance between the 192 gene RT-PCR results with the RNA-Seq analyses (Lin et al., Journal of the Royal Statistical Society, Series B 84, 1074 (1989)) (Lin concordance correlation: 0.810; Pearson correlation coefficient: 0.813; Figure 3). Significantly, RNA-Seq further associates many RefSeq RNAs with disease recurrence: a total of 1307 at FDR<10% (Table 1), hereafter referred to as "identified RefSeq RNAs." In contrast, the 192 gene RT-PCR study identified 32 RNAs at FDR<10%, and consumed five-fold more input RNA. Together, these results indicate that RNA-Seq can provide a practical, sensitive and precise platform for genome-wide biomarker discovery in FFPE tissue.
EXAMPLE 3 RefSeq Transcripts and Gene Networks that Associate with Risk of Breast Recurrence
There were 1307 RefSeqs associated with disease recurrence outcome at FDR <10% (Table 1). Because the reproducibility of within-sample transcript counts inevitably decreases as transcript abundance decreases, the impact of transcript abundance on initial biomarker discovery was evaluated. These 1307 RNAs were binned with respect to count abundance. Accounting for the 821 transcripts with maximum counts less than 5, which were deliberately excluded from analysis, rare transcripts (with less than 10 median counts) represent 28% of all RefSeq transcripts. The percent of RNAs identified decreases but is not dramatically different as median counts decrease from greater than 1,000 to 10-99. Even at median counts less than 10, the percent of RNAs identified fell by less than half compared to sequences present at higher abundance.
Among the 1307 identified RefSeq RNAs, many relate to recurrence with very high statistical significance (Table 1). TDRDA analysis identified 144 with standardized hazard ratio greater than 1.1, controlling FDR at 10%. Estimated standardized hazard ratios corrected for regression to the mean are as high as 1.66. Uncorrected hazard ratios range from approximately 0.4 to 2.5. The ratio of RNAs for which high expression associates with increased risk of cancer recurrence, versus decreased risk is approximately 1.
The library chemistry used in this study provides DNA strand-of-origin information for transcripts. The analysis that identifies 1307 prognostic RefSeq RNAs is not filtered for directionality. When this is done, 1023 of these RefSeq transcripts are still associated with disease recurrence at FDR<10% when only sense strand counts are analyzed. Less than 10% of the total RefSeq counts locate in the anti-sense direction. Nevertheless, 798 anti-sense transcripts associate with recurrence risk.
Validation of the Association of RefSeq transcripts with Breast Cancer Prognosis in an Independent Cohort
The performance of these identified RNAs was further evaluated using public gene expression data from an independent cohort of breast cancer patient tumors that had been assayed by DNA microarray technology. The microarray data set was assembled by merging patient sets published in two articles (M. J. van de Vijver et al., New England Journal of Medicine 347, 1999 (2002); L. J. Van't Veer et al., Nature 415, 530 (2002)), providing data on 337 patients ("NKI dataset"). Metastasis-free survival information was available for 319 patients. Standardized hazard ratios for cancer recurrence were estimated for each gene targeted by the microarray using univariate Cox proportional hazard regression analysis. Genes were identified as prognostic using a 10% FDR threshold as was done with the RNA-Seq data. Among the 11,659 genes common to both platforms, there is highly significant agreement in the classification of genes as prognostic (Figure 4) but concordance falls off as transcript abundance decreases. For RNA-Seq RNAs present at >100 counts, 44% were identified as prognostic in the NKI dataset.
Gene Networks
Hierarchical clustering (Eisen et al., Proceedings of the National Academy of Sciences 95, 14863 (1998)) of the 1307 identified RefSeq RNAs (Table 1) suggests the presence of co-expressed gene networks. Cytoscape (P. Shannon et al., Genome Research 13, 2498 (2003); M. E. Smoot et al., Bioinformatics 27, 431 (2011)) was used to evaluate the subset of these RNAs for which each member correlates in its expression with at least one other RNA at R ≥0.6. Figure 5 graphically represents the resulting correlation matrix of 597 genes and 4011 interactions. One prominent (51 member) RefSeq RNA network represented in Figure 5 is enriched in RNAs with Reactome database annotations (G. Joshi-Tope et al., Nucleic Acids Res 33, D428 (2005)) that are functionally related to regulation of the cell cycle and mitosis, and associates with poor prognosis ("cell cycle network") (Table 6). This network includes three of the five proliferation-associated Oncotype DX® genes (BIRC5, MYBL2, MKI67). A second network is enriched in RNAs that co-express with the estrogen receptor gene (ESR1) ("ESR1 network") and associate with reduced recurrence risk, including the Oncotype DX® genes, BCL2 and SCUBE2. The other ESR1 network genes include CPEB2, IL6ST, DNALI1, PGR, SLC7A8, C6orf97, RSPH1, EVL, BCL2, NXNL2, GATA3, GFRA1, GFRA1, ZNF740, MKL2, AFF3, ERBB4, RABEP1, KDM4B, ESR1, C4orf32, and CPLX1 (Table 7). ESR1 itself is not statistically associated with disease outcome in our RNA-Seq results, nor was it previously found to be significant in this cohort by RT-PCR analysis.
This analysis also reveals several novel RNA networks, three of which map to discrete cytogenetic bands (Figure 5): 1) a network of five poor prognosis RNAs mapping to a 289 kilobase region located at Chr9q22 ("Chr9q22 network"), which includes ASPN, CENPP, ECM2, OGN, and OMD (Table 8); 2) a network of twelve RNAs mapping to a 6.6 megabase region of Chr17q23-24 ("Chr17q23-24 network"), which includes CCDC45, POLG2, SMURF2, CCDC47, CLTC, DCAF7, DDX42, FTSJ3, PSMC5, RPS6KB1, SMARCD2, and TEX2 (Table 9); and 3) a fourteen RNA network mapping to a 47 megabase span on Chr8q21-24 ("Chr8q21-24 network"), which includes CYC1, DGAT1, GPAA1, GRINA, PUF60, PYCRL, RPL8, SQLE, TSTA3, ESRP1, GRHL2, INTS8, MTDH, and UQCRB (Table 10). Finally, Figure 5 represents a large (134 member) RNA network that has strong Gene Ontology and Biocarta annotations to olfactory signaling, glucose metabolism, and glucuronidation ("olfactory receptor network") (Table 11). Nine of the transcripts in this novel network encode olfactory receptors. (OR10H3, OR14J1, OR2J2, OR2W5, OR5T2, OR7E24, OR7G3, OR8S1, and OR9K2). Fifteen are microRNA precursors (MIR1208, MIR1266, MIR1297, MIR133A1, MIR195, MIR196A1, MIR3170, MIR3183, MIR4267, MIR4275, MIR4318, MIR501, MIR501, MIR539, and MIR542). Most of the RNAs in this network are rare (raw median counts less than 10). All but 2 of them associate with poor prognosis as shown in Table 1. TABLE 6: Cell cycle network
ANLN CDC25C EPR1 KIF18B NUSAP1
ASPM CDCA2 EXO1 KIF20A PGK1
BIRC5 CENPE FAM83D KIF23 PRC1
BLM CENPF GTSE1 KIF2C PRR11
BUB1 CENPN HIST1H2AH KPNA2 RRM2
BUB1B CENPO HJURP MELK SGOL1
C15orf23 CEP55 HMMR MKI67 TRIP13
CASC5 DLGAP5 INCENP MYBL2 TROAP
CCNA2 E2F1 KIF11 NEK2 TUBA1B
CCNB2 ECT2 KIF14 NUP93 UBE2C
ZNF695
TABLE 7: ESR1 network
BCL2 SCUBE2 CPEB2 IL6ST DNALI1 PGR
SLC7A8 C6orf97 RSPH1 EVL BCL2 NXNL2
GATA3 GFRA1 GFRA1 ZNF740 MKL2 AFF3
ERBB4 RABEP1 KDM4B ESR1 C4orf32 CPLX1
TABLE 8: Chr9q22 network
ASPN CENPP ECM2 OGN OMD
TABLE 9: Chr17q23-24 network
CCDC45 POLG2 SMURF2 CCDC47 CLTC DCAF7
DDX42 FTSJ3 PSMC5 RPS6KB1 SMARCD2 TEX2
TABLE 10: Chr8q21-24 network
CYC1 DGAT1 GPAA1 GRINA PUF60 PYCRL RPL8
SQLE TSTA3 ESRP1 GRHL2 INTS8 MTDH UQCRB
TABLE 11: Olfactory receptor network
AFM F11 LOC285577 NR1H4 SLC30A10
APCS F9 LOC401177 OCM SLC30A3
APQBEC1 FAM131C LOC401242 OPALIN SNAR-G1
ATOH7 FAM169B LOC642006 OR10H3 SNCB
ATXN3L FAM9C LOC646960 OR14J1 SNORD116
BARHL2 FEZF1 LOC729966 OR2J2 SNORD188
C17orf64 FOXD4L5 LRIT2 QR2W5 SP8
C18orf26 FTMT LYPD2 OR5T2 SPRR3
C19orf75 FZD9 MAGEB2 0R7E24 SPRYD5
C20orf185 GBX2 MIP1208 OR7G3 STATH
C7orf72 GPR33 MIR1266 OR8S1 TAAR6
C9orf27 GPX5 MIR1297 OR9K2 TFAP2D
CA5A GSTA2 MIR133A1 PABPC1L2B TRIM10
CAMKV GSTTP1 MIR195 PACRGL TRYX3
CHAT HBZ MIR196A1 PCDH11Y TSFAN19
CLCN1 HCRTR2 MIR3170 PGA3 TXNDC8
CLEC18B HMX1 MIR3183 PNLIP UGT2A1
COL20A1 HMX3 MIR4267 POM121L10 UGT2B10
COL9A1 KCNJ4 MIR4275 POTEG UGJ2B7
COX8C KCNV1 MIR4318 POU3F4 VWC2
CRYZ KRT20 MIR501 PRSS41 ZFP42
DEFB133 KRT72 MIRS39 RAB28 ZNF705D
DEFB135 KRT78 MIR542 RAB9BP1
DNAJC5G KRT83 MOXD2P RP1-177G6
DOC2GP LHX5 NCRNA0020 RXFP2
DSCR10 LOC100129 NCRNA0022 SCRT2
EVX1 LOC100133 NPFFR1 SERPINB10
EVX2 LOC144742 NPPB SI
Table 12. Case characteristics and outcomes
Tumor size (cm)
 0-2 81/136 (60%)
 2-5 49/136 (36%)
 >5 6/136 (4%)
No. lymph nodes at primary diagnosis
 0 110/136 (81%)
 1-9 11/136 (8%)
 10-15 9/136 (7%)
 16-20 6/136 (4%)
Adjuvant tamoxifen
 Yes 54/136 (40%)
 No 77/136 (57%)
 Unknown 5/136 (4%)
Adjuvant chemotherapy
 Yes 51/136 (38%)
 No 79/136 (58%)
 Unknown 6/136 (4%)
ER Status*
 ER positive 111/136 (82%)
 ER negative 25/136 (18%)
Vital Status
 Distant recurrence, death due to breast cancer, or death due to unknown cause
  Total 26/136 (19%)
  ER positive 16/136 (12%)
  ER negative 10/136 (7%)
 Alive without distant recurrence or death due to other cause
  Total 110/136 (81%)
  ER positive 95/136 (70%)
  ER negative 15/136 (11%)
Table 12. Case characteristics and outcomes
*ER status determined by RNA-Seq analysis as described
EXAMPLE 4 Risk of recurrence in ER+ patients
ER status, which is often described in clinical practice in binary terms as ER+ and ER- via immunohistochemistry evaluation of breast tumors, dichotomizes breast cancer with respect to clinical outcome and gene expression profiles. While ER status information was not part of patient records for this study cohort, RNA-Seq ESR1 counts were used to separate patients. This analysis is presented in Table 2. This is a novel method of defining ER status but note the small population size (10 recurrence events) and the absence of hormonal therapy in a significant fraction of those patients that were defined as ER+. Administration of hormonal therapy (e.g., tamoxifen or an aromatase inhibitor) is current standard clinical practice, and both significantly decreases recurrence risk and influences the nature of biomarkers that predict recurrence. Nevertheless, this analysis does identify the expected cell cycle gene signature as a marker of high recurrence risk (exemplified by the genes CCNA2; CENPN, KIF20, ARPP19 and BUB3). In all, expression of 363 RefSeq transcripts relate to recurrence risk at FDR<10% (Table 2). Within this set of transcripts, the most prominent RefSeq RNA network found using Cytoscape as described above is similar to the rare "olfactory receptor network" that was identified in the analysis of the entire 136 patient cohort. In the ESR1+ patients, this olfactory receptor network consists of 86 RefSeq RNAs (see Table 13), 6 of which are olfactory receptors (OR14J1, OR2B3, OR2J2, OR2W5, OR5T2, OR8S1) and 8 pre-microRNAs (MIR1208, MIR1251, MIR1266, MIR195, MIR4275, MIR4318, MIR542, MIR548I2). All RNAs in this network associate with increased risk of disease recurrence as shown in Table 2. TABLE 13: Olfactory receptor network in ER-positive patients
APCS APOBEC1 ATXN3L BAGE C17orf88
C18orf26 C19orf75 C9orf27 CA5A CCDC105
CHAT COL20A1 COX7B2 COX8C DEFB133
DKFZp779M DSCR10 DUSP13 EVX1 EVX2
FAM169B FEZF1 GAB4 GDF7 GPR50
GPX5 GSTA2 GUCY2F HCRTR2 HMX1
HMX3 KRT78 KRT83 LOC100129 LOC144742
LOC285577 LOC286186 LOC401177 LOC642345 LOC645971
LOC647107 LOC729966 LPO LRIT2 LYPD2
MAGEA10 MAGEB10 MIR1208 MIR1251 MIR1266
MIR195 MIR4275 MIR4318 MIR542 MIR548I2
NCRNA0020 NCRNA0022 NKX1-2 NPPB OR14J1
OR2B3 OR2J2 OR2W5 OR5T2 OR8S1
PCDH11Y PGA3 POTEG PRDM9 PRSS41
RAB9BP1 RAET1L RNASE9 RP1-177G6 SCRT2
SERPINB10 SLC17A6 SNAR-G1 SNCB SNORD115
SNORD116 SNORD18C SOST SPRR3 TPTE
WFDC9
EXAMPLE 5 Association of Intronic Sequences with Breast Cancer Prognosis
Reads mapping to intronic regions of the genome account for -65% of all of the sequence data. Introns tend to co-express with exons of the same genes (median R = 0.67), although these correlations vary over a wide range, from roughly zero to over 0.9. The percent of intronic RNAs that map in the antisense direction is slightly higher than in the case of RefSeq RNAs (median: ∼7.5% versus ∼5%, respectively). A large number (1698) of intronic RNAs associate with breast cancer recurrence (at FDR < 10%; non-directional analysis; Table 3), with ranges of hazard ratios and p-values are similar to those of the above-identified 1307 RefSeq RNAs.
Over two thirds (1154) of the identified intronic transcripts do not lie within the prognostic RefSeq RNAs listed in Table 1 above. That is, their cognate assembled exons are not also discovered. (Among the 100 most highly statistically significant intronic RNAs this fraction is 0.44.) This subset of the identified intronic RNAs is particularly likely to contain prognostic information that is not captured by the RefSeq RNAs. The basis for these might be statistical: average counts for all intronic RNAs are more than threefold higher than for all exons, so signal to noise ratio is more favorable for discovery of intronic RNAs. Nevertheless, in the population of exons that are not discovered along with discovered cognate introns, average exon abundance is just a little lower than in the entire population of discovered exons (mean counts (244, versus 312 average counts, respectively). This result is consistent with these intronic RNAs carrying prognostic information that is not carried in their corresponding exons.
EXAMPLE 6 Association of Intergenic Sequences with Breast Cancer Prognosis
Two approaches were used to search for biomarkers within the population of intergenic RNAs, first by interrogating reads that map to 2,500 well-documented long intergenic non-coding RNAs (lincRNAs) (A. M. Khalil et al., Proceedings of the National Academy of Sciences of the United States of America 106, 11667 (Jul 14, 2009)). Twenty-two of these (Table 4), associate with breast cancer recurrence risk at FDR<10%. Second, intergenic transcripts were screened more broadly by using a novel computational algorithm described in Example 1 to identify clusters of reads that map to intergenic regions of the genome in one or more of the tumor specimens. The number of reads mapped to these clusters was used as a measure of the relative expression of putative intergenic transcripts. Altogether, 2101 putative intergenic transcripts were identified, 775 of which are contained in or overlap with lincRNAs that have been identified previously in one or more previous studies of non-coding transcripts and their expression was tested for association with recurrence of breast cancer in the cohort of 136 patients. Expression of 194 (9%) of these transcripts correlates with breast cancer recurrence at FDR < 10%. This list of 194 transcripts was further condensed by merging clusters of reads separated by < 1000 bp to produce a set of 69 intergenic transcripts associated with recurrence of breast cancer (Table 5). Thirty-two of these 69 associate with decreased recurrence risk. The criterion for merging of clusters (< 1000 bp) is supported by the observation that the median correlation coefficient for co-expression of the merged clusters is extraordinarily high (median R = 0.94). Non-merged transcripts exhibited weak co-expression (median R = 0.27).
EXAMPLE 7
In a second study, 78 patient samples as described in Cobleigh et al., Clin. Cancer Res. 11:8623-8631 (2005) and in U.S. Patent No. 7,569,345 were obtained from women with invasive breast cancer and ≥ 10 positive nodes with no evidence of metastatic disease who had surgery at Rush University Medical Center from 1979 to 1999. Clinical outcome data were available for all patients. Patients who were still alive without breast cancer recurrence or who died due to known other causes were considered censored at the time of last follow-up or death. For the present study, 76 specimens had adequate RNA remaining for RNA-Seq.
Clinical characteristics of the 78 patients are shown in Table 14. RNA preparation, sequencing, and data analyses were performed as described in Example 1. Table 15 shows 125 RefSeq genes identified by RNA-Seq that were associated with breast cancer recurrence at FDR <10%. RefSeqs marked with "1" were associated with an increased likelihood of breast cancer recurrence and those marked with "-1" were associated with a decreased likelihood of breast cancer recurrence. Table 15 shows the maximum lower bound, greater or equal to 0 for identified genes at 10% FDR; StdHR, which is the estimated standardized Hazard Ratio from the proportional hazards model; StdHR.qvalue, which is the q-value computed from the set of StdHR p-values derived from the robust estimate of standard errors and using Storey's procedure as implemented in R qvalue package with lambda=0.5; and StdHR.pv, which is the p-value of the estimated standardized coefficient for null hypothesis coeff=0 or HR (hazard ratio)=1. The accession numbers of each of the 125 RefSeqs are shown in Table B. Twenty of these genes were also associated with recurrence in the first study described in Example 1. This overlap is unlikely to occur by chance (p<2.5 X 10-5). TABLE 14. Case characteristics and outcomes
Mean age ± SD (range), years 57±13 (33-86)
Tumor size (cm)
 0-2 26/78 (33%)
 2-5 28/78 (36%)
 >5 24/78 (31%)
No. lymph nodes at primary diagnosis
 0-9 0/78 (0%)
 10-15 40/78 (51%)
 15-20 18/78 (23%)
 20-30 12/78 (15%)
 >30 8/78 (10%)
Adjuvant tamoxifen
 Yes 42/78 (54%)
 No 36/78 (46%)
Adjuvant chemotherapy
 Yes 62/78 (80%)
 No 16/78 (20%)
Tumor grade
 1 11/78 (14%)
 2 37/78 (47%)
 3 30/78 (38%)
Vital Status
 Distant recurrence, death due to breast cancer, or death due to unknown cause 55/78 (71%)
 Alive without distant recurrence or death due to other cause 23/78(29%)
TRPS1 -1 0.05 0.600271454 0.013404626 3.19E-06
SHROOM3 -1 0.05 0.592316052 0.013404626 4.52E-06
GREB1L -1 0.05 0.589787342 0.013404626 4.78E-06
MICA -1 0.05 0.53495849 0.013404626 6.17E-06
PIP4K2B 1 0.05 1.766657976 0.013404626 1.26E-06
CWC25 0.05 1.710144609 0.013404626 3.99E-06
SLITRK2 1 0.05 1.742894004 0.013404626 4.77E-06
C3orf18 -1 0.049 0.603537151 0.013404626 6.91E-06
C3orf15 -1 0.049 0.56549207 0.014911144 8.54E-06
DIS3L -1 0.049 0.467081559 0.017557656 1.31E-05
PSMD8 0.048 1.584581143 0.013404626 6.47E-06
B4GALT5 1 0.047 1.722034237 0.015499558 1.07E-05
ARPC1B 1 0.046 1.621399637 0.015499558 9.90E-06
SLC26A5 -1 0.04 0.616339501 0.018957169 1.52E-05
ZNF837 -1 0.04 0.548382663 0.023868625 2.13E-05
BEND5 -1 0.038 0.589144544 0.023868625 2.38E-05
LOC100128675 -1 0.038 0.565506214 0.023868625 2.55E-05
GRTP1 -1 0.038 0.545883691 0.023868625 2.60E-05
AP1M1 1 0.035 1.600383771 0.023868625 2.43E-05
RTN4RL2 -1 0.03 0.610998068 0.029939316 3.43E-05
MAGI1 -1 0.03 0.616876931 0.030777252 3.93E-05
ENPP5 -1 0.03 0.595416002 0.031338122 4.31E-05
BZRAP1 -1 0.03 0.584798633 0.030777252 4.06E-05
DDB1 0.03 1.870965036 0.033898745 5.06E-05
NEDD4L -1 0.029 0.606690251 0.031907709 4.57E-05
TMEM56 -1 0.028 0.68559784 0.030777252 3.91E-05
LRRC49 -1 0.028 0.525377682 0.036410064 6.25E-05
CYBASC3 0.028 1.661030039 0.033898745 5.44E-05
CLINT1 0.028 1.671589497 0.033898745 5.38E-05
CLCA2 1 0.027 1.703214484 0.036410064 6.44E-05
RPRD1A -1 0.026 0.588692979 0.038013045 7.05E-05
TSPAN10 -1 0.026 0.571930206 0.038013045 7.19E-05
BCL2 0.023 0.607244603 0.038114312 7.57E-05
BBS5 -1 0.022 0.706595678 0.036410064 6.47E-05
LOC100128640 -1 0.022 0.611210083 0.039413064 8.14E-05
CAMK2G 1 0.022 1.577924166 0.039413064 8.36E-05
TSPAN14 1 0.022 1.677559326 0.042870801 9.33E-05
RWDD3 1 0.021 0.712509834 0.038114312 7.64E-05
TRAK1 -1 0.021 0.584711667 0.047369248 0.000117029
LOC730668 -1 0.021 0.545574613 0.047369248 0.000122501
ZNF621 -1 0.021 0.53393884 0.047369248 0.000120123
PELI3 -1 0.021 0.536673514 0.047369248 0.00012757
NCOA3 1 0.021 1.602212601 0.047369248 0.000107001
PSMB3 1 0.021 1.835670697 0.047369248 0.00012513
ZNF763 -1 0.018 0.646608385 0.047369248 0.000114793
CHDH -1 0.018 0.625931486 0.047369248 0.000123182
SUSD4 -1 0.017 0.681812692 0.047369248 0.000117816
DNAH14 -1 0.017 0.568526034 0.051201952 0.000149628
KRT4 1 0.016 1.544128591 0.048843319 0.000137137
STK3 1 0.015 1.577969259 0.051201952 0.000148028
CCDC24 -1 0.014 0.711374716 0.048843319 0.000135924
IQCH -1 0.013 0.690451374 0.05619298 0.000167433
NCRNA00173 -1 0.013 0.636905593 0.05928902 0.000183576
GTPBP10 -1 0.013 0.607771723 0.05928902 0.000200438
EML2 -1 0.013 0.594614968 0.05928902 0.000197289
LAPTM4B 1 0.013 1.559498582 0.057278344 0.000173949
SLC38A2 1 0.013 1.663522257 0.05928902 0.000197664
SCARNA15 1 0.013 1.873906539 0.05928902 0.000194249
MID2 -1 0.011 0.675617922 0.05928902 0.000196751
SLC26A8 -1 0.01 0.662530005 0.063180343 0.000220834
NKAPP1 -1 0.01 0.610606787 0.063891002 0.000226979
CLN5 -1 0.009 0.728165906 0.062238826 0.000213977
TLR5 -1 0.009 0.622951299 0.067031927 0.000241979
NPY5R -1 0.009 0.574139163 0.070777897 0.000259557
LOC402778 -1 0.008 0.678984812 0.070973513 0.000272475
RPL14 -1 0.008 0.656553359 0.070836186 0.00026788
C6orf155 -1 0.008 0.643543245 0.071686076 0.000283425
ABCA3 -1 0.008 0.635422012 0.070836186 0.000267888
LOC723809 1 0.008 1.659680175 0.071686076 0.000282431
EPB49 -1 0.006 0.682134101 0.076840825 0.000308209
PLEKHA7 -1 0.006 0.631608043 0.077339749 0.000314641
RNU6ATAC 1 0.006 1.879268984 0.081043767 0.000334354
LAMC2 -1 0.004 0.692500587 0.082276981 0.000357633
MST1 -1 0.004 0.680494962 0.082276981 0.000353331
GSTM2 -1 0.004 0.631940594 0.082276981 0.000348608
ZNF337 -1 0.004 0.605531534 0.082276981 0.0003583
MTR -1 0.004 0.601352242 0.083092569 0.000372137
WBSCR27 -1 0.004 0.574418341 0.083092569 0.000372492
LOC100130093 -1 0.003 0.727169905 0.083092569 0.000376135
FGFRL1 -1 0.003 0.684954343 0.086078557 0.000409381
TSNAXIP1 -1 0.003 0.667743065 0.086078557 0.000397407
BAIAP3 -1 0.003 0.657836003 0.086078557 0.000401136
TSC1 -1 0.003 0.635691021 0.086078557 0.000406333
LDLRAD3 -1 0.003 0.609908608 0.087926789 0.000430472
NPY1R -1 0.003 0.536099497 0.087926789 0.000433424
IKBIP 1 0.003 1.630733535 0.087926789 0.000438324
WDR67 1 0.003 1.660073877 0.087926789 0.000434133
HMGCR 1 0.003 1.692917307 0.089657364 0.000452088
ZNF415 -1 0.002 0.702493074 0.092515604 0.000493007
LMX1B -1 0.002 0.644058753 0.090095896 0.000459462
RBBP8 -1 0.002 0.611872583 0.093229516 0.000511211
SORBS2 -1 0.002 0.57041462 0.091505704 0.000474625
LASP1 1 0.002 1.577783177 0.092781758 0.000499741
PLCB3 1 0.002 1.591205516 0.092515604 0.000491513
CKAP4 1 0.002 1.608591213 0.093229516 0.000520375
RPPH1 1 0.002 1.722187729 0.093229516 0.000523521
SCARNA16 1 0.002 1.796667248 0.091505704 0.000477138
MFSD2A 1 0.002 1.81578939 0.093229516 0.000517013
ICA1 -1 0.001 0.713463664 0.095431649 0.000611726
OPLAH -1 0.001 0.689897885 0.095431649 0.000620497
C2orf55 -1 0.001 0.674335475 0.094641728 0.000573056
ZNF48 -1 0.001 0.669187687 0.095431649 0.000618057
APC2 -1 0.001 0.66649698 0.095431649 0.000633369
PSD -1 0.001 0.641610877 0.094641728 0.000555159
FAM201A -1 0.001 0.635911763 0.095431649 0.000634315
C9orf156 -1 0.001 0.607820806 0.094641728 0.000567374
LOC644759 -1 0.001 0.593692626 0.094641728 0.000578394
PPP1R9A -1 0.001 0.572844709 0.094641728 0.000585681
LRRN2 -1 0.001 0.569366964 0.094641728 0.000582567
OGFRL1 -1 0.001 0.542834434 0.095431649 0.000597706
OGDHL 1 0.001 1.506439856 0.094641728 0.000542532
G6PD 1 0.001 1.527692381 0.094641728 0.000539162
TMSB10 1 0.001 1.517112962 0.094641728 0.000579912
VASP 1 0.001 1.553404873 0.095431649 0.000632006
SEC23A 1 0.001 1.563911218 0.095431649 0.000608307
TMEM86A 1 0.001 1.655435111 0.094641728 0.000568909
ZNF774 -1 0 0.714351245 0.09802593 0.000674027
CLIC6 -1 0 0.691206304 0.098757456 0.000691447
ATL1 -1 0 0.686405034 0.098757456 0.000695989
C3orf23 -1 0 0.657672146 0.097719921 0.000663413
CHKB -1 0 0.627745021 0.097719921 0.000666323
ARMCX6 -1 0 0.614708597 0.097719921 0.000661617
PTPN18 -1 0 0.600263531 0.098757456 0.000701692
ENTPD8 -1 0 0.589002346 0.098757456 0.000696835
MTFR1 1 0 1.470708659 0.099147778 0.000710146
EXAMPLE 8 Identification of Metabolic-Like Gene Networks Associated with Breast Cancer Prognosis
IDH2 was identified as a gene that associated with recurrence risk in the "Providence" patient cohort described in Example 1 (see Table 1) but did not belong to either the proliferation or estrogen receptor gene groups of the Oncotype DX® Breast Cancer Assay. In fact, IDH2 encodes a key central metabolism gene, isocitrate dehydrogenase 2. It was discovered that IDH2 co-expresses with four other genes (ENO1, TMSB10, PGK1, and G6PD) that also co-express with each other, as show in Table 16. All but TMSB10 have known associations with metabolic pathways.
IDH2
IDH1 encodes isocitrate dehydrogenase 2, which is an NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. The protein may tightly associate or interact with the pyruvate dehydrogenase complex.
ENO1
ENO1 encodes alpha-enolase, one of three enolase isoenzymes found in mammals. Each isoenzyme is a homodimer composed of 2 alpha, 2 gamma, or 2 beta subunits, and functions as a glycolytic enzyme. Alternative splicing of this gene results in a shorter isoform that has been shown to bind to the c-myc promoter and function as a tumor suppressor. Several pseudogenes have been identified, including one on the long arm of chromosome 1. Alpha-enolase has also been identified as an autoantigen in Hashimoto encephalopathy.
PGK1
The PGK1 gene encodes phosphoglycerate kinase, another glycolytic enzyme, which converts 1,3-diphosphoglycerate to 3-phosphoglycerate. This reaction generates one molecule of adenosine triphosphate (ATP), which is the main energy source in cells.
G6PD
G6PD encodes glucose-6-phosphate dehydrogenase, a cytosolic enzyme whose main function is to produce NADPH in the pentose phosphate pathway. This pathway generates both energy and molecular building blocks for nucleic acids and aromatic amino acids.
TMSB10
TMSB10 encodes thymosin beta-10, which plays an important role in the organization of the cytoskeleton. It binds to and sequesters actin monomers (G actin) and therefore inhibits actin polymerization.
The association of these five genes with recurrence rate was explored in the Providence patient cohort (see Example 1), "Rush" patient cohort (see Example 7), and the Netherlands Cancer Institute ("NKI") patient cohort (van de Vijver et al., N. Engl. J. Med. 347:1999-2009, 2002). As shown in Table 17, all five genes independently significantly associated with increased risk of recurrence in all three patient cohorts.
The expression cohesion of the five genes was compared with the cohesion of expression of the proliferation gene group (comprising Ki-67, STK15, SURV, CCNB1, MYBL2) and estrogen receptor gene group (comprising ER, PR, BCL2, SCUBE2) of the Oncotype DX® Breast Cancer Assay. , The Pearson R value averages and ranges from the Providence cohort were as follows: five genes: R=0.56 (range 0.48-0.63); proliferation gene group: R=0.67 (range 0.62-0.70); estrogen receptor gene group: R=0.58 (range 0.55-0.62). Moreover, the five genes also co-expressed with the five proliferation genes with a Pearson correlation of R=0.44 (range 0.31-0.60). However, the cohesion of expression of each of the five genes with the five-gene cluster is higher than with the proliferation gene group. This analysis indicates that the five genes do belong to a co-expressed gene module that is approximately as cohesive as the previously defined proliferation and estrogen receptor co-expressed gene modules and that can justifiably be considered a distinct co-expressed gene module. This suggests that inclusion of one or more of the five genes (ENO1, G6PD, IDH2, PGK1, TMSB10) may provide additional prognostic information to the Oncotype DX® Recurrence Score® result.
Because the five gene set described above included at least three genes involved in central metabolism, the results of Table 1 were analyzed to identify additional genes that belong to the glycolysis, the citric acid (TCA) cycle, and the pentose phosphate pathways and that associate with risk of breast cancer recurrence. Fourteen (14) genes were found to have ap<0.005: PGD; TKT; TALD01; G6PD; GPI; SLC1A5; SLC7A5; OGDH; SUCLG1; ENO1; PGK1; IDH2; ACO2; and FBP1. As shown in Table 1, all of these genes except for FBP1, was associated with increased likelihood of cancer recurrence. This latter result is consistent with the fact that the FBP1gene product is anabolic (catalyzes gluconeogenesis), whereas the others are catabolic (generate energy).
The 14 gene set and 5 gene set were subjected to a gene set analysis ("GSA") by the method of Efron and Tibshirani (The Annals of Applied Statistics 1:107-129, 2007), which assesses the significance of pre-defined gene sets, rather than individual genes. The GSA scores for the 14 gene set and 5 gene set were evaluated in the Providence, Rush, and NKI cohorts, and compared to GSA scores of >800 canonical pathway ("CP") gene sets from the larger C2 ("curated gene sets") collection developed at the Broad Institute (see Molecular Signatures Database (MgSigDB) v3.0 on the Gene Set Enrichment Analysis website of the Broad (see also Subramanian et al. PNAS 102:15545-15550, 2005). The GSA scores, p values, and rank among all the gene sets are shown in Table 18.
As can be seen from Table 18, the 5 gene set and the 14 gene set both exhibited high GSA scores in all three patient cohorts, as indicated by their ranks among GSA scores for all >800 canonical gene sets. Also, the p values of the 5 gene and 14 gene metabolic gene modules were statistically significant across all three patient cohorts ((p<0.05).
While the present invention has been described with reference to what is considered to be specific embodiments, it is to be understood that the invention is not so limited. To the contrary, the invention is intended to cover various modifications and equivalents included within the spirit and scope of the appended claims.
Table 1. List of Assembled RefSeq RNAs Associated with Risk of Breast Cancer Recurrence in 136 Breast Cancer Patients
Gene Accession No. Direction of Association (1=Higher Expression Means Higher Risk) p-value Standardized Hazard Ratio Estimate (95% Confidence Interval) q-value (FDR) Maximum Lower Bound Std HR @ 10% FDR Regression-to-the-Mean-Corrected Std HR
KIF1B NM_183416 1 5.88E-10 2.43 (1.84, 3.23) <0.1% 1.29 1.66
KIF1B NM_015074 1 5.88E-10 2.43 (1.84, 3.23) <0.1% 1.29 1.66
ZFP3 NM_153018 -1 3.99E-09 0.36 (0.26, 0.51) <0.1% 1.29 1.62
FAM21C NM_015262 -1 1.20E-10 0.51 (0.41, 0.62) <0.1% 1.25 1.62
FAM21C NM_001169107 -1 1.20E-10 0.51 (0.41, 0.62) <0.1% 1.25 1.62
FAM21C NM_001169106 -1 1.20E-10 0.51 (0.41, 0.62) <0.1% 1.25 1.62
FU14186 NR_037596 -1 4.41E-09 0.44 (0.33, 0.58) <0.1% 1.25 1.61
DAP NM_004394 1 1.43E-08 2.27 (1.71, 3.02) <0.1% 1.24 1.59
P2RX4 NM_002560 -1 2.29E-09 0.49 (0.39, 0.62) <0.1% 1.24 1.6
GGCT NR_037669 1 7.24E-11 1.68 (1.43, 1.96) <0.1% 1.21 1.52
GGCT NM_001199815 1 7.24E-11 1.68 (1.43, 1.96) <0.1% 1.21 1.52
GGCT NM_001199817 1 7.24E-11 1.68 (1.43, 1.96) <0.1% 1.21 1.52
GGCT NM_001199816 1 7.24E-11 1.68 (1.43, 1.96) <0.1% 1.21 1.52
GGCT NM_024051 1 7.24E-11 1.68 (1.43, 1.96) <0.1% 1.21 1.52
TMEM91 NM_001098823 -1 2.68E-08 0.48 (0.37, 0.62) <0.1% 1.21 1.56
TMEM91 NM_001042595 -1 2.68E-08 0.48 (0.37, 0.62) <0.1% 1.21 1.56
TMEM91 NM_001098821 -1 2.68E-08 0.48 (0.37, 0.62) <0.1% 1.21 1.56
TMEM91 NM_001098822 -1 2.68E-08 0.48 (0.37, 0.62) <0.1% 1.21 1.56
TMEM91 NM_001098825 -1 2.68E-08 0.48 (0.37, 0.62) <0.1% 1.21 1.56
TMEM91 NM_001098824 -1 2.68E-08 0.48 (0.37, 0.62) <0.1% 1.21 1.56
ANKRD27 NM_032139 1 2.87E-10 1.69 (1.43, 1.99) <0.1% 1.2 1.52
CDK20 NM_001170639 -1 1.33E-09 0.60 (0.50, 0.70) <0.1% 1.19 1.5
CDK20 NM_178432 -1 1.33E-09 0.60 (0.50, 0.70) <0.1% 1.19 1.5
CDK20 NM_001170640 -1 1.33E-09 0.60 (0.50, 0.70) <0.1% 1.19 1.5
CDK20 NM_001039803 -1 1.33E-09 0.60 (0.50, 0.70) <0.1% 1.19 1.5
CDK20 NM_012119 -1 1.33E-09 0.60 (0.50, 0.70) <0.1% 1.19 1.5
GKAP1 NM_001135953 -1 2.68E-08 0.55 (0.45, 0.68) <0.1% 1.19 1.52
GKAP1 NM_025211 -1 2.68E-08 0.55 (0.45, 0.68) <0.1% 1.19 1.52
NAA35 NM_024635 -1 6.53E-07 0.43 (0.30, 0.60) <0.1% 1.19 1.5
OMD NM_005014 -1 4.64E-07 0.41 (0.29, 0.58) <0.1% 1.19 1.51
OR10H3 NM_013938 1 5.26E-09 1.78 (1.47, 2.16) <0.1% 1.19 1.53
TSPAN17 NM_012171 1 5.21E-08 1.88 (1.50, 2.37) <0.1% 1.19 1.53
TSPAN17 NM_130465 1 5.21E-08 1.88 (1.50, 2.37) <0.1% 1.19 1.53
TSPAN17 NM_001006616 1 5.21E-08 1.88 (1.50, 2.37) <0.1% 1.19 1.53
IDH2 NM_002168 1 1.34E-08 1.64 (1.38, 1.95) <0.1% 1.17 1.47
KCNV1 NM_014379 1 3.04E-08 1.74 (1.43, 2.12) <0.1% 1.17 1.5
SPTAN1 NM_003127 -1 6.87E-07 0.47 (0.34, 0.63) <0.1% 1.17 1.5
SPTAN1 NM_001130438 -1 6.87E-07 0.47 (0.34, 0.63) <0.1% 1.17 1.5
SPTAN1 NM_001195532 -1 6.87E-07 0.47 (0.34, 0.63) <0.1% 1.17 1.5
CANX NM_001746 1 1.14E-06 2.08 (1.55, 2.80) <0.1% 1.16 1.49
CANX NM_001024649 1 1.14E-06 2.08 (1.55, 2.80) <0.1% 1.16 1.49
CENPP NM_001012267 -1 1.82E-07 0.55 (0.44, 0.69) <0.1% 1.16 1.49
CYB5D2 NR_023346 -1 4.13E-07 0.55 (0.44, 0.69) <0.1% 1.16 1.48
CYB5D2 NR_023347 -1 4.13E-07 0.55 (0.44, 0.69) <0.1% 1.16 1.48
CYB5D2 NM_144611 -1 4.13E-07 0.55 (0.44, 0.69) <0.1% 1.16 1.48
MMP15 NM_002428 1 3.19E-06 2.46 (1.68, 3.59) 0.10% 1.16 1.46
RANBP10 NM_020850 1 1.79E-07 1.84 (1.46, 2.31) <0.1% 1.16 1.5
RTN1 NM_021136 1 1.15E-06 0.47 (0.35, 0.64) <0.1% 1.16 1.49
RTN1 NM_206852 1 1.15E-06 0.47 (0.35, 0.64) <0.1% 1.16 1.49
RTN1 NM_206857 -1 1.15E-06 0.47 (0.35, 0.64) <0.1% 1.16 1.49
STK32B NM_018401 -1 9.39E-07 0.49 (0.37, 0.65) <0.1% 1.16 1.49
TKT NM_01135055 1 7.52E-07 1.94 (1.49, 2.53) <0.1% 1.16 1.49
TKT NM_001064 1 7.52E-07 1.94 (1.49, 2.53) <0.1% 1.16 1.49
TRABD NM_025204 1 5.97E-09 1.53 (1.32, 1.76) <0.1% 1.16 1.43
UBXN11 NM_183008 4 9.88E-09 0.64 (0.55, 0.74) <0.1% 1.16 1.44
UBXN11 NM_145345 -1 9.88E-09 0.64 (0.55, 0.74) <0.1% 1.16 1.44
UBXN11 NM_01077262 -1 9.88E-09 0.64 (0.55, 0.74) <0.1% 1.16 1.44
ULBP3 NM_024518 1 1.34E-06 2.02 (1.52, 2.69) <0.1% 1.16 1.49
ADAMTS16 NM_139056 -1 2.10E-06 0.54 (0.42, 0.70) 0.10% 1.15 1.46
ARMCX1 NM_016608 -1 8.63E-09 0.67 (0.59, 0.77) <0.1% 1.15 1.4
CCDC68 NM_001143829 -1 4.63E-06 0.44 (0.31, 0.63) 0.10% 1.15 1.46
CCDC68 NM_025214 -1 4.63E-06 0.44 (0.31, 0.63) 0.10% 1.15 1.46
CDC25B NM_004358 1 6.27E-06 2.10 (1.52, 2.91) 0.10% 1.15 1.45
CDC25B NM_021873 1 6.27E-06 2.10 (1.52, 2.91) 0.10% 1.15 1.45
CDC25B NM_021872 1 6.27E-06 2.10 (1.52, 2.91) 0.10% 1.15 1.45
GAN NM_022041 1 4.35E-06 2.18 (1.56, 3.04) 0.10% 1.15 1.46
GLIS2 NM_032575 -1 3.86E-07 0.57 (0.46, 0.71) <0.1% 1.15 1.47
GPR126 NM_198569 1 5.93E-06 2.14 (1.54, 2.98) 0.10% 1.15 1.45
GPR126 NM_020455 1 5.93E-06 2.14 (1.54, 2.98) 0.10% 1.15 1.45
GPR126 NM_01032395 1 5.93E-06 2.14 (1.54, 2.98) 0.10% 1.15 1.45
GPR126 NM_001032394 1 5.93E-06 2.14 (1.54, 2.98) 0.10% 1.15 1.45
INTU NM_015693 -1 4.31E-07 0.57 (0.46, 0.71) <0.1% 1.15 1.47
LIPT1 NM_145197 -1 1.50E-08 0.66 (0.57, 0.76) <0.1% 1.15 1.42
LIPT1 NM_145196 -1 1.50E-08 0.66 (0.57, 0.76) <0.1% 1.15 1.42
LIPT1 NM_015929 -1 1.50E-08 0.66 (0.57, 0.76) <0.1% 1.15 1.42
LIPT1 NM_145198 -1 1.50E-08 0.66 (0.57, 0.76) <0.1% 1.15 1.42
LIPT1 NM_145199 -1 1.50E-08 0.66 (0.57, 0.76) <0.1% 1.15 1.42
MEGF9 NM_001080497 -1 5.50E-06 0.48 (0.35, 0.66) 0.10% 1.15 1.45
OR7E24 NM_001079935 1 1.56E-08 1.50 (1.30, 1.72) <0.1% 1.15 1.41
PHOSPHO2 NM_001008489 -1 1.27E-07 0.63 (0.54, 0.75) <0.1% 1.15 1.43
PHOSPHO2 NM_001199287 -1 1.27E-07 0.63 (0.54, 0.75) <0.1% 1.15 1.43
PHOSPHO2 NM_001199288 -1 1.27E-07 0.63 (0.54, 0.75) <0.1% 1.15 1.43
PHOSPHO2 NM_001199285 -1 1.27E-07 0.63 (0.54, 0.75) <0.1% 1.15 1.43
PHOSPHO2 NM_001199286 -1 1.27E-07 0.63 (0.54, 0.75) <0.1% 1.15 1.43
TEX2 NM_018469 1 1.34E-07 1.68 (1.38, 2.03) <0.1% 1.15 1.47
TXNDC16 NM_020784 -1 2.75E-08 0.66 (0.57, 0.77) <0.1% 1.15 1.41
TXNDC16 NM_001160047 -1 2.75E-08 0.66 (0.57, 0.77) <0.1% 1.15 1.41
ZNF141 NM_003441 -1 3.45E-08 0.63 (0.54, 0.74) <0.1% 1.15 1.44
ZNF239 NM_001099282 -1 9.30E-08 0.63 (0.53, 0.74) <0.1% 1.15 1.44
ZNF239 NM_005674 -1 9.30E-08 0.63 (0.53, 0.74) <0.1% 1.15 1.44
ZNF239 NM_001099284 -1 9.30E-08 0.63 (0.53, 0.74) <0.1% 1.15 1.44
ZNF239 NM_001099283 -1 9.30E-08 0.63 (0.53, 0.74) <0.1% 1.15 1.44
ZNF429 NM_001001415 -1 5.67E-09 0.67 (0.58, 0.77) <0.1% 1.15 1.41
ACP1 NM_004300 1 3.01E-06 1.80 (1.41, 2.31) 0.10% 1.14 1.45
ACP1 NM_007099 1 3.01E-06 1.80 (1.41, 2.31) 0.10% 1.14 1.45
ACP1 NR_024080 1 3.01E-06 1.80 (1.41, 2.31) 0.10% 1.14 1.45
ACP1 NM_00140649 1 3.01E-06 1.80 (1.41, 2.31) 0.10% 1.14 1.45
C17orf96 NM_001130677 1 1.84E-06 1.69 (1.36, 2.10) <0.1% 1.14 1.44
C7orf30 NM_138446 1 6.82E-06 2.08 (1.51, 2.86) 0.10% 1.14 1.45
CCDC40 NM_017950 -1 8.80E-06 0.50 (0.37, 0.68) 0.10% 1.14 1.44
CENPN NM_00110625 1 1.37E-05 2.27 (1.57, 3.29) 0.20% 1.14 1.43
CENPN NM_018455 1 1.37E-05 2.27 (1.57, 3.29) 0.20% 1.14 1.43
CENPN NM_001100624 1 1.37E-05 2.27 (1.57, 3.29) 0.20% 1.14 1.43
CLINT1 NM_014666 1 6.00E-06 1.98 (1.47, 2.66) 0.10% 1.14 1.45
CLINT1 NM_001195556 1 6.00E-06 1.98 (1.47, 2.66) 0.10% 1.14 1.45
CLINT1 NM_001195555 1 6.00E-06 1.98 (1.47, 2.66) 0.10% 1.14 1.45
FAM131C NM_182623 1 3.59E-06 1.87 (1.43, 2.43) 0.10% 1.14 1.46
FZD9 NM_00303508 1 4.24E-07 1.60 (1.33, 1.92) <0.1% 1.14 1.43
GPRIN1 NM_052899 1 1.21E-05 2.27 (1.57, 3.27) 0.20% 1.14 1.43
HMGCS1 NM_002130 1 2.74E-07 1.59 (1.33, 1.89) <0.1% 1.14 1.43
HMGCS1 NM_001098272 1 2.74E-07 1.59 (1.33, 1.89) <0.1% 1.14 1.43
KIF20A NM_005733 1 3.69E-05 2.62 (1.66, 4.14) 0.40% 1.14 1.38
KRT83 NM_002282 1 6.89E-07 1.66 (1.36, 2.04) <0.1% 1.14 1.45
MEX3B NM_032246 1 1.37E-05 2.25 (1.56, 3.25) 0.20% 1.14 1.43
NUDT19 NM_001105570 1 7.72E-06 2.03 (1.49, 2.77) 0.10% 1.14 1.45
RNF145 NM_001199383 1 6.56E-06 1.96 (1.46, 2.62) 0.10% 1.14 1.45
RNF145 NM_001199382 1 6.56E-06 1.96 (1.46, 2.62) 0.10% 1.14 1.45
RNF145 NM_144726 1 6.56E-06 1.96 (1.46, 2.62) 0.10% 1.14 1.45
RNF145 NM_001199381 1 6.56E-06 1.96 (146, 2.62) 0.10% 1.14 1.45
RNF145 NM_001199380 1 6.56E-06 1.96 (1.46, 2.62) 0.10% 1.14 1.45
RPS23 NM_001025 -1 2.24E-06 0.56 (0.44, 0.71) 0.10% 1.14 1.45
SDAD1 NM_018115 1 2.98E-07 1.54 (1.31, 1.82) <0.1% 1.14 1.41
SNAR-G1 NR_004383 1 8.18E-07 1.59 (1.32, 1.92) <0.1% 1.14 1.42
TBX4 NM_018488 1 1.12E-06 1.68 (1.36, 2.06) <0.1% 1.14 1.44
ULK4 NM_017886 -1 1.18E-05 0.48 (0.34, 0.66) 0.20% 1.14 1.43
USO1 NM_003715 1 1.01E-07 1.51 (1.30, 1.76) <0.1% 1.14 1.4
ZNF214 NM_013249 -1 9.49E-06 0.51 (0.38, 0.68) 0.10% 1.14 1.44
ZNF540 NM_152606 -1 4.66E-07 0.64 (0.54, 0.76) <0.1% 1.14 1.41
ZNF540 NM_001172225 -1 4.66E-07 0.64 (0.54, 0.76) <0.1% 1.14 1.41
ZNF540 NM_001172226 -1 4.66E-07 0.64 (0.54, 0.76) <0.1% 1.14 1.41
ZNF823 NM_001080493 -1 1.72E-08 0.70 (0.62, 0.79) <0.1% 1.14 1.37
ADC NM_052998 -1 4.67E-07 0.67 (0.57, 0.78) <0.1% 1.13 1.38
ADHFE1 NM_144650 -1 1.40E-05 0.53 (0.40, 0.71) 0.20% 1.13 1.42
C3orf15 NM_033364 -1 1.71E-05 0.47 (0.34, 0.67) 0.20% 1.13 1.42
CYB5B NM_030579 1 4.23E-05 2.44 (1.59, 3.73) 0.40% 1.13 1.39
DCDC5 NM_020869 -1 3.07E-05 0.45 (0.31, 0.65) 0.30% 1.13 1.4
DNAH6 NM_001370 -1 6.69E-06 0.58 (0.46, 0.73) 0.10% 1.13 1.42
ECM2 NM 001393 -1 2.26E-05 0.45 (0.31, 0.65) 0.30% 1.13 1.41
ECM2 NM_001197295 -1 2.26E-05 0.45 (0.31, 0.65) 0.30% 1.13 1.41
ECM2 NM_01197296 -1 2.26E-05 0.45 (0.31, 0.65) 0.30% 1.13 1.41
G6PD NM_000402 1 1.18E-06 1.54 (1.30, 1.84) <0.1% 1.13 1.4
G6PD NM_001042351 1 1.18E-06 1.54 (1.30, 1.84) <0.1% 1.13 1.4
GRHL2 NM_024915 1 2.62E-05 2.07 (1.47, 2.91) 0.30% 1.13 1.42
GTSE1 NM_016426 1 3.48E-05 2.45 (1.60, 3.75) 0.40% 1.13 1.39
HTR7P1 NR_002774 -1 1.10E-05 0.52 (0.39, 0.69) 0.20% 1.13 1.43
LOC100133308 NR_024472 1 1.27E-06 1.54 (1.30, 1.84) <0.1% 1.13 1.4
LOC400657 NR_024484 -1 1.20E-08 0.72 (0.64, 0.80) <0.1% 1.13 1.34
MAGEA10 NM_021048 1 1.09E-06 1.54 (1.30, 1.83) <0.1% 1.13 1.4
MAGEA10 NM_001011543 1 1.09E-06 1.54 (1.30, 1.83) <0.1% 1.13 1.4
MPP6 NM_016447 1 1.45E-05 2.05 (1.48, 2.83) 0.20% 1.13 1.43
RAB28 NM_001017979 -1 4.43E-10 0.74 (0.68, 0.82) <0.1% 1.13 1.31
RAB28 NM_001159601 -1 4.43E-10 0.74 (0.68, 0.82) <0.1% 1.13 1.31
RAB28 NM_004249 -1 4.43E-10 0.74 (0.68, 0.82) <0.1% 1.13 1.31
SMURF2 NM_022739 1 3.92E-06 1.76 (1.38, 2.23) 0.10% 1.13 1.44
TXNRD1 NM_182742 1 2.99E-05 2.13 (1.49, 3.03) 0.30% 1.13 1.41
TXNRD1 NM_003330 1 2.99E-05 2.13 (1.49, 3.03) 0.30% 1.13 1.41
TXNRD1 NM_001093771 1 2.99E-05 2.13 (1.49, 3.03) 0.30% 1.13 1.41
TXNRD1 NM_182743 1 2.99E-05 2.13 (1.49, 3.03) 0.30% 1.13 1.41
TXNRD1 NM_182729 1 2.99E-05 2.13 (1.49, 3.03) 0.30% 1.13 1.41
ZNF44 NM_016264 -1 2.33E-05 0.48 (0.34, 0.67) 0.30% 1.13 1.41
ZNF44 NM_001164276 -1 2.33E-05 0.48 (0.34, 0.67) 0.30% 1.13 1.41
BBS5 NM_152384 -1 8.81E-06 0.60 (0.47, 0.75) 0.10% 1.12 1.41
C14orf45 NM_025057 -1 3.59E-05 0.49 (0.35, 0.69) 0.40% 1.12 1.4
CAMTA2 NM_001171166 -1 2.25E-05 0.53 (0.39, 0.71) 0.30% 1.12 1.41
CAMTA2 NM_001171168 -1 2.25E-05 0.53 (0.39, 0.71) 0.30% 1.12 1.41
CAMTA2 NM_01171167 -1 2.25E-05 0.53 (0.39, 0.71) 0.30% 1.12 1.41
CAMTA2 NM_015099 -1 2.25E-05 0.53 (0.39, 0.71) 0.30% 1.12 1.41
CRYZ NM_001130042 -1 3.86E-08 0.73 (0.65, 0.81) <0.1% 1.12 1.33
CRYZ NM_001130043 -1 3.86E-08 0.73 (0.65, 0.81) <0.1% 1.12 1.33
CRYZ NM_001889 -1 3.86E-08 0.73 (0.65, 0.81) <0.1% 1.12 1.33
CRYZ NM_001134759 -1 3.86E-08 0.73 (0.65, 0.81) <0.1% 1.12 1.33
FDX1 NM_004109 -1 3.82E-06 0.63 (0.52, 0.77) 0.10% 1.12 1.4
G3BP2 NM_203504 1 2.29E-06 1.54 (1.29, 1.83) 0.10% 1.12 1.39
G3BP2 NM_203505 1 2.29E-06 1.54 (1.29, 1.83) 0.10% 1.12 1.39
G3BP2 NM_012297 1 2.29E-06 1.54 (1.29, 1.83) 0.10% 1.12 1.39
GARS NM_002047 1 6.42E-06 1.67 (1.34, 2.09) 0.10% 1.12 1.42
HYDIN NM_032821 -1 1.37E-05 0.54 (0.41, 0.71) 0.20% 1.12 1.42
HYDIN NM_017558 -1 1.37E-05 0.54 (0.41, 0.71) 0.20% 1.12 1.42
HYDIN NM_001198542 -1 1.37E-05 0.54 (0.41, 0.71) 0.20% 1.12 1.42
HYDIN NM_001198543 -1 1.37E-05 0.54 (0.41, 0.71) 0.20% 1.12 1.42
IFT74 NM_001099222 -1 1.72E-05 0.55 (0.42, 0.72) 0.20% 1.12 1.42
IFT74 NM_025103 -1 1.72E-05 0.55 (0.42, 0.72) 0.20% 1.12 1.42
IFT74 NM_01099224 -1 1.72E-05 0.55 (0.42, 0.72) 0.20% 1.12 1.42
IFT74 NM_001099223 -1 1.72E-05 0.55 (0.42, 0.72) 0.20% 1.12 1.42
KCNJ4 NM_152868 1 3.50E-06 1.59 (1.31, 1.93) 0.10% 1.12 1.4
KCNJ4 NM_004981 1 3.50E-06 1.59 (1.31, 1.93) 0.10% 1.12 1.4
MAPK6 NM_002748 1 3.70E-08 1.37 (1.22, 1.53) <0.1% 1.12 1.32
MYOF NM_133337 -1 8.78E-06 0.60 (0.48, 0.75) 0.10% 1.12 1.41
MYOF NM_013451 -1 8.78E-06 0.60 (0.48, 0.75) 0.10% 1.12 1.41
SH3GLB2 NM_020145 -1 1.89E-05 0.52 (0.39, 0.70) 0.20% 1.12 1.42
TRIM45 NM_001145635 -1 2.13E-05 0.54 (0.40, 0.71) 0.30% 1.12 1.41
TRIM45 NM_025188 -1 2.13E-05 0.54 (0.40, 0.71) 0.30% 1.12 1.41
VDAC1 NM_003374 1 7.01E-05 2.45 (1.57, 3.80) 0.60% 1.12 1.37
VDAC1 NR_036625 1 7.01E-05 2.45 (1.57, 3.80) 0.60% 1.12 1.37
VDAC1 NR_036624 1 7.01E-05 2.45 (1.57, 3.80) 0.60% 1.12 1.37
BCL2 NM_000657 -1 3.28E-05 0.54 (0.40, 0.72) 0.30% 1.11 1.4
BCL2 NM_000633 -1 3.28E-05 0.54 (0.40, 0.72) 0.30% 1.11 1.4
C9orf3 NM_001193329 -1 1.59E-05 0.60 (0.48, 0.76) 0.20% 1.11 1.4
C9orf3 NM_001193331 -1 1.59E-05 0.60 (0.48, 0.76) 0.20% 1.11 1.4
C9orf3 NM_032823 -1 1.59E-05 0.60 (0.48, 0.76) 0.20% 1.11 1.4
CEP72 NM_018140 1 9.55E-05 2.27 (1.50, 3.43) 0.70% 1.11 1.37
DNALI1 NM_003462 -1 9.88E-06 0.63 (0.51, 0.77) 0.10% 1.11 1.39
ECEL1 NM_004826 1 7.48E-06 1.54 (1.28, 1.86) 0.10% 1.11 1.38
FAM179B NM_015091 -1 6.45E-05 0.45 (0.31, 0.67) 0.50% 1.11 1.38
HEATR2 NM_017802 1 2.70E-05 1.83 (1.38, 2.43) 0.30% 1.11 1.41
IRAK4 NM_001145256 -1 0.000036189 0.51 (0.37, 0.70) 0.40% 1.11 1.4
IRAK4 NM_001114182 -1 0.000036189 0.51 (0.37, 0.70) 0.40% 1.11 1.4
IRAK4 NM_001145258 -1 0.000036189 0.51 (0.37, 0.70) 0.40% 1.11 1.4
IRAK4 NM_ 001145257 -1 0.000036189 0.51 (0.37, 0.70) 0.40% 1.11 1.4
IRAK4 NM_016123 -1 0.000036189 0.51 (0.37, 0.70) 0.40% 1.11 1.4
LOC147804 NR_003148 -1 5.76E-05 0.51 (0.36, 0.71) 0.50% 1.11 1.39
LOC645323 NR_015436 1 0.000032725 1.83 (1.38, 2.43) 0.30% 1.11 1.41
LOC645323 NR_024384 1 0.000032725 1.83 (1.38, 2.43) 0.30% 1.11 1.41
LOC645323 NR_024383 1 0.000032725 1.83 (1.38, 2.43) 0.30% 1.11 1.41
LRGUK NM_144648 -1 5.37E-05 0.51 (0.37, 0.71) 0.50% 1.11 1.39
LRRC46 NM_0333413 -1 3.76E-05 0.51 (0.37, 0.70) 0.40% 1.11 1.4
NOL8 NM_ 017948 -1 4.65E-05 0.53 (0.39, 0.72) 0.40% 1.11 1.4
NOL8 NR_024020 -1 4.65E-05 0.53 (0.39, 0.72) 0.40% 1.11 1.4
OR2J2 NM_030905 1 4.20E-06 1.53 (1.28, 1.84) 0.10% 1.11 1.38
PERP NM_0222121 1 2.52E-05 1.73 (1.34, 2.23) 0.30% 1.11 1.4
PHB NM_002634 1 1.15E-05 1.63 (1.31, 2.03) 0.20% 1.11 1.4
SCRN3 NM_024583 -1 8.57E-06 0.62 (0.50, 0.76) 0.10% 1.11 1.4
SCRN3 NM_001193528 -1 8.57E-06 0.62 (0.50, 0.76) 0.10% 1.11 1.4
SLC35D2 NM_007001 -1 4.26E-05 0.53 (0.39, 0.72) 0.40% 1.11 1.4
SMARCD2 NM_001098426 1 6.36E-06 1.60 (1.30, 1.96) 0.10% 1.11 1.4
SPIN1 NM_006717 -1 0.000050879 0.47 (0.32, 0.67) 0.50% 1.11 1.39
STARD3NL NM_032016 1 3.16E-05 1.91 (1.41, 2.59) 0.30% 1.11 1.41
TUBB1 NM_030773 -1 1.63E-05 0.60 (0.48, 0.76) 0.20% 1.11 1.4
ZNF211 NM_198855 -1 2.09E-05 0.60 (0.47, 0.76) 0.20% 1.11 1.4
ZNF211 NM_006385 -1 2.09E-05 0.60 (0.47, 0.76) 0.20% 1.11 1.4
ZNF227 NM_182490 -1 0.000077689 0.47 (0.32, 0.68) 0.60% 1.11 1.38
ZNF626 NM_145297 -1 1.76E-05 0.58 (0.46, 0.75) 0.20% 1.11 1.41
ZNF626 NM_001076675 -1 1.76E-05 0.58 (0.46, 0.75) 0.20% 1.11 1.41
ACAP2 NM_012287 1 5.36E-05 1.81 (1.36, 2.41) 0.50% 1.1 1.39
COL9A1 NM_078485 1 2.06E-07 1.32 (1.19, 1.47) <0.1% 1.1 1.29
COL9A1 NM_001851 1 2.06E-07 1.32 (1.19, 1.47) <0.1% 1.1 1.29
IQCD NM_138451 -1 6.49E-05 0.51 (0.37, 0.71) 0.50% 1.1 1.39
LOC100131726 NR_024479 1 6.29E-05 1.98 (1.42, 2.76) 0.50% 1.1 1.39
LOC401242 NR_033379 1 5.07E-06 1.44 (1.23, 1.68) 0.10% 1.1 1.34
MTHFSD NR_027490 1 7.01E-05 1.87 (1.37, 2.54) 0.60% 1.1 1.39
MTHFSD NR_027489 1 7.01E-05 1.87 (1.37, 2.54) 0.60% 1.1 1.39
MTHFSD NM_022764 1 7.01E-05 1.87 (1.37, 2.54) 0.60% 1.1 1.39
MTHFSD NM_001159379 1 7.01E-05 1.87 (1.37, 2.54) 0.60% 1.1 1.39
MTHFSD NM_001159378 1 7.01E-05 1.87 (1.37, 2.54) 0.60% 1.1 1.39
MTHFSD NM_001159377 1 7.01E-05 1.87 (1.37, 2.54) 0.60% 1.1 1.39
MTHFSD NM_001159380 1 7.01E-05 1.87 (1.37, 2.54) 0.60% 1.1 1.39
NCRNA00200 NR_015376 1 1.02E-06 1.37 (1.21, 1.55) <0.1% 1.1 1.31
NMNAT3 NM_178177 -1 6.81E-05 0.52 (0.38, 0.72) 0.60% 1.1 1.39
RAI2 NM_021785 -1 6.18E-05 0.52 (0.37, 0.71) 0.50% 1.1 1.39
RAI2 NR_033348 -1 6.18E-05 0.52 (0.37, 0.71) 0.50% 1.1 1.39
RAI2 NR_033349 -1 6.18E-05 0.52 (0.37, 0.71) 0.50% 1.1 1.39
RAI2 NM_001172732 -1 6.18E-05 0.52 (0.37, 0.71) 0.50% 1.1 1.39
RAI2 NM_001172739 -1 6.18E-05 0.52 (0.37, 0.71) 0.50% 1.1 1.39
RAI2 NM_001172743 -1 6.18E-05 0.52 (0.37, 0.71) 0.50% 1.1 1.39
RCHY1 NM_001009922 1 5.97E-06 1.45 (1.23, 1.70) 0.10% 1.1 1.35
RCHY1 NM_015436 1 5.97E-06 1.45 (1.23, 1.70) 0.10% 1.1 1.35
RCHY1 NM_01008925 1 5.97E-06 1.45 (1.23, 1.70) 0.10% 1.1 1.35
SI NM_001041 1 1.46E-08 1.27 (1.17, 1.38) <0.1% 1.1 1.25
SNORD18B NR_002442 1 1.73E-05 1.55 (1.27, 1.90) 0.20% 1.1 1.38
TMOD3 NM_014547 1 3.74E-07 1.32 (1.19, 1.47) <0.1% 1.1 1.29
UGT2B7 NM_001074 1 8.45E-06 1.49 (1.25, 1.77) 0.10% 1.1 1.36
ZNF433 NM_001080411 -1 5.49E-05 0.53 (0.39, 0.72) 0.50% 1.1 1.39
AACSP1 NR_024035 1 1.38E-05 1.46 (1.23, 1.73) 0.20% 1.09 1.35
AKD1 NM_001145128 -1 1.23E-05 0.70 (0.60, 0.82) 0.20% 1.09 1.33
AKD1 NM_145025 -1 1.23E-05 0.70 (0.60, 0.82) 0.20% 1.09 1.33
ANKFN1 NM_153228 1 0.000106619 1.73 (1.31, 2.28) 0.80% 1.09 1.37
ANKRDS4 NR_036556 1 0.000155771 1.98 (1.39, 2.82) 1.00% 1.09 1.37
ANKRDS4 NM_138797 1 0.000155771 1.98 (1.39, 2.82) 1.00% 1.09 1.37
ASB13 NM_024701 -1 4.43E-06 0.72 (0.62, 0.83) 0.10% 1.09 1.32
ASB13 NR_037164 -1 4.43E-06 0.72 (0.62, 0.83) 0.10% 1.09 1.32
ASB13 NR_024581 -1 4.43E-06 0.72 (0.62, 0.83) 0.10% 1.09 1.32
C17orf64 NM_181707 1 4.20E-06 1.38 (1.20, 1.58) 0.10% 1.09 1.31
C17orf68 NM_025099 -1 0.000123317 0.52 (0.38, 0.73) 0.90% 1.09 1.37
C5 NM_001735 -1 0.00013293 0.55 (0.40, 0.75) 0.90% 1.09 1.37
C7orf72 NM_001161834 1 4.05E-07 1.30 (1.17, 1.43) <0.1% 1.09 1.27
CASC1 NM_018272 -1 8.53E-05 0.58 (0.44, 0.76) 0.70% 1.09 1.38
CASC1 NM_001082972 -1 8.53E-05 0.58 (0.44, 0.76) 0.70% 1.09 1.38
CASC1 NM_001082973 -1 8.53E-05 0.58 (0.44, 0.76) 0.70% 1.09 1.38
CCDC47 NM_020198 1 2.73E-05 1.57 (1.27, 1.94) 0.30% 1.09 1.37
CCDC66 NM_001141947 -1 9.67E-05 0.54 (0.40, 0.74) 0.70% 1.09 1.38
CCDC66 NR_024460 -1 9.67E-05 0.54 (0.40, 0.74) 0.70% 1.09 1.38
CCDC66 NM_001012506 -1 9.67E-05 0.54 (0.40, 0.74) 0.70% 1.09 1.38
CCNA2 NM_001237 1 0.000135444 2.06 (1.42, 3.00) 0.90% 1.09 1.37
COL20A1 NM_020882 1 1.40E-05 1.45 (1.23, 1.71) 0.20% 1.09 1.34
DDIT4 NM_019058 1 0.000150778 1.93 (1.37, 2.71) 1.00% 1.09 1.37
DSCR10 NR_027695 1 1.43E-05 1.44 (1.22, 1.70) 0.20% 1.09 1.34
EIF3B NM_003751 1 0.000111832 1.82 (1.34, 2.48) 0.80% 1.09 1.38
EIF3B NM_001037283 1 0.000111832 1.82 (1.34, 2.48) 0.80% 1.09 1.38
EIF4G2 NM_001418 1 5.03E-05 1.66 (1.30, 2.12) 0.50% 1.09 1.38
EIF4G2 NM_001172705 1 5.03E-05 1.66 (1.30, 2.12) 0.50% 1.09 1.38
EIF4G2 NM_001042559 1 5.03E-05 1.66 (1.30, 2.12) 0.50% 1.09 1.38
EPS15L1 NM_021235 -1 8.57E-05 0.53 (0.38, 0.72) 0.70% 1.09 1.38
FAM18A NM_001079512 -1 0.000040247 0.61 (0.48, 0.77) 0.40% 1.09 1.38
FAM9C NM_174901 1 1.14E-06 1.30 (1.17, 1.44) <0.1% 1.09 1.27
FU45244 NR_015415 -1 0.000114635 0.55 (0.41, 0.75) 0.80% 1.09 1.37
FTMT NM_177478 1 3.09E-05 1.50 (1.24, 1.81) 0.30% 1.09 1.35
GBX2 NM_01485 1 1.64E-05 1.44 (1.22, 1.70) 0.20% 1.09 1.33
GOLT1B NM_016072 1 3.70E-05 1.57 (1.27, 1.94) 0.40% 1.09 1.37
GPR56 NM_001145774 1 0.000188458 2.06 (1.41, 3.02) 1.20% 1.09 1.36
GPR56 NM_201524 1 0.000188458 2.06 (1.41, 3.02) 1.20% 1.09 1.36
GPR56 NM_005682 1 0.000188458 2.06 (1.41, 3.02) 1.20% 1.09 1.36
GPR56 NM_001145771 1 0.000188458 2.06 (1.41, 3.02) 1.20% 1.09 1.36
GPR56 NM_001145770 1 0.000188458 2.06 (1.41, 3.02) 1.20% 1.09 1.36
GPR56 NM_001145773 1 0.000188458 2.06 (1.41, 3.02) 1.20% 1.09 1.36
GPR56 NM_001145772 1 0.000188458 2.06 (1.41, 3.02) 1.20% 1.09 1.36
GPR56 NM_201525 1 0.000188458 2.06 (1.41, 3.02) 1.20% 1.09 1.36
HEBP1 NM_015987 -1 0.000177204 0.50 (0.35, 0.72) 1.10% 1.09 1.36
HLA-DOA NM_002119 -1 3.94E-05 0.60 (0.47, 0.77) 0.40% 1.09 1.38
HRASLS5 NM_054108 -1 0.000093912 0.54 (0.40, 0.74) 0.70% 1.09 1.38
HRASLS5 NM_001146728 -1 0.000093912 0.54 (0.40, 0.74) 0.70% 1.09 1.38
HRASLS5 NM_001146729 -1 0.000093912 0.54 (0.40, 0.74) 0.70% 1.09 1.38
JAK1 NM_002227 -1 0.000193139 0.46 (0.31, 0.69) 1.20% 1.09 1.35
KMO NM_03679 1 0.000149756 2.05 (1.42, 2.98) 1.00% 1.09 1.37
KRT78 NM_173352 1 2.66E-05 1.48 (1.23, 1.78) 0.30% 1.09 1.35
LDLRAD3 NM_174902 -1 4.34E-05 0.64 (0.51, 0.79) 0.40% 1.09 1.36
MAP3K14 NM_003954 -1 9.19E-05 0.54 (0.40, 0.74) 0.70% 1.09 1.38
MIR196A1 NR_029582 1 2.40E-06 1.36 (1.19, 1.54) 0.10% 1.09 1.3
MIR4275 NR_036237 1 6.24E-06 1.43 (1.22, 1.66) 0.10% 1.09 1.34
NCRNA00221 NR_027457 1 5.62E-06 1.38 (1.20, 1.58) 0.10% 1.09 1.31
NGRN NM_001033088 1 2.38E-05 1.47 (1.23, 1.76) 0.30% 1.09 1.34
NGRN NR_028052 1 2.38E-05 1.47 (1.23, 1.76) 0.30% 1.09 1.34
NME1 NM_000269 1 7.11E-05 1.83 (1.36, 2.46) 0.60% 1.09 1.39
NME1 NM_198175 1 7.11E-05 1.83 (1.36, 2.46) 0.60% 1.09 1.39
NSUN2 NM_001193455 1 3.78E-05 1.61 (1.29, 2.03) 0.40% 1.09 1.38
NSUN2 NM_017755 1 3.78E-05 1.61 (1.29, 2.03) 0.40% 1.09 1.38
OR7G3 NM_001001958 1 6.32E-06 1.36 (1.19, 1.56) 0.10% 1.09 1.3
PIGA NM_002641 1 0.000138341 2.13 (1.44, 3.14) 0.90% 1.09 1.36
PIGA NM_020473 1 0.000138341 2.13 (1.44, 3.14) 0.90% 1.09 1.36
PIGA NR_033835 1 0.000138341 2.13 (1.44, 3.14) 0.90% 1.09 1.36
PIGA NR_033836 1 0.000138341 2.13 (1.44, 3.14) 0.90% 1.09 1.36
PRR11 NR_018304 1 0.000134896 2.14 (1.45, 3.16) 0.90% 1.09 1.36
PSMC5 NM_002805 1 3.01E-05 1.62 (1.29, 2.02) 0.30% 1.09 1.38
PSMC5 NM_001199163 1 3.01E-05 1.62 (1.29, 2.02) 0.30% 1.09 1.38
RDH10 NM_172037 1 0.000090299 1.81 (1.35, 2.44) 0.70% 1.09 1.38
RFWD3 NM_018124 1 0.000103613 1.85 (1.35, 2.51) 0.80% 1.09 1.38
RILPL2 NM_145058 -1 4.52E-05 0.61 (0.48, 0.77) 0.40% 1.09 1.38
ROBO1 NM_002941 1 6.22E-05 1.66 (1.29, 2.12) 0.50% 1.09 1.38
ROBO1 NM_001145845 1 6.22E-05 1.66 (1.29, 2.12) 0.50% 1.09 1.38
ROBO1 NM_133631 1 6.22E-05 1.66 (1.29, 2.12) 0.50% 1.09 1.38
SEPT3 NM_019106 1 0.000202646 2.23 (1.46, 3.41) 1.20% 1.09 1.35
SEPT3 NM_145733 1 0.000202646 2.23 (1.46, 3.41) 1.20% 1.09 1.35
SF3B3 NM_012426 1 8.05E-05 1.86 (1.37, 2.53) 0.60% 1.09 1.39
SKINTL NR_026749 -1 0.000155637 0.47 (0.32, 0.70) 1.00% 1.09 1.36
SLC1A5 NM_001145145 1 0.000173422 2.23 (1.47, 3.38) 1.10% 1.09 1.35
SLC1A5 NM_005628 1 0.000173422 2.23 (1.47, 3.38) 1.10% 1.09 1.35
SLC1A5 NM_001145144 1 0.000173422 2.23 (1.47, 3.38) 1.10% 1.09 1.35
SUN1 NM_001171945 1 3.24E-05 1.56 (1.27, 1.93) 0.30% 1.09 1.37
SUN1 NM_001171946 1 3.24E-05 1.56 (1.27, 1.93) 0.30% 1.09 1.37
SUN1 NM_001171944 1 3.24E-05 1.56 (1.27, 1.93) 0.30% 1.09 1.37
SUN1 NM_025154 1 3.24E-05 1.56 (1.27, 1.93) 0.30% 1.09 1.37
SUN1 NM_001130965 1 3.24E-05 1.56 (1.27, 1.93) 0.30% 1.09 1.37
TCEA3 NM_003196 -1 1.33E-05 0.67 (0.56, 0.80) 0.20% 1.09 1.36
TIGD7 NM_033208 -1 7.22E-05 0.60 (0.46, 0.77) 0.60% 1.09 1.37
TMED3 NM_007364 1 0.000118078 1.84 (1.35, 2.50) 0.80% 1.09 1.38
UPK1A NM_007000 1 3.33E-05 1.52 (1.25, 1.86) 0.30% 1.09 1.36
ZNF554 NM_001102651 -1 1.43E-05 0.67 (0.56, 0.80) 0.20% 1.09 1.36
ZZEF1 NM_015113 -1 0.000101352 0.51 (0.36, 0.71) 0.70% 1.09 1.38
ANKRD17 NM_198889 1 4.07E-05 1.48 (1.23, 1.79) 0.40% 1.08 1.34
ANKRD17 NM_032217 1 4.07E-05 1.48 (1.23, 1.79) 0.40% 1.08 1.34
C1orf168 NM_001004303 -1 0.000196331 0.52 (0.36, 0.73) 1.20% 1.08 1.36
CCDC103 NM_213607 -1 0.000156354 0.54 (0.39, 0.74) 1.00% 1.08 1.36
DBNDD1 NM_ 001042610 1 0.000265114 2.29 (1.47, 3.59) 1.40% 1.08 1.33
DBNDD1 NM_024043 1 0.000265114 2.29 (1.47, 3.59) 1.40% 1.08 1.33
EBF4 NM_001110514 -1 0.000177638 0.56 (0.42, 0.76) 1.10% 1.08 1.36
EVX1 NM_001989 1 4.40E-05 1.46 (1.22, 1.75) 0.40% 1.08 1.33
FAM120AOS NM_198841 -1 0.000311715 0.48 (0.32, 0.71) 1.50% 1.08 1.33
FYTTD1 NM_032288 1 0.000093964 1.62 (1.27, 2.06) 0.70% 1.08 1.36
FYTTD1 NR_ 027840 1 0.000093964 1.62 (1.27, 2.06) 0.70% 1.08 1.36
FYTTD1 NM_001011537 1 0.000093964 1.62 (1.27, 2.06) 0.70% 1.08 1.36
GOLGA1 NM_002077 -1 0.000103896 0.62 (0.48, 0.79) 0.80% 1.08 1.36
GPI NM_001184722 1 3.17E-05 1.46 (1.22, 1.75) 0.30% 1.08 1.34
GPI NM_000175 1 3.17E-05 1.46 (1.22, 1.75) 0.30% 1.08 1.34
GPR157 NM_024980 1 0.000371571 2.47 (1.50, 4.07) 1.70% 1.08 1.31
GSTM3 NR_.024537 -1 0.000174236 0.54 (0.39, 0.74) 1.10% 1.08 1.36
GSTM3 NM_000849 -1 0.000174236 0.54 (0.39, 0.74) 1.10% 1.08 1.36
GUK1 NM_000858 1 0.000160068 1.84 (1.34, 2.53) 1.00% 1.08 1.37
GUK1 NM_001159391 1 0.000160068 1.84 (1.34, 2.53) 1.00% 1.08 1.37
GUK1 NM_001159390 1 0.000160068 1.84 (1.34, 2.53) 1.00% 1.08 1.37
IGF2BP2 NM_001007225 1 0.000223003 1.98 (1.38, 2.85) 1.30% 1.08 1.36
IGF2BP2 NM_006548 1 0.000223003 1.98 (1.38, 2.85) 1.30% 1.08 1.36
KDM4B NM_015015 -1 0.000289488 0.49 (0.33, 0.72) 1.50% 1.08 1.34
KIAA0226 NM_014687 1 0.00010158 1.66 (1.29, 2.15) 0.70% 1.08 1.37
KIAA0226 NM_001145642 1 0.00010158 1.66 (1.29, 2.15) 0.70% 1.08 1.37
KRT81 NM_002281 1 0.000191877 1.79 (1.32, 2.43) 1.20% 1.08 1.36
LYPD6B NM_177964 -1 0.000135793 0.60 (0.46,0.78) 0.90% 1.08 1.36
MAPT NM_001123066 -1 0.000216473 0.56 (0.41, 0.76) 1.20% 1.08 1.35
MAPT NM_001123067 -1 0.000216473 0.56 (0.41, 0.76) 1.20% 1.08 1.35
MAPT NM_016835 -1 0.000216473 0.56 (0.41, 0.76) 1.20% 1.08 1.35
MAPT NM_005910 -1 0.000216473 0.56 (0.41, 0.76) 1.20% 1.08 1.35
MAPT NM_016841 -1 0.000216473 0.56 (0.41, 0.76) 1.20% 1.08 1.35
MAPT NM_016834 -1 0.000216473 0.56 (0.41, 0.76) 1.20% 1.08 1.35
MIR3170 NR_036129 1 1.03E-05 1.38 (1.19, 1.59) 0.20% 1.08 1.31
MIR4267 NR_036225 1 7.93E-06 1.33 (1.17, 1.51) 0.10% 1.08 1.28
NDUFS6 NM_004553 1 0.000254346 1.91 (1.35, 2.70) 1.40% 1.08 1.35
NPY1R NM_000909 -1 0.00017825 0.55 (0.41, 0.75) 1.10% 1.08 1.36
NRIP3 NM_020645 -1 0.000247739 0.50 (0.34, 0.72) 1.30% 1.08 1.35
NUDT8 NM_181843 1 7.84E-05 1.53 (1.24, 1.90) 0.60% 1.08 1.35
OPALIN NM_033207 1 3.68E-05 1.43 (1.21, 1.69) 0.40% 1.08 1.32
OPALIN NM_001040102 1 3.68E-05 1.43 (1.21, 1.69) 0.40% 1.08 1.32
OPALIN NM_001040103 1 3.68E-05 1.43 (1.21, 1.69) 0.40% 1.08 1.32
PABPC1L2B NM_001042506 1 9.64E-07 1.24 (1.14, 1.36) <0.1% 1.08 1.23
PDE6B NM_001145291 -1 0.000100399 0.59 (0.46, 0.77) 0.70% 1.08 1.37
PDE6B NM_001145292 -1 0.000100399 0.59 (0.46, 0.77) 0.70% 1.08 1.37
PDE6B NM_000283 -1 0.000100399 0.59 (0.46, 0.77) 0.70% 1.08 1.37
PRR7 NM_030567 1 0.000274525 2.20 (1.44, 3.37) 1.40% 1.08 1.34
PRR7 NM_001174101 1 0.000274525 2.20 (1.44, 3.37) 1.40% 1.08 1.34
PRR7 NM_001174102 1 0.000274525 2.20 (1.44, 3.37) 1.40% 1.08 1.34
PTP4A1 NM_003463 1 2.66E-05 1.45 (1.22, 1.73) 0.30% 1.08 1.34
RGS22 NM_015668 -1 0.000336901 0.44 (0.28, 0.69) 1.60% 1.08 1.32
SECISBP2L NM_014701 1 0.000213295 1.98 (1.38, 2.84) 1.20% 1.08 1.36
SECISBP2L NM_001193489 1 0.000213295 1.98 (1.38, 2.84) 1.20% 1.08 1.36
SFXN1 NM_022754 1 0.000256108 1.89 (1.34, 2.66) 1.40% 1.08 1.35
SLC27A1 NM_198580 -1 0.00014439 0.59 (0.45, 0.78) 1.00% 1.08 1.36
SLC35C1 NM_018389 1 0.000285265 1.97 (1.37, 2.84) 1.50% 1.08 1.35
SLC35C1 NM_001145265 1 0.000285265 1.97 (1.37, 2.84) 1.50% 1.08 1.35
SLC35C1 NM_001145266 1 0.000285265 1.97 (1.37, 2.84) 1.50% 1.08 1.35
SP8 NM_182700 1 6.71E-06 1.31 (1.17, 1.48) 0.10% 1.08 1.27
SP8 NM_198956 1 6.71E-06 1.31 (1.17, 1.48) 0.10% 1.08 1.27
TBRG4 NM_004749 1 8.91E-05 1.54 (1.24, 1.90) 0.70% 1.08 1.35
TBRG4 NM_199122 1 8.91E-05 1.54 (1.24, 1.90) 0.70% 1.08 1.35
TBRG4 NM_030900 1 8.91E-05 1.54 (1.24, 1.90) 0.70% 1.08 1.35
TFRC NM_003234 1 0.000294668 2.08 (1.40, 3.09) 1.50% 1.08 1.34
TFRC NM_001128148 1 0.000294668 2.08 (1.40, 3.09) 1.50% 1.08 1.34
USP39 NM_006590 1 0.000298617 2.18 (1.43, 3.33) 1.50% 1.08 1.34
WDR19 NM_025132 -1 0.000213805 0.53 (0.38, 0.74) 1.20% 1.08 1.35
YWHAZ NM_001135699 1 0.000160718 1.78 (1.32, 2.41) 1.00% 1.08 1.37
YWHAZ NM_001135701 1 0.000160718 1.78 (1.32, 2.41) 1.00% 1.08 1.37
YWHAZ NM_001135702 1 0.000160718 1.78 (1.32, 2.41) 1.00% 1.08 1.37
YWHAZ NM_001135700 1 0.000160718 1.78 (1.32, 2.41) 1.00% 1.08 1.37
YWHAZ NM_145690 1 0.000160718 1.78 (1.32, 2.41) 1.00% 1.08 1.37
YWHAZ NM_003406 1 0.000160718 1.78 (1.32, 2.41) 1.00% 1.08 1.37
ZBED4 NM_ 014838 1 0.000018032 1.37 (1.19, 1.59) 0.20% 1.08 1.3
ZBTB26 NM_020924 -1 0.000088049 0.65 (0.52, 0.80) 0.70% 1.08 1.35
ZNF174 NM_001032292 -1 0.00021639 0.48 (0.32, 0.71) 1.20% 1.08 1.35
ZNF174 NM_003450 -1 0.00021639 0.48 (0.32, 0.71) 1.20% 1.08 1.35
ZNF440 NM_152357 -1 0.000254996 0.53 (0.37, 0.74) 1.40% 1.08 1.35
ZNF441 NM_152355 -1 0.000204868 0.55 (0.40, 0.75) 1.20% 1.08 1.36
ZNF563 NM_145276 -1 7.39E-05 0.62 (0.49, 0.78) 0.60% 1.08 1.36
ZNF763 NM_001012753 -1 0.00014465 0.57 (0.42, 0.76) 1.00% 1.08 1.36
ZNF843 NM_001136509 -1 0.00031279 0.45 (0.29, 0.70) 1.50% 1.08 1.33
ZNF844 NM_001136501 -1 0.000119899 0.58 (0.44, 0.76) 0.80% 1.08 1.37
ANKRD30A NM_052997 -1 0.00042874 0.52 (0.36, 0.75) 1.90% 1.07 1.33
AP1G1 NM_001128 1 0.000237846 1.75 (1.30, 2.37) 1.30% 1.07 1.35
AP1G1 NM_001030007 1 0.000237846 1.75 (1.30, 2.37) 1.30% 1.07 1.35
BRD1 NM_014577 1 4.25E-05 1.40 (1.19, 1.65) 0.40% 1.07 1.31
BUD13 NM_032725 -1 0.00033707 0.53 (0.38, 0.75) 1.60% 1.07 1.34
BUD13 NM_001159736 -1 0.00033707 0.53 (0.38, 0.75) 1.60% 1.07 1.34
BZRAP1 NM_004758 -1 0.000315545 0.54 (0.39, 0.76) 1.50% 1.07 1.34
BZRAP1 NM_024418 -1 0.000315545 0.54 (0.39, 0.76) 1.50% 1.07 1.34
C17orf91 NR_028505 -1 0.000246829 0.60 (0.46, 0.79) 1.30% 1.07 1.34
C17orf91 NR_028504 -1 0.000246829 0.60 (0.46, 0.79) 1.30% 1.07 1.34
C17orf91 NR_028502 -1 0.000246829 0.60 (0.46, 0.79) 1.30% 1.07 1.34
C17orf91 NR_028503 -1 0.000246829 0.60 (0.46, 0.79) 1.30% 1.07 1.34
C1orf220 NR_033186 -1 0.000206926 0.63 (0.50, 0.81) 1.20% 1.07 1.34
C1orf51 NM_144697 -1 0.000164444 0.60 (0.46, 0.78) 1.00% 1.07 1.35
C2orf65 NM_138804 -1 0.000242505 0.57 (0.42, 0.77) 1.30% 1.07 1.35
C9orf27 NR_024032 1 3.24E-06 1.26 (1.15, 1.40) 0.10% 1.07 1.24
C9orf64 NM_032307 -1 0.000258832 0.57 (0.42, 0.77) 1.40% 1.07 1.35
CACNA1F NM_005183 -1 0.000196901 0.59 (0.45, 0.78) 1.20% 1.07 1.35
CBX3 NM_007276 1 0.00012881 1.53 (1.23, 1.90) 0.90% 1.07 1.34
CBX3 NM_016587 1 0.00012881 1.53 (1.23, 1.90) 0.90% 1.07 1.34
CLIC6 NM_53277 -1 0.000469076 0.47 (0.30, 0.72) 2.00% 1.07 1.32
COX6B1 NM_001863 1 7.59E-05 1.45 (1.21, 1.74) 0.60% 1.07 1.32
CWF19L2 NM_152434 -1 0.000485073 0.49 (0.33, 0.73) 2.00% 1.07 1.32
CX3CR1 NM_01171171 -1 0.000471876 0.48 (0.32, 0.72) 2.00% 1.07 1.32
CX3CR1 NM_001171172 -1 0.000471876 0.48 (0.32, 0.72) 2.00% 1.07 1.32
CX3CR1 NM_01171174 -1 0.000471876 0.48 (0.32, 0.72) 2.00% 1.07 1.32
CX3CR1 NM_001337 -1 0.000471876 0.48 (0.32, 0.72) 2.00% 1.07 1.32
DCDC1 NM_181807 -1 0.000241354 0.55 (0.40, 0.76) 1.30% 1.07 1.35
DET1 NM_07996 -1 5.20E-05 0.73 (0.63, 0.85) 0.50% 1.07 1.29
DET1 NM_01144074 -1 5.20E-05 0.73 (0.63, 0.85) 0.50% 1.07 1.29
DET1 NR_026645 -1 5.20E-05 0.73 (0.63, 0.85) 0.50% 1.07 1.29
EGLN1 NM_022051 1 0.000408781 1.87 (1.32, 2.64) 1.80% 1.07 1.34
EXO1 NM_03686 1 0.000583818 2.40 (1.46, 3.96) 2.30% 1.07 1.3
EXO1 NM_006027 1 0.000583818 2.40 (1.46, 3.96) 2.30% 1.07 1.3
EXO1 NM_130398 1 0.000583818 2.40 (1.46, 3.96) 2.30% 1.07 1.3
FAM92A1 NM_145269 1 0.000422905 1.96 (1.35, 2.84) 1.90% 1.07 1.34
FARP2 NM_014808 -1 0.000339695 0.56 (0.40, 0.77) 1.60% 1.07 1.34
FCGBP NM_003890 -1 0.000347245 0.57 (0.42, 0.77) 1.60% 1.07 1.34
FTSJ3 NM_017647 1 0.000174103 1.54 (1.23, 1.93) 1.10% 1.07 1.34
GFPT1 NM_002056 1 0.000294139 1.66 (1.26, 2.19) 1.50% 1.07 1.34
GMCL1L NR_003281 1 0.000277335 1.72 (1.28, 2.31) 1.40% 1.07 1.35
GPX5 NM_003996 1 0.00018895 1.58 (1.24, 2.02) 1.20% 1.07 1.34
GPX5 NM_001509 1 0.00018895 1.58 (1.24, 2.02) 1.20% 1.07 1.34
HIST1H2AJ NM_021066 1 0.000389048 2.18 (1.42, 3.35) 1.80% 1.07 1.33
INTS1 NM_001080453 1 0.000236705 1.60 (1.25, 2.06) 1.30% 1.07 1.34
LOC284023 NR_024349 -1 6.57E-05 0.69 (0.57, 0.83) 0.50% 1.07 1.33
LOC729966 NR_036575 1 3.17E-05 1.34 (1.17, 1.54) 0.30% 1.07 1.28
MIR1208 NR_031613 1 0.000232308 1.72 (1.29, 2.30) 1.30% 1.07 1.35
MR1 NM_001194999 -1 0.000294622 0.54 (0.39, 0.75) 1.50% 1.07 1.35
MR1 NM_001531 -1 0.000294622 0.54 (0.39, 0.75) 1.50% 1.07 1.35
MR1 NM_001195035 -1 0.000294622 0.54 (0.39, 0.75) 1.50% 1.07 1.35
MR1 NM_001195000 -1 0.000294622 0.54 (0.39, 0.75) 1.50% 1.07 1.35
NEGR1 NM_173808 -1 0.000194753 0.58 (0.44, 0.77) 1.20% 1.07 1.35
NT5C2 NM_012229 1 0.000251004 1.78 (1.31, 2.43) 1.40% 1.07 1.35
NT5C2 NM_001134373 1 0.000251004 1.78 (1.31, 2.43) 1.40% 1.07 1.35
ONECUT2 NM_004852 1 0.000300598 1.90 (1.34, 2.69) 1.50% 1.07 1.35
OR52E8 NM_001005168 1 0.000183129 1.64 (1.27, 2.12) 1.10% 1.07 1.35
OR9K2 NM_001005243 1 0.000023276 1.32 (1.16, 1.49) 0.30% 1.07 1.27
PADI3 NM_016233 1 0.000184726 1.59 (1.25, 2.02) 1.10% 1.07 1.35
PION NM_017439 -1 0.000214273 0.58 (0.44, 0.77) 1.20% 1.07 1.35
PLXNB2 NM_012401 1 0.000187459 1.55 (1.23, 1.94) 1.20% 1.07 1.34
SCARB2 NM_005506 1 9.94E-05 1.44 (1.20, 1.73) 0.70% 1.07 1.32
SERPINF2 NM_001165920 -1 0.000337351 0.56 (0.41, 0.77) 1.60% 1.07 1.34
SERPINF2 NM_000934 -1 0.000337351 0.56 (0.41, 0.77) 1.60% 1.07 1.34
SERPINF2 NM_001165921 -1 0.000337351 0.56 (0.41, 0.77) 1.60% 1.07 1.34
SHCBP1 NM_024745 1 0.000474183 2.26 (1.43, 3.58) 2.00% 1.07 1.31
SLC3A2 NM_002394 1 0.000205239 1.75 (1.30, 2.35) 1.20% 1.07 1.36
SLC3A2 NM_001012662 1 0.000205239 1.75 (1.30, 2.35) 1.20% 1.07 1.36
SLC3A2 NM_001012664 1 0.000205239 1.75 (1.30, 2.35) 1.20% 1.07 1.36
SLC3A2 NM_001012663 1 0.000205239 1.75 (1.30, 2.35) 1.20% 1.07 1.36
SLC3A2 NM_001013251 1 0.000205239 1.75 (1.30, 2.35) 1.20% 1.07 1.36
SLC3A2 NN_001012661 1 0.000205239 1.75 (1.30, 2.35) 1.20% 1.07 1.36
SLC3A2 NR_037193 1 0.000205239 1.75 (1.30, 2.35) 1.20% 1.07 1.36
SMARCC1 NM_003074 1 0.000285871 1.83 (1.32, 2.53) 1.50% 1.07 1.35
STK11IP NM_052902 -1 0.00030755 0.58 (0.43, 0.78) 1.50% 1.07 1.34
SUSD3 NM_145006 -1 0.000203286 0.58 (0.43, 0.77) 1.20% 1.07 1.35
TBCEL NM_152715 -1 0.000110632 0.64 (0.51, 0.80) 0.80% 1.07 1.35
TBCEL NM_001130047 -1 0.000110632 0.64 (0.51, 0.80) 0.80% 1.07 1.35
TMEM151A NM_153266 1 0.000109154 1.53 (1.23, 1.90) 0.80% 1.07 1.34
TMEM155 NM_152399 1 0.000285542 1.81 (1.31, 2.49) 1.50% 1.07 1.35
TMEM40 NM_018306 1 0.000431802 2.05 (1.37, 3.05) 1.90% 1.07 1.33
TMOD2 NM_014548 1 0.000120829 1.50 (1.22, 1.84) 0.80% 1.07 1.33
TMOD2 NM_001142885 1 0.000120829 1.50 (1.22, 1.84) 0.80% 1.07 1.33
TTC12 NM_017868 -1 0.000472605 0.45 (0.29, 0.70) 2.00% 1.07 1.31
ZDBF2 NM_020923 -1 0.00032201 0.55 (0.40, 0.76) 1.60% 1.07 1.34
ZNF326 NM_182976 -1 0.000367128 0.53 (0.37, 0.75) 1.70% 1.07 1.34
ZNF326 NM_182975 -1 0.000367128 0.53 (0.37, 0.75) 1.70% 1.07 1.34
ZNF484 NM_001007101 -1 0.000298688 0.52 (0.36, 0.74) 1.50% 1.07 1.34
ZNF484 NM_031486 -1 0.000298688 0.52 (0.36, 0.74) 1.50% 1.07 1.34
AARS NM_001605 1 0.00039842 1.78 (1.29, 2.46) 1.80% 1.06 1.34
ACCN5 NM_017419 1 0.000363129 1.64 (1.25, 2.16) 1.70% 1.06 1.34
ALG3 NM_005787 1 0.000546417 1.96 (1.34, 2.87) 2.20% 1.06 1.33
ALG3 NR_024534 1 0.000546417 1.96 (1.34, 2.87) 2.20% 1.06 1.33
ALG3 NR_024533 1 0.000546417 1.96 (1.34, 2.87) 2.20% 1.06 1.33
ALG3 NM_001006941 1 0.000546417 1.96 (1.34, 2.87) 2.20% 1.06 1.33
ANLN NM_018685 1 0.000861767 2.34 (1.42, 3.86) 2.90% 1.06 1.29
BARHL2 NM_020063 1 9.67E-05 1.33 (1.15, 1.53) 0.70% 1.06 1.27
BBC3 NM_014417 -1 0.000431133 0.58 (0.43, 0.79) 1.90% 1.06 1.33
BBC3 NM_001127240 -1 0.000431133 0.58 (0.43, 0.79) 1.90% 1.06 1.33
BBC3 NM_001127242 -1 0.000431133 0.58 (0.43, 0.79) 1.90% 1.06 1.33
BBC3 NM_001127241 -1 0.000431133 0.58 (0.43, 0.79) 1.90% 1.06 1.33
C17orf97 NM_001013672 -1 0.000476721 0.56 (0.41, 0.78) 2.00% 1.06 1.33
C7orf40 NR_003697 1 0.000244871 1.48 (1.20, 1.83) 1.30% 1.06 1.32
CCDC45 NM_138363 1 0.000315377 1.62 (1.25, 2.11) 1.50% 1.06 1.34
CCT5 NM_012073 1 0.000579782 1.92 (1.33, 2.79) 2.20% 1.06 1.33
CFL1 NM_005507 1 0.00041237 1.62 (1.24, 2.11) 1.80% 1.06 1.33
CROCC NM_014675 -1 0.000303212 0.61 (0.46, 0.80) 1.50% 1.06 1.34
DCAF16 NM_017741 -1 0.000539706 0.51 (0.35, 0.75) 2.10% 1.06 1.32
DUS3L NM_020175 -1 0.000318893 0.59 (0.44, 0.79) 1.50% 1.06 1.34
DUS3L NM_001161619 -1 0.000318893 0.59 (0.44, 0.79) 1.50% 1.06 1.34
EFCAB6 NM_022785 -1 0.000411749 0.62 (0.48, 0.81) 1.80% 1.06 1.33
EFCAB6 NM_198856 -1 0.000411749 0.62 (0.48, 0.81) 1.80% 1.06 1.33
F9 NM_000133 1 4.73E-05 1.28 (1.14, 1.44) 0.40% 1.06 1.24
FAM83D NM_030919 1 0.000660782 2.17 (1.39, 3.40) 2.50% 1.06 1.31
FANK1 NM_145235 -1 0.000363661 0.60 (0.45, 0.79) 1.70% 1.06 1.34
FSD2 NM_001007122 -1 0.000370322 0.61 (0.47, 0.80) 1.70% 1.06 1.33
GOLPH3 NM_022130 1 0.000490776 1.86 (1.31, 2.64) 2.00% 1.06 1.33
GPAA1 NM_003801 1 0.000555873 1.76 (1.28, 2.42) 2.20% 1.06 1.33
HBZ NM_005332 1 0.000192085 1.49 (1.21, 1.83) 1.20% 1.06 1.32
HOXA13 NM_000522 1 0.000245127 1.43 (1.18, 1.74) 1.30% 1.06 1.31
HSD3B7 NM_01142778 -1 0.00023229 0.66 (0.53, 0.82) 1.30% 1.06 1.33
HSD3B7 NM_001142777 -1 0.00023229 0.66 (0.53, 0.82) 1.30% 1.06 1.33
HSD3B7 NM_025193 -1 0.00023229 0.66 (0.53, 0.82) 1.30% 1.06 1.33
IFI27L1 NM_206949 -1 0.00033531 0.61 (0.47, 0.80) 1.60% 1.06 1.34
IFI27L1 NM_145249 -1 0.00033531 0.61 (0.47, 0.80) 1.60% 1.06 1.34
IGF2BP1 NM_006546 1 0.000397318 1.75 (1.28, 2.38) 1.80% 1.06 1.34
IGF2BP1 NM_01160423 1 0.000397318 1.75 (1.28, 2.38) 1.80% 1.06 1.34
KIAA0430 NM_001184998 -1 0.000703574 0.50 (0.34, 0.75) 2.50% 1.06 1.31
KIAA0430 NM_14647 -1 0.000703574 0.50 (0.34, 0.75) 2.50% 1.06 1.31
KIAA0430 NM_001184999 -1 0.000703574 0.50 (0.34, 0.75) 2.50% 1.06 1.31
KIAA1274 NM_014431 -1 0.00041306 0.61 (0.47, 0.80) 1.80% 1.06 1.33
KIAA1407 NM_020817 -1 0.0004264 0.61 (0.47, 0.81) 1.90% 1.06 1.33
KPNA2 NM_002266 1 0.000608282 1.88 (1.31, 2.70) 2.30% 1.06 1.33
LOC100130148 NR_024560 -1 0.000334314 0.59 (0.44, 0.79) 1.60% 1.06 1.34
LOC144742 NR_024246 1 0.00015428 1.41 (1.18, 1.69) 1.00% 1.06 1.3
LOC642006 NR_030766 1 0.000338823 1.61 (1.24, 2.08) 1.60% 1.06 1.34
LRIG3 NM_001136051 1 0.000531484 1.70 (1.26, 2.30) 2.10% 1.06 1.33
LRIG3 NM_153377 1 0.000531484 1.70 (1.26, 2.30) 2.10% 1.06 1.33
LRIT2 NM_001017924 1 8.60E-05 1.34 (1.16, 1.54) 0.70% 1.06 1.27
LYRM5 NM_001001660 -1 0.00030197 0.67 (0.54, 0.83) 1.50% 1.06 1.32
MEIS3P1 NR_002211 -1 0.000277359 0.66 (0.53, 0.83) 1.40% 1.06 1.32
METTL7B NM_152637 1 0.000534187 1.78 (1.28, 2.47) 2.10% 1.06 1.33
MIR133A1 NR_029675 1 0.000236845 1.54 (1.22, 1.93) 1.30% 1.06 1.33
MIR4256 NR_036210 1 0.000511214 1.72 (1.27, 2.33) 2.10% 1.06 1.33
MIR4258 NR_036212 1 0.000755224 2.19 (1.39, 3.46) 2.70% 1.06 1.3
NEK5 NM_199289 -1 0.000362458 0.65 (0.51, 0.82) 1.70% 1.06 1.32
NHLRC4 NM_176677 -1 0.000605306 0.55 (0.39, 0.77) 2.30% 1.06 1.32
NPM3 NM_006993 1 0.000857222 2.57 (1.47, 4.46) 2.90% 1.06 1.27
P4HB NM_000918 1 0.000519801 1.78 (1.29, 2.47) 2.10% 1.06 1.33
PACRGL NM_001130727 -1 0.000137922 0.70 (0.58, 0.84) 0.90% 1.06 1.31
PACRGL NM_145048 -1 0.000137922 0.70 (0.58, 0.84) 0.90% 1.06 1.31
PAPD7 NM_006999 1 0.000569528 1.84 (1.30, 2.60) 2.20% 1.06 1.33
PAPD7 NM_001171806 1 0.000569528 1.84 (1.30, 2.60) 2.20% 1.06 1.33
PAPD7 NM_001171805 1 0.000569528 1.84 (1.30, 2.60) 2.20% 1.06 1.33
PCGF3 NM_006315 -1 0.000375263 0.57 (0.42, 0.78) 1.70% 1.06 1.34
PIM3 NM_001001852 1 0.000223066 1.45 (1.19, 1.77) 1.30% 1.06 1.31
POLK NM_016218 -1 0.000694544 0.51 (0.34, 0.75) 2.50% 1.06 1.31
PPPDE1 NM_016076 1 0.000485656 1.95 (1.34, 2.83) 2.00% 1.06 1.33
PYGO1 NM_015617 -1 0.000513314 0.56 (0.40, 0.77) 2.10% 1.06 1.33
RASGRP4 NM_001146205 -1 0.000328822 0.60 (0.45, 0.79) 1.60% 1.06 1.34
RASGRP4 NM_170604 -1 0.000328822 0.60 (0.45, 0.79) 1.60% 1.06 1.34
RASGRP4 NM_001146203 -1 0.000328822 0.60 (0.45, 0.79) 1.60% 1.06 1.34
RASGRP4 NM_001146206 -1 0.000328822 0.60 (0.45, 0.79) 1.60% 1.06 1.34
RASGRP4 NM_001146204 -1 0.000328822 0.60 (0.45, 0.79) 1.60% 1.06 1.34
RASGRP4 NM_001146207 -1 0.000328822 0.60 (0.45, 0.79) 1.60% 1.06 1.34
RASGRP4 NM_001146202 -1 0.000328822 0.60 (0.45, 0.79) 1.60% 1.06 1.34
RHCG NM_016321 1 0.000306566 1.62 (1.25, 2.10) 1.50% 1.06 1.34
RP1-177G6-2 NR_028345 1 0.000135136 1.36 (1.16, 1.58) 0.90% 1.06 1.28
RP1-177G6-2 NR_028344 1 0.000135136 1.36 (1.16, 1.58) 0.90% 1.06 1.28
RPP21 NM_001199120 1 0.000396352 1.66 (1.26, 2.21) 1.80% 1.06 1.34
RPP21 NM_001199121 1 0.000396352 1.66 (1.26, 2.21) 1.80% 1.06 1.34
RPP21 NM_024839 1 0.000396352 1.66 (1.26, 2.21) 1.80% 1.06 1.34
SCUBE2 NM_001170690 -1 0.000697526 0.49 (0.32, 0.74) 2.50% 1.06 1.31
SCUBE2 NM_020974 -1 0.000697526 0.49 (0.32, 0.74) 2.50% 1.06 1.31
SEC61A1 NM_013336 1 0.000689339 1.92 (1.32, 2.79) 2.50% 1.06 1.32
SENP5 NM_152699 1 0.000451373 1.64 (1.24, 2.15) 1.90% 1.06 1.33
SGOL1 NM_001012411 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001199253 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001199252 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001199251 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001012412 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001012409 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001199254 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001012410 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_138484 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001199256 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001199257 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001012413 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SGOL1 NM_001199255 1 0.000679983 2.16 (1.38, 3.36) 2.50% 1.06 1.31
SIN3B NM_015260 -1 0.00042699 0.56 (0.41, 0.77) 1.90% 1.06 1.34
SMG6 NM_017575 -1 0.000476372 0.54 (0.38, 0.76) 2.00% 1.06 1.33
SMG6 NM_001170957 -1 0.000476372 0.54 (0.38, 0.76) 2.00% 1.06 1.33
STAT5A NM_003152 -1 0.000296856 0.61 (0.46, 0.80) 1.50% 1.06 1.34
STX6 NM_005819 1 0.000513875 1.78 (1.29, 2.46) 2.10% 1.06 1.33
STX8 NR_033656 -1 0.000363379 0.60 (0.45, 0.80) 1.70% 1.06 1.34
STX8 NM_004853 -1 0.000363379 0.60 (0.45, 0.80) 1.70% 1.06 1.34
SYNPO2L NM_024875 -1 0.000517753 0.50 (0.34, 0.74) 2.10% 1.06 1.32
SYNPO2L NM_001114133 -1 0.000517753 0.50 (0.34, 0.74) 2.10% 1.06 1.32
TMEM101 NM_032376 -1 0.000487894 0.51 (0.35, 0.75) 2.00% 1.06 1.33
TNFRSF14 NM_003820 -1 0.000653957 0.49 (0.32, 0.74) 2.50% 1.06 1.31
UBE2C NM_181799 1 0.000783989 2.51 (1.47, 4.30) 2.70% 1.06 1.28
UBE2C NM_181800 1 0.000783989 2.51 (1.47, 4.30) 2.70% 1.06 1.28
UBE2C NM_181803 1 0.000783989 2.51 (1.47, 4.30) 2.70% 1.06 1.28
UBE2C NM_007019 1 0.000783989 2.51 (1.47, 4.30) 2.70% 1.06 1.28
UBE2C NM_181802 1 0.000783989 2.51 (1.47, 4.30) 2.70% 1.06 1.28
UBE2C NM_181801 1 0.000783989 2.51 (1.47, 4.30) 2.70% 1.06 1.28
ZNF287 NM_020653 -1 0.000326457 0.64 (0.51, 0.82) 1.60% 1.06 1.33
ZNF576 NM_024327 -1 0.000481181 0.57 (0.42, 0.78) 2.00% 1.06 1.33
ZNF576 NM_001145347 -1 0.000481181 0.57 (0.42, 0.78) 2.00% 1.06 1.33
ZNF738 NR_027130 -1 0.000598215 0.55 (0.39, 0.77) 2.30% 1.06 1.32
ABCC10 NM_033450 1 0.000517309 1.57 (1.22, 2.03) 2.10% 1.05 1.32
ABCC10 NM_001198934 1 0.000517309 1.57 (1.22, 2.03) 2.10% 1.05 1.32
ACTR3C NM_01164458 -1 0.000635228 0.64 (0.50, 0.83) 2.40% 1.05 1.31
ACTR3C NM_001164459 -1 0.000635228 0.64 (0.50, 0.83) 2.40% 1.05 1.31
AFM NM_001133 1 0.000066704 1.23 (1.11, 1.36) 0.60% 1.05 1.21
AGBL2 NM_024783 -1 0.000684777 0.63 (0.48, 0.82) 2.50% 1.05 1.32
APOBEC1 NM_001644 1 5.53E-05 1.22 (1.11, 1.34) 0.50% 1.05 1.2
ARHGEF6 NM_004840 -1 0.000770839 0.54 (0.38, 0.78) 2.70% 1.05 1.32
ATAD3A NM_018188 1 0.001027877 2.28 (1.39, 3.72) 3.20% 1.05 1.28
ATAD3A NM_001170536 1 0.001027877 2.28 (1.39, 3.72) 3.20% 1.05 1.28
ATAD3A NM_01170535 1 0.001027877 2.28 (1.39, 3.72) 3.20% 1.05 1.28
ATP8A2 NM_016529 -1 0.000828234 0.56 (0.40, 0.79) 2.80% 1.05 1.31
AURKA NM_198437 1 0.001108089 2.00 (1.32, 3.02) 3.30% 1.05 1.3
AURKA NM_198436 1 0.001108089 2.00 (1.32, 3.02) 3.30% 1.05 1.3
AURKA NM_198435 1 0.001108089 2.00 (1.32, 3.02) 3.30% 1.05 1.3
AURKA NM_198434 1 0.001108089 2.00 (1.32, 3.02) 3.30% 1.05 1.3
AURKA NM_003600 1 0.001108089 2.00 (1.32, 3.02) 3.30% 1.05 1.3
AURKA NM_198433 1 0.001108089 2.00 (1.32, 3.02) 3.30% 1.05 1.32
BAI2 NM_001703 -1 0.000813324 0.59 (0.43, 0.80) 2.80% 1.05 1.3
C10orf68 NM_024688 -1 0.000766871 0.54 (0.38, 0.77) 2.70% 1.05 1.32
C14orf33 NR_027123 -1 0.000774142 0.62 (0.47,0.82) 2.70% 1.05 1.31
C9orf117 NM_001012502 -1 0.000748452 0.58 (0.43, 0.80) 2.60% 1.05 1.32
CDC25C NM_022809 1 0.00105986 2.22 (1.38, 3.57) 3.30% 1.05 1.29
CDC25C NM_001790 1 0.00105986 2.22 (1.38, 3.57) 3.30% 1.05 1.29
CENPO NM_24322 1 0.000898127 2.08 (1.35, 3.19) 2.90% 1.05 1.3
CENPO NM_001199803 1 0.000898127 2.08 (1.35, 3.19) 2.90% 1.05 1.3
CLCN5 NM_000084 1 0.000713564 1.83 (1.29, 2.60) 2.60% 1.05 1.32
CLCN5 NM_001127899 1 0.000713564 1.83 (1.29, 2.60) 2.60% 1.05 1.32
CLCN5 NM_001127898 1 0.000713564 1.83 (1.29, 2.60) 2.60% 1.05 1.32
CLK1 NR_027955 -1 0.000894665 0.56 (0.39, 0.79) 2.90% 1.05 1.31
CLK1 NR_027856 -1 0.000894665 0.56 (0.39, 0.79) 2.90% 1.05 1.31
CLK1 NM_004071 -1 0.000894665 0.56 (0.39, 0.79) 2.90% 1.05 1.31
CLK1 NM_001162407 -1 0.000894665 0.56 (0.39, 0.79) 2.90% 1.05 1.31
CLTC NM_004859 1 0.000563537 1.55 (1.21, 1.98) 2.20% 1.05 1.32
COPG NM_016128 1 0.000702768 1.78 (1.28, 2.49) 2.50% 1.05 1.32
DEFB133 NM_001166478 1 0.000294095 1.38 (1.16, 1.64) 1.50% 1.05 1.28
DGCR10 NR_026651 1 0.000654253 1.69 (1.25, 2.29) 2.50% 1.05 1.33
DHCR7 NM_001360 1 0.000806605 1.76 (1.26, 2.44) 2.80% 1.05 1.32
DHCR7 NM_001163817 1 0.000806605 1.76 (1.26, 2.44) 2.80% 1.05 1.32
DLX6-AS1 NR_015448 1 0.000705367 1.57 (1.21, 2.03) 2.50% 1.05 1.32
DMRTC2 NM_001040283 1 0.000492509 1.49 (1.19, 1.86) 2.00% 1.05 1.31
ESRP1 NM_001122827 1 0.000764406 1.86 (1.30, 2.67) 2.70% 1.05 1.32
ESRP1 NM_017697 1 0.000764406 1.86 (1.30, 2.67) 2.70% 1.05 1.32
ESRP1 NM_001122825 1 0.000764406 1.86 (1.30, 2.67) 2.70% 1.05 1.32
ESRP1 NM_001122826 1 0.000764406 1.86 (1.30, 2.67) 2.70% 1.05 1.32
ESRP1 NM_001034915 1 0.000764406 1.86 (1.30, 2.67) 2.70% 1.05 1.32
FAM184B NM_015688 -1 0.000919699 0.50 (0.33, 0.75) 3.00% 1.05 1.3
FGD3 NM_001083536 -1 0.000878971 0.48 (0.31, 0.74) 2.90% 1.05 1.3
FGD3 NM_033086 -1 0.000878971 0.48 (0.31, 0.74) 2.90% 1.05 1.3
FRMPD2 NM_001018071 -1 0.000916891 0.50 (0.33, 0.75) 3.00% 1.05 1.3
FRMPD2 NR_033178 -1 0.000916891 0.50 (0.33, 0.75) 3.00% 1.05 1.3
GALNS NM_000512 1 0.000779802 1.73 (1.26, 2.39) 2.70% 1.05 1.32
GPA33 NM_005814 1 0.000455791 1.51 (1.20, 1.91) 1.90% 1.05 1.32
GRIK4 NM_014619 -1 0.000983512 0.49 (0.32, 0.75) 3.10% 1.05 1.3
GRSF1 NM_002092 1 0.000455403 1.42 (1.17, 1.73) 1.90% 1.05 1.29
GRSF1 NM_001098477 1 0.000455403 1.42 (1.17, 1.73) 1.90% 1.05 1.29
GSG1 NM_031289 -1 0.000746247 0.57 (0.41, 0.79) 2.60% 1.05 1.32
GSG1 NM_153823 -1 0.000746247 0.57 (0.41, 0.79) 2.60% 1.05 1.32
GSG1 NM_001080555 -1 0.000746247 0.57 (0.41, 0.79) 2.60% 1.05 1.32
GSG1 NM_001080554 -1 0.000746247 0.57 (0.41, 0.79) 2.60% 1.05 1.32
GSTTP1 NR_003081 1 0.000281335 1.36 (1.15, 1.61) 1.50% 1.05 1.28
GZMB NM_004131 1 0.000774473 1.64 (1.23, 2.20) 2.70% 1.05 1.32
HIVEP3 NM_024503 -1 0.000637807 0.56 (0.40, 0.78) 2.40% 1.05 1.32
HIVEP3 NM_001127714 -1 0.000637807 0.56 (0.40, 0.78) 2.40% 1.05 1.32
HRK NM_003806 1 0.000573791 1.56 (1.21, 2.02) 2.20% 1.05 1.32
ICK NM_016513 1 0.000708599 1.76 (1.27, 2.45) 2.50% 1.05 1.32
ICK NM_014920 1 0.000708599 1.76 (1.27, 2.45) 2.50% 1.05 1.32
IDI1 NM_004508 1 0.000576826 1.62 (1.23, 2.12) 2.20% 1.05 1.32
INPP5K NM_001135642 -1 0.000606796 0.61 (0.45, 0.81) 2.30% 1.05 1.32
INPP5K NM_130766 -1 0.000606796 0.61 (0.45, 0.81) 2.30% 1.05 1.32
INPP5K NM_016532 -1 0.000606796 0.61 (0.45, 0.81) 2.30% 1.05 1.32
KDELR2 NM_001100603 1 0.000640872 1.78 (1.28, 2.48) 2.40% 1.05 1.33
KDELR2 NM_006854 1 0.000640872 1.78 (1.28, 2.48) 2.40% 1.05 1.33
KIAA0528 NM_014802 -1 0.00067798 0.60 (0.45, 0.81) 2.50% 1.05 1.32
KIAA0664L3 NR_024034 -1 0.000538791 0.68 (0.54, 0.84) 2.10% 1.05 1.3
KIAA0753 NM_014804 -1 0.000792844 0.58 (0.43, 0.80) 2.70% 1.05 1.32
KIF14 NM_014875 1 0.000991316 2.07 (1.34, 3.20) 3.10% 1.05 1.3
KLHL5 NM_015990 -1 0.001075498 0.51 (0.34, 0.76) 3.30% 1.05 1.3
KLHL5 NM_199039 -1 0.001075498 0.51 (0.34, 0.76) 3.30% 1.05 1.3
KLHL5 NM_001007075 -1 0.001075498 0.51 (0.34, 0.76) 3.30% 1.05 1.3
KLHL5 NM_001171654 -1 0.001075498 0.51 (0.34, 0.76) 3.30% 1.05 1.3
LARP1 NM_015315 1 0.000776893 1.98 (1.33, 2.95) 2.70% 1.05 1.31
LMAN1L NM_021819 1 0.000694431 1.58 (1.21, 2.05) 2.50% 1.05 1.32
LOC284440 NR_026956 -1 0.00064239 0.56 (0.40, 0.78) 2.40% 1.05 1.32
LOC644961 NR_033926 -1 0.000821483 0.51 (0.35, 0.76) 2.80% 1.05 1.31
MAGEA3 NM_005362 1 0.000259711 1.40 (1.17, 1.67) 1.40% 1.05 1.29
MAGEB2 NM_002364 1 0.000109866 1.28 (1.13, 1.45) 0.80% 1.05 1.24
MIR1297 NR_031628 1 0.000213996 1.30 (1.13, 1.50) 1.20% 1.05 1.25
NXNL2 NM_001161625 -1 0.000679325 0.53 (0.37, 0.77) 2.50% 1.05 1.32
NXNL2 NM_145283 -1 0.000679325 0.53 (0.37, 0.77) 2.50% 1.05 1.32
PCDH11Y NM_032972 1 0.000256294 1.35 (1.15, 1.58) 1.40% 1.05 1.27
PCDH11Y NM_032973 1 0.000256294 1.35 (1.15, 1.58) 1.40% 1.05 1.27
PCDH11Y NM_032971 1 0.000256294 1.35 (1.15, 1.58) 1.40% 1.05 1.27
PGD NM_002631 1 0.00082458 1.77 (1.27, 2.46) 2.80% 1.05 1.32
PHF2 NM_005392 -1 0.00054667 0.62 (0.47, 0.81) 2.20% 1.05 1.32
POU3F4 NM_00307 1 0.000444079 1.56 (1.22, 2.00) 1.90% 1.05 1.32
POU4F1 NM_006237 1 0.000488435 1.52 (1.20, 1.92) 2.00% 1.05 1.32
PTGER3 NM_001126044 -1 0.000851253 0.52 (0.36,0.77) 2.80% 1.05 1.31
PTGER3 NM_198716 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
PTGER3 NM_198718 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
PTGER3 NM_198715 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
PTGER3 NM_198719 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
PTGER3 NM_198714 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
PTGER3 NR 028292 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
PTGER3 NR_028293 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
PTGER3 NM_198717 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
PTGER3 NR_028294 -1 0.000851253 0.52 (0.36, 0.77) 2.80% 1.05 1.31
RGP1 NM_001080496 -1 0.000674124 0.64 (0.49, 0.83) 2.50% 1.05 1.31
RHOV NM_133639 1 0.000910194 1.91 (1.30, 2.81) 3.00% 1.05 1.31
RPF1 NM_025065 -1 0.000516752 0.60 (0.45, 0.80) 2.10% 1.05 1.33
SEMA4B NM_198925 1 0.000425026 1.49 (1.19, 1.86) 1.90% 1.05 1.31
SEMA4B NM_020210 1 0.000425026 1.49 (1.19, 1.86) 1.90% 1.05 1.31
SLC30A3 NM_003459 1 0.000459198 1.58 (1.22, 2.03) 2.00% 1.05 1.33
SLC35A2 NM_005660 1 0.000949606 2.03 (1.33, 3.08) 3.00% 1.05 1.3
SLC35A2 NM_001042498 1 0.000949606 2.03 (1.33, 3.08) 3.00% 1.05 1.3
SLC35A2 NM_001032289 1 0.000949606 2.03 (1.33, 3.08) 3.00% 1.05 1.3
SLC40A1 NM_014585 -1 0.000901525 0.50 (0.33, 0.75) 2.90% 1.05 1.3
SLC45A4 NM_001080431 1 0.000795498 1.90 (1.31, 2.76) 2.70% 1.05 1.32
SLC4A10 NM_022058 -1 0.000922314 0.50 (0.33, 0.75) 3.00% 1.05 1.3
SLC4A10 NM_001178016 -1 0.000922314 0.50 (0.33, 0.75) 3.00% 1.05 1.3
SLC4A10 NM_001178015 -1 0.000922314 0.50 (0.33, 0.75) 3.00% 1.05 1.3
SMPD2 NM_003080 -1 0.000636112 0.62 (0.47, 0.81) 2.40% 1.05 1.32
SMU1 NM_018225 -1 0.000694202 0.54 (0.37, 0.77) 2.50% 1.05 1.32
STON2 NM_033104 -1 0.000687523 0.54 (0.38, 0.77) 2.50% 1.05 1.32
TECTA NM_005422 -1 0.000626178 0.58 (0.43, 0.79) 2.40% 1.05 1.32
TMEM8B NM_001042590 -1 0.000970606 0.55 (0.39,0.78) 3.10% 1.05 1.31
TMEM8B NM_001042589 -1 0.000970606 0.55 (0.39, 0.78) 3.10% 1.05 1.31
TMEM8B NM_016446 -1 0.000970606 0.55 (0.39, 0.78) 3.10% 1.05 1.31
TRAF3IP1 NM_015650 -1 0.000567431 0.59 (0.44, 0.80) 2.20% 1.05 1.33
TRAF3IP1 NM_001139490 -1 0.000567431 0.59 (0.44, 0.80) 2.20% 1.05 1.33
TROAP NM_005480 1 0.000902469 1.97 (1.32, 2.94) 2.90% 1.05 1.31
TROAP NM_001100620 1 0.000902469 1.97 (1.32, 2.94) 2.90% 1.05 1.31
TSTA3 NM_003313 1 0.000809687 1.67 (1.24, 2.25) 2.80% 1.05 1.32
TUBG2 NM_016437 -1 0.000282337 0.72 (0.60, 0.86) 1.50% 1.05 1.29
TXNDC8 NM_001003936 1 0.000444509 1.48 (1.19, 1.85) 1.90% 1.05 1.31
UGT2B10 NM_001075 1 0.000213893 1.39 (1.17, 1.65) 1.20% 1.05 1.29
UGT2B10 NM_001075 1 0.000213893 1.39 (1.17, 1.65) 1.20% 1.05 1.29
UGT2B10 NM_001144767 1 0.000213893 1.39 (1.17, 1.65) 1.20% 1.05 1.29
UGT2B10 NM_001144767 1 0.000213893 1.39 (1.17, 1.65) 1.20% 1.05 1.29
WAPAL NM_015045 -1 0.000856095 0.55 (0.39, 0.78) 2.90% 1.05 1.31
ZNF20 NM_021143 -1 0.000772771 0.58 (0.43, 0.80) 2.70% 1.05 1.32
ZNF317 NM_020933 -1 0.000545984 0.59 (0.44, 0.80) 2.20% 1.05 1.33
ZNF317 NM_001190791 -1 0.000545984 0.59 (0.44, 0.80) 2.20% 1.05 1.33
ZNF516 NM_014643 -1 0.000706877 0.57 (0.41, 0.79) 2.50% 1.05 1.32
ZNF594 NM_032530 -1 0.000728948 0.56 (0.40, 0.78) 2.60% 1.05 1.32
ZNF625 NM_145233 -1 0.00079499 0.56 (0.40, 0.79) 2.70% 1.05 1.32
ZNF695 NM_020394 1 0.000959311 2.11 (1.35, 3.28) 3.10% 1.05 1.3
ABR NM_001092 -1 0.00124577 0.57 (0.41, 0.80) 3.60% 1.04 1.3
ABR NM_001159746 -1 0.00124577 0.57 (0.41, 0.80) 3.60% 1.04 1.3
ABR NN_021962 -1 0.00124577 0.57 (0.41, 0.80) 3.60% 1.04 1.3
ACBD3 NM_022735 1 0.001654232 1.92 (1.28, 2.87) 4.10% 1.04 1.29
ACY3 NM_080658 1 0.000456993 1.33 (1.13, 1.55) 1.90% 1.04 1.26
AMY2B NM_020978 -1 0.001380606 0.59 (0.42, 0.81) 3.80% 1.04 1.3
AP4E1 NM_007347 1 0.000480692 1.26 (1.11, 1.44) 2.00% 1.04 1.22
ASTN2 NM_001184735 -1 0.001083598 0.56 (0.40, 0.79) 3.30% 1.04 1.31
ASTN2 NM_198188 -1 0.001083598 0.56 (0.40, 0.79) 3.30% 1.04 1.31
ASTN2 NM_001184734 -1 0.001083598 0.56 (0.40, 0.79) 3.30% 1.04 1.31
ASTN2 NM_014010 -1 0.001083598 0.56 (0.40, 0.79) 3.30% 1.04 1.31
ASTN2 NM_198187 -1 0.001083598 0.56 (0.40, 0.79) 3.30% 1.04 1.31
ASTN2 NM_198186 -1 0.001083598 0.56 (0.40, 0.79) 3.30% 1.04 1.31
ATP5S NM_001003805 -1 0.001099833 0.60 (0.44, 0.81) 3.30% 1.04 1.31
ATP5S NR_033761 -1 0.001099833 0.60 (0.44, 0.81) 3.30% 1.04 1.31
ATP5S NM_015684 -1 0.001099833 0.60 (0.44, 0.81) 3.30% 1.04 1.31
ATP5S NM_001003803 -1 0.001099833 0.60 (0.44, 0.81) 3.30% 1.04 1.31
AZU1 NM_001700 1 0.001184365 1.57 (1.20, 2.06) 3.50% 1.04 1.3
BOD1L NM_148894 -1 0.001481913 0.53 (0.36, 0.78) 3.90% 1.04 1.29
C14orf102 NM_199043 -1 0.001090373 0.57 (0.41, 0.80) 3.30% 1.04 1.31
C14orf102 NM_017970 -1 0.001090373 0.57 (0.41, 0.80) 3.30% 1.04 1.31
C15orf23 NM_001142762 1 0.001423858 1.90 (1.28, 2.82) 3.80% 1.04 1.3
C15orf23 NM_033286 1 0.001423858 1.90 (1.28, 2.82) 3.80% 1.04 1.3
C15orf23 NM_001142761 1 0.001423858 1.90 (1.28, 2.82) 3.80% 1.04 1.3
C19orf18 NM_152474 -1 0.001597281 0.52 (0.35,0.78) 4.10% 1.04 1.29
C20orf132 NM_213631 -1 0.000972217 0.58 (0.42, 0.80) 3.10% 1.04 1.31
C20orf132 NM_152503 -1 0.000972217 0.58 (0.42, 0.80) 3.10% 1.04 1.31
C20orf132 NM_213632 -1 0.000972217 0.58 (0.42, 0.80) 3.10% 1.04 1.31
C21orf90 NR_026547 1 0.001031689 1.54 (1.19, 1.99) 3.20% 1.04 1.3
C21orf90 NR_026548 1 0.001031689 1.54 (1.19, 1.99) 3.20% 1.04 1.3
C3orf65 NR_027317 1 0.001227976 1.72 (1.24, 2.38) 3.50% 1.04 1.31
C6orf225 NM_001033564 -1 0.000824925 0.64 (0.49, 0.83) 2.80% 1.04 1.31
CDCA2 NM_152562 1 0.001763324 2.19 (1.34, 3.58) 4.30% 1.04 1.27
CLDN4 NM_001305 1 0.001451467 1.97 (1.30, 2.98) 3.90% 1.04 1.29
COL16A1 NM_001856 -1 0.00135906 0.60 (0.44, 0.82) 3.70% 1.04 1.3
COQ9 NM_020312 1 0.001364105 1.78 (1.25, 2.53) 3.70% 1.04 1.3
COX18 NM_173827 1 0.000877732 1.43 (1.16, 1.76) 2.90% 1.04 1.29
COX4NB NM_006067 1 0.001769748 2.07 (1.31, 3.28) 4.30% 1.04 1.28
COX4NB NM_001142288 1 0.001769748 2.07 (1.31, 3.28) 4.30% 1.04 1.28
CYCS NM_018947 1 0.001320528 1.65 (1.22, 2.25) 3.70% 1.04 1.3
DACT2 NM_214462 1 0.001302736 1.62 (1.21, 2.17) 3.60% 1.04 1.3
DEGS1 NM_003676 1 0.001061247 1.48 (1.17, 1.87) 3.30% 1.04 1.29
DUSP9 NM_001395 1 0.001256936 1.61 (1.20, 2.14) 3.60% 1.04 1.3
DYNC2H1 NM_001080463 -1 0.001370915 0.59 (0.43, 0.82) 3.70% 1.04 1.3
DYNC2H1 NM_001377 -1 0.001370915 0.59 (0.43, 0.82) 3.70% 1.04 1.3
EIF4G1 NM_198241 1 0.001353974 1.68 (1.22, 2.31) 3.70% 1.04 1.3
EIF4G1 NM_001194947 1 0.001353974 1.68 (1.22, 2.31) 3.70% 1.04 1.3
EIF4G1 NM_198244 1 0.001353974 1.68 (1.22, 2.31) 3.70% 1.04 1.3
EIF4G1 NM_198242 1 0.001353974 1.68 (1.22, 2.31) 3.70% 1.04 1.3
EIF4G1 NM_001194946 1 0.001353974 1.68 (1.22, 2.31) 3.70% 1.04 1.3
EIF4G1 NM_182917 1 0.001353974 1.68 (1.22,2.31) 3.70% 1.04 1.3
EIF4G1 NM_004953 1 0.001353974 1.68 (1.22, 2.31) 3.70% 1.04 1.3
ENO1 NM_001428 1 0.001364087 1.81 (1.26, 2.61) 3.70% 1.04 1.31
FAF2 NM_014613 1 0.00108376 1.88 (1.29, 2.74) 3.30% 1.04 1.3
FAM149A NM_015398 -1 0.001194251 0.64 (0.49, 0.84) 3.50% 1.04 1.3
FAM149A NM_001006655 -1 0.001194251 0.64 (0.49, 0.84) 3.50% 1.04 1.31
FAM154B NM_001008226 -1 0.001023443 0.54 (0.37, 0.78) 3.20% 1.04 1.3
FGG NM_021870 1 0.000888207 1.49 (1.18, 1.88) 2.90% 1.04 1.3
FGG NM_000509 1 0.000888207 1.49 (1.18, 1.88) 2.90% 1.04 1.3
GET4 NM_015949 1 0.001268692 1.58 (1.20, 2.10) 3.60% 1.04 1.31
GGT1 NM_005265 1 0.00125253 1.75 (1.25, 2.46) 3.60% 1.04 1.31
GGT1 NM_013430 1 0.00125253 1.75 (1.25, 2.46) 3.60% 1.04 1.31
GGT1 NM_001032365 1 0.00125253 1.75 (1.25, 2.46) 3.60% 1.04 1.31
GGT1 NM_001032364 1 0.00125253 1.75 (1.25, 2.46) 3.60% 1.04 1.31
GPC4 NM_001448 -1 0.000911024 0.69 (0.56, 0.86) 3.00% 1.04 1.29
HNMT NM_001024074 -1 0.001007463 0.61 (0.45, 0.82) 3.20% 1.04 1.31
HNMT NM_006895 -1 0.001007463 0.61 (0.45, 0.82) 3.20% 1.04 1.31
HNMT NM_001024075 -1 0.001007463 0.61 (0.45, 0.82) 3.20% 1.04 1.31
HSBP1 NM_001537 1 0.001388414 1.93 (1.29, 2.89) 3.80% 1.04 1.3
ILF2 NM_004515 1 0.001444137 1.77 (1.25, 2.51) 3.80% 1.04 1.3
INCENP NM_001040694 1 0.001350727 1.77 (1.25, 2.52) 3.70% 1.04 1.3
INCENP NM_020238 1 0.001350727 1.77 (1.25, 2.52) 3.70% 1.04 1.3
KIAA0802 NM_015210 -1 0.000733238 0.66 (0.52, 0.84) 2.60% 1.04 1.3
LOC100129636 NM_001195202 1 0.000568239 1.41 (1.16, 1.71) 2.20% 1.04 1.29
LRRC50 NM_178452 -1 0.001142207 0.62 (0.46, 0.83) 3.40% 1.04 1.3
LSS NM_001145436 1 0.00102682 1.85 (1.28, 2.68) 3.20% 1.04 1.31
LSS NM_001145437 1 0.00102682 1.85 (1.28, 2.68) 3.20% 1.04 1.31
LSS NM_001001438 1 0.00102682 1.85 (1.28, 2.68) 3.20% 1.04 1.31
LSS NM_002340 1 0.00102682 1.85 (1.28, 2.68) 3.20% 1.04 1.31
LYPD2 NM_205545 1 0.000432072 1.29 (1.12, 1.48) 1.90% 1.04 1.24
MARCH6 NM_005885 1 0.001493132 1.94 (1.29, 2.93) 3.90% 1.04 1.29
MDH1B NM_001039845 -1 0.001226529 0.59 (0.43, 0.82) 3.50% 1.04 1.3
MELK NM_014791 1 0.001334491 1.89 (1.28, 2.78) 3.70% 1.04 1.3
MEPE NM_001184695 1 0.000345187 1.35 (1.14, 1.59) 1.60% 1.04 1.27
MEPE NM_001184696 1 0.000345187 1.35 (1.14, 1.59) 1.60% 1.04 1.27
MEPE NM_001184694 1 0.000345187 1.35 (1.14, 1.59) 1.60% 1.04 1.27
MEPE NM_001184697 1 0.000345187 1.35 (1.14, 1.59) 1.60% 1.04 1.27
MEPE NM_020203 1 0.000345187 1.35 (1.14, 1.59) 1.60% 1.04 1.27
MGAT4B NM_014275 1 0.001660199 1.94 (1.28, 2.93) 4.10% 1.04 1.29
MGAT48 NM_054013 1 0.001660199 1.94 (1.28, 2.93) 4.10% 1.04 1.29
MIR1266 NR_031670 1 0.000694086 1.45 (1.17, 1.79) 2.50% 1.04 1.29
MKL2 NM_014048 -1 0.001149841 0.55 (0.38, 0.79) 3.40% 1.04 1.3
MND1 NM_032117 1 0.001547106 1.80 (1.25, 2.59) 4.00% 1.04 1.3
MORC2 NM_014941 1 0.001258176 1.73 (1.24, 2.42) 3.60% 1.04 1.31
MUM1L1 NM_152423 -1 0.001393772 0.60 (0.44, 0.82) 3.80% 1.04 1.3
MUM1L1 NM_001171020 -1 0.001393772 0.60 (0.44, 0.82) 3.80% 1.04 1.3
NCRNA00094 NR_015427 -1 0.001103609 0.60 (0.44, 0.82) 3.30% 1.04 1.31
NDUFV1 NM_007103 1 0.001409686 1.72 (1.23, 2.41) 3.80% 1.04 1.3
NDUFV1 NM_001166102 1 0.001409686 1.72 (1.23, 2.41) 3.80% 1.04 1.3
NEFL NM_006158 -1 0.001687285 0.45 (0.27, 0.74) 4.20% 1.04 1.26
NOSTRIN NM_001171631 -1 0.001252393 0.54 (0.37, 0.78) 3.60% 1.04 1.3
NOSTRIN NM_052946 -1 0.001252393 0.54 (0.37, 0.78) 3.60% 1.04 1.3
NOSTRIN NM_001039724 -1 0.001252393 0.54 (0.37, 0.78) 3.60% 1.04 1.3
NOSTRIN NM_001171632 -1 0.001252393 0.54 (0.37, 0.78) 3.60% 1.04 1.3
NPFFR1 NM_022146 1 0.000403573 1.37 (1.15, 1.63) 1.80% 1.04 1.28
NR1H4 NM_005123 1 0.000190977 1.21 (1.09, 1.34) 1.20% 1.04 1.19
OR52E6 NM_001005167 1 0.000848918 1.64 (1.23, 2.18) 2.80% 1.04 1.32
OR8S1 NM_001005203 1 0.00023101 1.27 (1.12, 1.45) 1.30% 1.04 1.23
ORM1 N_000607 1 0.000975674 1.51 (1.18, 1.93) 3.10% 1.04 1.3
OSCP1 NM_145047 -1 0.001246562 0.64 (0.49, 0.84) 3.60% 1.04 1.3
OSCP1 NM_206837 -1 0.001246562 0.64 (0.49, 0.84) 3.60% 1.04 1.3
PAR-SN NR_022011 -1 0.001065009 0.68 (0.54, 0.86) 3.30% 1.04 1.29
PDE4A NM_001111308 -1 0.001540235 0.56 (0.39, 0.80) 4.00% 1.04 1.29
PDE4A NM_001111307 -1 0.001540235 0.56 (0.39, 0.80) 4.00% 1.04 1.29
PDE4A NM_006202 -1 0.001540235 0.56 (0.39, 0.80) 4.00% 1.04 1.29
PDE4A NM_001111309 -1 0.001540235 0.56 (0.39, 0.80) 4.00% 1.04 1.29
PGA3 NM_001079807 1 0.000794713 1.37 (1.14, 1.65) 2.70% 1.04 1.27
PHF23 NM_024297 -1 0.00118066 0.57 (0.41, 0.80) 3.50% 1.04 1.3
PLEKHA8 NM_001197026 1 0.001145142 1.67 (1.22, 2.26) 3.40% 1.04 1.31
PLEKHA8 NM_032639 1 0.001145142 1.67 (1.22, 2.26) 3.40% 1.04 1.31
PLEKHA8 NM_001197027 1 0.001145142 1.67 (1.22, 2.26) 3.40% 1.04 1.31
POLG2 NM_007215 1 0.001113968 1.50 (1.18, 1.92) 3.30% 1.04 1.3
POTEG NR_027480 1 0.000753813 1.52 (1.19, 1.93) 2.70% 1.04 1.31
POTEG NM_001005356 1 0.000753813 1.52 (1.19, 1.93) 2.70% 1.04 1.31
PRDX1 NM_002574 1 0.001365139 1.96 (1.30, 2.97) 3.70% 1.04 1.29
PRDX1 NM_181697 1 0.001365139 1.96 (1.30, 2.97) 3.70% 1.04 1.29
PRDX1 NM_181696 1 0.001365139 1.96 (1.30, 2.97) 3.70% 1.04 1.29
PRKCG NM_002739 1 0.000915815 1.43 (1.16, 1.77) 3.00% 1.04 1.29
PRRC1 NM_130809 1 0.001282446 2.02 (1.32, 3.10) 3.60% 1.04 1.29
PSMD7 NM_002811 1 0.00121422 1.76 (1.25, 2.49) 3.50% 1.04 1.31
PTPN13 NM_080683 -1 0.001238326 0.57 (0.40, 0.80) 3.60% 1.04 1.3
PTPN13 NM_080684 -1 0.001238326 0.57 (0.40, 0.80) 3.60% 1.04 1.3
PTPN13 NM_080685 -1 0.001238326 0.57 (0.40, 0.80) 3.60% 1.04 1.3
PTPN13 NM_006264 -1 0.001238326 0.57 (0.40, 0.80) 3.60% 1.04 1.3
PTPRF NM_130440 1 0.001244621 1.71 (1.23, 2.36) 3.60% 1.04 1.31
PTPRF NM_002840 1 0.001244621 1.71 (1.23, 2.36) 3.60% 1.04 1.31
RCBTB1 NM_018191 -1 0.001286867 0.57 (0.41, 0.80) 3.60% 1.04 1.3
RPH3A NM_014954 1 0.00083144 1.42 (1.16, 1.75) 2.80% 1.04 1.29
RPH3A NM_001143854 -1 0.00083144 1.42 (1.16, 1.75) 2.80% 1.04 1.29
RPS19BP1 NM_194326 1 0.00131552 2.03 (1.32, 3.12) 3.70% 1.04 1.29
RRM2 NM_001034 1 0.001359597 2.12 (1.34, 3.37) 3.70% 1.04 1.28
RRM2 NM_001165931 1 0.001359597 2.12 (1.34, 3.37) 3.70% 1.04 1.28
RTKN2 NM_145307 1 0.001215644 1.79 (1.26, 2.55) 3.50% 1.04 1.31
SHMT2 NM_001166359 1 0.001409397 1.76 (1.24, 2.50) 3.80% 1.04 1.3
SHMT2 NM_901166358 1 0.001409397 1.76 (1.24, 2.50) 3.80% 1.04 1.3
SHMT2 NM_001166357 1 0.001409397 1.76 (1.24, 2.50) 3.80% 1.04 1.3
SHMT2 NM_001166356 1 0.001409397 1.76 (1.24, 2.50) 3.80% 1.04 1.3
SHMT2 NM_005412 1 0.001409397 1.76 (1.24, 2.50) 3.80% 1.04 1.3
SHMT2 NR_029416 1 0.001409397 1.76 (1.24, 2.50) 3.80% 1.04 1.3
SHMT2 NR_029417 1 0.001409397 1.76 (1.24, 2.50) 3.80% 1.04 1.3
SHMT2 NR_029415 1 0.001409397 1.76 (1.24, 2.50) 3.80% 1.04 1.3
SHPK NM_013276 -1 0.001138133 0.50 (0.33, 0.76) 3.40% 1.04 1.29
SLC43A1 NM_001198810 -1 0.001564414 0.54 (0.37, 0.79) 4.10% 1.04 1.29
SLC43A1 NM_003627 -1 0.001564414 0.54 (0.37, 0.79) 4.10% 1.04 1.29
SMAD7 NM_001190821 -1 0.001127632 0.63 (0.48, 0.83) 3.40% 1.04 1.3
SMAD7 NM_005904 -1 0.001127632 0.63 (0.48, 0.83) 3.40% 1.04 1.3
SMAD7 NM_001190822 -1 0.001127632 0.63 (0.48, 0.83) 3.40% 1.04 1.3
SMAD7 NM_001190823 -1 0.001127632 0.63 (0.48, 0.83) 3.40% 1.04 1.3
SMG5 NM_015327 1 0.001368035 1.81 (1.26, 2.61) 3.70% 1.04 1.3
SPAG17 NM_206996 -1 0.001277464 0.54 (0.37, 0.79) 3.60% 1.04 1.3
SPRR3 NM_001097589 1 0.000735393 1.43 (1.16, 1.77) 2.60% 1.04 1.29
SPRR3 NM_005416 1 0.000735393 1.43 (1.16, 1.77) 2.60% 1.04 1.29
STARD13 NM_178007 -1 0.001355506 0.51 (0.33, 0.77) 3.70% 1.04 1.29
STARD13 NM_178006 -1 0.001355506 0.51 (0.33, 0.77) 3.70% 1.04 1.29
STARD13 NM_052851 -1 0.001355506 0.51 (0.33, 0.77) 3.70% 1.04 1.29
STH NM_001007532 -1 0.001002598 0.61 (0.45, 0.82) 3.20% 1.04 1.31
TALDO1 NM_006755 1 0.001614891 2.06 (1.31, 3.23) 4.10% 1.04 1.28
TMC6 NM_007267 1 0.001392884 1.78 (1.25, 2.53) 3.80% 1.04 1.3
TMC6 NM_001127198 1 0.001392884 1.78 (1.25, 2.53) 3.80% 1.04 1.3
TMEM194A NM_015257 1 0.001255127 1.78 (1.25, 2.52) 3.60% 1.04 1.31
TMEM194A NM_001130963 1 0.001255127 1.78 (1.25, 2.52) 3.60% 1.04 1.31
TMEM229B NM_182526 -1 0.001174425 0.60 (0.44, 0.82) 3.50% 1.04 1.3
TMPRSS11E NM_014058 1 0.001024924 1.57 (1.20, 2.06) 3.20% 1.04 1.31
TOR1AIP2 NM_022347 1 0.001376663 1.89 (1.28, 2.80) 3.80% 1.04 1.3
TOR1AIP2 NM_145034 1 0.001376663 1.89 (1.28, 2.80) 3.80% 1.04 1.3
TOR1AIP2 NM_001199260 1 0.001376663 1.89 (1.28, 2.80) 3.80% 1.04 1.3
TPD52L2 NM_199359 1 0.001081496 1.60 (1.21, 2.12) 3.30% 1.04 1.31
TPD52L2 NM_199360 1 0.001081496 1.60 (1.21, 2.12) 3.30% 1.04 1.31
TPD52L2 NM_199361 1 0.001081496 1.60 (1.21, 2.12) 3.30% 1.04 1.31
TPD52L2 NM_199362 1 0.001081496 1.60 (1.21, 2.12) 3.30% 1.04 1.31
TPD52L2 NM_199363 1 0.001081496 1.60 (1.21, 2.12) 3.30% 1.04 1.31
TPD52L2 NM_003288 1 0.001081496 1.60 (1.21, 2.12) 3.30% 1.04 1.31
TPH2 NM_173353 1 0.001086792 1.61 (1.21, 2.14) 3.30% 1.04 1.31
TRAK1 NM_001042646 -1 0.001111813 0.57 (0.41, 0.80) 3.30% 1.04 1.31
TRAK1 NM_014965 -1 0.001111813 0.57 (0.41, 0.80) 3.30% 1.04 1.31
TTC23L NM_144725 -1 0.00182818 0.46 (0.28, 0.75) 4.40% 1.04 1.26
UNC119B NM_001080533 -1 0.001111663 0.56 (0.40, 0.80) 3.30% 1.04 1.31
ZNF442 NM_030824 -1 0.001384421 0.60 (0.44, 0.82) 3.80% 1.04 1.3
ZNF512 NM_032434 -1 0.001588962 0.53 (0.35, 0.78) 4.10% 1.04 1.29
ZNF528 NM_032423 -1 0.001148516 0.54 (0.38, 0.78) 3.40% 1.04 1.3
ACOX3 NM_003501 -1 0.001635988 0.59 (0.43, 0.82) 4.10% 1.03 1.29
ACOX3 NM_001101667 -1 0.001635988 0.59 (0.43, 0.82) 4.10% 1.03 1.29
ANUBL1 NM_001128324 -1 0.001585772 0.57 (0.40, 0.81) 4.10% 1.03 1.29
ANUBL1 NM_174890 -1 0.001585772 0.57 (0.40, 0.81) 4.10% 1.03 1.29
AVL9 NM_015060 1 0.001403234 1.42 (1.14, 1.75) 3.80% 1.03 1.28
BICD2 NM_001003800 -1 0.002587505 0.52 (0.34, 0.79) 5.40% 1.03 1.27
BICD2 NM_015250 -1 0.002587505 0.52 (0.34, 0.79) 5.40% 1.03 1.27
BUB1B NM_001211 1 0.002718314 1.97 (1.27, 3.08) 5.50% 1.03 1.27
C10orf82 NM_144661 -1 0.002795215 0.48 (0.29, 0.77) 5.60% 1.03 1.25
C11orf61 NM_024631 -1 0.001104328 0.72 (0.59, 0.87) 3.30% 1.03 1.27
C12orf65 NM_001194995 -1 0.001612306 0.75 (0.62, 0.90) 4.10% 1.03 1.25
C12orf65 NM_001143905 -1 0.001612306 0.75 (0.62, 0.90) 4.10% 1.03 1.25
C12orf65 NM_152269 -1 0.001612306 0.75 (0.62, 0.90) 4.10% 1.03 1.25
C14orf147 NM_138288 1 0.001459289 1.61 (1.20, 2.15) 3.90% 1.03 1.3
C17orf85 NM_001114118 -1 0.002505604 0.55 (0.37, 0.81) 5.30% 1.03 1.28
C17orf85 NM_018553 -1 0.002505604 0.55 (0.37, 0.81) 5.30% 1.03 1.28
C19orf75 NM_173635 1 0.00067445 1.25 (1.10, 1.41) 2.50% 1.03 1.21
C1orf198 NM_032800 1 0.002616809 1.80 (1.23, 2.63) 5.50% 1.03 1.28
C1orf198 NM_ 001136495 1 0.002616809 1.80 (1.23, 2.63) 5.50% 1.03 1.28
C1orf198 NM_001136494 1 0.002616809 1.80 (1.23, 2.63) 5.50% 1.03 1.28
C1RL NM_016546 -1 0.001589374 0.61 (0.45, 0.83) 4.10% 1.03 1.3
C20orf185 NM_182658 1 0.001202794 1.41 (1.15, 1.74) 3.50% 1.03 1.28
C4orf29 NM_001039717 -1 0.002120732 0.60 (0.43, 0.83) 4.90% 1.03 1.29
C5orf54 NM_022090 -1 0.000954196 0.73 (0.61, 0.88) 3.10% 1.03 1.26
C6orf155 NR_26807 -1 0.002572118 0.55 (0.37, 0.81) 5.40% 1.03 1.27
C7orf63 NM_001160138 -1 0.001543596 0.59 (0.42, 0.82) 4.00% 1.03 1.3
C7orf63 NM_001039706 -1 0.001543596 0.59 (0.42, 0.82) 4.00% 1.03 1.3
C9orf57 NM _001128618 1 0.001866683 1.51 (1.17, 1.96) 4.50% 1.03 1.29
C9orf78 NM_016520 -1 0.002244374 0.54 (0.36, 0.80) 5.00% 1.03 1.28
CASZ1 NM_017766 -1 0.002238185 0.59 (0.43, 0.83) 5.00% 1.03 1.28
CASZ1 NM_001079843 -1 0.002238185 0.59 (0.43, 0.83) 5.00% 1.03 1.29
CBLN4 NM_080617 -1 0.001922952 0.58 (0.41, 0.82) 4.60% 1.03 1.28
CCDC94 NM_018074 -1 0.002570559 0.57 (0.40, 0.82) 5.40% 1.03 1.28
CDK5RAP2 NM_001011649 -1 0.001639429 0.57 (0.40, 0.81) 4.10% 1.03 1.29
CDK5RAP2 NM_018249 -1 0.001639429 0.57 (0.40, 0.81) 4.10% 1.03 1.29
CEP55 NM_018131 1 0.002707603 2.06 (1.28, 3.30) 5.50% 1.03 1.26
CEP55 NM_001127182 1 0.002707603 2.06 (1.28, 3.30) 5.50% 1.03 1.26
CHAT NM_020986 1 0.001696264 1.39 (1.13, 1.70) 4.20% 1.03 1.26
CHAT NM_001142934 1 0.001696264 1.39 (1.13, 1.70) 4.20% 1.03 1.26
CHAT NM_020985 1 0.001696264 1.39 (1.13, 1.70) 4.20% 1.03 1.26
CHAT NM_001142933 1 0.001696264 1.39 (1.13, 1.70) 4.20% 1.03 1.26
CHAT NM_020549 1 0.001696264 1.39 (1.13, 1.70) 4.20% 1.03 1.26
CHAT NM_020984 1 0.001696264 1.39 (1.13,1.70) 4.20% 1.03 1.26
CHAT NM_001142929 1 0.001696264 1.39 (1.13, 1.70) 4.20% 1.03 1.26
COL4A5 NM_033380 -1 0.002200738 0.63 (0.47, 0.85) 5.00% 1.03 1.28
COL4A5 NM_000495 -1 0.002200738 0.63 (0.47, 0.85) 5.00% 1.03 1.28
CRELD2 NM_024324 1 0.001485273 1.40 (1.14, 1.72) 3.90% 1.03 1.27
CRELD2 NM_001135101 1 0.001485273 1.40 (1.14, 1.72) 3.90% 1.03 1.27
CYB5D1 NM_144607 -1 0.001747826 0.58 (0.41, 0.81) 4.30% 1.03 1.29
CYP19A1 NM_000103 1 0.002444512 1.73 (1.21, 2.46) 5.20% 1.03 1.28
CYP19A1 NM_031226 1 0.002444512 1.73 (1.21, 2.46) 5.20% 1.03 1.28
DDX20 NM_007204 -1 0.002289514 0.48 (0.30, 0.77) 5.10% 1.03 1.26
DDX42 NM_007372 1 0.001720318 1.44 (1.15, 1.81) 4.20% 1.03 1.28
DDX42 NM_203499 1 0.001720318 1.44 (1.15, 1.81) 4.20% 1.03 1.28
DEF8 NM_207514 1 0.002624521 2.11 (1.30, 3.43) 5.50% 1.03 1.26
DEF8 NM_017702 1 0.002624521 2.11 (1.30, 3.43) 5.50% 1.03 1.26
DGAT1 NM_012079 1 0.001720682 1.63 (1.20, 2.22) 4.20% 1.03 1.3
DNAJC28 NM_017833 -1 0.001409688 0.66 (0.51, 0.85) 3.80% 1.03 1.29
DNAJC28 NM_001040192 -1 0.001409688 0.66 (0.51, 0.85) 3.80% 1.03 1.29
DYNC1LI2 NM_006141 1 0.002089376 1.61 (1.19, 2.17) 4.80% 1.03 1.29
E2F5 NM_001951 1 0.002136056 2.12 (1.31, 3.43) 4.90% 1.03 1.27
E2F5 NM_001083588 1 0.002136056 2.12 (1.31, 3.43) 4.90% 1.03 1.27
E2F5 NM_001083589 1 0.002136056 2.12 (1.31, 3.43) 4.90% 1.03 1.27
EGOT NR_004428 -1 0.001636301 0.65 (0.50, 0.85) 4.10% 1.03 1.29
ELOVL2 NM_017770 -1 0.002382215 0.62 (0.45, 0.84) 5.20% 1.03 1.28
ELP3 NM_018091 -1 0.002213346 0.61 (0.44, 0.84) 5.00% 1.03 1.29
EVX2 NM_001080458 1 0.001725038 1.37 (1.12, 1.66) 4.20% 1.03 1.26
FANCD2 NM_001018115 1 0.001545769 1.74 (1.23, 2.45) 4.00% 1.03 1.3
FANCD2 NM_033084 1 0.001545769 1.74 (1.23, 2.45) 4.00% 1.03 1.3
FBN3 NM_032447 1 0.001991297 1.57 (1.18, 2.10) 4.70% 1.03 1.29
FEZF1 NM_001160264 1 0.001027358 1.39 (1.14, 1.68) 3.20% 1.03 1.27
FEZF1 NM_001024613 1 0.001027358 1.39 (1.14, 1.68) 3.20% 1.03 1.27
FHL3 NM_004468 -1 0.001474563 0.70 (0.56, 0.87) 3.90% 1.03 1.27
FST NM_013409 -1 0.001727143 0.66 (0.51, 0.85) 4.20% 1.03 1.29
FST NM_006350 -1 0.001727143 0.66 (0.51, 0.85) 4.20% 1.03 1.29
FURIN NM_002569 1 0.002269916 1.64 (1.19, 2.25) 5.10% 1.03 1.29
FUT2 NM_001097638 -1 0.001525692 0.72 (0.59, 0.88) 4.00% 1.03 1.27
FUT2 NM_000511 -1 0.001525692 0.72 (0.59, 0.88) 4.00% 1.03 1.27
GGCX NM_000821 1 0.002396435 1.80 (1.23, 2.62) 5.20% 1.03 1.28
GGCX NM_001142269 1 0.002396435 1.80 (1.23, 2.62) 5.20% 1.03 1.28
GGH NM_003878 1 0.002274114 2.01 (1.28, 3.16) 5.10% 1.03 1.27
GLIPR1L2 NM_152436 -1 0.001862715 0.53 (0.36, 0.79) 4.50% 1.03 1.28
GNG3 NM_012202 -1 0.002062355 0.64 (0.48, 0.85) 4.80% 1.03 1.29
GRINA NM_000837 1 0.001753597 1.62 (1.20, 2.20) 4.30% 1.03 1.3
GRINA NM_001009184 1 0.001753597 1.62 (1.20, 2.20) 4.30% 1.03 1.3
GSTM4 NR_024538 -1 0.001336578 0.65 (0.50, 0.85) 3.70% 1.03 1.29
GSTM4 NM_147148 -1 0.001336578 0.65 (0.50, 0.85) 3.70% 1.03 1.29
GSTM4 NM_000850 -1 0.001336578 0.65 (0.50, 0.85) 3.70% 1.03 1.29
HMMR NM_001142557 1 0.002208484 2.21 (1.33, 3.66) 5.00% 1.03 1.26
HMMR NM_012485 1 0.002208484 2.21 (1.33, 3.66) 5.00% 1.03 1.26
HMMR NM_012484 1 0.002208484 2.21 (1.33, 3.66) 5.00% 1.03 1.26
HMMR NM_001142556 1 0.002208484 2.21 (1.33, 3.66) 5.00% 1.03 1.26
HMX3 NM_01105574 1 0.001618681 1.50 (1.17, 1.93) 4.10% 1.03 1.29
HTATIP2 NM_001098523 1 0.002516349 1.85 (1.24, 2.75) 5.30% 1.03 1.28
HTATIP2 NM_001098520 1 0.002516349 1.85 (1.24, 2.75) 5.30% 1.03 1.28
HTATIP2 NM_001098522 1 0.002516349 1.85 (1.24, 2.75) 5.30% 1.03 1.28
HTATIP2 NM_006410 1 0.002516349 1.85 (1.24, 2.75) 5.30% 1.03 1.28
HTATIP2 NM_001098521 1 0.002516349 1.85 (1.24, 2.75) 5.30% 1.03 1.28
IFT57 NM_018010 -1 0.001435878 0.63 (0.47, 0.84) 3.80% 1.03 1.3
IKBKB NR_033819 -1 0.002214905 0.58 (0.41, 0.82) 5.00% 1.03 1.28
IKBKB NM_001190721 -1 0.002214905 0.58 (0.41, 0.82) 5.00% 1.03 1.28
IKBKB NM_001556 -1 0.002214905 0.58 (0.41, 0.82) 5.00% 1.03 1.28
IKBKB NM_001190722 -1 0.002214905 0.58 (0.41, 0.82) 5.00% 1.03 1.28
IKBKB NR_033818 -1 0.002214905 0.58 (0.41, 0.82) 5.00% 1.03 1.28
IKBKB NM_001190720 -1 0.002214905 0.58 (0.41, 0.82) 5.00% 1.03 1.28
IKBKB NR_033820 -1 0.002214905 0.58 (0.41, 0.82) 5.00% 1.03 1.28
INTS8 NM_017864 1 0.002325883 1.59 (1.18, 2.13) 5.10% 1.03 1.29
IYD NM_001164694 1 0.002010449 1.71 (1.22, 2.40) 4.70% 1.03 1.29
IYD NM_001164695 1 0.002010449 1.71 (1.22, 2.40) 4.70% 1.03 1.29
IYD NM_203395 1 0.002010449 1.71 (1.22, 2.40) 4.70% 1.03 1.29
KBTBD10 NM_006063 -1 0.001722602 0.60 (0.44, 0.83) 4.20% 1.03 1.29
KIAA1310 NM_017991 -1 0.002113999 0.54 (0.37, 0.80) 4.90% 1.03 1.28
KIAA1310 NM_001115016 -1 0.002113999 0.54 (0.37, 0.80) 4.90% 1.03 1.28
KIF25 NM_030615 1 0.002238069 1.56 (1.17, 2.08) 5.00% 1.03 1.29
KIF25 NM_005355 1 0.002238069 1.56 (1.17, 2.08) 5.00% 1.03 1.29
KIF5C NM_004522 -1 0.002437989 0.52 (0.34, 0.79) 5.20% 1.03 1.27
KLRC1 NM_213657 1 0.002384431 1.66 (1.20, 2.31) 5.20% 1.03 1.29
KLRC1 NM_213658 1 0.002384431 1.66 (1.20, 2.31) 5.20% 1.03 1.29
KLRC1 NM_002259 1 0.002384431 1.66 (1.20, 2.31) 5.20% 1.03 1.29
KLRC1 NM_007328 1 0.002384431 1.66 (1.20, 2.31) 5.20% 1.03 1.29
KLRD1 NM_002262 1 0.002060071 1.75 (1.23, 2.50) 4.80% 1.03 1.29
KLRD1 NM_01114396 1 0.002060071 1.75 (1.23, 2.50) 4.80% 1.03 1.29
KLRD1 NM_007334 1 0.002060071 1.75 (1.23, 2.50) 4.80% 1.03 1.29
LAD1 NM_005558 1 0.001800788 1.98 (1.29, 3.04) 4.30% 1.03 1.28
LHX5 NM_022363 1 0.00111698 1.42 (1.15, 1.75) 3.30% 1.03 1.28
LHX9 NM_020204 1 0.00171801 1.41 (1.14, 1.74) 4.20% 1.03 1.27
LHX9 NM_001014434 1 0.00171801 1.41 (1.14, 1.74) 4.20% 1.03 1.27
LOC100289187 NM_001195543 -1 0.002038702 0.55 (0.37, 0.80) 4.70% 1.03 1.28
LOC100289187 NM_001195542 -1 0.002038702 0.55 (0.37, 0.80) 4.70% 1.03 1.28
LOC100289187 NM_001195541 -1 0.002038702 0.55 (0.37, 0.80) 4.70% 1.03 1.28
LOC145474 NR_027046 -1 0.001569524 0.70 (0.56, 0.87) 4.10% 1.03 1.27
LOC284276 NR_915417 -1 0.002303624 0.46 (0.28, 0.76) 5.10% 1.03 1.26
LOC648740 NR_024438 -1 0.002018901 0.63 (0.47, 0.84) 4.70% 1.03 1.29
LRP2 NM_004525 -1 0.002286764 0.61 (0.44, 0.84) 5.10% 1.03 1.28
LRRC39 NM_144620 -1 0.001617813 0.61 (0.45, 0.83) 4.10% 1.03 1.29
LRRC48 NM_031294 -1 0.002131791 0.59 (0.42, 0.83) 4.90% 1.03 1.29
LRRC48 NM_001130092 -1 0.002131791 0.59 (0.42, 0.83) 4.90% 1.03 1.29
LRRC48 NM_001130091 -1 0.002131791 0.59 (0.42, 0.83) 4.90% 1.03 1.29
LRRC48 NM_001130090 -1 0.002131791 0.59 (0.42,0.83) 4.90% 1.03 1.29
METT10D NM_024086 -1 0.002064663 0.55 (0.37, 0.80) 4.80% 1.03 1.28
MIR3143 NR_036096 1 0.001719228 1.51 (1.17, 1.95) 4.20% 1.03 1.29
MIR539 NR_030256 1 0.001267367 1.53 (1.18, 1.98) 3.60% 1.03 1.3
MRPL46 NM_022163 1 0.002420243 1.72 (1.21, 2.44) 5.20% 1.03 1.29
MRPS6 NM_032476 1 0.00225102 1.79 (1.23, 2.61) 5.00% 1.03 1.29
MUC21 NM_001010909 1 0.002145168 1.56 (1.18, 2.08) 4.90% 1.03 1.29
MYBL2 NM_002466 1 0.002287866 1.94 (1.27, 2.96) 5.10% 1.03 1.28
MYO15B NR_003587 -1 0.001947645 0.61 (0.44, 0.83) 4.60% 1.03 1.29
NCAM2 NM_004540 -1 0.002198648 0.57 (0.39, 0.81) 5.00% 1.03 1.28
NEIL3 NM_018248 1 0.002666588 1.89 (1.25, 2.86) 5.50% 1.03 1.27
NEK10 NM_199347 -1 0.002329341 0.54 (0.37, 0.81) 5.10% 1.03 1.28
NEK2 NM_002497 1 0.002473048 2.01 (1.28, 3.15) 5.30% 1.03 1.27
NFXL1 NM_152995 1 0.001183142 1.45 (1.16, 1.82) 3.50% 1.03 1.29
NPPB NM_002521 1 0.000858578 1.35 (1.13, 1.61) 2.90% 1.03 1.26
OGN NM_014057 -1 0.002456696 0.45 (0.27, 0.75) 5.30% 1.03 1.25
OGN NM_033014 -1 0.002456696 0.45 (0.27, 0.75) 5.30% 1.03 1.25
PARD3B NM_205863 -1 0.001655273 0.57 (0.41, 0.81) 4.10% 1.03 1.29
PARD3B NM_057177 -1 0.001655273 0.57 (0.41, 0.81) 4.10% 1.03 1.29
PARD3B NM_152526 -1 0.001655273 0.57 (0.41, 0.81) 4.10% 1.03 1.29
PCM1 NM_006197 -1 0.002032488 0.50 (0.32, 0.78) 4.70% 1.03 1.27
PDE11A NM_001077197 -1 0.001651988 0.64 (0.48, 0.84) 4.10% 1.03 1.29
PDE11A NM_016953 -1 0.001651988 0.64 (0.48, 0.84) 4.10% 1.03 1.29
PDE11A NM_001077196 -1 0.001651988 0.64 (0.48, 0.84) 4.10% 1.03 1.29
PDE11A NM_001077358 -1 0.001651988 0.64 (0.48, 0.84) 4.10% 1.03 1.29
PDIA6 NM_005742 1 0.001634746 1.67 (1.21, 2.29) 4.10% 1.03 1.3
PEX1 NM_000466 -1 0.002362939 0.61 (0.44, 0.84) 5.20% 1.03 1.28
PEX13 NM_002618 1 0.001593701 1.69 (1.22, 2.34) 4.10% 1.03 1.3
PGCP NM_016134 -1 0.001725315 0.60 (0.44, 0.83) 4.20% 1.03 1.29
PGR NM_000926 -1 0.001909419 0.57 (0.40, 0.81) 4.50% 1.03 1.29
PHF2P1 NR_002801 1 0.001167977 1.35 (1.13, 1.62) 3.40% 1.03 1.26
PIK3C2A NM_002645 -1 0.001585299 0.59 (0.43, 0.82) 4.10% 1.03 1.3
PMAIP1 NM_021127 -1 0.001954098 0.64 (0.49, 0.85) 4.60% 1.03 1.29
POMC NM_001035256 1 0.001777068 1.50 (1.16, 1.93) 4.30% 1.03 1.29
POMC NM_000939 1 0.001777068 1.50 (1.16, 1.93) 4.30% 1.03 1.29
PPP1R2P1 NR_027771 1 0.00211075 1.58 (1.18, 2.12) 4.90% 1.03 1.29
PRC1 NM_0003981 1 0.0023281 1.83 (1.24, 2.70) 5.10% 1.03 1.28
PRC1 NM_199414 1 0.0023281 1.83 (1.24, 2.70) 5.10% 1.03 1.28
PRC1 NM_199413 1 0.0023281 1.83 (1.24, 2.70) 5.10% 1.03 1.28
PRSS41 NM_01135086 1 0.000819741 1.29 (1.11, 1.50) 2.80% 1.03 1.24
PVRL4 NM_030916 1 0.002436856 1.77 (1.22, 2.55) 5.20% 1.03 1.28
PVT1 NR_003367 -1 0.000985501 0.76 (0.65, 0.89) 3.10% 1.03 1.24
PYCRL NM_023078 1 0.002594279 2.02 (1.28, 3.20) 5.40% 1.03 1.27
RAB1A NM_004161 1 0.001769368 1.72 (1.22, 2.42) 4.30% 1.03 1.3
RAB1A NM_015543 1 0.001769368 1.72 (1.22, 2.42) 4.30% 1.03 1.3
RAB9BP1 NR_000039 1 0.0016054 1.48 (1.16, 1.89) 4.10% 1.03 1.29
RAET1K NR_024045 1 0.001800197 1.51 (1.16, 1.95) 4.30% 1.03 1.29
RAPGEF5 NM_012294 1 0.002154043 1.56 (1.17, 2.08) 4.90% 1.03 1.29
RBM24 NM_001143941 -1 0.002564648 0.51 (0.33, 0.79) 5.40% 1.03 1.27
RBM24 NM_153020 -1 0.002564648 0.51 (0.33, 0.79) 5.40% 1.03 1.27
RBM24 NM_001143942 -1 0.002564648 0.51 (0.33, 0.79) 5.40% 1.03 1.27
RPL6 NM_000970 -1 0.001139844 0.71 (0.57, 0.87) 3.40% 1.03 1.28
RPL6 NM_ 001024662 -1 0.001139844 0.71 (0.57, 0.87) 3.40% 1.03 1.28
SALL2 NM_005407 -1 0.001427511 0.66 (0.52, 0.85) 3.80% 1.03 1.29
SETBP1 NM_015559 -1 0.002219007 0.52 (0.34, 0.79) 5.00% 1.03 1.27
SETBP1 NM_ 001130110 -1 0.002219007 0.52 (0.34, 0.79) 5.00% 1.03 1.27
SFI1 NM_001007467 -1 0.002372759 0.62 (0.45, 0.84) 5.20% 1.03 1.28
SFI1 NM_014775 -1 0.002372759 0.62 (0.45, 0.84) 5.20% 1.03 1.28
SHC2 NM_012435 -1 0.001912735 0.57 (0.41, 0.82) 4.50% 1.03 1.29
SKA3 NM_145061 1 0.002169941 2.22 (1.33, 3.69) 4.90% 1.03 1.26
SKA3 NM_001166017 1 0.002169941 2.22 (1.33, 3.69) 4.90% 1.03 1.26
SLC25A12 NM_003705 -1 0.002428642 0.58 (0.40, 0.82) 5.20% 1.03 1.28
SNCB NM_001001502 1 0.00093158 1.37 (1.14, 1.66) 3.00% 1.03 1.27
SNCB NM_003085 1 0.00093158 1.37 (1.14, 1.66) 3.00% 1.03 1.27
SNORA4 NR_02588 1 0.002448167 1.75 (1.22, 2.50) 5.20% 1.03 1.28
SNX29 NML001080530 -1 0.002032127 0.66 (0.51, 0.86) 4.70% 1.03 1.28
SPRYD5 NM_0032681 1 0.001186552 1.40 (1.14, 1.72) 3.50% 1.03 1.27
SRD5A1 NM_001047 1 0.001898168 1.80 (1.24, 2.62) 4.50% 1.03 1.29
SRM NM_003132 1 0.00241018 2.18 (1.32, 3.59) 5.20% 1.03 1.26
STK36 NM_015690 -1 0.001844542 0.61 (0.44, 0.83) 4.40% 1.03 1.29
SUCLG1 NM_003849 1 0.00282029 2.20 (1.31, 3.68) 5.60% 1.03 1.25
SYNC NM_030786 -1 0.001703858 0.62 (0.46, 0.84) 4.20% 1.03 1.29
SYNC NM_001161708 -1 0.001703858 0.62 (0.46, 0.84) 4.20% 1.03 1.29
TBX3 NM_005996 -1 0.001955061 0.60 (0.44, 0.83) 4.60% 1.03 1.29
TBX3 NM_016569 -1 0.001955061 0.60 (0.44, 0.83) 4.60% 1.03 1.29
TMEM165 NM_018475 1 0.00206432 1.59 (1.18, 2.13) 4.80% 1.03 1.29
TMEM214 NM_017727 1 0.001586499 1.76 (1.24, 2.50) 4.10% 1.03 1.3
TMEM214 NM_001083590 1 0.001586499 1.76 (1.24, 2.50) 4.10% 1.03 1.3
TPRG1 NM_198485 1 0.001640284 0.56 (0.39, 0.81) 4.10% 1.03 1.29
TRIM10 NM_052828 1 0.000954844 1.38 (1.14, 1.68) 3.10% 1.03 1.27
TRIM10 NM_006778 1 0.000954844 1.38 (1.14, 1.68) 3.10% 1.03 1.27
TRIM8 NM_030912 -1 0.001839592 0.60 (0.44, 0.83) 4.40% 1.03 1.29
UBA6 NM_018227 1 0.001297805 1.52 (1.18, 1.96) 3.60% 1.03 1.3
UGT2A1 NM_006798 1 0.001411139 1.31 (1.11, 1.55) 3.80% 1.03 1.24
USP16 NM_006447 -1 0.001528441 0.58 (0.41, 0.81) 4.00% 1.03 1.3
USP16 NM_001032410 -1 0.001528441 0.58 (0.41, 0.81) 4.00% 1.03 1.3
USP16 NM_001001992 -1 0.001528441 0.58 (0.41, 0.81) 4.00% 1.03 1.3
WDR26 NM_025160 1 0.002023353 1.90 (1.26, 2.85) 4.70% 1.03 1.28
WDR26 NM_01115113 1 0.002023353 1.90 (1.26, 2.85) 4.70% 1.03 1.28
WDR81 NM_001163673 -1 0.001691753 0.60 (0.43, 0.82) 4.20% 1.03 1.29
WDR81 NM_152348 -1 0.001691753 0.60 (0.43, 0.82) 4.20% 1.03 1.29
WDR81 NM_001163811 -1 0.001691753 0.60 (0.43, 0.82) 4.20% 1.03 1.29
WDR81 NM_LP01163809 -1 0.001691753 0.60 (0.43, 0.82) 4.20% 1.03 1.29
YPEL3 NM_001145524 -1 0.001617231 0.58 (0.41, 0.81) 4.10% 1.03 1.29
YPEL3 NM_031477 -1 0.001617231 0.58 (0.41, 0.81) 4.10% 1.03 1.29
ZBTB1 NM_001123329 -1 0.00145875 0.67 (0.53, 0.86) 3.90% 1.03 1.29
ZBTB1 NM_014950 -1 0.00145875 0.67 (0.53, 0.86) 3.90% 1.03 1.29
ZFHX2 NM_033400 -1 0.002397291 0.58 (0.41, 0.82) 5.20% 1.03 1.28
ZMAT1 NR_036431 -1 0.002074568 0.55 (0.38, 0.81) 4.80% 1.03 1.28
ZMAT1 NM_001011657 -1 0.002074568 0.55 (0.38, 0.81) 4.80% 1.03 1.28
ZNF219 NM_016423 -1 0.001654385 0.59 (0.43, 0.82) 4.10% 1.03 1.29
ZNF219 NM_001101672 -1 0.001654385 0.59 (0.43, 0.82) 4.10% 1.03 1.29
ZNF219 NM_001102454 -1 0.001654385 0.59 (0.43, 0.82) 4.10% 1.03 1.29
ZNF682 NM_001077349 -1 0.001906028 0.61 (0.44, 0.83) 4.50% 1.03 1.29
ZNF682 NM_033196 -1 0.001906028 0.61 (0.44, 0.83) 4.50% 1.03 1.29
ZNF705D NM_001039615 1 0.001227404 1.35 (1.13, 1.62) 3.50% 1.03 1.26
ZNF747 NM_023931 -1 0.002131843 0.64 (0.48, 0.85) 4.90% 1.03 1.28
ZNF808 NM_001039886 -1 0.002223951 0.52 (0.34, 0.79) 5.00% 1.03 1.27
ABCA11P NR_002451 -1 0.002873693 0.67 (0.51, 0.87) 5.70% 1.02 1.27
ABCA12 NM_015657 1 0.00300345 1.71 (1.20, 2.44) 5.80% 1.02 1.28
ABCA12 NM_173076 1 0.00300345 1.71 (1.20, 2.44) 5.80% 1.02 1.28
AMT NM_000481 -1 0.002804366 0.65 (0.50, 0.86) 5.60% 1.02 1.27
AMT NM_001164711 -1 0.002804366 0.65 (0.50, 0.86) 5.60% 1.02 1.27
AMT NM_001164710 -1 0.002804366 0.65 (0.50, 0.86) 5.60% 1.02 1.27
AMT NM_001164712 -1 0.002804366 0.65 (0.50, 0.86) 5.60% 1.02 1.27
AMT NR_028435 -1 0.002804366 0.65 (0.50, 0.86) 5.60% 1.02 1.27
ANAPC2 NM_013366 -1 0.00312125 0.66 (0.50, 0.87) 6.00% 1.02 1.27
ANKRA2 NM_023039 -1 0.002819729 0.55 (0.37, 0.81) 5.60% 1.02 1.27
AP2M1 NM_001025205 1 0.002571858 1.57 (1.17, 2.11) 5.40% 1.02 1.28
AP2M1 NM_004068 1 0.002571858 1.57 (1.17, 2.11) 5.40% 1.02 1.28
ARF1 NM_001024227 1 0.003644362 1.90 (1.23, 2.92) 6.50% 1.02 1.26
ARF1 NM_001658 1 0.003644362 1.90 (1.23, 2.92) 6.50% 1.02 1.26
ARF1 NM_001024228 1 0.003644362 1.90 (1.23, 2.92) 6.50% 1.02 1.26
ARF1 NM_001024226 1 0.003644362 1.90 (1.23, 2.92) 6.50% 1.02 1.26
ATAD1 NM_032810 -1 0.004007343 0.63 (0.45, 0.86) 6.80% 1.02 1.27
ATOH7 NM_145178 1 0.00372128 1.46 (1.13, 1.90) 6.60% 1.02 1.26
ATP9B NM_198531 -1 0.002646669 0.58 (0.41, 0.83) 5.50% 1.02 1.28
ATXN3L NM_001135995 1 0.002748019 1.28 (1.09, 1.50) 5.60% 1.02 1.22
BCL2L2 NM_004050 -1 0.003979713 0.49 (0.31, 0.80) 6.80% 1.02 1.24
BCL2L2 NM_001199839 -1 0.003979713 0.49 (0.31, 0.80) 6.80% 1.02 1.24
BENDS NM_024603 -1 0.00262047 0.59 (0.42, 0.83) 5.50% 1.02 1.28
BLM NM_000057 1 0.003237886 1.81 (1.22, 2.69) 6.10% 1.02 1.27
C10orf79 NM_025145 -1 0.003108477 0.64 (0.48, 0.86) 6.00% 1.02 1.27
C10orf91 NM_173541 1 0.002971656 1.41 (1.13, 1.78) 5.80% 1.02 1.26
C14orf34 NR_026796 1 0.0029697 1.65 (1.19, 2.29) 5.80% 1.02 1.28
C14orf34 NR_026797 1 0.0029697 1.65 (1.19, 2.29) 5.80% 1.02 1.28
C15orf39 NM_015492 1 0.002808036 1.64 (1.19, 2.28) 5.60% 1.02 1.28
C15orf42 NM_152259 1 0.004003005 1.73 (1.19, 2.51) 6.80% 1.02 1.27
C17orf48 NM_020233 -1 0.003577923 0.69 (0.54, 0.89) 6.40% 1.02 1.26
C17orf49 NM_001142798 -1 0.003771563 0.57 (0.39, 0.83) 6.60% 1.02 1.26
C17orf49 NM_174893 -1 0.003771563 0.57 (0.39, 0.83) 6.60% 1.02 1.26
C17orf49 NM_001142799 -1 0.003771563 0.57 (0.39, 0.83) 6.60% 1.02 1.26
C18orf26 NM_173629 1 0.002705318 1.52 (1.16, 1.99) 5.50% 1.02 1.28
C1orf131 NM_152379 1 0.003424964 1.93 (1.24, 2.99) 6.30% 1.02 1.26
C1orf173 NM_001002912 -1 0.003149398 0.57 (0.39, 0.83) 6.00% 1.02 1.27
Clorf63 NM_020317 -1 0.004174801 0.53 (0.34, 0.82) 7.00% 1.02 1.25
C20orf26 NM_001167816 -1 0.004008624 0.56 (0.38, 0.83) 6.80% 1.02 1.26
C20orf26 NM_015585 -1 0.004008624 0.56 (0.38, 0.83) 6.80% 1.02 1.26
C3orf25 NM_207307 -1 0.004109239 0.58 (0.39, 0.84) 6.90% 1.02 1.26
C4orf32 NM_152400 -1 0.00283046 0.60 (0.43, 0.84) 5.60% 1.02 1.28
C6orf97 NM_025059 -1 0.003169135 0.63 (0.46, 0.86) 6.00% 1.02 1.27
C7orf54 NR_027330 1 0.002867207 1.97 (1.26, 3.07) 5.70% 1.02 1.27
C9orf53 NR_024274 1 0.002759518 1.53 (1.16, 2.03) 5.60% 1.02 1.28
CAP2 NM_006366 -1 0.002320274 0.65 (0.49, 0.86) 5.10% 1.02 1.28
CASP14 NM_012114 1 0.003818253 1.57 (1.16, 2.13) 6.70% 1.02 1.27
CBX2 NM_032647 1 0.003622138 1.74 (1.20, 2.53) 6.50% 1.02 1.27
CBX2 NM_005189 1 0.003622138 1.74 (1.20, 2.53) 6.50% 1.02 1.27
CCDC104 NM_080667 -1 0.003352077 0.57 (0.39, 0.83) 6.20% 1.02 1.27
CCDC3 NM_031455 -1 0.002624067 0.58 (0.41, 0.83) 5.50% 1.02 1.28
CCDC76 NM_019083 -1 0.003763724 0.52 (0.34, 0.81) 6.60% 1.02 1.25
CCNH NM_001239 -1 0.002673892 0.64 (0.48, 0.86) 5.50% 1.02 1.28
CCNH NM_00199189 -1 0.002673892 0.64 (0.48, 0.86) 5.50% 1.02 1.28
CD1E NM_001042583 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001185112 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001185113 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001185114 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001185110 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001042584 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001185108 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001042585 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001042586 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001042587 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001185107 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_030893 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CD1E NM_001185115 -1 0.002526018 0.60 (0.44, 0.84) 5.40% 1.02 1.28
CDC6 NM_001254 1 0.002718983 1.76 (1.22, 2.55) 5.50% 1.02 1.28
CDRT1 NM_006382 1 0.003880336 1.65 (1.17, 2.32) 6.70% 1.02 1.27
CENPE NM_001813 1 0.002827598 1.93 (1.25, 2.97) 5.60% 1.02 1.27
CHEK1 NM_001274 1 0.002862306 1.81 (1.23, 2.67) 5.70% 1.02 1.28
CHEK1 NM_001114122 1 0.002862306 1.81 (1.23, 2.67) 5.70% 1.02 1.28
CHEK1 NM_001114121 1 0.002862306 1.81 (1.23, 2.67) 5.70% 1.02 1.28
CHML NM_001821 1 0.003315346 1.64 (1.18, 2.29) 6.20% 1.02 1.28
CIRBP NM_001280 -1 0.004062264 0.61 (0.43, 0.85) 6.90% 1.02 1.27
CIRBP NR_023313 -1 0.004062264 0.61 (0.43, 0.85) 6.90% 1.02 1.27
CIRBP NR_023312 -1 0.004062264 0.61 (0.43, 0.85) 6.90% 1.02 1.27
CLCN1 NM_000083 1 0.003227573 1.40 (1.12, 1.75) 6.10% 1.02 1.26
CMAS NM_018686 1 0.002866433 1.48 (1.14, 1.91) 5.70% 1.02 1.27
CNGB3 NM_019098 1 0.00409123 1.81 (1.21, 2.71) 6.90% 1.02 1.26
COL6A4P1 NR_027927 1 0.003761834 1.50 (1.14, 1.97) 6.60% 1.02 1.27
COX8C NM_182971 1 0.003378935 1.36 (1.11, 1.68) 6.20% 1.02 1.25
CPLX1 NM_006651 -1 0.002909325 0.64 (0.47, 0.86) 5.70% 1.02 1.28
CRABP1 NM_004378 1 0.002927588 1.69 (1.20, 2.38) 5.70% 1.02 1.28
CREBBP NM_004380 -1 0.003871914 0.54 (0.36, 0.82) 6.70% 1.02 1.26
CREBBP NM_001079846 -1 0.003871914 0.54 (0.36, 0.82) 6.70% 1.02 1.26
CSDC2 NM_014460 -1 0.004125038 0.59 (0.41, 0.84) 6.90% 1.02 1.26
CYC1 NM_001916 1 0.003973641 1.69 (1.18, 2.42) 6.80% 1.02 1.27
DEFB135 NM_001033017 1 0.002321015 1.51 (1.16, 1.96) 5.10% 1.02 1.28
DIAPH1 NM_005219 1 0.004027699 1.70 (1.18, 2.44) 6.90% 1.02 1.27
DIAPH1 NM_001079812 1 0.004027699 1.70 (1.18, 2.44) 6.90% 1.02 1.27
DIXDC1 NM_01037954 -1 0.003336293 0.60 (0.43, 0.84) 6.20% 1.02 1.27
DIXDC1 NM_033425 -1 0.003336293 0.60 (0.43, 0.84) 6.20% 1.02 1.27
DKK3 NM_013253 -1 0.00325914 0.70 (0.55, 0.89) 6.10% 1.02 1.26
DKK3 NM_015881 -1 0.00325914 0.70 (0.55, 0.89) 6.10% 1.02 1.26
DKK3 NM_001018057 -1 0.00325914 0.70 (0.55, 0.89) 6.10% 1.02 1.26
DNAJC12 NM_021800 -1 0.003141124 0.61 (0.43, 0.84) 6.00% 1.02 1.27
DNAJC12 NM_201262 -1 0.003141124 0.61 (0.43, 0.84) 6.00% 1.02 1.27
DNMT3B NM_175848 1 0.002642423 1.68 (1.20, 2.36) 5.50% 1.02 1.28
DNMT3B NM_006892 1 0.002642423 1.68 (1.20, 2.36) 5.50% 1.02 1.28
DNMT3B NM_175849 1 0.002642423 1.68 (1.20, 2.36) 5.50% 1.02 1.28
DNMT3B NM_175850 1 0.002642423 1.68 (1.20, 2.36) 5.50% 1.02 1.28
DOC2GP NR_033791 1 0.001636762 1.29 (1.10, 1.52) 4.10% 1.02 1.23
DOK1 NM_001381 -1 0.002983362 0.54 (0.35, 0.81) 5.80% 1.02 1.27
DOK1 NM_001197260 -1 0.002983362 0.54 (0.35, 0.81) 5.80% 1.02 1.27
DUSP13 NM_001007273 1 0.002852767 1.66 (1.19, 2.30) 5.70% 1.02 1.28
DUSP13 NM_001007271 1 0.002852767 1.66 (1.19, 2.30) 5.70% 1.02 1.28
DUSP13 NM_001007272 1 0.002852767 1.66 (1.19, 2.30) 5.70% 1.02 1.28
DUSP13 NM_016364 1 0.002852767 1.66 (1.19, 2.30) 5.70% 1.02 1.28
E2F1 NM_005225 1 0.002966928 1.81 (1.22, 2.68) 5.80% 1.02 1.27
ESRP2 NM_024939 1 0.004340825 1.90 (1.22, 2.96) 7.10% 1.02 1.25
EVL NM_016337 -1 0.003294207 0.50 (0.31, 0.79) 6.20% 1.02 1.25
FADS1 NM_013402 1 0.003861317 1.69 (1.18, 2.41) 6.70% 1.02 1.27
FAM110B NM_147189 -1 0.002415136 0.69 (0.54, 0.88) 5.20% 1.02 1.27
FAM161A NM_032180 -1 0.003214575 0.68 (0.52, 0.88) 6.10% 1.02 1.27
FAM26E NM_153711 -1 0.003603321 0.63 (0.46, 0.86) 6.40% 1.02 1.27
FBP1 NM_000507 -1 0.004003056 0.59 (0.41, 0.85) 6.80% 1.02 1.26
FBP1 NM_001127628 -1 0.004003056 0.59 (0.41, 0.85) 6.80% 1.02 1.26
FLI37201 NR_026835 -1 0.003681387 0.62 (0.45, 0.86) 6.50% 1.02 1.27
FRY NM_023037 -1 0.002884774 0.53 (0.35,0.80) 5.70% 1.02 1.27
GSTA2 NM_000846 1 0.003594941 1.43 (1.12, 1.82) 6.40% 1.02 1.26
GUCA1A NM_000409 1 0.003909224 1.58 (1.16, 2.15) 6.70% 1.02 1.27
HIST1H1C NM_005319 1 0.003225985 1.68 (1.19, 2.38) 6.10% 1.02 1.28
HIST1H2AG NM_021064 1 0.003513384 2.14 (1.28, 3.56) 6.40% 1.02 1.25
HIST1H2AH NM_080596 1 0.003239424 1.96 (1.25, 3.06) 6.10% 1.02 1.26
HIST1H2AL NM_003511 1 0.003196371 2.03 (1.27, 3.26) 6.10% 1.02 1.26
HJURP NM_018410 1 0.003065128 1.91 (1.24, 2.93) 5.90% 1.02 1.27
HMGB3 NM_005342 1 0.003821392 1.67 (1.18, 2.35) 6.70% 1.02 1.27
HPGDS NM_014485 -1 0.003509052 0.67 (0.51, 0.88) 6.40% 1.02 1.27
ICA1L NM_138468 -1 0.003324089 0.60 (0.42, 0.84) 6.20% 1.02 1.27
ICA1L NM_178231 -1 0.003324089 0.60 (0.42, 0.84) 6.20% 1.02 1.27
INCA1 NM_001167987 -1 0.003836717 0.62 (0.45, 0.86) 6.70% 1.02 1.27
INCA1 NM_001167986 -1 0.003836717 0.62 (0.45, 0.86) 6.70% 1.02 1.27
INCA1 NM_001167985 -1 0.003836717 0.62 (0.45, 0.86) 6.70% 1.02 1.27
INCA1 NM_213726 -1 0.003836717 0.62 (0.45, 0.86) 6.70% 1.02 1.27
KIAA0556 NM_015202 -1 0.00378804 0.58 (0.40, 0.84) 6.70% 1.02 1.26
KIAA0649 NM_014911 -1 0.003489552 0.60 (0.43, 0.85) 6.30% 1.02 1.27
KIAA1632 NM_020964 -1 0.004110188 0.57 (0.39, 0.84) 6.90% 1.02 1.26
KIF11 NM_004523 1 0.003849177 1.77 (1.20, 2.61) 6.70% 1.02 1.27
KIF13B NM_015254 -1 0.003183516 0.56 (0.38, 0.82) 6.00% 1.02 1.27
KIF18B NM_001080443 1 0.004363327 1.89 (1.22, 2.92) 7.10% 1.02 1.25
KIF2C NM_006845 1 0.004041299 2.10 (1.27, 3.49) 6.90% 1.02 1.24
KLHDC2 NM_014315 -1 0.002795444 0.59 (0.42, 0.84) 5.60% 1.02 1.28
KLHDC4 NM_001184856 1 0.004284709 2.00 (1.24, 3.21) 7.10% 1.02 1.25
KLHDC4 NM_001184854 1 0.004284709 2.00 (1.24, 3.21) 7.10% 1.02 1.25
KLHDC4 NM_017566 1 0.004284709 2.00 (1.24, 3.21) 7.10% 1.02 1.25
LEMD1 NM_001001552 1 0.003532642 1.43 (1.12, 1.82) 6.40% 1.02 1.26
LEMD1 NM_001199051 1 0.003532642 1.43 (1.12, 1.82) 6.40% 1.02 1.26
LEMD1 NM_001199052 1 0.003532642 1.43 (1.12, 1.82) 6.40% 1.02 1.26
LEMD1 NR_037583 1 0.003532642 1.43 (1.12, 1.82) 6.40% 1.02 1.26
LEMD1 NM_001199050 1 0.003532642 1.43 (1.12, 1.82) 6.40% 1.02 1.26
LETMD1 NM_015416 -1 0.003381908 0.55 (0.37, 0.82) 6.20% 1.02 1.26
LETMD1 NM_001024668 -1 0.003381908 0.55 (0.37, 0.82) 6.20% 1.02 1.26
LOC100128338 NR_033849 1 0.003117505 1.65 (1.18, 2.29) 6.00% 1.02 1.28
LOC100190938 NR_024462 -1 0.003341277 0.64 (0.47, 0.86) 6.20% 1.02 1.27
LOC100190938 NR_024461 -1 0.003341277 0.64 (0.47, 0.86) 6.20% 1.02 1.27
LOC254559 NR_015411 1 0.003591948 1.78 (1.21, 2.63) 6.40% 1.02 1.27
LOC285577 NR_033898 1 0.002606176 1.24 (1.08, 1.43) 5.50% 1.02 1.2
LOC401177 NR_033975 1 0.001598219 1.23 (1.08, 1.40) 4.10% 1.02 1.2
LOC646960 NM_001195129 1 0.002275041 1.35 (1.11, 1.64) 5.10% 1.02 1.25
LOC728606 NR_024259 -1 0.003080953 0.56 (0.38, 0.82) 5.90% 1.02 1.27
LOC90834 NR_026993 1 0.002787462 1.49 (1.15, 1.93) 5.60% 1.02 1.27
LRP12 NM_001135703 1 0.003559777 1.69 (1.19, 2.41) 6.40% 1.02 1.27
LRP12 NM_013437 1 0.003559777 1.69 (1.19, 2.41) 6.40% 1.02 1.27
LRP8 NM_004631 1 0.003269601 1.87 (1.23, 2.84) 6.10% 1.02 1.27
LRP8 NM_017522 1 0.003269601 1.87 (1.23, 2.84) 6.10% 1.02 1.27
LRP8 NM_033300 1 0.003269601 1.87 (1.23, 2.84) 6.10% 1.02 1.27
LRP8 NM_001018054 1 0.003269601 1.87 (1.23, 2.84) 6.10% 1.02 1.27
LRRC4C NM_020929 -1 0.003685417 0.56 (0.38, 0.83) 6.50% 1.02 1.26
LSM4 NM_012321 1 0.002719555 1.53 (1.16, 2.01) 5.50% 1.02 1.28
MACF1 NM_033044 -1 0.003907446 0.59 (0.42, 0.85) 6.70% 1.02 1.27
MACF1 NM_012090 -1 0.003907446 0.59 (0.42, 0.85) 6.70% 1.02 1.27
MBIP NM_016586 1 0.00342382 1.87 (1.23, 2.86) 6.30% 1.02 1.26
MBIP NM_001144891 1 0.00342382 1.87 (1.23, 2.86) 6.30% 1.02 1.26
MGC87042 NM_207342 1 0.002700608 1.46 (1.14, 1.87) 5.50% 1.02 1.27
MGC87042 NM_001164460 1 0.002700608 1.46 (1.14, 1.87) 5.50% 1.02 1.27
MIR542 NR_030399 1 0.002819598 1.53 (1.16, 2.01) 5.60% 1.02 1.28
MTHFD2 NM_006636 1 0.00387651 1.72 (1.19, 2.47) 6.70% 1.02 1.27
MTHFD2 NR_027405 1 0.00387651 1.72 (1.19, 2.47) 6.70% 1.02 1.27
NCRNA00168 NR_033387 1 0.002775618 1.39 (1.12, 1.72) 5.60% 1.02 1.26
NCRNA00242 NR_026781 -1 0.003823018 0.54 (0.36, 0.82) 6.70% 1.02 1.26
NCRNA00287 NR_026677 -1 0.002783862 0.60 (0.43, 0.84) 5.60% 1.02 1.28
NHSL1 NM_020464 1 0.003334053 1.72 (1.20, 2.48) 6.20% 1.02 1.27
NHSL1 NM_001144060 1 0.003334053 1.72 (1.20, 2.48) 6.20% 1.02 1.27
NTRK3 NM_001012338 -1 0.003070056 0.57 (0.40, 0.83) 5.90% 1.02 1.27
NTRK3 NM_002530 -1 0.003070056 0.57 (0.40, 0.83) 5.90% 1.02 1.27
NTRK3 NM_001007156 -1 0.003070056 0.57 (0.40, 0.83) 5.90% 1.02 1.27
NUDT15 NM_018283 1 0.003029893 1.74 (1.21, 2.52) 5.90% 1.02 1.28
NUDT16P1 NR_027766 -1 0.00283035 0.66 (0.51, 0.87) 5.60% 1.02 1.27
NUDT16P1 NR_002949 -1 0.00283035 0.66 (0.51, 0.87) 5.60% 1.02 1.27
NUDT21 NM_007006 1 0.002332854 1.57 (1.17, 2.10) 5.10% 1.02 1.29
NUP155 NM_004298 1 0.002877998 1.74 (1.21, 2.51) 5.70% 1.02 1.28
NUP155 NM_153485 1 0.002877998 1.74 (1.21, 2.51) 5.70% 1.02 1.28
NXPH4 NM_007224 1 0.003577666 1.74 (1.20, 2.53) 6.40% 1.02 1.27
OR2A4 NM_030908 1 0.002718898 1.46 (1.14, 1.86) 5.50% 1.02 1.27
OR2W5 NM_001004698 1 0.001067476 1.21 (1.08, 1.36) 3.30% 1.02 1.19
P2RY13 NM_176894 -1 0.002437174 0.65 (0.50, 0.86) 5.20% 1.02 1.28
PALM NM_002579 -1 0.003697526 0.67 (0.51, 0.88) 6.50% 1.02 1.26
PALM NM_001040134 -1 0.003697526 0.67 (0.51, 0.88) 6.50% 1.02 1.26
PCDH11X NM_032969 1 0.002679604 1.52 (1.16, 2.01) 5.50% 1.02 1.28
PCDH11X NM_001168360 1 0.002679604 1.52 (1.16, 2.01) 5.50% 1.02 1.28
PCDH11X NM_032969 1 0.002679604 1.52 (1.16, 2.01) 5.50% 1.02 1.28
PCDH11X NM_032967 1 0.002679604 1.52 (1.16, 2.01) 5.50% 1.02 1.28
PCDH11X NM_001168363 1 0.002679604 1.52 (1.16, 2.01) 5.50% 1.02 1.28
PCDH11X NM_001168362 1 0.002679604 1.52 (1.16, 2.01) 5.50% 1.02 1.28
PCDH11X NM_001168361 1 0.002679604 1.52 (1.16, 2.01) 5.50% 1.02 1.28
PCDH11X NM_014522 1 0.002679604 1.52 (1.16, 2.01) 5.50% 1.02 1.28
PCSK4 NM_017573 -1 0.002585422 0.60 (0.43, 0.84) 5.40% 1.02 1.28
PCSK5 NM_006200 -1 0.002479594 0.71 (0.56, 0.88) 5.30% 1.02 1.26
PCSK5 NM_001190482 -1 0.002479594 0.71 (0.56, 0.88) 5.30% 1.02 1.26
PCTP NM_001102402 1 0.00297204 1.62 (1.18, 2.22) 5.80% 1.02 1.28
PCTP NM_021213 1 0.00297204 1.62 (1.18, 2.22) 5.80% 1.02 1.28
PLTP NM_006227 1 0.00399448 1.58 (1.16, 2.16) 6.80% 1.02 1.27
PLTP NM_182676 1 0.00399448 1.58 (1.16, 2.16) 6.80% 1.02 1.27
PNLIP NM_000936 1 0.00197645 1.31 (1.11, 1.56) 4.70% 1.02 1.24
PODXL2 NM_015720 1 0.003706982 1.91 (1.23, 2.96) 6.60% 1.02 1.26
PPP1R14B NM_138689 1 0.002581467 1.64 (1.19, 2.26) 5.40% 1.02 1.28
PPP1R3C NM_005398 -1 0.003328551 0.61 (0.44, 0.85) 6.20% 1.02 1.27
PRRC2B NM_013318 -1 0.004341057 0.51 (0.32, 0.81) 7.10% 1.02 1.24
PSMD2 NM_002808 1 0.003173532 1.76 (1.21, 2.56) 6.00% 1.02 1.27
PUF60 NM_001136033 1 0.003952504 1.67 (1.18, 2.36) 6.80% 1.02 1.27
PUF60 NM_014281 1 0.003952504 1.67 (1.18, 2.36) 6.80% 1.02 1.27
PUF60 NM_078480 1 0.003952504 1.67 (1.18, 2.36) 6.80% 1.02 1.27
RABEP1 NM_001083585 -1 0.003501962 0.54 (0.35, 0.82) 6.40% 1.02 1.26
RABEP1 NM_004703 -1 0.003501962 0.54 (0.35, 0.82) 6.40% 1.02 1.26
RABGAP1 NM_012197 -1 0.003415188 0.54 (0.36, 0.82) 6.30% 1.02 1.26
RIPK4 NM_020639 1 0.003549519 2.23 (1.30, 3.83) 6.40% 1.02 1.24
RNF214 NM_207343 -1 0.002544607 0.63 (0.47, 0.85) 5.40% 1.02 1.28
RNF214 NM_001077239 -1 0.002544607 0.63 (0.47, 0.85) 5.40% 1.02 1.28
RPPH1 NR_002312 1 0.00400948 1.72 (1.19, 2.48) 6.80% 1.02 1.27
SCNN1D NM_002978 -1 0.002973296 0.60 (0.42, 0.84) 5.80% 1.02 1.28
SCNN1D NR_037668 -1 0.002973296 0.60 (0.42, 0.84) 5.80% 1.02 1.28
SCNN1D NM_001130413 -1 0.002973296 0.60 (0.42, 0.84) 5.80% 1.02 1.28
SCRT2 NM_033129 1 0.001721059 1.23 (1.08, 1.41) 4.20% 1.02 1.2
SDCCAG3 NM_001039707 1 0.003470913 1.88 (1.23, 2.88) 6.30% 1.02 1.26
SDCCAG3 NM_001039708 1 0.003470913 1.88 (1.23, 2.88) 6.30% 1.02 1.26
SDCCAG3 NM_006643 1 0.003470913 1.88 (1.23, 2.88) 6.30% 1.02 1.26
SERINC5 NM_178276 1 0.003590438 1.51 (1.14, 2.00) 6.40% 1.02 1.27
SERINC5 NM_001174071 1 0.003590438 1.51 (1.14, 2.00) 6.40% 1.02 1.27
SERINC5 NM_001174072 1 0.003590438 1.51 (1.14, 2.00) 6.40% 1.02 1.27
SEZ6L NM_001184776 -1 0.004348114 0.49 (0.30, 0.80) 7.10% 1.02 1.24
SEZ6L NM_021115 -1 0.004348114 0.49 (0.30, 0.80) 7.10% 1.02 1.24
SEZ6L NM_001184777 -1 0.004348114 0.49 (0.30, 0.80) 7.10% 1.02 1.24
SEZ6L NM_001184775 -1 0.004348114 0.49 (0.30, 0.80) 7.10% 1.02 1.24
SEZ6L NM_001184774 -1 0.004348114 0.49 (0.30, 0.80) 7.10% 1.02 1.24
SEZ6L NM_001184773 -1 0.004348114 0.49 (0.30, 0.80) 7.10% 1.02 1.24
SGSM2 NM_014853 -1 0.002777129 0.55 (0.38, 0.82) 5.60% 1.02 1.27
SGSM2 NM_001098509 -1 0.002777129 0.55 (0.38, 0.82) 5.60% 1.02 1.27
SLC15A1 NM_005073 1 0.003057481 1.64 (1.18, 2.28) 5.90% 1.02 1.28
SLC26A6 NM_022911 1 0.002410675 1.55 (1.17, 2.05) 5.20% 1.02 1.28
SLC26A6 NM_134426 1 0.002410675 1.55 (1.17, 2.05) 5.20% 1.02 1.28
SLC26A6 NM_134263 1 0.002410675 1.55 (1.17, 2.05) 5.20% 1.02 1.28
SLC26A6 NM_001040454 1 0.002410675 1.55 (1.17, 2.05) 5.20% 1.02 1.28
SLC7A5 NM_003486 1 0.003613709 1.88 (1.23, 2.89) 6.50% 1.02 1.26
SLC7A8 NM_182728 -1 0.00381186 0.63 (0.46, 0.86) 6.70% 1.02 1.27
SLC7A8 NM_012244 -1 0.00381186 0.63 (0.46, 0.86) 6.70% 1.02 1.27
SMG1 NM_015092 -1 0.003487141 0.57 (0.39, 0.83) 6.30% 1.02 1.27
SNRPD3 NM_004175 1 0.003488489 1.54 (1.15, 2.07) 6.30% 1.02 1.27
SPPL2B NM_152988 -1 0.003064537 0.64 (0.48, 0.86) 5.90% 1.02 1.27
SPPL2B NM_001077238 -1 0.003064537 0.64 (0.48, 0.86) 5.90% 1.02 1.27
ST8SIA6 NM_001004470 -1 0.002791716 0.61 (0.44, 0.84) 5.60% 1.02 1.28
STAU2 NM_001164380 1 0.002783168 1.62 (1.18, 2.22) 5.60% 1.02 1.28
STAU2 NM_014393 1 0.002783168 1.62 (1.18, 2.22) 5.60% 1.02 1.28
STAU2 NM_001164384 1 0.002783168 1.62 (1.18, 2.22) 5.60% 1.02 1.28
STAU2 NM_001164382 1 0.002783168 1.62 (1.18, 2.22) 5.60% 1.02 1.28
STAU2 NM_001164381 1 0.002783168 1.62 (1.18, 2.22) 5.60% 1.02 1.28
STAU2 NM_001164385 1 0.002783168 1.62 (1.18, 2.22) 5.60% 1.02 1.28
STAU2 NM_001164383 1 0.002783168 1.62 (1.18, 2.22) 5.60% 1.02 1.28
STC2 NM_003714 -1 0.002916534 0.54 (0.35, 0.81) 5.70% 1.02 1.27
SYT5 NM_003180 1 0.002277553 1.32 (1.10, 1.58) 5.10% 1.02 1.24
SYT9 NM_175733 -1 0.003474054 0.65 (0.48, 0.87) 6.30% 1.02 1.27
TAAR6 NM_175067 1 0.002711741 1.45 (1.14, 1.84) 5.50% 1.02 1.27
TAF13 NM_005645 1 0.003926491 1.57 (1.16, 2.13) 6.80% 1.02 1.27
TFAP2D NM_172238 1 0.001850588 1.38 (1.13, 1.70) 4.40% 1.02 1.26
THOC3 NM_032361 1 0.004239158 2.03 (1.25, 3.29) 7.00% 1.02 1.25
TMED9 NM_017510 1 0.002890032 1.91 (1.25, 2.92) 5.70% 1.02 1.27
TMEM30C NR_028358 1 0.002560059 1.51 (1.15, 1.96) 5.40% 1.02 1.28
TMEM30C NR_028357 1 0.002560059 1.51 (1.15, 1.96) 5.40% 1.02 1.28
TMOD4 NM_013353 -1 0.003403959 0.58 (0.40, 0.84) 6.30% 1.02 1.27
TMPRSS13 NM_001077263 1 0.003417183 1.79 (1.21, 2.66) 6.30% 1.02 1.27
TMSB10 NM_021103 1 0.004188438 1.78 (1.20, 2.63) 7.00% 1.02 1.26
TNRC6A NM_014494 -1 0.003074972 0.51 (0.32, 0.79) 5.90% 1.02 1.26
TRAF3 NM_145726 -1 0.00293145 0.53 (0.35, 0.81) 5.70% 1.02 1.27
TRAF3 NM_001199427 -1 0.00293145 0.53 (0.35, 0.81) 5.70% 1.02 1.27
TRAF3 NM_ 003300 -1 0.00293145 0.53 (0.35, 0.81) 5.70% 1.02 1.27
TRAF3 NM_145725 -1 0.00293145 0.53 (0.35, 0.81) 5.70% 1.02 1.27
TRAM1 NM_014294 1 0.002697324 1.64 (1.19, 2.26) 5.50% 1.02 1.28
TRAM1L1 NM_152402 -1 0.003024509 0.64 (0.48, 0.86) 5.80% 1.02 1.27
TRPC7 NM_001167577 1 0.003198969 1.42 (1.12, 1.79) 6.10% 1.02 1.26
TRPC7 NM_020389 1 0.003198969 1.42 (1.12, 1.79) 6.10% 1.02 1.26
TRPC7 NM_001167576 1 0.003198969 1.42 (1.12, 1.79) 6.10% 1.02 1.26
TSC1 NM_001162427 -1 0.004320082 0.53 (0.34, 0.82) 7.10% 1.02 1.25
TSC1 NM_00368 -1 0.004320082 0.53 (0.34, 0.82) 7.10% 1.02 1.25
TSC1 NM_001162426 -1 0.004320082 0.53 (0.34, 0.82) 7.10% 1.02 1.25
TSNAX-DISC1 NR_028399 1 0.003821941 1.51 (1.14, 1.99) 6.70% 1.02 1.27
TSNAX-DISC1 NR_028400 1 0.003821941 1.51 (1.14, 1.99) 6.70% 1.02 1.27
TSNAX-DISC1 NR_028398 1 0.003821941 1.51 (1.14, 1.99) 6.70% 1.02 1.27
TSNAX-DISC1 NR_028397 1 0.003821941 1.51 (1.14, 1.99) 6.70% 1.02 1.27
TSNAX-DISC1 NR_028393 1 0.003821941 1.51 (1.14, 1.99) 6.70% 1.02 1.27
TSNAX-DISC1 NR_028396 1 0.003821941 1.51 (1.14, 1.99) 6.70% 1.02 1.27
TSNAX-DISC1 NR_028395 1 0.003821941 1.51 (1.14, 1.99) 6.70% 1.02 1.27
TSNAX-DISC1 NR_028394 1 0.003821941 1.51 (1.14, 1.99) 6.70% 1.02 1.27
TTC30A NM_152275 -1 0.002251039 0.66 (0.51, 0.86) 5.00% 1.02 1.28
TTF1 NM_007344 -1 0.002675227 0.61 (0.44, 0.84) 5.50% 1.02 1.28
TUBA1C NM_032704 1 0.003245041 2.12 (1.29, 3.50) 6.10% 1.02 1.25
TUSC1 NM_001004125 -1 0.003519464 0.66 (0.50, 0.87) 640% 1.02 1.27
UBXN10 NM_152376 -1 0.002709535 0.63 (0.46, 0.85) 5.50% 1.02 1.28
UQCRB NM_006294 1 0.003314393 1.76 (1.21, 2.56) 6.20% 1.02 1.27
UQCRB NM_001199975 1 0.003314393 1.76 (1.21, 2.56) 6.20% 1.02 1.27
VILL NM_015873 -1 0.003667617 0.65 (0.49, 0.87) 6.50% 1.02 1.27
VWC2 NM_198570 1 0.002039885 1.31 (1.10, 1.56) 4.70% 1.02 1.24
WDR47 NM_901142551 -1 0.002875073 0.74 (0.61, 0.90) 5.70% 1.02 1.24
WDR47 NM_001142550 -1 0.002875073 0.74 (0.61, 0.90) 5.70% 1.02 1.24
WDR47 NM_014969 -1 0.002875073 0.74 (0.61, 0.90) 5.70% 1.02 1.24
WDR75 NM_032168 -1 0.003637692 0.53 (0.35, 0.82) 6.50% 1.02 1.26
XPOT NM_007235 1 0.003529958 1.66 (1.18, 2.33) 6.40% 1.02 1.27
ZER1 NM_006336 -1 0.003281615 0.61 (0.44, 0.85) 6.10% 1.02 1.27
ZFP42 NM_174900 1 0.002027244 1.34 (1.11, 1.61) 4.70% 1.02 1.25
ZFYVE26 NM_015346 -1 0.003488824 0.47 (0.28, 0.78) 6.30% 1.02 1.24
ZNF487P NR_026693 -1 0.002718434 0.62 (0.45, 0.85) 5.50% 1.02 1.28
ZNF610 NM_001161427 -1 0.00379397 0.66 (0.50, 0.88) 6.70% 1.02 1.26
ZNF610 NM_001161425 -1 0.00379397 0.66 (0.50, 0.88) 6.70% 1.02 1.26
ZNF610 NM_001161426 -1 0.00379397 0.66 (0.50, 0.88) 6.70% 1.02 1.26
ZNF610 NM_173530 -1 0.00379397 0.66 (0.50, 0.88) 6.70% 1.02 1.26
ZNF653 NM_138783 -1 0.00333192 0.58 (0.40, 0.83) 6.20% 1.02 1.27
ZNF655 NM_024061 -1 0.002999752 0.58 (0.40, 0.83) 5.80% 1.02 1.27
ZNF655 NM_001083956 -1 0.002999752 0.58 (0.40, 0.83) 5.80% 1.02 1.27
ZNF655 NM_001009958 -1 0.002999752 0.58 (0.40, 0.83) 5.80% 1.02 1.27
ZNF655 NM_001085368 -1 0.002999752 0.58 (0.40, 0.83) 5.80% 1.02 1.27
ZNF655 NM_001085366 -1 0.002999752 0.58 (0.40, 0.83) 5.80% 1.02 1.27
ZNF655 NM_138494 -1 0.002999752 0.58 (0.40, 0.83) 5.80% 1.02 1.27
ZNF655 NM_001009960 -1 0.002999752 0.58 (0.40, 0.83) 5.80% 1.02 1.27
ZNF655 NM_001085367 -1 0.002999752 0.58 (0.40, 0.83) 5.80% 1.02 1.27
ZNF701 NM_018260 -1 0.003268807 0.59 (0.41, 0.84) 6.10% 1.02 1.27
ZNF701 NM_001172655 -1 0.003268807 0.59 (0.41, 0.84) 6.10% 1.02 1.27
ZNF740 NM_001004304 -1 0.004118629 0.58 (0.40, 0.84) 6.90% 1.02 1.26
ZNF788 NR 027049 -1 0.00249849 0.60 (0.43, 0.84) 5.30% 1.02 1.28
ABCD1 NM_000033 1 0.005827069 1.69 (1.16, 2.46) 8.30% 1.01 1.25
ABCG8 NM_022437 1 0.00511131 1.41 (1.11, 1.80) 7.70% 1.01 1.25
ACAT1 NM_000019 -1 0.00445572 0.66 (0.50, 0.88) 7.20% 1.01 1.26
ACO2 NM_001098 1 0.004314322 1.70 (1.18, 2.44) 7.10% 1.01 1.27
ACTL8 NM_030812 1 0.005453351 1.59 (1.15, 2.20) 7.90% 1.01 1.26
ADRA2A NM_000681 -1 0.004645911 0.59 (0.41, 0.85) 7.30% 1.01 1.26
AFF3 NM_001025108 -1 0.005402057 0.63 (0.45, 0.87) 7.90% 1.01 1.26
AFF3 NM_002285 -1 0.005402057 0.63 (0.45, 0.87) 7.90% 1.01 1.26
AGAP4 NM_133446 -1 0.006470733 0.61 (0.43, 0.87) 8.70% 1.01 1.25
AGAP5 NM_001144000 -1 0.005031188 0.64 (0.47, 0.87) 7.60% 1.01 1.26
AGTR1 NM_004835 -1 0.004024812 0.63 (0.46, 0.86) 6.90% 1.01 1.27
AGTR1 NM_009585 -1 0.004024812 0.63 (0.46, 0.86) 6.90% 1.01 1.27
AGTR1 NM_000685 -1 0.004024812 0.63 (0.46, 0.86) 6.90% 1.01 1.27
AGTR1 NM_032049 -1 0.004024812 0.63 (0.46, 0.86) 6.90% 1.01 1.27
AGTR1 NM_031850 -1 0.004024812 0.63 (0.46, 0.86) 6.90% 1.01 1.27
ALG10B NM_001013620 -1 0.004720162 0.64 (0.47, 0.87) 7.40% 1.01 1.26
AMDHD1 NM_152435 -1 0.0061723 0.60 (0.41, 0.86) 8.50% 1.01 1.25
ARMC9 NM_025139 -1 0.004214321 0.63 (0.46, 0.86) 7.00% 1.01 1.26
ARPC5 NM_005717 1 0.005346223 1.71 (1.17, 2.50) 7.90% 1.01 1.26
ASPM NM_018136 1 0.004397362 1.87 (1.22, 2.89) 7.10% 1.01 1.26
ASPN NM_017680 -1 0.005869465 0.59 (0.40, 0.86) 8.30% 1.01 1.25
ASPN NM_001193335 -1 0.005869465 0.59 (0.40, 0.86) 8.30% 1.01 1.25
ATP2A2 NM_001681 1 0.005992169 1.56 (1.14, 2.15) 8.40% 1.01 1.26
ATP2A2 NM_001135765 1 0.005992169 1.56 (1.14, 2.15) 8.40% 1.01 1.26
ATP2A2 NM 170665 1 0.005992169 1.56 (1.14, 2.15) 8.40% 1.01 1.26
AUP1 NM_181575 1 0.00584932 2.10 (1.24, 3.57) 8.30% 1.01 1.23
BIRC5 NM_001168 1 0.005913421 1.71 (1.17, 2.51) 8.30% 1.01 1.25
BIRC5 NM_001012270 1 0.005913421 1.71 (1.17, 2.51) 8.30% 1.01 1.25
BIRC5 NM_001012271 1 0.005913421 1.71 (1.17, 2.51) 8.30% 1.01 1.25
BTRC NM_003939 -1 0.00443052 0.55 (0.37, 0.83) 7.10% 1.01 1.25
BTRC NM_033637 -1 0.00443052 0.55 (0.37, 0.83) 7.10% 1.01 1.25
BUB1 NM_004336 1 0.004890814 2.22 (1.27, 3.86) 7.50% 1.01 1.23
C12orf35 NM 018169 -1 0.00533497 0.51 (0.32, 0.82) 7.90% 1.01 1.24
C12orf48 NM_017915 1 0.004706823 2.07 (1.25, 3.43) 7.40% 1.01 1.24
C14orf38 NM_001164399 -1 0.0065299 0.61 (0.43, 0.87) 8.70% 1.01 1.25
C16orf53 NM_024516 -1 0.004893843 0.58 (0.40, 0.85) 7.50% 1.01 1.26
C1orf65 NM_152610 1 0.00558459 1.52 (1.13, 2.05) 8.10% 1.01 1.26
C1orf88 NM_181643 -1 0.006237565 0.64 (0.46, 0.88) 8.50% 1.01 1.25
C22orf15 NM_182520 1 0.006327763 1.56 (1.13, 2.14) 8.60% 1.01 1.25
C2orf77 NM_001085447 -1 0.005006318 0.63 (0.46, 0.87) 7.60% 1.01 1.26
C4orf14 NM_032313 1 0.005587578 1.73 (1.17, 2.56) 8.10% 1.01 1.25
C5orf36 NM_173665 -1 0.004656591 0.61 (0.43, 0.86) 7.30% 1.01 1.26
C5orf36 NM_001145678 -1 0.004656591 0.61 (0.43, 0.86) 7.30% 1.01 1.26
C7orf70 NN_001037163 1 0.006375541 1.77 (1.17, 2.67) 8.60% 1.01 1.25
C9orf156 NM_016481 -1 0.005997679 0.68 (0.51, 0.89) 8.40% 1.01 1.25
CACNA1D NM_001128840 -1 0.005382035 0.63 (0.46, 0.87) 7.90% 1.01 1.26
CACNA1D NM_000720 -1 0.005382035 0.63 (0.46, 0.87) 7.90% 1.01 1.26
CACNA1D NM_001128839 -1 0.005382035 0.63 (0.46, 0.87) 7.90% 1.01 1.26
CALCOCO1 NM_020898 -1 0.00571028 0.63 (0.45, 0.87) 8.20% 1.01 1.25
CALCOCO1 NM_001143682 -1 0.00571028 0.63 (0.45, 0.87) 8.20% 1.01 1.25
CALCOCO1 NR_026554 -1 0.00571028 0.63 (0.45, 0.87) 8.20% 1.01 1.25
CAMKV NM_024046 1 0.004566931 1.44 (1.12, 1.85) 7.20% 1.01 1.26
CASC5 NM_170589 1 0.005135757 2.23 (1.27, 3.92) 7.70% 1.01 1.22
CASC5 NM_144508 1 0.005135757 2.23 (1.27, 3.92) 7.70% 1.01 1.22
CCDC146 NM_020879 -1 0.006404542 0.62 (0.44, 0.87) 8.60% 1.01 1.25
CCDC85A NM_001080433 -1 0.004932883 0.64 (0.47, 0.88) 7.50% 1.01 1.26
CDK5R2 NM_003936 1 0.004167684 1.31 (1.09, 1.58) 7.00% 1.01 1.23
CENPF NM_016343 1 0.006440669 1.86 (1.19, 2.91) 8.70% 1.01 1.24
CHMP1A NM_002768 1 0.005284675 1.93 (1.22, 3.07) 7.80% 1.01 1.24
CHMP1A NM_001083314 1 0.005284675 1.93 (1.22, 3.07) 7.80% 1.01 1.24
CHRNA5 NM_000745 1 0.004550155 1.82 (1.20, 2.75) 7.20% 1.01 1.26
CIB1 NM_006384 1 0.005380782 1.41 (1.11, 1.80) 7.90% 1.01 1.25
CLEC18B NM_001011880 1 0.005051242 1.39 (1.10, 1.74) 7.60% 1.01 1.24
CLPTM1L NM_030782 1 0.005097651 1.61 (1.15, 2.25) 7.70% 1.01 1.26
CLRN1 NM_052995 -1 0.006214457 0.54 (0.34, 0.84) 8.50% 1.01 1.24
CLRN1 NM_174878 -1 0.006214457 0.54 (0.34, 0.84) 8.50% 1.01 1.24
CLRN1 NM_001195794 -1 0.006214457 0.54 (0.34, 0.84) 8.50% 1.01 1.24
CLUAP1 NM_015041 -1 0.005214813 0.55 (0.36, 0.84) 7.70% 1.01 1.25
CLUAP1 NM_024793 -1 0.005214813 0.55 (0.36, 0.84) 7.70% 1.01 1.25
CNGB1 NM_001135639 1 0.004913341 1.44 (1.12, 1.85) 7.50% 1.01 1.25
CNGB1 NM_001297 1 0.004913341 1.44 (1.12, 1.85) 7.50% 1.01 1.25
COL6A4P2 NR_027898 -1 0.004926414 0.62 (0.45, 0.87) 7.50% 1.01 1.26
COPE NM_199442 1 0.004505534 1.56 (1.15, 2.12) 7.20% 1.01 1.27
COPE NM_007263 1 0.004505534 1.56 (1.15, 2.12) 7.20% 1.01 1.27
COPE NM_199444 1 0.004505534 1.56 (1.15, 2.12) 7.20% 1.01 1.27
CPEB2 NM_001177381 -1 0.005399996 0.60 (0.42, 0.86) 7.90% 1.01 1.25
CPEB2 NM_182646 -1 0.005399996 0.60 (0.42, 0.86) 7.90% 1.01 1.25
CPEB2 NM_001177384 -1 0.005399996 0.60 (0.42, 0.86) 7.90% 1.01 1.25
CPEB2 NM_182485 -1 0.005399996 0.60 (0.42, 0.86) 7.90% 1.01 1.25
CPEB2 NM_001177382 -1 0.005399996 0.60 (0.42, 0.86) 7.90% 1.01 1.25
CPEB2 NM_001177383 -1 0.005399996 0.60 (0.42, 0.86) 7.90% 1.01 1.25
CPLX3 NM_001030005 1 0.004089055 1.54 (1.15, 2.08) 6.90% 1.01 1.27
CSPG5 NM_006574 1 0.004918683 1.64 (1.16, 2.31) 7.50% 1.01 1.26
CT62 NM_001102658 -1 0.005814335 0.61 (0.42, 0.87) 8.30% 1.01 1.25
CTCF NM_001191022 1 0.006404212 1.78 (1.18, 2.70) 8.60% 1.01 1.25
CTCF NM_006565 1 0.006404212 1.78 (1.18, 2.70) 8.60% 1.01 1.25
CTSA NM_000308 1 0.006003343 1.58 (1.14, 2.20) 8.40% 1.01 1.26
CTSA NM_001127695 1 0.006003343 1.58 (1.14, 2.20) 8.40% 1.01 1.26
CTSA NM_001167594 1 0.006003343 1.58 (1.14, 2.20) 8.40% 1.01 1.26
CYBRD1 NM_001127383 -1 0.004229211 0.64 (0.47, 0.87) 7.00% 1.01 1.26
CYBRD1 NM_024843 -1 0.004229211 0.64 (0.47, 0.87) 7.00% 1.01 1.26
DBF4 NM_006716 1 0.004613835 1.87 (1.21, 2.88) 7.30% 1.01 1.25
DBI NM_001178042 1 0.006179033 1.45 (1.11, 1.90) 8.50% 1.01 1.25
DBI NM_001079863 1 0.006179033 1.45 (1.11, 1.90) 8.50% 1.01 1.25
DBI NM_001178043 1 0.006179033 1.45 (1.11, 1.90) 8.50% 1.01 1.25
DBI NM_001178041 1 0.006179033 1.45 (1.11, 1.90) 8.50% 1.01 1.25
DBI NM_001178017 1 0.006179033 1.45 (1.11, 1.90) 8.50% 1.01 1.25
DBI NM_001079862 1 0.006179033 1.45 (1.11, 1.90) 8.50% 1.01 1.25
DBI NM_020548 1 0.006179033 1.45 (1.11, 1.90) 8.50% 1.01 1.25
DCAF7 NM_005828 1 0.005185203 1.38 (1.10, 1.73) 7.70% 1.01 1.24
DDB2 NM_000107 -1 0.005118224 0.63 (0.46, 0.87) 7.70% 1.01 1.26
DGCR2 NM_005137 1 0.006382852 1.63 (1.15, 2.31) 8.60% 1.01 1.25
DGCR2 NM_001173534 1 0.006382852 1.63 (1.15, 2.31) 8.60% 1.01 1.25
DGCR2 NM_001173533 1 0.006382852 1.63 (1.15, 2.31) 8.60% 1.01 1.25
DGCR2 NM_01184781 1 0.006382852 1.63 (1.15, 2.31) 8.60% 1.01 1.25
DGCR2 NR_033674 1 0.006382852 1.63 (1.15, 2.31) 8.60% 1.01 1.25
DGCR9 NR_024159 1 0.005993007 1.59 (1.14, 2.22) 8.40% 1.01 1.26
DHRS3 NM_004753 1 0.006567842 1.68 (1.16, 2.45) 8.80% 1.01 1.25
DHX32 NM_018180 -1 0.006433684 0.58 (0.40, 0.86) 8.70% 1.01 1.25
DKK4 NM_014420 -1 0.006648293 0.56 (0.37, 0.85) 8.80% 1.01 1.24
DLGAP5 NM_001146015 1 0.006185847 1.81 (1.18, 2.78) 8.50% 1.01 1.25
DLGAP5 NM_014750 1 0.006185847 1.81 (1.18, 2.78) 8.50% 1.01 1.25
DNA2 NM_001080449 1 0.005009309 1.65 (1.16, 2.35) 7.60% 1.01 1.26
DNAH7 NM_018897 -1 0.004588402 0.68 (0.52, 0.89) 7.30% 1.01 1.26
DNAJB11 NM_016306 1 0.005873219 1.60 (1.14, 2.23) 8.30% 1.01 1.26
DNAJC3 NM_006260 1 0.006415627 1.54 (1.13, 2.10) 8.60% 1.01 1.25
DNAJC5G NM_173650 1 0.00515377 1.31 (1.08, 1.59) 7.70% 1.01 1.22
DPY30 NM_032574 1 0.006797135 2.07 (1.22, 3.50) 8.90% 1.01 1.22
EBP NM_006579 1 0.006200067 1.72 (1.17, 2.53) 8.50% 1.01 1.25
EFHC1 NR_033327 -1 0.004990192 0.58 (0.40, 0.85) 7.60% 1.01 1.25
EFHC1 NM_018100 -1 0.004990192 0.58 (0.40, 0.85) 7.60% 1.01 1.25
EFHC1 NM_001172420 -1 0.004990192 0.58 (0.40, 0.85) 7.60% 1.01 1.25
EFNA3 NM_004952 1 0.006168226 1.55 (1.13, 2.12) 8.50% 1.01 1.26
EFNA5 NM_001962 1 0.005036941 1.70 (1.17, 2.46) 7.60% 1.01 1.26
EID2B NM_152361 -1 0.00574852 0.66 (0.49, 0.89) 8.20% 1.01 1.25
ELOVL6 NM_024090 1 0.004827708 1.77 (1.19, 2.63) 7.40% 1.01 1.26
ELOVL6 NM_001130721 1 0.004827708 1.77 (1.19, 2.63) 7.40% 1.01 1.26
EMP3 NM_001425 -1 0.004017208 0.64 (0.47, 0.87) 6.90% 1.01 1.27
EPCAM NM_002354 1 0.006251902 1.69 (1.16, 2.46) 8.50% 1.01 1.25
EPR1 NR_002219 1 0.00602072 1.80 (1.18, 2.73) 8.40% 1.01 1.25
ERBB4 NM_005235 -1 0.004724805 0.62 (0.45, 0.86) 7.40% 1.01 1.26
ERBB4 NM_001042599 -1 0.004724805 0.62 (0.45, 0.86) 7.40% 1.01 1.26
ERN2 NM_033266 1 0.00383262 1.46 (1.13, 1.88) 6.70% 1.01 1.26
F11 NM_000128 1 0.004222479 1.48 (1.13, 1.93) 7.00% 1.01 1.26
FADS2 NM_004265 1 0.00574684 1.85 (1.20, 2.86) 8.20% 1.01 1.25
FAM102A NM_203305 -1 0.005644483 0.62 (0.44, 0.87) 8.10% 1.01 1.25
FAM102A NM_001035254 -1 0.005644483 0.62 (0.44, 0.87) 8.10% 1.01 1.25
FAM155B NM_015686 1 0.005996344 1.62 (1.15, 2.29) 8.40% 1.01 1.26
FAM19A1 NM_213609 1 0.006014024 1.54 (1.13, 2.09) 8.40% 1.01 1.26
FAM200A NM_145111 -1 0.004137595 0.67 (0.51, 0.88) 6.90% 1.01 1.26
FBXL2 NM_001171713 -1 0.005598664 0.67 (0.51, 0.89) 8.10% 1.01 1.25
FBXL2 NM_012157 -1 0.005598664 0.67 (0.51, 0.89) 8.10% 1.01 1.25
FBXO45 NM_001105573 1 0.00563526 1.69 (1.17, 2.46) 8.10% 1.01 1.26
FDXACB1 NM_138378 -1 0.004699684 0.71 (0.56, 0.90) 7.40% 1.01 1.25
FGF2 NM_002006 -1 0.004723067 0.57 (0.39, 0.84) 7.40% 1.01 1.26
FU30403 NR_034159 -1 0.004967441 0.63 (0.46, 0.87) 7.50% 1.01 1.26
FU41200 NR_033863 1 0.004925314 1.75 (1.18, 2.58) 7.50% 1.01 1.26
FU44635 NM_207422 -1 0.006189338 0.63 (0.45, 0.88) 8.50% 1.01 1.25
FOXM1 NM_202002 1 0.004332916 1.63 (1.17, 2.28) 7.10% 1.01 1.27
FOXM1 NM_202003 1 0.004332916 1.63 (1.17, 2.28) 7.10% 1.01 1.27
FOXM1 NM_021953 1 0.004332916 1.63 (1.17, 2.28) 7.10% 1.01 1.27
FSTL3 NM_005860 -1 0.004470174 0.61 (0.44, 0.86) 7.20% 1.01 1.26
GALNT14 NM_024572 1 0.006578564 1.80 (1.18, 2.74) 8.80% 1.01 1.24
GALNTL1 NM_001168368 -1 0.004149532 0.63 (0.46, 0.86) 6.90% 1.01 1.26
GALNTL1 NM_ 020692 -1 0.004149532 0.63 (0.46, 0.86) 6.90% 1.01 1.26
GFRA1 NM_145793 -1 0.005973491 0.61 (0.43, 0.87) 8.40% 1.01 1.25
GFRA1 NM_001145453 -1 0.005973491 0.61 (0.43, 0.87) 8.40% 1.01 1.25
GFRA1 NM_005264 -1 0.005973491 0.61 (0.43, 0.87) 8.40% 1.01 1.25
GLRX2 NM_016066 1 0.006629201 2.04 (1.22, 3.43) 8.80% 1.01 1.23
GLRX2 NM_197962 1 0.006629201 2.04 (1.22, 3.43) 8.80% 1.01 1.23
GPR17 NM_001161415 -1 0.004359195 0.66 (0.50, 0.88) 7.10% 1.01 1.26
GPR17 NM_001161417 -1 0.004359195 0.66 (0.50, 0.88) 7.10% 1.01 1.26
GPR17 NM_001161416 -1 0.004359195 0.66 (0.50, 0.88) 7.10% 1.01 1.26
GPR17 NM_005291 -1 0.004359195 0.66 (0.50, 0.88) 7.10% 1.01 1.26
GPR33 NM_001197184 1 0.004512989 1.30 (1.08, 1.56) 7.20% 1.01 1.22
GPR33 NR_036675 1 0.004512989 1.30 (1.08, 1.56) 7.20% 1.01 1.22
GPR63 NM_001143957 1 0.006597235 1.68 (1.15, 2.44) 8.80% 1.01 1.25
GPR63 NM_030784 1 0.006597235 1.68 (1.15, 2.44) 8.80% 1.01 1.25
GREB1L NM_001142966 -1 0.004120083 0.63 (0.46, 0.86) 6.90% 1.01 1.27
GRPEL2 NM_152407 1 0.005432863 1.99 (1.23, 3.24) 7.90% 1.01 1.24
HIF1A NM_001530 1 0.006328987 1.64 (1.15, 2.33) 8.60% 1.01 1.25
HIF1A NM_181054 1 0.006328987 1.64 (1.15, 2.33) 8.60% 1.01 1.25
HIST2H2AC NM_003517 1 0.00431244 1.73 (1.19, 2.52) 7.10% 1.01 1.26
HMX1 NM_018942 1 0.003648411 1.34 (1.10, 1.63) 6.50% 1.01 1.24
HOMER1 NM_004272 1 0.004348297 1.84 (1.21, 2.79) 7.10% 1.01 1.26
HSPA12A NM_025015 -1 0.00605439 0.62 (0.44, 0.87) 8.40% 1.01 1.25
HSPBAP1 NM_024610 -1 0.005349517 0.60 (0.42, 0.86) 7.90% 1.01 1.25
IDH1 NM_005896 1 0.004957583 1.57 (1.15, 2.15) 7.50% 1.01 1.26
IL20RB NM_144717 1 0.004776866 1.77 (1.19, 2.64) 7.40% 1.01 1.26
IL6ST NM_001190981 -1 0.006042753 0.55 (0.36, 0.84) 8.40% 1.01 1.24
IL6ST NM_175767 -1 0.006042753 0.55 (0.36, 0.84) 8.40% 1.01 1.24
IL6ST NM_002184 -1 0.006042753 0.55 (0.36, 0.84) 8.40% 1.01 1.24
IPW NR_023915 -1 0.004512207 0.64 (0.47, 0.87) 7.20% 1.01 1.26
IRGM NM_001145805 1 0.004422765 1.53 (1.14, 2.06) 7.10% 1.01 1.26
ITGB4 NM_001005731 1 0.004372283 1.60 (1.16, 2.21) 7.10% 1.01 1.27
ITGB4 NM_000213 1 0.004372283 1.60 (1.16, 2.21) 7.10% 1.01 1.27
ITGB4 NN_001005619 1 0.004372283 1.60 (1.16, 2.21) 7.10% 1.01 1.27
KDELR1 NM_006801 1 0.005637 1.63 (1.15, 2.31) 8.10% 1.01 1.26
KDM5A NM_001042603 -1 0.006234911 0.58 (0.39, 0.86) 8.50% 1.01 1.25
KIAA1109 NM_015312 -1 0.004341596 0.63 (0.46, 0.87) 7.10% 1.01 1.26
KIAA1217 NM_001098500 -1 0.004307668 0.60 (0.43, 0.85) 7.10% 1.01 1.26
KIAA1217 NM_019590 -1 0.004307668 0.60 (0.43, 0.85) 7.10% 1.01 1.26
KIAA1217 NM_001098501 -1 0.004307668 0.60 (0.43, 0.85) 7.10% 1.01 1.26
KIAA1324 NM_020775 -1 0.004339938 0.68 (0.52, 0.88) 7.10% 1.01 1.26
KIF23 NM_138555 1 0.005200001 1.91 (1.21, 3.01) 7.70% 1.01 1.25
KIF23 NM_004856 1 0.005200001 1.91 (1.21, 3.01) 7.70% 1.01 1.25
KIF27 NM_017576 -1 0.005549882 0.66 (0.50, 0.89) 8.00% 1.01 1.25
KIRREL NM_018240 -1 0.004133502 0.67 (0.51, 0.88) 6.90% 1.01 1.26
KLHL7 NR_033328 1 0.005009326 1.46 (1.12, 1.91) 7.60% 1.01 1.26
KLHL7 NM_018846 1 0.005009326 1.46 (1.12, 1.91) 7.60% 1.01 1.26
KLHL7 NR_033329 1 0.005009326 1.46 (1.12, 1.91) 7.60% 1.01 1.26
KLHL7 NM_001172428 1 0.005009326 1.46 (1.12, 1.91) 7.60% 1.01 1.26
KLHL7 NM_001031710 1 0.005009326 1.46 (1.12, 1.91) 7.60% 1.01 1.26
KRT20 NM 019010 1 0.004928084 1.36 (1.10, 1.68) 7.50% 1.01 1.24
KRT72 NM_001146225 1 0.006068111 1.44 (1.11, 1.86) 8.40% 1.01 1.25
KRT72 NM_080747 1 0.006068111 1.44 (1.11, 1.86) 8.40% 1.01 1.25
KRT72 NM_001146226 1 0.006068111 1.44 (1.11, 1.86) 8.40% 1.01 1.25
LIN54 NM_001115007 1 0.004747521 1.88 (1.21, 2.93) 7.40% 1.01 1.25
LIN54 NM_194282 1 0.004747521 1.88 (1.21, 2.93) 7.40% 1.01 1.25
LIN54 NM_001115008 1 0.004747521 1.88 (1.21, 2.93) 7.40% 1.01 1.25
LINGO1 NM_032808 1 0.004519614 1.93 (1.23, 3.03) 7.20% 1.01 1.25
LOC100129046 NR_034091 -1 0.005971508 0.58 (0.40, 0.86) 8.40% 1.01 1.25
LOC100499484 NR_036526 -1 0.004306021 0.60 (0.42, 0.85) 7.10% 1.01 1.26
LOC344595 NR_028301 -1 0.004316669 0.61 (0.43, 0.86) 7.10% 1.01 1.26
LOC344595 NR_028302 -1 0.004316669 0.61 (0.43, 0.86) 7.10% 1.01 1.26
LOC728323 NR_024437 -1 0.004035146 0.69 (0.53, 0.89) 6.90% 1.01 1.26
LRRIQ1 NM_001079910 -1 0.006050079 0.62 (0.44, 0.87) 8.40% 1.01 1.25
LRRIQ1 NM 032165 -1 0.006050079 0.62 (0.44, 0.87) 8.40% 1.01 1.25
MAD2L1 NM_002358 1 0.006190566 1.86 (1.19, 2.90) 8.50% 1.01 1.24
MAGT1 NM_032121 1 0.006485501 1.59 (1.14, 2.22) 8.70% 1.01 1.25
MAPK81P3 NM_001040439 -1 0.0062091 0.62 (0.44, 0.87) 8.50% 1.01 1.25
MAPK8IP3 NM_015133 -1 0.0062091 0.62 (0.44, 0.87) 8.50% 1.01 1.25
MATN3 NM 002381 -1 0.004632692 0.61 (0.43, 0.86) 7.30% 1.01 1.26
METTL3 NM_019852 -1 0.005935671 0.59 (0.41, 0.86) 8.40% 1.01 1.25
MFSD7 NM_032219 -1 0.005041383 0.68 (0.52, 0.89) 7.60% 1.01 1.25
MIR501 NR 030225 1 0.004596181 1.39 (1.11, 1.74) 7.30% 1.01 1.25
MKI67 NM_002417 1 0.004838869 1.85 (1.21, 2.83) 7.40% 1.01 1.25
MKI67 NM_001145966 1 0.004838869 1.85 (1.21, 2.83) 7.40% 1.01 1.25
MOXD2P NR_024346 1 0.00477089 1.52 (1.14, 2.02) 7.40% 1.01 1.26
MPHOSPH6 NM_005792 1 0.00484696 1.48 (1.13, 1.94) 7.40% 1.01 1.26
MTDH NM_178812 1 0.004800288 1.55 (1.14, 2.10) 7.40% 1.01 1.26
MTMR9LP NR_026850 -1 0.00483402 0.67 (0.51, 0.89) 7.40% 1.01 1.26
MUC12 NM_001164462 -1 0.006098226 0.59 (0.40, 0.86) 8.40% 1.01 1.25
MVD NM_002461 1 0.005857959 2.04 (1.23, 3.39) 8.30% 1.01 1.23
NBN NM_002485 1 0.005163332 1.63 (1.16, 2.30) 7.70% 1.01 1.26
NBPF1 NM_017940 -1 0.005126436 0.63 (0.46, 0.87) 7.70% 1.01 1.26
NOTCH 1 NM_017617 1 0.004096101 1.50 (1.14, 1.99) 6.90% 1.01 1.27
NPC1L1 NM_001101648 1 0.005266683 1.44 (1.11, 1.85) 7.80% 1.01 1.25
NPC1L1 NM_013389 1 0.005266683 1.44 (1.11, 1.85) 7.80% 1.01 1.25
NUAK1 NM_014840 -1 0.00483339 0.66 (0.50, 0.88) 7.40% 1.01 1.26
NUF2 NM_145697 1 0.004332713 1.64 (1.17, 2.30) 7.10% 1.01 1.27
NUF2 NM_031423 1 0.004332713 1.64 (1.17, 2.30) 7.10% 1.01 1.27
NUP93 NM_014669 1 0.005806313 1.70 (1.17, 2.48) 8.30% 1.01 1.25
NUSAP1 NM_001129897 1 0.005759989 1.86 (1.20, 2.88) 8.20% 1.01 1.25
NUSAP1 NM_018454 1 0.005759989 1.86 (1.20, 2.88) 8.20% 1.01 1.25
NUSAP1 NM_016359 1 0.005759989 1.86 (1.20, 2.88) 8.20% 1.01 1.25
OCM NM_001097622 1 0.004906929 1.30 (1.08, 1.56) 7.50% 1.01 1.22
ODC1 NM_002539 1 0.006073792 1.66 (1.16, 2.38) 8.40% 1.01 1.25
OGDHL NM_001143997 1 0.005912877 1.58 (1.14, 2.18) 8.30% 1.01 1.26
OGDHL NM_001143996 1 0.005912877 1.58 (1.14, 2.18) 8.30% 1.01 1.26
OGDHL NM_018245 1 0.005912877 1.58 (1.14, 2.18) 8.30% 1.01 1.26
OR14J1 NM_030946 1 0.004503814 1.46 (1.12, 1.89) 7.20% 1.01 1.26
OR5T2 NM_001004746 1 0.005223593 1.71 (1.17, 2.50) 7.70% 1.01 1.26
P4HA1 NM_001017962 1 0.004247315 1.44 (1.12, 1.84) 7.00% 1.01 1.26
P4HA1 NM_001142595 1 0.004247315 1.44 (1.12, 1.84) 7.00% 1.01 1.26
P4HA1 NM_001142596 1 0.004247315 1.44 (1.12, 1.84) 7.00% 1.01 1.26
P4HA1 NM_000917 1 0.004247315 1.44 (1.12, 1.84) 7.00% 1.01 1.26
PACSIN2 NM_001184970 1 0.004070682 1.60 (1.16, 2.21) 6.90% 1.01 1.27
PACSIN2 NM_007229 1 0.004070682 1.60 (1.16, 2.21) 6.90% 1.01 1.27
PACSIN2 NM_001184971 1 0.004070682 1.60 (1.16, 2.21) 6.90% 1.01 1.27
PAPL NM_001004318 1 0.00430893 1.48 (1.13, 1.93) 7.10% 1.01 1.26
PAR1 NR_022009 -1 0.005038754 0.64 (0.47, 0.87) 7.60% 1.01 1.26
PCDP1 NM_001029996 -1 0.00550873 0.56 (0.37, 0.84) 8.00% 1.01 1.25
PCP4L1 NM_001102566 1 0.005705339 1.77 (1.18, 2.64) 8.20% 1.01 1.25
PCYOX1L NM_024028 -1 0.006326101 0.63 (0.45, 0.88) 8.60% 1.01 1.25
PDZRN3 NM_015009 -1 0.004230075 0.63 (0.46, 0.87) 7.00% 1.01 1.26
PGRMC1 NM_006667 1 0.005470607 1.48 (1.12, 1.95) 7.90% 1.01 1.26
PIAS2 NM_004671 -1 0.006115119 0.69 (0.53, 0.90) 8.50% 1.01 1.25
PIAS2 NM_173206 -1 0.006115119 0.69 (0.53, 0.90) 8.50% 1.01 1.25
PIH1D2 NM_001082619 -1 0.00647425 0.59 (0.40, 0.86) 8.70% 1.01 1.25
PIH1D2 NM_138789 -1 0.00647425 0.59 (0.40, 0.86) 8.70% 1.01 1.25
PINK1 NM_032409 -1 0.006364293 0.70 (0.54, 0.90) 8.60% 1.01 1.24
PLA2G2F NM_022819 1 0.004792716 1.53 (1.14, 2.05) 7.40% 1.01 1.26
PLCD3 NM_133373 -1 0.004835269 0.68 (0.52, 0.89) 7.40% 1.01 1.25
PRKAR2A NM_004157 1 0.004456628 1.74 (1.19, 2.56) 7.20% 1.01 1.26
PSMA4 NM_001102667 1 0.006063723 1.93 (1.21, 3.07) 8.40% 1.01 1.24
PSMA4 NM_001102668 1 0.006063723 1.93 (1.21, 3.07) 8.40% 1.01 1.24
PSMA4 NM_002789 1 0.006063723 1.93 (1.21, 3.07) 8.40% 1.01 1.24
PSMC4 NM_006503 1 0.004218907 1.38 (1.11, 1.72) 7.00% 1.01 1.25
PSMC4 NM_153001 1 0.004218907 1.38 (1.11, 1.72) 7.00% 1.01 1.25
PSMG3 NM_001134340 1 0.004706287 1.68 (1.17, 2.40) 7.40% 1.01 1.26
PSMG3 NM_032302 1 0.004706287 1.68 (1.17, 2.40) 7.40% 1.01 1.26
RALA NM_005402 1 0.005804625 1.66 (1.16, 2.39) 8.30% 1.01 1.26
RECQL4 NM_004260 1 0.005197018 1.75 (1.18, 2.58) 7.70% 1.01 1.26
RHEB NM_005614 1 0.005237779 1.90 (1.21, 2.98) 7.80% 1.01 1.25
RLIM NM_183353 1 0.005064841 1.66 (1.16, 2.36) 7.60% 1.01 1.26
RLIM NM_016120 1 0.005064841 1.66 (1.16, 2.36) 7.60% 1.01 1.26
RPL23AP53 NR_003572 -1 0.006006153 0.60 (0.42, 0.86) 8.40% 1.01 1.25
RPL8 NM_000973 1 0.005660274 1.52 (1.13, 2.05) 8.10% 1.01 1.26
RPL8 NM_033301 1 0.005660274 1.52 (1.13, 2.05) 8.10% 1.01 1.26
RSPH1 NM_080860 -1 0.004552589 0.64 (0.46, 0.87) 7.20% 1.01 1.26
RUNX1 NM_001001890 -1 0.005414839 0.53 (0.34, 0.83) 7.90% 1.01 1.24
RUNX1 NM_001754 -1 0.005414839 0.53 (0.34, 0.83) 7.90% 1.01 1.24
RUNX1 NM_001122607 -1 0.005414839 0.53 (0.34, 0.83) 7.90% 1.01 1.24
RXFP2 NM_130806 1 0.004747273 1.24 (1.07, 1.44) 7.40% 1.01 1.19
RXFP2 NM_001166058 1 0.004747273 1.24 (1.07, 1.44) 7.40% 1.01 1.19
SC4MOL NM_006745 1 0.00570173 1.51 (1.13, 2.02) 8.20% 1.01 1.26
SC4MOL NM_001017369 1 0.00570173 1.51 (1.13, 2.02) 8.20% 1.01 1.26
SCD NM_005063 1 0.00542315 1.91 (1.21, 3.02) 7.90% 1.01 1.24
SEC13 NR_024273 1 0.006369561 1.64 (1.15, 2.35) 8.60% 1.01 1.25
SEC13 NM_001136232 1 0.006369561 1.64 (1.15, 2.35) 8.60% 1.01 1.25
SEC13 NR_024272 1 0.006369561 1.64 (1.15, 2.35) 8.60% 1.01 1.25
SEC13 NM_183352 1 0.006369561 1.64 (1.15, 2.35) 8.60% 1.01 1.25
SEC24A NM_021982 1 0.006121721 1.65 (1.15, 2.37) 8.50% 1.01 1.25
SERPIND1 NM_000185 -1 0.004249699 0.57 (0.39, 0.84) 7.00% 1.01 1.26
SFXN5 NM_144579 -1 0.005790443 0.64 (0.47, 0.88) 8.20% 1.01 1.25
SKA2 NN_182620 1 0.004751619 1.58 (1.15, 2.18) 7.40% 1.01 1.26
SKA2 NM_001100595 1 0.004751619 1.58 (1.15, 2.18) 7.40% 1.01 1.26
SLC30A10 NM_018713 1 0.005198017 1.37 (1.10, 1.71) 7.70% 1.01 1.24
SLC41A2 NM_032148 1 0.005498771 1.44 (1.11, 1.87) 8.00% 1.01 1.25
SLC44A1 NM_080546 -1 0.004388528 0.62 (0.45, 0.86) 7.10% 1.01 1.26
SLC9A5 NM_004594 1 0.006146031 1.70 (1.16, 2.47) 8.50% 1.01 1.25
SMG7 NM_173156 1 0.005723927 1.47 (1.12, 1.93) 8.20% 1.01 1.25
SMG7 NM_201569 1 0.005723927 1.47 (1.12, 1.93) 8.20% 1.01 1.25
SMG7 NM_201568 1 0.005723927 1.47 (1.12, 1.93) 8.20% 1.01 1.25
SMG7 NM_001174061 1 0.005723927 1.47 (1.12, 1.93) 8.20% 1.01 1.25
SND1 NM_014390 1 0.004484231 1.70 (1.18, 2.45) 7.20% 1.01 1.26
SNORD116-12 NR_003327 1 0.006075002 1.32 (1.08, 1.60) 8.40% 1.01 1.22
SNRNP70 NM_003089 -1 0.004606328 0.54 (0.36, 0.83) 7.30% 1.01 1.25
SQSTM1 NM_003900 1 0.004571164 1.83 (1.20, 2.78) 7.20% 1.01 1.26
SQSTM1 NM_001142299 1 0.004571164 1.83 (1.20, 2.78) 7.20% 1.01 1.26
SQSTM1 NM_001142298 1 0.004571164 1.83 (1.20, 2.78) 7.20% 1.01 1.26
SREBF2 NM_004599 1 0.004241128 1.61 (1.16, 2.22) 7.00% 1.01 1.27
SRSF5 NM_006925 -1 0.005863942 0.54 (0.35, 0.84) 8.30% 1.01 1.24
SRSF5 NM_001039465 -1 0.005863942 0.54 (0.35, 0.84) 8.30% 1.01 1.24
SSR1 NM_003144 1 0.005569398 1.63 (1.15, 2.31) 8.10% 1.01 1.26
STATH NM_001009181 1 0.003857366 1.36 (1.11, 1.68) 6.70% 1.01 1.24
STATH NM_003154 1 0.003857366 1.36 (1.11, 1.68) 6.70% 1.01 1.24
STIP1 NM_006819 1 0.006434469 1.58 (1.14, 2.19) 8.70% 1.01 1.25
STX1A NM_004603 1 0.006602765 1.71 (1.16, 2.52) 8.80% 1.01 1.25
STX1A NM_001165903 1 0.006602765 1.71 (1.16, 2.52) 8.80% 1.01 1.25
STX1B NM_052874 -1 0.004730101 0.61 (0.44, 0.86) 7.40% 1.01 1.26
SUMO3 NM_006936 1 0.005665759 1.83 (1.19, 2.80) 8.10% 1.01 1.25
TADA1 NM_053053 1 0.00455637 1.54 (1.14, 2.08) 7.20% 1.01 1.26
TARS NM_152295 1 0.005460832 1.63 (1.15, 2.30) 7.90% 1.01 1.26
TBC1D19 NM_018317 -1 0.004309516 0.66 (0.50, 0.88) 7.10% 1.01 1.26
TCTN2 NM_024809 -1 0.00482289 0.58 (0.40, 0.85) 7.40% 1.01 1.26
TCTN2 NM_001143850 -1 0.00482289 0.58 (0.40, 0.85) 7.40% 1.01 1.26
TMEM132A NM_178031 1 0.005666749 1.66 (1.16, 2.38) 8.10% 1.01 1.26
TMEM132A NM_017870 1 0.005666749 1.66 (1.16, 2.38) 8.10% 1.01 1.26
TMEM150A NR_033179 1 0.004738486 1.78 (1.19, 2.67) 7.40% 1.01 1.26
TMEM150A NM_001031738 1 0.004738486 1.78 (1.19, 2.67) 7.40% 1.01 1.26
TMEM200C NM_001080209 -1 0.006303527 0.59 (0.41, 0.86) 8.60% 1.01 1.25
TOMM70A NM_014820 1 0.005119582 1.65 (1.16, 2.34) 7.70% 1.01 1.26
TPD52L1 NM_003287 1 0.00467689 1.74 (1.18, 2.55) 7.30% 1.01 1.26
TPD52L1 NM_001003397 1 0.00467689 1.74 (1.18, 2.55) 7.30% 1.01 1.26
TPD52L1 NM_001003396 1 0.00467689 1.74 (1.18, 2.55) 7.30% 1.01 1.26
TPD52L1 NM_001003395 1 0.00467689 1.74 (1.18, 2.55) 7.30% 1.01 1.26
TPTE NM_199259 1 0.003424575 1.34 (1.10, 1.63) 6.30% 1.01 1.24
TPTE NM_199261 1 0.003424575 1.34 (1.10, 1.63) 6.30% 1.01 1.24
TPTE NM_199260 1 0.003424575 1.34 (1.10, 1.63) 6.30% 1.01 1.24
TRIM66 NM_014818 -1 0.006607717 0.60 (0.41, 0.87) 8.80% 1.01 1.25
TRIP13 NM_004237 1 0.006392425 2.19 (1.25, 3.86) 8.60% 1.01 1.22
TRIP13 NM_001166260 1 0.006392425 2.19 (1.25, 3.86) 8.60% 1.01 1.22
TRPC6 NM_004621 -1 0.004611756 0.63 (0.46, 0.87) 7.30% 1.01 1.26
TRPM1 NM_002420 1 0.003408407 1.31 (1.09, 1.56) 6.30% 1.01 1.23
TRYX3 NM_001001317 1 0.005404072 1.62 (1.15, 2.28) 7.90% 1.01 1.26
TSPAN19 NM_001100917 1 0.005213327 1.31 (1.08, 1.59) 7.70% 1.01 1.22
TTC4 NM_004623 -1 0.005824634 0.53 (0.34, 0.83) 8.30% 1.01 1.24
UNC5B NM_170744 -1 0.005298662 0.63 (0.46, 0.87) 7.80% 1.01 1.26
VTA1 NM_016485 1 0.006405376 1.46 (1.11, 1.92) 8.60% 1.01 1.25
WDR60 NM_018051 -1 0.005425427 0.64 (0.47, 0.88) 7.90% 1.01 1.26
WDR65 NM_001195831 -1 0.005313098 0.62 (0.45, 0.87) 7.80% 1.01 1.26
WDR65 NM_001167965 -1 0.005313098 0.62 (0.45, 0.87) 7.80% 1.01 1.26
WDR65 NM_152498 -1 0.005313098 0.62 (0.45, 0.87) 7.80% 1.01 1.26
WDR65 NM_001167966 -1 0.005313098 0.62 (0.45, 0.87) 7.80% 1.01 1.26
WDR65 NR_030778 -1 0.005313098 0.62 (0.45, 0.87) 7.80% 1.01 1.26
WDTC1 NM_015023 -1 0.006462542 0.69 (0.53, 0.90) 8.70% 1.01 1.24
YIF1A NM_020470 1 0.004460223 1.70 (1.18, 2.46) 7.20% 1.01 1.26
ZBTB4 NM_001128833 -1 0.004317842 0.63 (0.46, 0.86) 7.10% 1.01 1.26
ZBTB4 NM_020899 -1 0.004317842 0.63 (0.46, 0.86) 7.10% 1.01 1.26
ZCCHC7 NM_032226 -1 0.00624057 0.51 (0.31, 0.83) 8.50% 1.01 1.23
ZNF43 NM_003423 -1 0.005996525 0.64 (0.47, 0.88) 8.40% 1.01 1.25
ZNF438 NM_001143771 -1 0.005439166 0.62 (0.44, 0.87) 7.90% 1.01 1.26
ZNF438 NM_001143767 -1 0.005439166 0.62 (0.44, 0.87) 7.90% 1.01 1.26
ZNF438 NM_001143766 -1 0.005439166 0.62 (0.44, 0.87) 7.90% 1.01 1.26
ZNF438 NM_001143770 -1 0.005439166 0.62 (0.44, 0.87) 7.90% 1.01 1.26
ZNF438 NM_182755 -1 0.005439166 0.62 (0.44, 0.87) 7.90% 1.01 1.26
ZNF438 NR_026560 -1 0.005439166 0.62 (0.44, 0.87) 7.90% 1.01 1.26
ZNF438 NM_001143768 -1 0.005439166 0.62 (0.44, 0.87) 7.90% 1.01 1.26
ZNF438 NM_001143769 -1 0.005439166 0.62 (0.44, 0.87) 7.90% 1.01 1.26
ZNF564 NM_144976 -1 0.004988278 0.59 (0.41, 0.85) 7.60% 1.01 1.26
ZNF668 NM_024706 -1 0.004456171 0.66 (0.50, 0.88) 7.20% 1.01 1.26
ZNF668 NM_001172670 -1 0.004456171 0.66 (0.50, 0.88) 7.20% 1.01 1.26
ZNF668 NM_001172669 -1 0.004456171 0.66 (0.50, 0.88) 7.20% 1.01 1.26
ZNF668 NM_001172668 -1 0.004456171 0.66 (0.50, 0.88) 7.20% 1.01 1.26
ZNF839 NM_018335 -1 0.005746311 0.56 (0.37, 0.85) 8.20% 1.01 1.25
ADAM22 NM_004194 -1 0.008205802 0.65 (0.47, 0.89) 9.80% 1 1.24
ADAM22 NM_021722 -1 0.008205802 0.65 (0.47, 0.89) 9.80% 1 1.24
ADAM22 NM_021721 -1 0.008205802 0.65 (0.47, 0.89) 9.80% 1 1.24
ADAM22 NM_021723 -1 0.008205802 0.65 (0.47, 0.89) 9.80% 1 1.24
ADAM22 NM_016351 -1 0.008205802 0.65 (0.47, 0.89) 9.80% 1 1.24
ADM NM_001124 1 0.007902715 1.60 (1.13, 2.27) 9.70% 1 1.25
ALG9 NM_001077691 -1 0.006987624 0.69 (0.52, 0.90) 9.10% 1 1.24
ALG9 NM_024740 -1 0.006987624 0.69 (0.52, 0.90) 9.10% 1 1.24
ALG9 NM_001077690 -1 0.006987624 0.69 (0.52, 0.90) 9.10% 1 1.24
ALG9 NM_001077692 -1 0.006987624 0.69 (0.52, 0.90) 9.10% 1 1.24
APCS NM_001639 1 0.00751427 1.21 (1.05, 1.40) 9.40% 1 1.18
ARMCX4 NR_028407 -1 0.007606047 0.59 (0.40, 0.87) 9.50% 1 1.24
ATL2 NM_022374 1 0.006753427 1.47 (1.11, 1.94) 8.90% 1 1.25
ATL2 NM_001135673 1 0.006753427 1.47 (1.11, 1.94) 8.90% 1 1.25
ATL2 NR_024191 1 0.006753427 1.47 (1.11, 1.94) 8.90% 1 1.25
BAZ2B NM_013450 -1 0.007896861 0.63 (0.44, 0.88) 9.70% 1 1.24
BNIP3 NM_004052 1 0.008214484 1.55 (1.12, 2.13) 9.90% 1 1.25
BRDT NM_001726 -1 0.00773667 0.53 (0.33, 0.85) 9.60% 1 1.23
BRDT NM_207189 -1 0.00773667 0.53 (0.33, 0.85) 9.60% 1 1.23
BUB3 NM_004725 1 0.007105129 1.48 (1.11, 1.98) 9.10% 1 1.25
BUB3 NM_001007793 1 0.007105129 1.48 (1.11, 1.98) 9.10% 1 1.25
C15orf2 NM_018958 1 0.007451532 1.51 (1.12, 2.04) 9.30% 1 1.25
C6orf123 NR_026773 1 0.007331897 1.64 (1.14, 2.34) 9.30% 1 1.25
C9orf116 NM_144654 -1 0.007781927 0.62 (0.44, 0.88) 9.60% 1 1.24
C9orf116 NM_001048265 -1 0.007781927 0.62 (0.44, 0.88) 9.60% 1 1.24
CA5A NM_001739 1 0.007743248 1.74 (1.16, 2.62) 9.60% 1 1.24
CASK NM_01126055 1 0.008238136 1.60 (1.13, 2.26) 9.90% 1 1.24
CASK NM_001126054 1 0.008238136 1.60 (1.13, 2.26) 9.90% 1 1.24
CASK NM_003688 1 0.008238136 1.60 (1.13, 2.26) 9.90% 1 1.24
CAV3 NM_033337 1 0.007209523 1.56 (1.13, 2.15) 9.20% 1 1.25
CAV3 NM_001234 1 0.007209523 1.56 (1.13, 2.15) 9.20% 1 1.25
CCDC41 NM_016122 -1 0.008020691 0.60 (0.41, 0.88) 9.70% 1 1.24
CCDC41 NM_001042399 -1 0.008020691 0.60 (0.41, 0.88) 9.70% 1 1.24
CCNB2 NM_004701 1 0.007331535 2.05 (1.21, 3.47) 9.30% 1 1.22
CCR10 NM_016602 -1 0.007757267 0.60 (0.41, 0.87) 9.60% 1 1.24
CDHR3 NM_152750 -1 0.008293294 0.63 (0.44, 0.89) 9.90% 1 1.24
CHCHD2 NM_016139 1 0.006949779 1.76 (1.17, 2.65) 9.10% 1 1.24
CHP NM_007236 1 0.007990476 1.61 (1.13, 2.30) 9.70% 1 1.25
CHRNA6 NM_004198 -1 0.00809738 0.64 (0.47, 0.89) 9.80% 1 1.24
CHRNA6 NM_01199279 -1 0.00809738 0.64 (0.47, 0.89) 9.80% 1 1.24
CHRNE NM_000080 -1 0.007041906 0.68 (0.51, 0.90) 9.10% 1 1.24
CMYA5 NM_153610 -1 0.006763751 0.61 (0.42, 0.87) 8.90% 1 1.25
COL8A2 NM_005202 -1 0.007593958 0.64 (0.46, 0.89) 9.50% 1 1.24
COLEC12 NM_130386 -1 0.007113712 0.67 (0.50, 0.90) 9.20% 1 1.25
COQ4 NM_016035 -1 0.008371696 0.66 (0.48, 0.90) 10.00% 1 1.24
COX5A NM_004255 1 0.008188332 1.79 (1.16, 2.76) 9.80% 1 1.23
CREB3L2 NM_194071 1 0.007316954 1.72 (1.16, 2.55) 9.30% 1 1.24
CSNK2A2 NM_001896 1 0.007911319 1.76 (1.16, 2.67) 9.70% 1 1.24
CST5 NM_001900 -1 0.007660357 0.41 (0.21, 0.79) 9.50% 1 1.19
CTDSP1 NM_021198 -1 0.006755543 0.63 (0.45, 0.88) 8.90% 1 1.25
CTDSP1 NM_182642 -1 0.006755543 0.63 (0.45, 0.88) 8.90% 1 1.25
DCDC2 NM_001195610 -1 0.007215502 0.61 (0.43, 0.88) 9.20% 1 1.24
DCDC2 NM_016356 -1 0.007215502 0.61 (0.43, 0.88) 9.20% 1 1.24
DSCR4 NM_005867 1 0.006963957 1.35 (1.09, 1.68) 9.10% 1 1.23
ECT2 NM_018098 1 0.007045075 1.62 (1.14, 2.30) 9.10% 1 1.25
EPRS NM_004446 1 0.007248665 1.70 (1.15, 2.50) 9.20% 1 1.25
ESRRA NM_004451 1 0.008289243 1.77 (1.16, 2.71) 9.90% 1 1.24
F5 NM_000130 1 0.007141726 1.45 (1.11, 1.90) 9.20% 1 1.25
FAM169B NM_182562 1 0.006944878 1.33 (1.08, 1.63) 9.10% 1 1.22
FAM38B NM_022068 -1 0.007143819 0.50 (0.30, 0.83) 9.20% 1 1.22
FBXO15 NM_152676 -1 0.008149201 0.63 (0.44, 0.89) 9.80% 1 1.24
FBXO15 NM_001142958 -1 0.008149201 0.63 (0.44, 0.89) 9.80% 1 1.24
FCAR NM_133279 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCAR NM_133274 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCAR NM_133273 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCAR NM_002000 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCAR NM_133277 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCAR NM_133278 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCAR NM_133271 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCAR NM_133269 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCAR NM_133272 -1 0.00758047 0.60 (0.42, 0.87) 9.50% 1 1.24
FCGR2C NM_201563 -1 0.007000324 0.62 (044, 0.88) 9.10% 1 1.25
FMNL3 NM_175736 -1 0.007177176 0.64 (0.47, 0.89) 9.20% 1 1.25
FMNL3 NM_198900 -1 0.007177176 0.64 (0.47, 0.89) 9.20% 1 1.25
FOXD4L5 NM_01126334 1 0.00836323 1.43 (1.10, 1.87) 10.00% 1 1.24
FOXJ2 NM_018416 -1 0.006621301 0.65 (0.48, 0.89) 8.80% 1 1.25
GALNT5 NM_014568 -1 0.007050223 0.61 (0.43, 0.87) 9.10% 1 1.25
GATA3 NM_001002295 -1 0.007666942 0.66 (0.48, 0.89) 9.50% 1 1.24
GATA3 NM_002051 -1 0.007666942 0.66 (048, 0.89) 9.50% 1 1.24
GATAD2A NM_017660 1 0.006855234 1.35 (1.09, 1.68) 9.00% 1 1.23
GGT3P NR_003267 1 0.00774438 1.41 (1.10, 1.83) 9.60% 1 1.24
GOT1 NM_002079 1 0.007928124 1.68 (1.14, 2.45) 9.70% 1 1.24
GPR12 NM_005288 1 0.006922215 1.38 (1.09, 1.75) 9.10% 1 1.24
GPR156 NM_153002 1 0.007917594 1.57 (1.13, 2.20) 9.70% 1 1.25
GPR156 NM_001168271 1 0.007917594 1.57 (1.13, 2.20) 9.70% 1 1.25
HCRTR2 NM_001526 1 0.007044644 1.27 (1.07, 1.52) 9.10% 1 1.21
HDC NM_002112 -1 0.006715858 0.61 (0.43, 0.87) 8.90% 1 1.25
HNRNPA2B1 NM_002137 1 0.006950753 1.38 (1.09, 1.75) 9.10% 1 1.24
HNRNPA2B1 NM_031243 1 0.006950753 1.38 (1.09, 1.75) 9.10% 1 1.24
HOXB13 NM_006361 1 0.00679441 1.59 (1.14, 2.21) 8.90% 1 1.25
INSIG1 NM_005542 1 0.007908076 1.75 (1.16, 2.64) 9.70% 1 1.24
INSIG1 NM_198337 1 0.007908076 1.75 (1.16, 2.64) 9.70% 1 1.24
INSIG1 NM_198336 1 0.007908076 1.75 (1.16, 2.64) 9.70% 1 1.24
ITIH3 NM_002217 -1 0.008089965 0.58 (0.39, 0.87) 9.80% 1 1.24
KCNK5 NM_003740 1 0.006644671 1.52 (1.12, 2.05) 8.80% 1 1.25
KIAA1609 NM_020947 1 0.006816877 1.56 (1.13, 2.15) 9.00% 1 1.25
KLF6 NR_027653 1 0.007216712 1.54 (1.12, 2.10) 9.20% 1 1.25
KLF6 NM_001160124 1 0.007216712 1.54 (1.12, 2.10) 9.20% 1 1.25
KLF6 NM_001300 1 0.007216712 1.54 (1.12, 2.10) 9.20% 1 1.25
KLF6 NM_001160125 1 0.007216712 1.54 (1.12, 2.10) 9.20% 1 1.25
LIX1 NM_153234 1 0.007284268 1.70 (1.15, 2.50) 9.30% 1 1.25
LOC145845 NR_024264 1 0.007192082 1.42 (1.10, 1.83) 9.20% 1 1.24
LPCAT1 NM_024830 1 0.006993251 1.67 (1.15, 2.42) 9.10% 1 1.25
MAGI2 NM_012301 -1 0.008130755 0.57 (0.38, 0.86) 9.80% 1 1.23
MAP3K12 NM_006301 -1 0.007048049 0.62 (0.44, 0.88) 9.10% 1 1.25
MAP3K12 NM_001193511 -1 0.007048049 0.62 (0.44, 0.88) 9.10% 1 1.25
MFGE8 NM_001114614 1 0.006919473 1.56 (1.13, 2.16) 9.10% 1 1.25
MFGE8 NM_005928 1 0.006919473 1.56 (1.13, 2.16) 9.10% 1 1.23
MINK1 NM_015716 -1 0.007173123 0.54 (0.35, 0.85) 9.20% 1 1.23
MINK1 NM_153827 -1 0.007173123 0.54 (0.35, 0.85) 9.20% 1 1.23
MINK1 NM_170663 -1 0.007173123 0.54 (0.35, 0.85) 9.20% 1 1.23
MINK1 NM_001024937 -1 0.007173123 0.54 (0.35, 0.85) 9.20% 1 1.23
MIR195 NR_029712 1 0.00787247 1.37 (1.09, 1.74) 9.70% 1 1.25
MIR3183 NR_036148 1 0.006747778 1.68 (1.15, 2.44) 8.90% 1 1.25
MIR4318 NR_036202 1 0.007957654 1.61 (1.13, 2.29) 9.70% 1 1.24
MTA1 NM_004689 -1 0.007359437 0.59 (0.40, 0.87) 9.30% 1 1.25
NOL11 NM_015462 1 0.006772141 1.56 (1.13, 2.14) 8.90% 1 1.23
NR1I2 NM_022002 -1 0.007225406 0.55 (0.36, 0.85) 9.20% 1 1.23
NR1I2 NM_003889 -1 0.007225406 0.55 (0.36, 0.85) 9.20% 1 1.23
NR1I2 NM_0333013 -1 0.007225406 0.55 (0.36, 0.85) 9.20% 1 1.24
NXF1 NM_001081491 -1 0.00708175 0.60 (0.41, 0.87) 9.10% 1 1.24
NXF1 NM_006362 -1 0.00708175 0.60 (0.41, 0.87) 9.10% 1 1.25
OGDH NM_002541 1 0.007291529 1.46 (1.11, 1.93) 9.30% 1 1.25
OGDH NM_001003941 1 0.007291529 1.46 (1.11, 1.93) 9.30% 1 1.25
OGDH NM_001165036 1 0.007291529 1.46 (1.11, 1.93) 9.30% 1 1.24
OPLAH NM_017570 1 0.007363069 1.73 (1.16, 2.59) 9.30% 1 1.25
OR52E4 NM_001005165 1 0.007563025 1.58 (1.13, 2.22) 9.40% 1 1.24
PA2G4P4 NR_003284 -1 0.007765185 0.66 (0.48, 0.90) 9.60% 1 1.24
PALLD NM_001166108 -1 0.007412269 0.62 (0.44, 0.88) 9.30% 1 1.24
PALLD NM_001166109 -1 0.007412269 0.62 (0.44, 0.88) 9.30% 1 1.24
PALLD NM_001166110 -1 0.007412269 0.62 (0.44, 0.88) 9.30% 1 1.24
PALLD NM_016081 -1 0.007412269 0.62 (0.44, 0.88) 9.30% 1 1.25
PARP11 NM 020367 -1 0.006969466 0.62 (0.44, 0.88) 9.10% 1 1.24
PFN4 NM_199346 -1 0.007867198 0.63 (0.44, 0.88) 9.70% 1 1.24
PGK1 NM_000291 1 0.007371341 1.70 (1.15, 2.50) 9.30% 1 1.24
PIK3C3 NM_002647 -1 0.007928522 0.63 (0.45, 0.89) 9.70% 1 1.24
PLA2G16 NM_001128203 -1 0.007338932 0.59 (0.40, 0.87) 9.30% 1 1.24
PLA2G16 NM_007069 -1 0.007338932 0.59 (0.40, 0.87) 9.30% 1 1.24
POM121L10P NR_024593 1 0.008015909 1.47 (1.11, 1.96) 9.70% 1 1.24
PPIB NM_000942 1 0.008136977 1.60 (1.13, 2.27) 9.80% 1 1.25
PPIG NM_004792 -1 0.007743418 0.67 (0.50, 0.90) 9.60% 1 1.24
PRAME NM_206954 1 0.00807234 1.60 (1.13, 2.28) 9.80% 1 1.25
PRAME NM_206953 1 0.00807234 1.60 (1.13, 2.28) 9.80% 1 1.25
PRAME NM_006115 1 0.00807234 1.60 (1.13, 2.28) 9.80% 1 1.25
PRAME NM_206956 1 0.00807234 1.60 (1.13, 2.28) 9.80% 1 1.25
PRAME NM_206955 1 0.00807234 1.60 (1.13, 2.28) 9.80% 1 1.25
PTPRT NM_007050 -1 0.007844377 0.64 (0.46, 0.89) 9.70% 1 1.24
PTPRT NM_133170 -1 0.007844377 0.64 (0.46, 0.89) 9.70% 1 1.24
PVR NM_006505 1 0.007178986 1.73 (1.16, 2.57) 9.20% 1 1.24
PVR NM_001135768 1 0.007178986 1.73 (1.16, 2.57) 9.20% 1 1.24
PVR NM_001135769 1 0.007178986 1.73 (1.16, 2.57) 9.20% 1 1.24
PVR NM_001135770 1 0.007178986 1.73 (1.16, 2.57) 9.20% 1 1.24
RBBP6 NM_006910 -1 0.008045393 0.59 (0.40, 0.87) 9.80% 1 1.24
RBBP6 NM_032626 -1 0.008045393 0.59 (0.40, 0.87) 9.80% 1 1.24
RBBP6 NM_018703 -1 0.008045393 0.59 (0.40, 0.87) 9.80% 1 1.24
RBM38 NM_017495 1 0.007553277 1.79 (1.17, 2.73) 9.40% 1 1.24
RBM38 NM_183425 1 0.007553277 1.79 (1.17, 2.73) 9.40% 1 1.24
RILPL1 NM_178314 -1 0.007013837 0.61 (0.43, 0.88) 9.10% 1 1.25
RNFT1 NM_016125 1 0.007629214 1.78 (1.17, 2.73) 9.50% 1 1.24
RPAP2 NM_024813 -1 0.007531085 0.57 (0.38, 0.86) 9.40% 1 1.24
RPS6KB1 NM_003161 1 0.008065183 1.43 (1.10, 1.87) 9.80% 1 1.24
SAMD15 NM_001010860 -1 0.007388814 0.67 (0.50, 0.90) 9.30% 1 1.24
SCARNA23 NR_003007 1 0.007993669 1.51 (1.11, 2.04) 9.70% 1 1.25
SERPINB10 NM_005024 1 0.006313415 1.26 (1.07, 1.49) 8.60% 1 1.2
SERPINB8 NM_002640 -1 0.007336561 0.64 (0.46, 0.89) 9.30% 1 1.25
SERPINB8 NM_001031848 -1 0.007336561 0.64 (0.46, 0.89) 9.30% 1 1.25
SERPINB8 NM_198833 -1 0.007336561 0.64 (0.46, 0.89) 9.30% 1 1.25
SHISA3 NM_001080505 1 0.007387467 1.38 (1.09, 1.75) 9.30% 1 1.24
SLC25A13 NR_027662 1 0.007684969 1.69 (1.15, 2.49) 9.50% 1 1.24
SLC25A13 NM_014251 1 0.007684969 1.69 (1.15, 2.49) 9.50% 1 1.24
SLC25A13 NM_001160210 1 0.007684969 1.69 (1.15, 2.49) 9.50% 1 1.24
SLC35C2 NM_173073 1 0.006914089 1.48 (1.11, 1.97) 9.10% 1 1.25
SLC35C2 NM_015945 1 0.006914089 1.48 (1.11, 1.97) 9.10% 1 1.25
SLC35C2 NM_173179 1 0.006914089 1.48 (1.11, 1.97) 9.10% 1 1.25
SLC37A2 NM_001145290 -1 0.007397611 0.61 (0.42, 0.88) 9.30% 1 1.24
SLC37A2 NM_198277 -1 0.007397611 0.61 (0.42, 0.88) 9.30% 1 1.24
SPAG7 NM_004890 -1 0.007433804 0.66 (0.49, 0.89) 9.30% 1 1.24
SQLE NM_003129 1 0.008169599 1.61 (1.13, 2.29) 9.80% 1 1.24
SRR NM_021947 -1 0.007802797 0.68 (0.51, 0.90) 9.60% 1 1.24
STAU1 NM_004602 1 0.007966457 1.46 (1.10, 1.93) 9.70% 1 1.24
STAU1 NM_017454 1 0.007966457 1.46 (1.10, 1.93) 9.70% 1 1.24
STAU1 NM_001037328 1 0.007966457 1.46 (1.10, 1.93) 9.70% 1 1.24
STAU1 NM_017452 1 0.007966457 1.46 (1.10, 1.93) 9.70% 1 1.24
STAU1 NM_017453 1 0.007966457 1.46 (1.10, 1.93) 9.70% 1 1.24
SURF4 NM_033161 1 0.00710138 1.61 (1.14, 2.28) 9.10% 1 1.25
TBC1D16 NM_019020 -1 0.007903348 0.57 (0.38, 0.86) 9.70% 1 1.23
TCP11L2 NM_152772 -1 0.006709472 0.63 (0.46, 0.88) 8.90% 1 1.25
THEG NM_016585 1 0.007652171 1.50 (1.11, 2.03) 9.50% 1 1.25
THEG NM_199202 1 0.007652171 1.50 (1.11, 2.03) 9.50% 1 1.25
TMED11P NR_033768 -1 0.008112229 0.60 (0.41, 0.88) 9.80% 1 1.24
TMEM189 NM_001162505 1 0.007119372 1.79 (1.17, 2.74) 9.20% 1 1.24
TMEM189 NR_027889 1 0.007119372 1.79 (1.17, 2.74) 9.20% 1 1.24
TMEM189 NM_199129 1 0.007119372 1.79 (1.17, 2.74) 9.20% 1 1.24
TNFSF12 NR_037146 -1 0.006806283 0.65 (0.48, 0.89) 8.90% 1 1.25
TNFSF12 NM_003809 -1 0.006806283 0.65 (0.48, 0.89) 8.90% 1 1.25
TNK1 NM_003985 -1 0.007866596 0.63 (0.45, 0.89) 9.70% 1 1.24
TNS1 NM_022648 -1 0.008198294 0.60 (0.41, 0.88) 9.80% 1 1.24
TRIM39 NM_021253 -1 0.006654211 0.67 (0.50, 0.89) 8.80% 1 1.25
TRIM39 NM_172016 -1 0.006654211 0.67 (0.50, 0.89) 8.80% 1 1.25
TUBA1B NM_006082 1 0.006986711 1.56 (1.13, 2.15) 9.10% 1 1.25
USP51 NM_201286 -1 0.007929716 0.66 (0.49, 0.90) 9.70% 1 1.24
WDR52 NM_001164496 -1 0.007394432 0.61 (0.42, 0.87) 9.30% 1 1.24
WDR52 NM_018338 -1 0.007394432 0.61 (0.42, 0.87) 9.30% 1 1.24
WWP2 NM_199424 1 0.006541054 1.34 (1.09,1.66) 8.70% 1 1.23
WWP2 NM_007014 1 0.006541054 1.34 (1.09, 1.66) 8.70% 1 1.23
WWP2 NM_199423 1 0.006541054 1.34 (1.09, 1.66) 8.70% 1 1.23
XPO1 NM_003400 1 0.006983767 1.63 (1.14, 2.34) 9.10% 1 1.25
YES1 NM_005433 1 0.007385459 1.78 (1.17, 2.70) 9.30% 1 1.24
ZFAND1 NM_001170797 1 0.007371855 1.59 (1.13, 2.23) 9.30% 1 1.25
ZFAND1 NM_001170796 1 0.007371855 1.59 (1.13, 2.23) 9.30% 1 1.25
ZFAND1 NR_033193 1 0.007371855 1.59 (1.13, 2.23) 9.30% 1 1.25
ZFAND1 NR_033194 1 0.007371855 1.59 (1.13, 2.23) 9.30% 1 1.25
ZFAND1 NM_024699 1 0.007371855 1.59 (1.13, 2.23) 9.30% 1 1.25
ZFAND1 NR_033195 1 0.007371855 1.59 (1.13, 2.23) 9.30% 1 1.25
ZFAND1 NR_033196 1 0.007371855 1.59 (1.13, 2.23) 9.30% 1 1.25
ZMYND10 NM_015896 -1 0.008232538 0.61 (0.42, 0.88) 9.90% 1 1.24
ZNF160 NM_001102603 -1 0.008143054 0.58 (0.39, 0.87) 9.80% 1 1.24
ZNF160 NM_198893 -1 0.008143054 0.58 (0.39, 0.87) 9.80% 1 1.24
ZNF160 NM_033288 -1 0.008143054 0.58 (0.39, 0.87) 9.80% 1 1.24
ZNF175 NM_007147 -1 0.007576003 0.63 (0.44, 0.88) 9.50% 1 1.24
ZNF187 NM_001023560 -1 0.006949723 0.67 (0.50, 0.90) 9.10% 1 1.25
ZNF187 NM_001111039 -1 0.006949723 0.67 (0.50, 0.90) 9.10% 1 1.25
ZNF187 NM_152736 -1 0.006949723 0.67 (0.50, 0.90) 9.10% 1 1.25
ZNF486 NM_052852 -1 0.008185949 0.50 (0.30, 0.84) 9.80% 1 1.21
ZNF782 NM_001001662 -1 0.007410404 0.50 (0.30, 0.83) 9.30% 1 1.22
Table 2. List of Assembled RefSeq RNAs Associated with Risk of Breast Cancer Recurrence In 111 Patients Designated as ESR1 Positive
Gene Accession no. Direction of Association (1=Higher Expression Means Higher Risk) p-value Standardized Hazard Ratio Estimate (95% Confidence Interval) q-value (FDR) Maximum Lower Bound Std HR @ 10% FDR Regression-to-the-Mean-Corrected Std HR
C17orf97 NM_001013672 -1 1.28E-08 0.38 (6.27, 0.53) <0.1% 1.24 1.58
ZFP3 NM_153018 -1 6.18E-08 0.31 (0.21, 0.48) <0.1% 1.24 1.52
ULBP3 NM_024518 1 1.95E-08 2.51 (1.82, 3.46) <0.1% 1.23 1.6
GUCY2F NM_001522 1 3.37E-11 1.68 (1.44, 1.96) <0.1% 1.2 1.53
IFT74 NM_001099222 -1 2.40E-08 0.49 (0.38, 0.63) <0.1% 1.2 1.55
IFT74 NM_025103 -1 2.40E-08 0.49 (0.38, 0.63) <0.1% 1.2 1.55
IFT74 NM_001099224 -1 2.40E-08 0.49 (0.38, 0.63) <0.1% 1.2 1.55
IFT74 NM_001099223 -1 2.40E-08 0.49 (0.38, 0.63) <0.1% 1.2 1.55
MIR1208 NR_031613 1 1.43E-08 1.95 (1.55, 2.46) <0.1% 1.2 1.56
PADI3 NM_016233 1 9.99E-09 1.93 (1.54, 2.42) <0.1% 1.2 1.56
RPP21 NM_001199120 1 3.14E-08 2.02 (1.58, 2.59) <0.1% 1.2 1.56
RPP21 NM_001199121 1 3.14E-08 2.02 (1.58, 2.59) <0.1% 1.2 1.56
RPP21 NM_024839 1 3.14E-08 2.02 (1.58, 2.59) <0.1% 1.2 1.56
CWF19L2 NM_152434 -1 1.30E-06 0.37 (0.24, 0.55) 0.10% 1.17 1.46
ZNF141 NM_003441 -1 6.43E-07 0.41 (0.29, 0.58) <0.1% 1.17 1.49
RP1-177G6-2 NR_028345 1 1.05E-09 1.55 (1.35, 1.79) <0.1% 1.16 1.45
RP1-177G6-2 NR_028344 1 1.05E-09 1.55 (1.35, 1.79) <0.1% 1.16 1.45
APOL3 NR_027834 -1 5.44E-07 0.50 (0.38, 0.66) <0.1% 1.15 1.49
APOL3 NR_027833 -1 5.44E-07 0.50 (0.38, 0.66) <0.1% 1.15 1.49
APOL3 NR_027835 -1 5.44E-07 0.50 (0.38, 0.66) <0.1% 1.15 1.49
APOL3 NM_145642 -1 5.44E-07 0.50 (0.38, 0.66) <0.1% 1.15 1.49
APOL3 NM_145641 -1 5.44E-07 0.50 (0.38, 0.66) <0.1% 1.15 1.49
APOL3 NM_145640 -1 5.44E-07 0.50 (0.38, 0.66) <0.1% 1.15 1.49
CYB5B NM_030579 1 6.41E-06 3.17 (1.92, 5.22) 0.20% 1.15 1.42
DEGS1 NM_003676 1 2.21E-07 1.76 (1.42, 2.18) <0.1% 1.15 1.49
FLI14186 NR_037596 -1 1.79E-06 0.46 (0.34, 0.63) 0.10% 1.15 1.47
HMX1 NM_018942 1 2.17E-09 1.53 (1.33, 1.75) <0.1% 1.15 1.43
KIAA0664L3 NR_024034 -1 2.18E-07 0.56 (0.45, 0.70) <0.1% 1.15 1.48
KRT83 NM_002282 1 2.64E-08 1.60 (1.35, 1.88) <0.1% 1.15 1.45
ZNF326 NM_182976 -1 4.30E-06 0.41 (0.28, 0.60) 0.20% 1.15 1.44
ZNF326 NM_182975 -1 4.30E-06 0.41 (0.28, 0.60) 0.20% 1.15 1.44
ZNF486 NM_052852 -1 3.31E-06 0.35 (0.23, 0.55) 0.10% 1.15 1.43
NAA35 NM_024635 -1 5.42E-06 0.43 (0.30, 0.62) 0.20% 1.14 1.44
RBMXL1 NM_001162536 -1 3.46E-06 0.45 (0.32, 0.63) 0.10% 1.14 1.45
RBMXL1 NM_019610 -1 3.46E-06 0.45 (0.32, 0.63) 0.10% 1.14 1.45
TMEM81 NM_203376 1 1.08E-05 3.15 (1.89, 5.26) 0.30% 1.14 1.4
CENPN NM_001100625 1 1.82E-05 3.08 (1.84, 5.15) 0.40% 1.13 1.39
CENPN NM_018455 1 1.82E-05 3.08 (1.84, 5.15) 0.40% 1.13 1.39
CENPN NM_001100624 1 1.82E-05 3.08 (1.84, 5.15) 0.40% 1.13 1.39
FUBP1 NM_003902 -1 1.31E-05 0.36 (0.22, 0.57) 0.30% 1.13 1.38
LOC642345 NR_033829 1 2.97E-07 1.62 (1.35, 1.95) <0.1% 1.13 1.44
ZZZ3 NM_015534 -1 1.63E-05 0.34 (0.21, 0.56) 0.40% 1.13 1.37
CDK20 NM_001170639 -1 1.0423E-05 0.46 (0.33, 0.65) 0.30% 1.12 1.42
CDK20 NM_179432 -1 1.0423E-05 0.46 (0.33, 0.65) 0.30% 1.12 1.42
CDK20 NM_001170640 -1 1.0423E-05 0.46 (0.33, 0.65) 0.30% 1.12 1.42
CDK20 NM_001039803 -1 1.0423E-05 0.46 (0.33, 0.65) 0.30% 1.12 1.42
CDK20 NM_012119 -1 1.0423E-05 0.46 (0.33, 0.65) 0.30% 1.12 1.42
DEFB133 NM_001166478 1 1.74E-07 1.50 (1.29, 1.75) <0.1% 1.12 1.4
GLMN NM_053274 -1 2.57E-05 0.36 (0.22, 0.58) 0.60% 1.12 1.36
LOC100129636 NM_0001195202 1 2.82E-06 1.83 (1.42, 2.36) 0.10% 1.12 1.46
LPO NM_001160102 1 6.17E-07 1.60 (1.33, 1.92) <0.1% 1.12 1.43
LPO NM_006151 1 6.17E-07 1.60 (1.33, 1.92) <0.1% 1.12 1.43
LPO NR_027647 1 6.17E-07 1.60 (1.33, 1.92) <0.1% 1.12 1.43
OMA1 NM_145243 -1 4.89E-06 0.53 (0.40, 0.70) 0.20% 1.12 1.44
PCDH11Y NM_032972 1 1.89E-07 1.48 (1.28, 1.72) <0.1% 1.12 1.39
PCDH11Y NM_032973 1 1.89E-07 1.48 (1.28, 1.72) <0.1% 1.12 1.39
PCDH11Y NM_032971 1 1.89E-07 1.48 (1.28, 1.72) <0.1% 1.12 1.39
PPP3CB NM_021132 1 1.02E-06 1.70 (1.37, 2.10) 0.10% 1.12 1.45
PPP3CB NM_01142354 1 1.02E-06 1.70 (1.37, 2.10) 0.10% 1.12 1.45
PPP3CB NM_001142353 1 1.02E-06 1.70 (1.37, 2.10) 0.10% 1.12 1.45
ATXN3L NM_001135995 1 2.23E-07 1.40 (1.23, 1.60) <0.1% 1.11 1.34
C3orf15 NM_033364 -1 2.52E-05 0.42 (0.28, 0.63) 0.60% 1.11 1.39
C9orf27 NR_024032 1 6.75E-09 1.34 (1.21, 1.47) <0.1% 1.11 1.31
CCDC105 NM_173482 1 1.01E-06 1.55 (1.30, 1.84) 0.10% 1.11 1.41
FANK1 NM_145235 -1 1.13E-05 0.49 (0.35, 0.67) 0.30% 1.11 1.42
GGCT NR_037669 1 1.21E-05 1.86 (1.41, 2.45) 0.30% 1.11 1.44
GGCT NM_01199815 1 1.21E-05 1.86 (1.41, 2.45) 0.30% 1.11 1.44
GGCT NM_001199817 1 1.21E-05 1.86 (1.41, 2.45) 0.30% 1.11 1.44
GGCT NM_001199816 1 1.21E-05 1.86 (1.41, 2.45) 0.30% 1.11 1.44
GGCT NM_024051 1 1.21E-05 1.86 (1.41, 2.45) 0.30% 1.11 1.44
GPAA1 NM_003801 1 2.95E-05 2.28 (1.55, 3.35) 0.60% 1.11 1.41
HCRTR2 NM_001526 1 2.02E-07 1.41 (1.24, 1.60) <0.1% 1.11 1.35
KLHDC8A NM_018203 -1 4.87E-05 0.36 (0.22, 0.59) 0.80% 1.11 1.35
LOC339290 NR_015389 -1 4.68E-05 0.35 (0.21, 0.58) 0.80% 1.11 1.34
LOC729966 NR_036575 1 8.19E-08 1.40 (1.24, 1.59) <0.1% 1.11 1.35
MARCH6 NM_005885 1 2.93E-05 2.22 (1.53, 3.23) 0.60% 1.11 1.42
MEX3B NM_032246 1 2.55E-05 2.66 (1.69, 4.20) 0.60% 1.11 1.4
NQO1 NM_01025434 1 3.17E-05 2.58 (1.65, 4.04) 0.60% 1.11 1.4
NQO1 NM_000903 1 3.17E-05 2.58 (1.65, 4.04) 0.60% 1.11 1.4
NQO1 NM_001025433 1 3.17E-05 2.58 (1.65, 4.04) 0.60% 1.11 1.4
ORM1 NM_000607 1 1.22E-06 1.55 (1.30, 1.85) 0.10% 1.11 1.4
RAET1L NM_130900 1 2.80E-06 1.66 (1.34, 2.05) 0.10% 1.11 1.43
SERPINB10 NN_005024 1 1.11E-07 1.43 (1.25, 1.63) <0.1% 1.11 1.36
TMOD3 NM_014547 1 2.08E-08 1.39 (1.24, 1.55) <0.1% 1.11 1.34
TSKU NM_015516 1 6.77E-06 1.84 (1.41, 2.41) 0.20% 1.11 1.45
CG030 NR_026928 -1 2.93E-05 0.49 (0.35, 0.68) 0.60% 1.1 1.4
GAN NM_022041 1 7.87E-05 3.09 (1.76, 5.40) 1.10% 1.1 1.34
LRGUK NM_144648 -1 3.71E-05 0.45 (0.31, 0.66) 0.70% 1.1 1.39
MAGEA10 NM_021048 1 7.05E-07 1.45 (1.25, 1.67) <0.1% 1.1 1.36
MAGEA10 NM_01011543 1 7.05E-07 1.45 (1.25, 1.67) <0.1% 1.1 1.36
NCRNA00200 NR_015376 1 9.14E-07 1.44 (1.24, 1.66) 0.10% 1.1 1.36
NCRNA00221 NR_027457 1 1.13E-06 1.45 (1.25, 1.68) 0.10% 1.1 1.36
PGA3 NM_001079807 1 2.24E-06 1.47 (1.25, 1.73) 0.10% 1.1 1.37
PYCRL NM_023078 1 7.01E-05 2.88 (1.71, 4.86) 1.10% 1.1 1.35
AZU1 NM_001700 1 4.61E-05 1.90 (1.40, 2.60) 0.80% 1.09 1.41
C21orf63 NM_058187 -1 4.43E-05 0.48 (0.34, 0.68) 0.80% 1.09 1.39
C7orf30 NM_138446 1 3.48E-05 1.94 (1.42, 2.64) 0.70% 1.09 1.41
CHAT NM_020986 1 5.09E-06 1.50 (1.26, 1.78) 0.20% 1.09 1.37
CHAT NM_001142934 1 5.09E-06 1.50 (1.26, 1.78) 0.20% 1.09 1.37
CHAT NM 020985 1 5.09E-06 1.50 (1.26,1.78) 0.20% 1.09 1.37
CHAT NM_001142933 1 5.09E-06 1.50 (1.26, 1.78) 0.20% 1.09 1.37
CHAT NM_020549 1 5.09E-06 1.50 (1.26, 1.78) 0.20% 1.09 1.37
CHAT NM_020984 1 5.09E-06 1.50 (1.26,1.78) 0.20% 1.09 1.37
CHAT NM_001142929 1 5.09E-06 1.50 (1.26, 1.78) 0.20% 1.09 1.37
COX8C NM_182971 1 8.22E-06 1.55 (1.28, 1.88) 0.30% 1.09 1.39
GOLPH3 NM_022130 1 9.17E-05 2.38 (1.54, 3.67) 1.30% 1.09 1.37
GSTA2 NM_000846 1 5.09E-06 1.50 (1.26, 1.78) 0.20% 1.09 1.37
J AK1 NM_002227 -1 9.2776E-05 0.38 (0.23, 0.62) 1.30% 1.09 1.33
LOC647107 NR_033945 1 1.27E-05 1.64 (1.31, 2.04) 0.30% 1.09 1.4
LRIT2 NM_001017924 1 6.98E-07 1.38 (1.21, 1.56) <0.1% 1.09 1.32
LRP12 NM_001135703 1 6.92E-05 2.17 (1.48, 3.18) 1.10% 1.09 1.39
LRP12 NM_013437 1 6.92E-05 2.17 (1.48, 3.18) 1.10% 1.09 1.39
MAPK6 NM_002748 1 4.24E-07 1.37 (1.21, 1.55) <0.1% 1.09 1.32
MIR1266 NR_031670 1 1.70E-05 1.68 (1.33, 2.12) 0.40% 1.09 1.41
MIR3117 NR_036060 1 4.01E-05 2.00 (1.44, 2.78) 0.70% 1.09 1.41
PAR-SN NR_022011 -1 1.63E-05 0.61 (0.48, 0.76) 0.40% 1.09 1.39
SF3B3 NM_012426 1 4.66E-05 2.11 (1.47, 3.02) 0.80% 1.09 1.41
SLC35D2 NM_007001 -1 4.11E-05 0.54 (0.41, 0.73) 0.70% 1.09 1.39
TFF2 NM_005423 1 3.48E-06 1.42 (1.22, 1.65) 0.10% 1.09 1.34
USO1 NM_003715 1 1.60E-06 1.40 (1.22, 1.60) 0.10% 1.09 1.33
WFDC9 NM_147198 1 7.58E-05 2.21 (1.49, 3.28) 1.10% 1.09 1.39
ACAP2 NM_012287 1 6.50E-05 1.92 (1.39, 2.64) 1.00% 1.08 1.4
ACSL5 NM_016234 -1 0.00011296 0.45 (0.30, 0.67) 1.50% 1.08 1.35
ACSL5 NM_203380 -1 0.00011296 0.45 (0.30, 0.67) 1.50% 1.08 1.35
ACSL5 NM_203379 -1 0.00011296 0.45 (0.30, 0.67) 1.50% 1.08 1.35
APOBEC1 NM_001644 1 1.27E-07 1.27 (1.16, 1.39) <0.1% 1.08 1.25
CCNA2 NM_001237 1 0.00013361 2.46 (1.55, 3.91) 1.70% 1.08 1.36
DBNDD1 NM_001042610 1 0.00014445 2.73 (1.63, 4.58) 1.80% 1.08 1.34
DBNDD1 NM_024043 1 0.00014445 2.73 (1.63, 4.58) 1.80% 1.08 1.34
EVX2 NM_001080458 1 1.16E-05 1.51 (1.25, 1.81) 0.30% 1.08 1.37
FAM18A NM_001079512 -1 3.73E-05 0.59 (0.46, 0.76) 0.70% 1.08 1.38
GRSF1 NM_002092 1 1.87E-05 1.51 (1.25, 1.83) 0.50% 1.08 1.36
GRSF1 NM_001098477 1 1.87E-05 1.51 (1.25, 1.83) 0.50% 1.08 1.36
LOC145845 NR_024264 1 5.07E-05 1.79 (1.35, 2.37) 0.80% 1.08 1.4
LOC645971 NM_001195256 1 1.00E-04 2.15 (1.46, 3.16) 1.40% 1.08 1.38
LRRC37A4 NR_002940 -1 2.18E-05 0.66 (0.54, 0.80) 0.50% 1.08 1.35
MIR542 NR_030399 1 3.03E-05 1.65 (1.31, 2.10) 0.60% 1.08 1.39
OR14J1 NM_030946 1 2.85E-05 1.65 (1.30, 2.08) 0.60% 1.08 1.39
PKN2 NM_06256 -1 0.00014097 0.33 (0.18, 0.58) 1.80% 1.08 1.29
PRPF38B NR_037185 -1 0.00016322 0.36 (0.22, 0.62) 2.00% 1.08 1.3
PRPF38B NM_18061 -1 0.00016322 0.36 (0.22, 0.62) 2.00% 1.08 1.3
RAB9BP1 NR_00039 1 2.04E-05 1.59 (1.29, 1.97) 0.50% 1.08 1.39
SERINC5 NM_178276 1 3.54E-05 1.72 (1.33, 2.23) 0.70% 1.08 1.4
SERINC5 NM_001174071 1 3.54E-05 1.72 (1.33, 2.23) 0.70% 1.08 1.4
SERINC5 NM_001174072 1 3.54E-05 1.72 (1.33, 2.23) 0.70% 1.08 1.4
TRPM8 NM_024080 1 2.78E-05 1.56 (1.27, 1.92) 0.60% 1.08 1.37
USPL1 NM_005800 -1 0.00016305 0.38 (0.23, 0.63) 2.00% 1.08 1.31
ZNF227 NM_182490 -1 0.00013956 0.41 (0.26, 0.65) 1.80% 1.08 1.33
ZNF512 NM_032434 -1 7.91E-05 0.46 (0.32, 0.68) 1.10% 1.08 1.36
ZNF595 NM_182524 -1 3.08E-05 0.64 (0.51, 0.79) 0.60% 1.08 1.36
AP1G1 NM_001128 1 0.00015448 2.04 (1.41, 2.96) 1.90% 1.07 1.37
AP1G1 NM_001030007 1 0.00015448 2.04 (1.41, 2.96) 1.90% 1.07 1.37
AP4E1 NM_007347 1 1.22E-05 1.35 (1.18, 1.55) 0.30% 1.07 1.3
C15orf34 NR_027262 -1 7.82E-05 0.59 (0.45, 0.76) 1.10% 1.07 1.37
COL20A1 NM_020882 1 2.83E-05 1.44 (1.21, 1.71) 0.60% 1.07 1.33
COX7B2 NM_130902 1 1.35E-06 1.25 (1.14, 1.38) 0.10% 1.07 1.23
EVX1 NM_001989 1 3.66E-05 1.58 (1.27, 1.95) 0.70% 1.07 1.37
HLA-DOA NM_002119 -1 7.86E-05 0.55 (0.41, 0.74) 1.10% 1.07 1.37
MMP15 NM_002428 1 0.0001989 2.48 (1.54, 4.00) 2.30% 1.07 1.34
PIBF1 NM_006346 -1 0.00012808 0.50 (0.35, 0.71) 1.70% 1.07 1.36
SNCB NM_001001502 1 2.13E-05 1.43 (1.21, 1.68) 0.50% 1.07 1.33
SNCB NM_003085 1 2.13E-05 1.43 (1.21, 1.68) 0.50% 1.07 1.33
STX8 NR_033656 -1 0.00012845 0.52 (0.37, 0.73) 1.70% 1.07 1.36
STX8 NM_004853 -1 0.00012845 0.52 (0.37, 0.73) 1.70% 1.07 1.36
TMEM91 NM_001098823 -1 0.00013958 0.51 (0.36, 0.72) 1.80% 1.07 1.36
TMEM91 NM_001042595 -1 0.00013958 0.51 (0.36, 0.72) 1.80% 1.07 1.36
TMEM91 NM_001098821 -1 0.00013958 0.51 (0.36, 0.72) 1.80% 1.07 1.36
TMEM91 NM_001098822 -1 0.00013958 0.51 (0.36, 0.72) 1.80% 1.07 1.36
TMEM91 NM_001098825 -1 0.00013958 0.51 (0.36, 0.72) 1.80% 1.07 1.36
TMEM91 NM_001098824 -1 0.00013958 0.51 (0.36, 0.72) 1.80% 1.07 1.36
ZNF738 NR_027130 -1 0.00018472 0.44 (0.28, 0.67) 2.20% 1.07 1.33
ANKZF1 NM_018089 -1 0.00013353 0.54 (0.39,0.74) 1.70% 1.06 1.36
ANKZF1 NM_001042410 -1 0.00013353 0.54 (0.39, 0.74) 1.70% 1.06 1.36
APCS NM_001639 1 6.64E-06 1.27 (1.15, 1.41) 0.20% 1.06 1.24
BAGE NM_001187 1 4.69E-05 1.44 (1.21,1.72) 0.80% 1.06 1.33
FAM21C NM_015262 -1 0.00021151 0.49 (0.33, 0.71) 2.30% 1.06 1.34
FAM21C NM_001169107 -1 0.00021151 0.49 (0.33, 0.71) 2.30% 1.06 1.34
FAM21C NM_001169106 -1 0.00021151 0.49 (0.33, 0.71) 2.30% 1.06 1.34
GFOD2 NM_030819 1 0.0002683 2.24 (1.45, 3.45) 2.70% 1.06 1.34
GFOD2 NR_027398 1 0.0002683 2.24 (1.45, 3.45) 2.70% 1.06 1.34
GFOD2 NR_027399 1 0.0002683 2.24 (1.45, 3.45) 2.70% 1.06 1.34
GPX5 NM_003996 1 7.14E-05 1.58 (1.26, 1.98) 1.10% 1.06 1.36
GPX5 NM_001509 1 7.14E-05 1.58 (1.26, 1.98) 1.10% 1.06 1.36
IRAK4 NM_001145256 -1 0.00018709 0.47 (0.32, 0.70) 2.20% 1.06 1.34
IRAK4 NM_01114182 -1 0.00018709 0.47 (0.32, 0.70) 2.20% 1.06 1.34
IRAK4 NM_001145258 -1 0.00018709 0.47 (0.32, 0.70) 2.20% 1.06 1.34
IRAK4 NM_001145257 -1 0.00018709 0.47 (0.32, 0.70) 2.20% 1.06 1.34
IRAK4 NM_016123 -1 0.00018709 0.47 (0.32, 0.70) 2.20% 1.06 1.34
KIAA1324 NM_020775 -1 0.00020766 0.46 (0.31, 0.69) 2.30% 1.06 1.33
LOC286186 NR_033893 1 6.18E-05 1.50 (1.23, 1.83) 1.00% 1.06 1.35
LOC401177 NR_033975 1 9.63E-06 1.29 (1.15, 1.45) 0.30% 1.06 1.26
LRRC46 NM_033413 -1 0.00020068 0.48 (0.33, 0.71) 2.30% 1.06 1.34
MIR1251 NR_031653 1 0.00019134 1.89 (1.35, 2.65) 2.20% 1.06 1.37
MIR195 NR_029712 1 9.96E-05 1.56 (1.25, 1.96) 1.40% 1.06 1.36
MIR4275 NR_036237 1 6.85E-05 1.53 (1.24, 1.89) 1.10% 1.06 1.35
NKX1-2 NM_001146340 1 9.19E-05 1.58 (1.26, 1.99) 1.30% 1.06 1.36
OR2W5 NM_001004698 1 3.95E-06 1.25 (1.14, 1.38) 0.10% 1.06 1.23
SCARB2 NM_005506 1 0.00010943 1.71 (1.30, 2.24) 1.50% 1.06 1.38
SNAR-G1 NR_004383 1 7.37E-05 1.47 (1.21, 1.77) 1.10% 1.06 1.33
TKT NM_001135055 1 0.00011508 1.77 (1.32, 2.37) 1.60% 1.06 1.38
TKT NM_001064 1 0.00011508 1.77 (1.32, 2.37) 1.60% 1.06 1.38
TMOD2 NM_014548 1 6.75E-05 1.50 (1.23, 1.82) 1.10% 1.06 1.34
TMOD2 NM_001142885 1 6.75E-05 1.50 (1.23, 1.82) 1.10% 1.06 1.34
USP33 NM_201626 -1 0.00030132 0.36 (0.21, 0.63) 3.00% 1.06 1.28
USP33 NM_015017 -1 0.00030132 0.36 (0.21, 0.63) 3.00% 1.06 1.28
USP33 NM_201624 -1 0.00030132 0.36 (0.21, 0.63) 3.00% 1.06 1.28
VDAC1 NM_003374 1 0.00026933 2.74 (1.59, 4.72) 2.70% 1.06 1.31
VDAC1 NR_036625 1 0.00026933 2.74 (1.59, 4.72) 2.70% 1.06 1.31
VDAC1 NR_036624 1 0.00026933 2.74 (1.59, 4.72) 2.70% 1.06 1.31
C12orf35 NM_018169 -1 0.00036212 0.34 (0.19, 0.62) 3.40% 1.05 1.27
GALNS NM_000512 1 0.00030441 2.31 (1.47, 3.65) 3.00% 1.05 1.34
KRT78 NM_173352 1 5.86E-05 1.41 (1.19, 1.66) 1.00% 1.05 1.31
LSM4 NM_012321 1 0.00018189 1.79 (1.32, 2.43) 2.20% 1.05 1.37
MIR4318 NR_036202 1 0.00020629 1.76 (1.30, 2.37) 2.30% 1.05 1.36
OR5T2 NM_001004746 1 0.00020529 1.85 (1.34, 2.57) 2.30% 1.05 1.37
PNPLA4 NM_004650 -1 0.00020112 0.57 (0.43, 0.77) 2.30% 1.05 1.35
PNPLA4 NM_001142389 -1 0.00020112 0.57 (0.43, 0.77) 2.30% 1.05 1.35
PNPLA4 NM_001172672 -1 0.00020112 0.57 (0.43, 0.77) 2.30% 1.05 1.35
SNORD116-12 NR_003327 1 0.00013681 1.49 (1.21, 1.82) 1.80% 1.05 1.33
TFAP2A NM_003220 -1 0.00019691 0.60 (0.45, 0.78) 2.30% 1.05 1.34
TFAP2A NM_001032280 -1 0.00019691 0.60 (0.45, 0.78) 2.30% 1.05 1.34
TFAP2A NM_001042425 -1 0.00019691 0.60 (0.45, 0.78) 2.30% 1.05 1.34
TTC9 NM_015351 1 0.00025891 1.89 (1.34, 2.67) 2.60% 1.05 1.36
C17orf88 NR_026770 1 0.00022622 1.66 (1.27, 2.17) 2.40% 1.04 1.36
C19orf75 NM_173635 1 3.05E-05 1.26 (1.13, 1.40) 0.60% 1.04 1.23
DUSP13 NM_001007273 1 0.00031933 1.95 (1.35, 2.80) 3.10% 1.04 1.35
DUSP13 NM_001007271 1 0.00031933 1.95 (1.35, 2.80) 3.10% 1.04 1.35
DUSP13 NM_001007272 1 0.00031933 1.95 (1.35, 2.80) 3.10% 1.04 1.35
DUSP13 NM_016364 1 0.00031933 1.95 (1.35, 2.80) 3.10% 1.04 1.35
G3BP2 NM_203504 1 0.00018881 1.58 (1.24, 2.02) 2.20% 1.04 1.35
G3BP2 NM_203505 1 0.00018881 1.58 (1.24, 2.02) 2.20% 1.04 1.35
G3BP2 NM_012297 1 0.00018881 1.58 (1.24, 2.02) 2.20% 1.04 1.35
HSPBAP1 NM_024610 -1 0.00032784 0.48 (0.32, 0.72) 3.10% 1.04 1.32
LRRIQ1 NM_001079910 -1 0.00037432 0.50 (0.34, 0.73) 3.50% 1.04 1.32
LRRIQ1 NM_032165 -1 0.00037432 0.50 (0.34, 0.73) 3.50% 1.04 1.32
LYPD2 NM_205545 1 4.58E-05 1.27 (1.13, 1.43) 0.80% 1.04 1.24
MAGEB10 NM_182506 1 0.00022296 1.50 (1.21, 1.86) 2.40% 1.04 1.33
MGC87042 NM_207342 1 0.00026627 1.56 (1.23, 1.99) 2.70% 1.04 1.34
MGC87042 NM_001164460 1 0.00026627 1.56 (1.23, 1.99) 2.70% 1.04 1.34
MOBKL1A NM_173468 1 0.00023167 1.52 (1.22, 1.91) 2.40% 1.04 1.33
PILRA NM_013439 -1 0.00022195 0.63 (0.50, 0.81) 2.40% 1.04 1.33
PILRA NM_178273 -1 0.00022195 0.63 (0.50, 0.81) 2.40% 1.04 1.33
PILRA NM_178272 -1 0.00022195 0.63 (0.50, 0.81) 2.40% 1.04 1.33
POGK NM_017542 1 0.00029434 1.82 (1.32, 2.51) 2.90% 1.04 1.36
PRSS41 NM_001135086 1 3.53E-05 1.25 (1.12, 1.39) 0.70% 1.04 1.23
SOST NM_025237 1 0.00021545 1.59 (1.24, 2.03) 2.30% 1.04 1.35
ZNF140 NM_003440 -1 0.00023704 0.64 (0.51, 0.81) 2.50% 1.04 1.33
ZNF682 NM_001077349 -1 0.00029535 0.53 (0.37, 0.75) 2.90% 1.04 1.33
ZNF682 NM_033196 -1 0.00029535 0.53 (0.37, 0.75) 2.90% 1.04 1.33
AAGAB NM_024666 1 0.0003973 1.50 (1.20, 1.89) 3.70% 1.03 1.32
AARS NM_001605 1 0.00051635 2.05 (1.37, 3.08) 4.40% 1.03 1.33
ADHFE1 NM_144650 -1 0.00059544 0.53 (0.37, 0.76) 4.80% 1.03 1.31
ARPP19 NM_006628 1 0.00025921 1.32 (1.14, 1.53) 2.60% 1.03 1.26
BZRAP1 NM_004758 -1 0.00068405 0.50 (0.34, 0.75) 5.30% 1.03 1.3
BZRAP1 NM_024418 -1 0.00068405 0.50 (0.34, 0.75) 5.30% 1.03 1.3
C14orf102 NM_199043 -1 0.00056259 0.50 (0.34, 0.74) 4.70% 1.03 1.31
C14orf102 NM_017970 -1 0.00056259 0.50 (0.34, 0.74) 4.70% 1.03 1.31
C17orf68 NM_025099 -1 0.00057208 0.38 (0.22, 0.66) 4.70% 1.03 1.27
CLUL1 NM_014410 -1 0.00044779 0.57 (0.42, 0.78) 4.00% 1.03 1.32
CLUL1 NM_199167 -1 0.00044779 0.57 (0.42, 0.78) 4.00% 1.03 1.32
DEF8 NM_207514 1 0.00060461 3.04 (1.61, 5.73) 4.90% 1.03 1.27
DEF8 NM_017702 1 0.00060461 3.04 (1.61, 5.73) 4.90% 1.03 1.27
DKFZp779M06 52 NR_027134 1 0.00043937 1.53 (1.21, 1.95) 4.00% 1.03 1.32
DKK4 NM_014420 -1 0.00068191 0.43 (0.27, 0.70) 5.30% 1.03 1.28
DSCR10 NR_027695 1 0.00037115 1.40 (1.16, 1.68) 3.50% 1.03 1.29
FAM169B NM_182562 1 0.00023936 1.46 (1.19, 1.78) 2.50% 1.03 1.32
GARS NM_002047 1 0.0002165 1.39 (1.17, 1.65) 2.30% 1.03 1.29
HIST2H2AC NM_003517 1 0.00055643 2.72 (1.54, 4.79) 4.70% 1.03 1.29
HMX3 NM_001105574 1 0.00032223 1.63 (1.25, 2.13) 3.10% 1.03 1.34
HOXA13 NM_000522 1 0.00047312 1.47 (1.18, 1.82) 4.20% 1.03 1.31
IDI1 NM_004508 1 0.00059295 2.54 (1.49, 4.33) 4.80% 1.03 1.3
JUND NM_005354 1 0.00044453 1.44 (1.18, 1.77) 4.00% 1.03 1.3
LOC285577 NR_033898 1 0.00019503 1.30 (1.13, 1.50) 2.20% 1.03 1.25
LOC648740 NR_024438 -1 0.00063182 0.54 (0.38, 0.77) 5.00% 1.03 1.31
MCMBP NM_024834 1 0.00056948 1.77 (1.28, 2.46) 4.70% 1.03 1.34
MIR133A1 NR_029675 1 0.00035238 1.67 (1.26, 2.22) 3.30% 1.03 1.35
MMP25 NM_022468 -1 0.00050839 0.45 (0.28, 0.70) 4.40% 1.03 1.3
NPPB NM_002521 1 0.00015182 1.29 (1.13, 1.47) 1.90% 1.03 1.25
NTRK3 NM_001012338 -1 0.00048234 0.50 (0.34, 0.74) 4.20% 1.03 1.31
NTRK3 NM_002530 -1 0.00048234 0.50 (0.34, 0.74) 4.20% 1.03 1.31
NTRK3 NM_001007156 -1 0.00048234 0.50 (0.34, 0.74) 4.20% 1.03 1.31
ODF2L NM_001007022 -1 0.00054085 0.50 (0.34, 0.74) 4.60% 1.03 1.31
ODF2L NM_020729 -1 0.00054085 0.50 (0.34, 0.74) 4.60% 1.03 1.31
ODF2L NM_001184765 -1 0.00054085 0.50 (0.34, 0.74) 4.60% 1.03 1.31
ODF2L NM_001184766 -1 0.00054085 0.50 (0.34, 0.74) 4.60% 1.03 1.31
OR2B3 NM_001005226 1 0.00055355 1.60 (1.23, 2.09) 4.70% 1.03 1.33
OR8S1 NM_001005203 1 0.00014925 1.33 (1.15, 1.54) 1.90% 1.03 1.27
PGM5P2 NR_002836 -1 0.00047907 0.48 (0.32, 0.72) 4.20% 1.03 1.31
RAD51L3 NM_133629 1 0.00053965 1.68 (1.25, 2.25) 4.60% 1.03 1.34
RAD51L3 NM_001142571 1 0.00053965 1.68 (1.25, 2.25) 4.60% 1.03 1.34
RAD51L3 NM_002878 1 0.00053965 1.68 (1.25, 2.25) 4.60% 1.03 1.34
RBM27 NM_018989 1 0.00056605 1.93 (1.33, 2.80) 4.70% 1.03 1.33
RILPL2 NM_145058 -1 0.00047818 0.61 (0.46, 0.80) 4.20% 1.03 1.32
RNASE9 NM_001001673 1 0.00047969 2.10 (1.39, 3.20) 4.20% 1.03 1.33
RNASE9 NM_001110358 1 0.00047969 2.10 (1.39, 3.20) 4.20% 1.03 1.33
RNASE9 NM_001110359 1 0.00047969 2.10 (1.39, 3.20) 4.20% 1.03 1.33
RNASE9 NM_001110360 1 0.00047969 2.10 (1.39, 3.20) 4.20% 1.03 1.33
RNASE9 NM_001110361 1 0.00047969 2.10 (1.39, 3.20) 4.20% 1.03 1.33
RNASE9 NM_001110356 1 0.00047969 2.10 (1.39, 3.20) 4.20% 1.03 1.33
RNASE9 NM_001110357 1 0.00047969 2.10 (1.39, 3.20) 4.20% 1.03 1.33
SCRT2 NM_033129 1 0.00019487 1.27 (1.12, 1.44) 2.20% 1.03 1.23
SENP5 NM_152699 1 0.00049234 1.68 (1.26, 2.26) 4.30% 1.03 1.34
SPRR3 NM_001097589 1 0.00034206 1.40 (1.16, 1.68) 3.30% 1.03 1.29
SPRR3 NM_005416 1 0.00034206 1.40 (1.16, 1.68) 3.30% 1.03 1.29
TPTE NM_199259 1 0.00025602 1.34 (1.15, 1.58) 2.60% 1.03 1.27
TPTE NM_199261 1 0.00025602 1.34 (1.15, 1.58) 2.60% 1.03 1.27
TPTE NM_199260 1 0.00025602 1.34 (1.15, 1.58) 2.60% 1.03 1.27
TSC22D3 NM_198057 1 0.00043616 1.96 (1.35, 2.85) 4.00% 1.03 1.34
TSC22D3 NM_004089 1 0.00043616 1.96 (1.35, 2.85) 4.00% 1.03 1.34
TSC22D3 NM_001015881 1 0.00043616 1.96 (1.35, 2.85) 4.00% 1.03 1.34
USP40 NM_018218 -1 0.00058533 0.52 (0.36, 0.75) 4.80% 1.03 1.31
ZCWPW1 NM_017984 -1 0.00057031 0.59 (0.43, 0.80) 4.70% 1.03 1.32
AMY2B NM_020978 -1 0.00080037 0.46 (0.29, 0.72) 5.90% 1.02 1.28
ATG5 NM_004849 1 0.00080307 1.39 (1.15, 1.68) 5.90% 1.02 1.28
C18orf26 NM_173629 1 0.00074956 1.66 (1.24, 2.23) 5.70% 1.02 1.33
C2orf70 NM_001105519 1 0.00075733 1.87 (1.30, 2.69) 5.70% 1.02 1.33
CCDC66 NM_001141947 -1 0.0008218 0.54 (0.37, 0.77) 6.00% 1.02 1.3
CCDC66 NR_024460 -1 0.0008218 0.54 (0.37, 0.77) 6.00% 1.02 1.3
CCDC66 NM_001012506 -1 0.0008218 0.54 (0.37, 0.77) 6.00% 1.02 1.3
CCDC93 NM_019044 -1 0.00078652 0.49 (0.32, 0.74) 5.90% 1.02 1.29
COQ6 NM_182480 -1 0.00096649 0.60 (0.45, 0.81) 6.50% 1.02 1.3
COQ6 NM_182476 -1 0.00096649 0.60 (0.45, 0.81) 6.50% 1.02 1.3
CRNDE NR_034106 1 0.00080709 2.12 (1.37, 3.29) 5.90% 1.02 1.31
CRNDE NR_034105 1 0.00080709 2.12 (1.37, 3.29) 5.90% 1.02 1.31
CRY1 NM_004075 -1 0.00115448 0.45 (0.28, 0.73) 7.10% 1.02 1.27
CSF2RB NM_000395 -1 0.00105596 0.47 (0.30, 0.74) 6.80% 1.02 1.28
CYP20A1 NM_177538 -1 0.00090837 0.40 (0.23, 0.69) 6.30% 1.02 1.26
DAG1 NM_001177644 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177643 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177642 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177641 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177640 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177634 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_004393 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_01165928 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177637 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177639 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177638 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177635 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAG1 NM_001177636 1 0.00099617 2.35 (1.41, 3.92) 6.60% 1.02 1.29
DAP NM_004394 1 0.00098142 2.05 (1.34, 3.15) 6.60% 1.02 1.31
DDX56 NM_019082 1 0.00044191 1.38 (1.15, 1.64) 4.00% 1.02 1.28
DNAH6 NM_001370 -1 0.00084767 0.53 (0.36, 0.77) 6.10% 1.02 1.3
DUSP9 NM_ 001395 1 0.00099293 1.67 (1.23, 2.27) 6.60% 1.02 1.32
EBP NM_006579 1 0.0008591 2.33 (1.42, 3.82) 6.10% 1.02 1.3
FEZF1 NM_001160264 1 0.00066372 1.53 (1.20, 1.95) 5.20% 1.02 1.32
FEZF1 NM_001024613 1 0.00066372 1.53 (1.20, 1.95) 5.20% 1.02 1.32
FRMPD2 NM_001018071 -1 0.00102321 0.51 (0.34, 0.76) 6.70% 1.02 1.29
FRMPD2 NR_033178 -1 0.00102321 0.51 (0.34, 0.76) 6.70% 1.02 1.29
G6PD NM_000402 1 0.00095547 2.06 (1.34, 3.16) 6.50% 1.02 1.31
G6PD NM_001042351 1 0.00095547 2.06 (1.34, 3.16) 6.50% 1.02 1.31
GABPB1 NM_016654 1 0.0007582 1.44 (1.16, 1.78) 5.70% 1.02 1.29
GABPB1 NM_181427 1 0.0007582 1.44 (1.16, 1.78) 5.70% 1.02 1.29
GABPB1 NM_005254 1 0.0007582 1.44 (1.16, 1.78) 5.70% 1.02 1.29
GABPB1 NM_ 002041 1 0.0007582 1.44 (1.16, 1.78) 5.70% 1.02 1.29
GABPB1 NM_016655 1 0.0007582 1.44 (1.16, 1.78) 5.70% 1.02 1.29
GALNT1 NM_020474 1 0.00088364 1.87 (1.29, 2.71) 6.20% 1.02 1.32
GPR50 NM_004224 1 0.00059725 1.26 (1.11, 1.45) 4.80% 1.02 1.22
HKR1 NM_181786 -1 0.00088702 0.48 (0.32, 0.74) 6.20% 1.02 1.29
HSPA14 NM_016299 1 0.00115563 2.11 (1.34, 3.30) 7.10% 1.02 1.3
IGF2BP2 NM_001007225 1 0.00095786 2.69 (1.49, 4.83) 6.50% 1.02 1.27
IGF2BP2 NM_006548 1 0.00095786 2.69 (1.49, 4.83) 6.50% 1.02 1.27
IPW NR_023915 -1 0.00102737 0.62 (0.46, 0.82) 6.70% 1.02 1.3
KIAA0467 NM_015284 -1 0.00107902 0.39 (0.22, 0.69) 6.80% 1.02 1.25
KIF20A NM_005733 1 0.00106069 2.64 (1.48, 4.72) 6.80% 1.02 1.27
LOC144742 NR_024246 1 0.00076829 1.38 (1.14, 1.66) 5.80% 1.02 1.28
LRRC39 NM_144620 -1 0.00099003 0.54 (0.38, 0.78) 6.60% 1.02 1.3
MIR24-2 NR_029497 1 0.00095954 1.64 (1.22, 2.19) 6.50% 1.02 1.32
MTHFR NM_005957 -1 0.00117686 0.46 (0.29, 0.74) 7.20% 1.02 1.27
MTHFSD NR_027490 1 0.00078921 1.89 (1.30, 2.73) 5.90% 1.02 1.32
MTHFSD NR_027489 1 0.00078921 1.89 (1.30, 2.73) 5.90% 1.02 1.32
MTHFSD NM_022764 1 0.00078921 1.89 (1.30, 2.73) 5.90% 1.02 1.32
MTHFSD NM_ 001159379 1 0.00078921 1.89 (1.30, 2.73) 5.90% 1.02 1.32
MTHFSD NM_001159378 1 0.00078921 1.89 (1.30, 2.73) 5.90% 1.02 1.32
MTHFSD NM_001159377 1 0.00078921 1.89 (1.30, 2.73) 5.90% 1.02 1.32
MTHFSD NM_001159380 1 0.00078921 1.89 (1.30, 2.73) 5.90% 1.02 1.32
MYSM1 NM_001085487 -1 0.00086284 0.38 (0.21, 0.67) 6.10% 1.02 1.25
N4BP2L2 NM_033111 -1 0.00082672 0.54 (0.38, 0.78) 6.00% 1.02 1.3
N4BP2L2 NM_014887 -1 0.00082672 0.54 (0.38, 0.78) 6.00% 1.02 1.3
NENF NM_013349 1 0.00111716 2.06 (1.33, 3.19) 7.00% 1.02 1.3
NENF NR_26598 1 0.00111716 2.06 (1.33, 3.19) 7.00% 1.02 1.3
NPY1R NM_00909 -1 0.00069841 0.53 (0.37, 0.77) 5.40% 1.02 1.31
OR2J2 NM_030905 1 0.0006695 1.55 (1.20, 1.99) 5.20% 1.02 1.32
PLA2G2F NM_022819 1 0.00106176 1.72 (1.24, 2.38) 6.80% 1.02 1.32
POTEG NR_027480 1 0.0008735 1.50 (1.18, 1.90) 6.20% 1.02 1.31
POTEG NM_001005356 1 0.0008735 1.50 (1.18, 1.90) 6.20% 1.02 1.31
PRDM9 NM_020227 1 0.00109686 1.80 (1.26, 2.56) 6.90% 1.02 1.32
PRPF38A NM_032864 -1 0.00092473 0.45 (0.28, 0.72) 6.40% 1.02 1.28
RPAP2 NM_024813 -1 0.0010711 0.35 (0.19, 0.66) 6.80% 1.02 1.23
SERPINF2 NM_001165920 -1 0.00083318 0.51 (0.34, 0.76) 6.00% 1.02 1.3
SERPINF2 NM_000934 -1 0.00083318 0.51 (0.34, 0.76) 6.00% 1.02 1.3
SERPINF2 NM_001165921 -1 0.00083318 0.51 (0.34, 0.76) 6.00% 1.02 1.3
SLC17A6 NM_020346 1 0.00061603 1.59 (1.22, 2.07) 4.90% 1.02 1.33
SMC5 NM_015110 -1 0.00090526 0.52 (0.35, 0.76) 6.30% 1.02 1.3
SNORD115-40 NR_003355 1 0.00100408 1.58 (1.20, 2.08) 6.60% 1.02 1.31
SRSF11 NM_01190987 -1 0.00107233 0.52 (0.35, 0.77) 6.80% 1.02 1.29
SRSF11 NM_004768 -1 0.00107233 0.52 (0.35, 0.77) 6.80% 1.02 1.29
THEG NM_016585 1 0.00063156 1.70 (1.25, 2.30) 5.00% 1.02 1.33
THEG NM_199202 1 0.00063156 1.70 (1.25, 2.30) 5.00% 1.02 1.33
TMEM30C NR_028358 1 0.00083733 1.66 (1.23, 2.23) 6.00% 1.02 1.32
TMEM30C NR_028357 1 0.00083733 1.66 (1.23, 2.23) 6.00% 1.02 1.32
TRAF3IP1 NM_015650 -1 0.00080751 0.47 (0.30, 0.73) 5.90% 1.02 1.29
TRAF3IP1 NM_001139490 -1 0.00080751 0.47 (0.30, 0.73) 5.90% 1.02 1.29
TTC12 NM_ 017868 -1 0.00111797 0.40 (0.23, 0.69) 7.00% 1.02 1.25
USP24 NM 015306 -1 0.00099068 0.46 (0.29, 0.73) 6.60% 1.02 1.28
WBP4 NM_007187 -1 0.00083437 0.48 (0.32, 0.74) 6.00% 1.02 1.29
ZNF440 NM_152357 -1 0.00113941 0.50 (0.33, 0.76) 7.10% 1.02 1.28
ZNF644 NM_032186 -1 0.001187 0.44 (0.27, 0.72) 7.20% 1.02 1.26
ZNF644 NM_016620 -1 0.001187 0.44 (0.27, 0.72) 7.20% 1.02 1.26
ZNF644 NM_201269 -1 0.001187 0.44 (0.27, 0.72) 7.20% 1.02 1.26
ZNF701 NM_018260 -1 0.00075297 0.47 (0.31, 0.73) 5.70% 1.02 1.29
ZNF701 NM_001172655 -1 0.00075297 0.47 (0.31, 0.73) 5.70% 1.02 1.29
AGBL2 NM_024783 -1 0.00142443 0.61 (0.45, 0.82) 7.80% 1.01 1.29
BRP44 NM_001143674 1 0.00172654 1.99 (1.30, 3.07) 8.70% 1.01 1.29
BRP44 NM_015415 1 0.00172654 1.99 (1.30, 3.07) 8.70% 1.01 1.29
BRP44 NR_026550 1 0.00172654 1.99 (1.30, 3.07) 8.70% 1.01 1.29
BUB3 NM_004725 1 0.00114919 1.73 (1.24, 2.40) 7.10% 1.01 1.32
BUB3 NM_001007793 1 0.00114919 1.73 (1.24, 2.40) 7.10% 1.01 1.32
C10orf68 NM_024688 -1 0.00138334 0.52 (0.34, 0.77) 7.70% 1.01 1.28
C1orf168 NM_001004303 -1 0.00118419 0.53 (0.36, 0.78) 7.20% 1.01 1.29
CA5A NM_001739 1 0.00164802 1.82 (1.25, 2.64) 8.50% 1.01 1.3
CCDC39 NM_181426 -1 0.00165504 0.69 (0.55, 0.87) 8.50% 1.01 1.27
CDC25B NM_P04358 1 0.00150067 1.93 (1.28, 2.88) 8.10% 1.01 1.3
CDC25B NM_021873 1 0.00150067 1.93 (1.28, 2.88) 8.10% 1.01 1.3
CDC25B NM_021872 1 0.00150067 1.93 (1.28, 2.88) 8.10% 1.01 1.3
CDK5RAP2 NM_001011649 -1 0.00157691 0.49 (0.32, 0.76) 8.30% 1.01 1.27
CDK5RAP2 NM_018249 -1 0.00157691 0.49 (0.32, 0.76) 8.30% 1.01 1.27
CEP110 NM_007018 -1 0.00153006 0.40 (0.23, 0.71) 8.20% 1.01 1.24
CEP72 NM_018140 1 0.00125053 2.10 (1.34, 3.28) 7.30% 1.01 1.3
CRABP1 NM_004378 1 0.00130325 1.86 (1.27, 2.71) 7.50% 1.01 1.31
CROCC NM_014675 -1 0.00134738 0.58 (0.42, 0.81) 7.50% 1.01 1.29
DBT NM_001918 -1 0.00183357 0.36 (0.19, 0.68) 9.00% 1.01 1.21
DGCR10 NR_026651 1 0.00120541 1.77 (1.25, 2.51) 7.20% 1.01 1.31
DMRTC2 NM_001040283 1 0.0016167 1.43 (1.14, 1.78) 8.40% 1.01 1.28
EIF4EBP1 NM_004095 1 0.00155936 1.58 (1.19, 2.09) 8.30% 1.01 1.3
FAM120AOS NM_198841 -1 0.00179665 0.45 (0.27, 0.74) 8.90% 1.01 1.25
FAM184B NM_015688 -1 0.00132516 0.41 (0.24, 0.71) 7.50% 1.01 1.25
FANCD2 NM_001018115 1 0.00173006 1.97 (1.29, 3.00) 8.70% 1.01 1.29
FANCD2 NM_033084 1 0.00173006 1.97 (1.29, 3.00) 8.70% 1.01 1.29
FANCL NM_001114636 -1 0.00127386 0.61 (0.45, 0.82) 7.40% 1.01 1.29
FANCL NM_018062 -1 0.00127386 0.61 (0.45, 0.82) 7.40% 1.01 1.29
FRY NM_023037 -1 0.00162735 0.48 (0.30, 0.76) 8.40% 1.01 1.26
GAB4 NM_001037814 1 0.0010639 1.31 (1.12, 1.55) 6.80% 1.01 1.25
GATS NR 028040 -1 0.00180899 0.45 (0.27, 0.74) 9.00% 1.01 1.25
GATS NR_028038 -1 0.00180899 0.45 (0.27, 0.74) 9.00% 1.01 1.25
GATS NR_028039 -1 0.00180899 0.45 (0.27, 0.74) 9.00% 1.01 1.25
GATS NM 178831 -1 0.00180899 0.45 (0.27, 0.74) 9.00% 1.01 1.25
GDF15 NM_004864 1 0.00152308 1.91 (1.28, 2.86) 8.20% 1.01 1.3
GDF7 NM_182828 1 0.00091412 1.28 (1.10, 1.47) 6.30% 1.01 1.23
GMCL1L NR_003281 1 0.00162165 1.74 (1.23, 2.45) 8.40% 1.01 1.3
GPRIN1 NM_052899 1 0.00164633 2.21 (1.35, 3.63) 8.50% 1.01 1.28
HAX1 NM_006118 1 0.00171232 2.26 (1.36, 3.76) 8.70% 1.01 1.27
HAX1 NM_001018837 1 0.00171232 2.26 (1.36, 3.76) 8.70% 1.01 1.27
HYDIN NM_032821 -1 0.0013742 0.55 (0.38, 0.79) 7.60% 1.01 1.29
HYDIN NM_017558 -1 0.0013742 0.55 (0.38, 0.79) 7.60% 1.01 1.29
HYDIN NM_001198542 -1 0.0013742 0.55 (0.38, 0.79) 7.60% 1.01 1.29
HYDIN NM_001198543 -1 0.0013742 0.55 (0.38, 0.79) 7.60% 1.01 1.29
KDELR1 NM_006801 1 0.00120971 1.94 (1.30, 2.90) 7.20% 1.01 1.31
LAMP1 NM_005561 1 0.00113874 1.89 (1.29, 2.77) 7.10% 1.01 1.31
LOC646862 NM_001195135 1 0.00178119 1.81 (1.25, 2.62) 8.90% 1.01 1.3
MAP3K14 NM_003954 -1 0.00125057 0.51 (0.34, 0.77) 7.30% 1.01 1.28
MEGF9 NM_001080497 -1 0.00183087 0.37 (0.20, 0.69) 9.00% 1.01 1.22
MIR54812 NR_031688 1 0.00172026 1.48 (1.16, 1.90) 8.70% 1.01 1.29
MITD1 NM_138798 -1 0.00149032 0.58 (0.42, 0.81) 8.10% 1.01 1.29
MRPL45P2 NR_033934 -1 0.00136399 0.49 (0.31, 0.76) 7.60% 1.01 1.27
MST4 NM_001042452 1 0.00185523 2.47 (1.40, 4.35) 9.00% 1.01 1.26
MST4 NM_016542 1 0.00185523 2.47 (1.40, 4.35) 9.00% 1.01 1.26
MST4 NM_001042453 1 0.00185523 2.47 (1.40, 4.35) 9.00% 1.01 1.26
MVD NM_002461 1 0.001646 2.33 (1.38, 3.94) 8.50% 1.01 1.27
NCRNA00115 NR_024321 -1 0.00141638 0.49 (0.32, 0.76) 7.80% 1.01 1.27
NCRNA00287 NR_026677 -1 0.00120549 0.50 (0.32, 0.76) 7.20% 1.01 1.28
NFAM1 NM_145912 -1 0.00171875 0.55 (0.38, 0.80) 8.70% 1.01 1.28
NME1 NM_000269 1 0.00140178 1.88 (1.28, 2.77) 7.70% 1.01 1.31
NME1 NM_198175 1 0.00140178 1.88 (1.28, 2.77) 7.70% 1.01 1.31
NUDT21 NM_007006 1 0.0017855 1.91 (1.27, 2.86) 8.90% 1.01 1.3
PARD3B NM_205863 -1 0.00120268 0.61 (0.46, 0.82) 7.20% 1.01 1.29
PARD3B NM_057177 -1 0.00120268 0.61 (0.46, 0.82) 7.20% 1.01 1.29
PARD3B NM_152526 -1 0.00120268 0.61 (0.46, 0.82) 7.20% 1.01 1.29
PBX1 NM_002585 1 0.00147845 1.64 (1.21, 2.23) 8.00% 1.01 1.31
RFWD3 NM_018124 1 0.00121663 1.83 (1.27, 2.64) 7.20% 1.01 1.31
RFX7 NM_022841 -1 0.00158617 0.46 (0.28, 0.74) 8.30% 1.01 1.26
RGS4 NM_005613 1 0.00159894 2.17 (1.34, 3.51) 8.40% 1.01 1.28
RGS4 NM_001113381 1 0.00159894 2.17 (1.34, 3.51) 8.40% 1.01 1.28
RGS4 NM_001102445 1 0.00159894 2.17 (1.34, 3.51) 8.40% 1.01 1.28
RGS4 NM_001113380 1 0.00159894 2.17 (1.34, 3.51) 8.40% 1.01 1.28
RHCG NM_016321 1 0.0015871 1.72 (1.23, 2.40) 8.30% 1.01 1.31
RNPC3 NM_017619 -1 0.0015841 0.45 (0.28, 0.74) 8.30% 1.01 1.26
SEC61A1 NM_013336 1 0.00127515 1.92 (1.29, 2.85) 7.40% 1.01 1.31
SFXN1 NM_022754 1 0.00126021 1.97 (1.30, 2.97) 7.40% 1.01 1.3
SGIP1 NM_032291 1 0.00131363 2.33 (1.39, 3.90) 7.50% 1.01 1.28
SH3GLB2 NM_020145 -1 0.00133594 0.57 (0.40, 0.80) 7.50% 1.01 1.29
SIN3B NM_015260 -1 0.001324 0.47 (0.30, 0.75) 7.50% 1.01 1.27
SLC1A5 NM 001145145 1 0.00133504 2.79 (1.49, 5.23) 7.50% 1.01 1.25
SLC1A5 NM_005628 1 0.00133504 2.79 (1.49, 5.23) 7.50% 1.01 1.25
SLC1A5 NM_001145144 1 0.00133504 2.79 (1.49, 5.23) 7.50% 1.01 1.25
SMU1 NM_018225 -1 0.00176915 0.51 (0.34, 0.78) 8.90% 1.01 1.27
SNORD18C 1 0.00106266 1.56 (1.20, 2.04) 6.80% 1.01 1.31
SPCS1 NM_014041 1 0.00124058 2.15 (1.35, 3.42) 7.30% 1.01 1.29
TBRG4 NM_004749 1 0.0009404 1.46 (1.17, 1.83) 6.40% 1.01 1.3
TBRG4 NM 199122 1 0.0009404 1.46 (1.17, 1.83) 6.40% 1.01 1.3
TBRG4 NM_030900 1 0.0009404 1.46 (1.17, 1.83) 6.40% 1.01 1.3
TEX2 NM_018469 1 0.00126006 1.64 (1.22, 2.22) 7.40% 1.01 1.31
TNFSF4 NM_003326 1 0.00129531 2.33 (1.39, 3.90) 7.50% 1.01 1.28
UPK1A NM_007000 1 0.00147695 1.46 (1.16, 1.84) 8.00% 1.01 1.29
ZIC2 NM_007129 1 0.00133972 2.12 (1.34, 3.36) 7.50% 1.01 1.29
ZNF317 NM_020933 -1 0.00145044 0.58 (0.41, 0.81) 7.90% 1.01 1.29
ZNF317 NM_001190791 -1 0.00145044 0.58 (0.41, 0.81) 7.90% 1.01 1.29
ZNF626 NM_145297 -1 0.0015675 0.53 (0.36, 0.79) 8.30% 1.01 1.28
ZNF626 NM_001076675 -1 0.0015675 0.53 (0.36, 0.79) 8.30% 1.01 1.28
ZNF829 NM_001171979 -1 0.00120516 0.56 (0.39, 0.79) 7.20% 1.01 1.29
ZNF829 NM_001037232 -1 0.00120516 0.56 (0.39, 0.79) 7.20% 1.01 1.29
ZRANB2 NM_005455 -1 0.00127193 0.47 (0.30, 0.75) 7.40% 1.01 1.27
ZRANB2 NM_203350 -1 0.00127193 0.47 (0.30, 0.75) 7.40% 1.01 1.27
APOBEC2 NM_006789 -1 0.00205447 0.50 (0.33, 0.78) 9.60% 1 1.26
BICD2 NM_001003800 -1 0.00208035 0.43 (0.25, 0.73) 9.60% 1 1.24
BICD2 NM_015250 -1 0.00208035 0.43 (0.25, 0.73) 9.60% 1 1.24
BUD13 NM_032725 -1 0.0020833 0.47 (0.29, 0.76) 9.60% 1 1.25
BUD13 NM_001159736 -1 0.0020833 0.47 (0.29, 0.76) 9.60% 1 1.25
CCDC103 NM_213607 -1 0.00214716 0.55 (0.38, 0.81) 9.80% 1 1.27
CHCHD1 NM_203298 1 0.00187362 1.95 (1.28, 2.97) 9.10% 1 1.29
CLDN4 NM_001305 1 0.00214986 1.92 (1.27, 2.91) 9.80% 1 1.29
CLK1 NR_027855 -1 0.00214838 0.54 (0.36, 0.80) 9.80% 1 1.27
CLK1 NR_027856 -1 0.00214838 0.54 (0.36, 0.80) 9.80% 1 1.27
CLK1 NM_004071 -1 0.00214838 0.54 (0.36, 0.80) 9.80% 1 1.27
CLK1 NM_001162407 -1 0.00214838 0.54 (0.36, 0.80) 9.80% 1 1.27
DCK NM_000788 1 0.00205322 1.78 (1.23, 2.57) 9.60% 1 1.3
EGLN1 NM_022051 1 0.00196644 1.82 (1.25, 2.66) 9.40% 1 1.3
ESRP2 NM_024939 1 0.00213417 2.28 (1.35, 3.86) 9.80% 1 1.26
FNBP4 NM_015308 -1 0.0020334 0.53 (0.35, 0.79) 9.60% 1 1.27
FUT11 NM_173540 1 0.00189847 1.98 (1.29, 3.06) 9.20% 1 1.29
FYTTD1 NM_032288 1 0.00192913 1.54 (1.17, 2.03) 9.20% 1 1.29
FYTTD1 NR_027840 1 0.00192913 1.54 (1.17, 2.03) 9.20% 1 1.29
FYTTD1 NM_001011537 1 0.00192913 1.54 (1.17, 2.03) 9.20% 1 1.29
GALNTL1 NM_001168368 -1 0.00217436 0.48 (0.30, 0.77) 9.90% 1 1.25
GALNTL1 NM_020692 -1 0.00217436 0.48 (0.30, 0.77) 9.90% 1 1.25
GSTM3 NR_024537 -1 0.00185428 0.50 (0.32, 0.77) 9.00% 1 1.26
GSTM3 NM_000849 -1 0.00185428 0.50 (0.32, 0.77) 9.00% 1 1.26
HECW2 NM_020760 -1 0.0021151 0.55 (0.38, 0.81) 9.70% 1 1.27
KIF27 NM_017576 -1 0.00181164 0.58 (0.41, 0.81) 9.00% 1 1.28
KRTCAP2 NM_173852 1 0.00192061 1.92 (1.27, 2.90) 9.20% 1 1.29
LAMA1 NM_005559 1 0.00202571 2.18 (1.33, 3.56) 9.60% 1 1.27
MIR603 NR_030334 1 0.00201767 1.78 (1.24, 2.57) 9.60% 1 1.3
MYO5A NM_000259 1 0.00177654 1.36 (1.12, 1.65) 8.90% 1 1.26
MYO5A NM_001142495 1 0.00177654 1.36 (1.12, 1.65) 8.90% 1 1.26
PCGF3 NM_006315 -1 0.00202742 0.54 (0.36, 0.80) 9.60% 1 1.27
RAB11B NM_004218 -1 0.00191529 0.48 (0.30, 0.76) 9.20% 1 1.26
SCD NM_005063 1 0.00208616 2.39 (1.37, 4.16) 9.60% 1 1.26
SMG5 NM_015327 1 0.0020908 1.80 (1.24, 2.62) 9.60% 1 1.29
SYNPO NM_001109974 -1 0.00206694 0.51 (0.33, 0.78) 9.60% 1 1.26
SYNPO NM_007286 -1 0.00206694 0.51 (0.33, 0.78) 9.60% 1 1.26
SYNPO NM_001166209 -1 0.00206694 0.51 (0.33, 0.78) 9.60% 1 1.26
SYNPO NM_001166208 -1 0.00206694 0.51 (0.33, 0.78) 9.60% 1 1.26
TAF5L NM_014409 1 0.00200753 1.92 (1.27, 2.90) 9.50% 1 1.29
TAF5L NM_001025247 1 0.00200753 1.92 (1.27, 2.90) 9.50% 1 1.29
USP16 NM_006447 -1 0.00184893 0.56 (0.39, 0.81) 9.00% 1 1.28
USP16 NM_001032410 -1 0.00184893 0.56 (0.39, 0.81) 9.00% 1 1.28
USP16 NM_001001992 -1 0.00184893 0.56 (0.39, 0.81) 9.00% 1 1.28
ZNF44 NM_016264 -1 0.00189847 0.36 (0.19, 0.68) 9.20% 1 1.21
ZNF44 NM_001164276 -1 0.00189847 0.36 (0.19, 0.68) 9.20% 1 1.21
Table 3. Assembled Intronic RNAs identified as Associated with Risk of Breast Cancer Recurrence in 136 Breast Cancer Patients
Intron Direction of Association (1=Higher Expression Means Higher Risk) p-value Standardized Hazard Ratio Estimate (95% Confidence Interval) q-value (FDR) Maximum Lower Bound Std HR @ 10% FDR Regression-to-the-Mean-Corrected Std HR
NUDT19 1 2.99E-13 2.22 (1.79, 2.75) <0.1% 1.35 1.77
CLINT1 1 1.74E-11 2.17 (1.73, 2.72) <0.1% 1.31 1.71
CLINT1 1 1.74E-11 2.17 (1.73, 2.72) <0.1% 1.31 1.71
CLINT1 1 1.74E-11 2.17 (1.73, 2.72) <0.1% 1.31 1.71
KIF1B 1 8.27E-09 2.85 (2.00, 4.07) <0.1% 1.3 1.65
KIF1B 1 8.27E-09 2.85 (2.00, 4.07) <0.1% 1.3 1.65
ANKRD27 1 5.11E-16 1.66 (1.47, 1.88) <0.1% 1.28 1.57
NOL8 -1 3.80E-09 0.43 (0.32, 0.57) <0.1% 1.28 1.67
NOL8 -1 3.80E-09 0.43 (0.32, 0.57) <0.1% 1.28 1.67
TTLL3 -1 4.56E-09 0.41 (0.30, 0.55) <0.1% 1.28 1.68
TTLL3 -1 4.56E-09 0.41 (0.30, 0.55) <0.1% 1.28 1.68
SECISBP2L 1 3.74E-10 1.93 (1.57, 2.37) <0.1% 1.25 1.62
SECISBP2L 1 3.74E-10 1.93 (1.57, 2.37) <0.1% 1.25 1.62
FOXJ2 -1 5.35E-08 0.48 (0.37, 0.62) <0.1% 1.21 1.6
SEC24A 1 7.26E-09 1.90 (1.53, 2.37) <0.1% 1.21 1.58
FRS3 -1 2.70E-08 0.52 (0.41, 0.65) <0.1% 1.2 1.58
LOC100129518 1 1.04E-09 1.73 (1.45, 2.07) <0.1% 1.2 1.54
MEGF9 -1 3.53E-07 0.42 (0.30, 0.59) <0.1% 1.2 1.58
CANX 1 6.36E-08 1.94 (1.52, 2.46) <0.1% 1.19 1.55
CANX 1 6.36E-08 1.94 (1.52, 2.46) <0.1% 1.19 1.55
LRCH3 1 5.43E-09 1.71 (1.43, 2.04) <0.1% 1.19 1.52
MPP6 1 6.89E-09 1.74 (1.44, 2.10) <0.1% 1.19 1.53
TOMM20L -1 3.52E-08 0.56 (0.45, 0.68) <0.1% 1.19 1.54
ZNF484 -1 7.30E-07 0.43 (0.31, 0.60) <0.1% 1.19 1.56
ZNF484 -1 7.30E-07 0.43 (0.31, 0.60) <0.1% 1.19 1.56
AACSP1 1 1.95E-08 1.71 (1.42, 2.06) <0.1% 1.18 1.51
CDHR2 1 2.94E-07 1.83 (1.45, 2.31) <0.1% 1.17 1.51
CDHR2 1 2.94E-07 1.83 (1.45, 2.31) <0.1% 1.17 1.51
CEP152 1 6.13E-07 1.87 (1.46, 2.39) <0.1% 1.17 1.51
CEP152 1 6.13E-07 1.87 (1.46, 2.39) <0.1% 1.17 1.51
FAM83A 1 3.27E-06 2.24 (1.59, 3.14) 0.10% 1.17 1.5
FAM83A 1 3.27E-06 2.24 (1.59, 3.14) 0.10% 1.17 1.5
GALNT12 1 7.50E-08 1.70 (1.40, 2.06) <0.1% 1.17 1.49
HIVEP2 1 1.01E-06 2.17 (1.59, 2.96) <0.1% 1.17 1.52
HOMEZ -1 1.87E-08 0.61 (0.52, 0.73) <0.1% 1.17 1.49
NCCRP1 1 1.69E-07 1.72 (1.41, 2.12) <0.1% 1.17 1.49
NPRL2 -1 1.39E-10 0.69 (0.62, 0.77) <0.1% 1.17 1.4
POLG2 1 8.71E-08 1.68 (1.39, 2.03) <0.1% 1.17 1.48
PRAM1 -1 1.56E-07 0.54 (0.43, 0.68) <0.1% 1.17 1.53
SPATA21 -1 1.74E-07 0.55 (0.44, 0.69) <0.1% 1.17 1.53
SUN1 1 2.45E-08 1.60 (1.36, 1.89) <0.1% 1.17 1.46
SUN1 1 2.45E-08 1.60 (1.36, 1.89) <0.1% 1.17 1.46
SUN1 1 2.45E-08 1.60 (1.36, 1.89) <0.1% 1.17 1.46
SUN1 1 2.45E-08 1.60 (1.36, 1.89) <0.1% 1.17 1.46
SUN1 1 2.45E-08 1.60 (1.36, 1.89) <0.1% 1.17 1.46
TCTN2 -1 7.74E-07 0.52 (0.40, 0.68) <0.1% 1.17 1.52
TCTN2 -1 7.74E-07 0.52 (0.40, 0.68) <0.1% 1.17 1.52
TMEM101 -1 1.18E-06 0.51 (0.39, 0.67) <0.1% 1.17 1.52
ZMAT1 -1 1.22E-06 0.46 (0.34, 0.63) <0.1% 1.17 1.54
ZMAT1 -1 1.22E-06 0.46 (0.34, 0.63) <0.1% 1.17 1.54
C14orf50 -1 9.54E-08 0.61 (0.51, 0.73) <0.1% 1.16 1.47
C2orf73 -1 2.94E-07 0.57 (0.46, 0.71) <0.1% 1.16 1.5
C9orf64 -1 2.45E-06 0.49 (0.37, 0.66) <0.1% 1.16 1.52
KCMF1 1 3.74E-07 1.73 (1.40, 2.13) <0.1% 1.16 1.48
PDE6B -1 5.88E-06 0.45 (0.32, 0.64) 0.10% 1.16 1.5
PDE6B -1 5.88E-06 0.45 (0.32, 0.64) 0.10% 1.16 1.5
PDE6B -1 5.88E-06 0.45 (0.32, 0.64) 0.10% 1.16 1.5
SF3B3 1 4.06E-06 2.03 (1.50, 2.75) 0.10% 1.16 1.49
SIRT6 -1 2.10E-08 0.64 (0.55, 0.75) <0.1% 1.16 1.45
SIRT6 -1 2.10E-08 0.64 (0.55, 0.75) <0.1% 1.16 1.45
SLC35D1 -1 4.54E-06 0.45 (0.32, 0.63) 0.10% 1.16 1.51
SMURF2 1 3.34E-07 1.75 (1.41, 2.16) <0.1% 1.16 1.49
SPIN1 -1 5.97E-06 0.43 (0.30, 0.62) 0.10% 1.16 1.5
TEX2 1 1.23E-07 1.62 (1.35, 1.94) <0.1% 1.16 1.46
ZNF44 -1 1.16E-06 0.53 (0.40, 0.68) <0,1% 1.16 1.52
ZNF44 -1 1.16E-06 0.53 (0.40, 0.68) <0.1% 1.16 1.52
ACAP2 1 2.30E-06 1.82 (1.42, 2.33) <0.1% 1.15 1.48
CCDC47 1 2.83E-07 1.61 (1.34, 1.92) <0.1% 1.15 1.45
CIC -1 3.57E-06 0.52 (0.40, 0.69) 0.10% 1.15 1.5
GPR126 1 5.67E-06 2.00 (1.48, 2.69) 0.10% 1.15 1.48
GPR126 1 5.67E-06 2.00 (1.48, 2.69) 0.10% 1.15 1.48
GPR126 1 5.67E-06 2.00 (1.48, 2.69) 0.10% 1.15 1.48
GPR126 1 5.67E-06 2.00 (1.48, 2.69) 0.10% 1.15 1.48
IDH2 1 1.20E-07 1.60 (1.34, 1.90) <0.1% 1.15 1.45
KIAA0649 -1 2.15E-06 0.54 (0.42, 0.70) <0.1% 1.15 1.5
LOC100128977 -1 7.62E-06 0.50 (0.37, 0.68) 0.10% 1.15 1.49
MAGEA10 1 7.79E-08 1.55 (1.32, 1.82) <0.1% 1.15 1.43
MAGEA10 1 7.79E-08 1.55 (1.32, 1.82) <0.1% 1.15 1.43
MARCH6 1 8.72E-06 2.14 (1.53, 2.99) 0.10% 1.15 1.47
MCART6 -1 1.04E-05 0.48 (0.35, 0.67) 0.10% 1.15 1.48
PAPD7 1 1.08E-05 2.13 (1.52, 2.99) 0.10% 1.15 1.46
PAPD7 1 1.08E-05 2.13 (1.52, 2.99) 0.10% 1.15 1.46
PAPD7 1 1.08E-05 2.13 (1.52, 2.99) 0.10% 1.15 1.46
PLD1 1 3.54E-08 1.53 (1.32, 1.78) <0.1% 1.15 1.43
PLD1 1 3.54E-08 1.53 (1.32, 1.78) <0.1% 1.15 1.43
RAD9B -1 1.83E-06 0.57 (0.45, 0.72) <0.1% 1.15 1.48
SMARCD2 1 7.24E-07 1.63 (1.34, 1.98) <0.1% 1.15 1.45
TRPM8 1 1.83E-06 1.82 (1.42, 2.33) <0.1% 1.15 1.48
TTF1 -1 1.08E-05 0.47 (0.33, 0.66) 0.10% 1.15 1.48
UGT2B7 1 4.60E-08 1.50 (1.29, 1.73) <0.1% 1.15 1.41
WARS2 -1 2.69E-05 0.40 (0.26, 0.61) 0.20% 1.15 1.45
WARS2 -1 2.69E-05 0.40 (0.26, 0.61) 0.20% 1.15 1.45
ZDHHC19 1 1.05E-05 2.22 (1.56, 3.17) 0.10% 1.15 1.46
ZFR 1 1.11E-05 2.08 (1.50, 2.88) 0.10% 1.15 1.46
ANKRD17 1 2.20E-07 1.49 (1.28, 1.74) <0.1% 1.14 1.4
ANKRD17 1 2.20E-07 1.49 (1.28,1.74) <0.1% 1.14 1.4
C10orf93 -1 2.49E-05 044 (0.30, 0.65) 0.20% 1.14 1.46
DAP 1 1.93E-05 2.05 (1.47, 2.85) 0.20% 1.14 1.45
G3BP2 1 1.38E-07 1.50 (1.29, 1.75) <0.1% 1.14 1.4
G3BP2 1 1.38E-07 1.50 (1.29, 1.75) <0.1% 1.14 1.4
G3BP2 1 1.38E-07 1.50 (1.29, 1.75) <0.1% 1.14 1.4
GAN 1 2.40E-05 2.16 (1.51, 3.09) 0.20% 1.14 1.44
GSTM2 -1 1.12E-05 0.53 (0.40, 0.70) 0.10% 1.14 1.47
GSTM2 -1 1.12E-05 0.53 (0.40, 0.70) 0.10% 1.14 1.47
IGF2BP2 1 6.05E-06 1.84 (1.41, 2.40) 0.10% 1.14 1.46
IGF2BP2 1 6.05E-06 1.84 (1.41, 2.40) 0.10% 1.14 1.46
INPP5K -1 1.47E-05 0.48 (0.35, 0.67) 0.10% 1.14 1.47
INPP5K -1 1.47E-05 0.48 (0.35, 0.67) 0.10% 1.14 1.47
INPP5K -1 1.47E-05 0.48 (0.35, 0.67) 0.10% 1.14 1.47
LANCL1 -1 2.01E-05 0.48 (0.34, 0.67) 0.20% 1.14 1.47
LANCL1 -1 2.01E-05 0.48 (0.34, 0.67) 0.20% 1.14 1.47
LANCL1 -1 2.01E-05 0.48 (0.34, 0.67) 0.20% 1.14 1.47
MT4 1 8.97E-10 1.35 (1.22, 1.48) <0.1% 1.14 1.32
SCN1B -1 1.11E-05 0.52 (0.39, 0.70) 0.10% 1.14 1.47
SCN1B -1 1.11E-05 0.52 (0.39, 0.70) 0.10% 1.14 1.47
TXNRD1 1 9.57E-06 1.93 (1.44, 2.58) 0.10% 1.14 1.46
TXNRD1 1 9.57E-06 1.93 (1.44, 2.58) 0.10% 1.14 1.46
TXNRD1 1 9.57E-06 1.93 (1.44, 2.58) 0.10% 1.14 1.46
TXNRD1 1 9.57E-06 1.93 (1.44, 2.58) 0.10% 1.14 1.46
TXNRD1 1 9.57E-06 1.93 (1.44, 2.58) 0.10% 1.14 1.46
USO1 1 1.96E-07 1.49 (1.28, 1.74) <0.1% 1.14 1.4
ZBED4 1 1.01E-07 1.47 (1.27, 1.69) <0.1% 1.14 1.39
ZFP42 1 1.85E-07 1.50 (1.29, 1.75) <0.1% 1.14 1.4
ZNF415 -1 5.33E-06 0.57 (0.44, 0.72) 0.10% 1.14 1.47
ZNF415 -1 5.33E-06 0.57 (0.44, 0.72) 0.10% 1.14 1.47
ZNF415 -1 5.33E-06 0.57 (0.44, 0.72) 0.10% 1.14 1.47
ZNF415 -1 5.33E-06 0.57 (0.44, 0.72) 0.10% 1.14 1.47
ZNF625 -1 6.20E-06 0.53 (0.40, 0.69) 0.10% 1.14 1.48
ACBD4 -1 4.09E-06 0.62 (0.51, 0.76) 0.10% 1.13 1.43
ACBD4 -1 4.09E-06 0.62 (0.51, 0.76) 0.10% 1.13 1.43
ACBD4 -1 4.09E-06 0.62 (0.51, 0.76) 0.10% 1.13 1.43
ACBD4 -1 4.09E-06 0.62 (0.51, 0.76) 0.10% 1.13 1.43
ACBD4 -1 4.09E-06 0.62 (0.51, 0.76) 0.10% 1.13 1.43
ANKRD19 -1 7.74E-06 0.56 (0.44, 0.72) 0.10% 1.13 1.46
BPTF 1 2.42E-06 1.61 (1.32, 1.96) <0.1% 1.13 1.43
BPTF 1 2.42E-06 1.61 (1.32, 1.96) <0.1% 1.13 1.43
C17orf49 -1 5.27E-07 0.69 (0.59, 0.79) <0.1% 1.13 1.38
C17orf49 -1 5.27E-07 0.69 (0.59, 0.79) <0.1% 1.13 1.38
C17orf49 -1 5.27E-07 0.69 (0.59, 0.79) <0.1% 1.13 1.38
C2orf84 -1 3.24E-06 0.62 (0.51, 0.76) 0.10% 1.13 1.43
C3orf15 -1 5.65E-05 0.45 (0.30, 0.66) 0.40% 1.13 1.43
C6orf225 -1 3.63E-06 0.60 (0.49, 0.75) 0.10% 1.13 1.45
CCDC45 1 3.36E-06 1.62 (1.32, 1.99) 0.10% 1.13 1.43
CDK20 -1 0.000014394 0.52 (0.38, 0.70) 0.10% 1.13 1.47
CDK20 -1 0.000014394 0.52 (0.38, 0.70) 0.10% 1.13 1.47
CDK20 -1 0.000014394 0.52 (0.38, 0.70) 0.10% 1.13 1.47
CDK20 -1 0.000014394 0.52 (0.38, 0.70) 0.10% 1.13 1.47
CDK20 -1 0.000014394 0.52 (0.38, 0.70) 0.10% 1.13 1.47
COG4 1 2.32E-05 1.94 (1.43, 2.64) 0.20% 1.13 1.44
COG4 1 2.32E-05 1.94 (1.43, 2.64) 0.20% 1.13 1.44
CXCL13 1 1.08E-05 1.84 (1.40, 2.41) 0.10% 1.13 1.45
FBP1 -1 2.23E-05 0.53 (0.40, 0.71) 0.20% 1.13 1.45
FBP1 -1 2.23E-05 0.53 (0.40, 0.71) 0.20% 1.13 1.45
FRMPD2 -1 7.60E-06 0.57 (0.45, 0.73) 0.10% 1.13 1.46
FRMPD2 -1 7.60E-06 0.57 (0.45, 0.73) 0.10% 1.13 1.46
GUCA2B 1 4.56E-06 1.63 (1.32, 2.00) 0.10% 1.13 1.42
LALBA 1 1.41E-05 1.76 (1.36, 2.28) 0.10% 1.13 1.43
LOC100131366 1 7.36E-06 1.70 (1.35, 2.14) 0.10% 1.13 1.43
LRIG3 1 7.68E-06 1.70 (1.35, 2.15) 0.10% 1.13 1.43
LRIG3 1 7.68E-06 1.70 (1.35, 2.15) 0.10% 1.13 1.43
OLIG2 1 2.36E-05 2.09 (1.48, 2.94) 0.20% 1.13 1.44
PADI3 1 1.40E-05 1.80 (1.38, 2.35) 0.10% 1.13 1.44
PRICKLE4 -1 1.17E-07 0.69 (0.60, 0.79) <0.1% 1.13 1.38
RNF145 1 1.10E-05 1.80 (1.38, 2.33) 0.10% 1.13 1.44
RNF145 1 1.10E-05 1.80 (1.38, 2.33) 0.10% 1.13 1.44
RNF145 1 1.10E-05 1.80 (1.38, 2.33) 0.10% 1.13 1.44
RNF145 1 1.10E-05 1.80 (1.38, 2.33) 0.10% 1.13 1.44
RNF145 1 1.10E-05 1.80 (1.38, 2.33) 0.10% 1.13 1.44
SNRPN -1 7.19E-06 0.57 (0.45, 0.73) 0.10% 1.13 1.46
SNRPN -1 7.19E-06 0.57 (0.45, 0.73) 0.10% 1.13 1.46
SNRPN -1 7.19E-06 0.57 (0.45, 0.73) 0.10% 1.13 1.46
SNRPN -1 7.19E-06 0.57 (0.45, 0.73) 0.10% 1.13 1.46
SNRPN -1 7.19E-06 0.57 (0.45, 0.73) 0.10% 1.13 1.46
SUSD3 -1 1.88E-05 0.50 (0.37, 0.69) 0.20% 1.13 1.46
TBX10 1 3.65E-06 1.61 (1.32, 1.98) 0.10% 1.13 1.42
TRAIP 1 4.20E-05 2.16 (1.49, 3.12) 0.30% 1.13 1.42
UGT2B10 1 1.95E-07 1.47 (1.27, 1.70) <0.1% 1.13 1.38
UGT2B10 1 1.95E-07 1.47 (1.27, 1.70) <0.1% 1.13 1.38
UGT2B10 1 1.95E-07 1.47 (1.27, 1.70) <0.1% 1.13 1.38
UGT2B10 1 1.95E-07 1.47 (1.27, 1.70) <0.1% 1.13 1.38
ZNF214 -1 6.93E-06 0.57 (0.44, 0.73) 0.10% 1.13 1.46
ZNF835 -1 4.54E-05 0.45 (0.31, 0.66) 0.30% 1.13 1.44
ATAD2B 1 0.000010614 1.61 (1.30, 1.99) 0.10% 1.12 1.41
C10orf18 1 1.23E-05 1.61 (1.30, 2.00) 0.10% 1.12 1.41
C14orf79 -1 5.74E-05 0.51 (0.37, 0.71) 0.40% 1.12 1.43
C9orf27 1 3.70E-06 1.51 (1.27, 1.79) 0.10% 1.12 1.38
CALU 1 1.63E-05 1.75 (1.35, 2.25) 0.20% 1.12 1.43
CALU 1 1.63E-05 1.75 (1.35, 2.25) 0.20% 1.12 1.43
CALU 1 1.63E-05 1.75 (1.35, 2.25) 0.20% 1.12 1.43
CALU 1 1.63E-05 1.75 (1.35, 2.25) 0.20% 1.12 1.43
CALU 1 1.63E-05 1.75 (1.35, 2.25) 0.20% 1.12 1.43
CALU 1 1.63E-05 1.75 (1.35, 2.25) 0.20% 1.12 1.43
CARD18 1 4.65E-06 1.54 (1.28, 1.86) 0.10% 1.12 1.39
CCL2 -1 3.89E-05 0.53 (0.39, 0.72) 0.30% 1.12 1.44
CELF6 -1 7.61E-05 0.50 (0.35, 0.70) 0.50% 1.12 1.43
CELF6 -1 7.61E-05 0.50 (0.35, 0.70) 0.50% 1.12 1.43
CELF6 -1 7.61E-05 0.50 (0.35, 0.70) 0.50% 1.12 1.43
CREBL2 -1 2.02E-05 0.61 (0.48, 0.76) 0.20% 1.12 1.42
CSHL1 1 1.03E-06 1.42 (1.23, 1.63) <0.1% 1.12 1.35
CSHL1 1 1.03E-06 1.42 (1.23, 1.63) <0.1% 1.12 1.35
CSHL1 1 1.03E-06 1.42 (1.23, 1.63) <0.1% 1.12 1.35
CSHL1 1 1.03E-06 1.42 (1.23, 1.63) <0.1% 1.12 1.35
CXorf64 1 1.85E-06 1.49 (1.26, 1.75) <0.1% 1.12 1.38
DCDC5 -1 0.000050342 0.49 (0.35, 0.69) 0.30% 1.12 1.44
DDX42 1 3.64E-06 1.54 (1.28, 1.85) 0.10% 1.12 1.4
DDX42 1 3.64E-06 1.54 (1.28, 1.85) 0.10% 1.12 1.4
DLG1 1 1.70E-05 1.74 (1.35, 2.24) 0.20% 1.12 1.43
DLG1 1 1.70E-05 1.74 (1.35, 2.24) 0.20% 1.12 1.43
DSCR10 1 9.45E-07 1.48 (1.26, 1.73) <0.1% 1.12 1.38
HIST1H2BK 1 6.59E-05 2.00 (1.42, 2.82) 0.40% 1.12 1.41
HRASLS5 -1 2.85E-05 0.53 (0.39, 0.71) 0.20% 1.12 1.45
HRASLS5 -1 2.85E-05 0.53 (0.39, 0.71) 0.20% 1.12 1.45
HRASLS5 -1 2.85E-05 0.53 (0.39, 0.71) 0.20% 1.12 1.45
INSIG1 1 6.08E-05 1.98 (1.42, 2.76) 0.40% 1.12 1.41
INSIG1 1 6.08E-05 1.98 (1.42, 2.76) 0.40% 1.12 1.41
INSIG1 1 6.08E-05 1.98 (1.42, 2.76) 0.40% 1.12 1.41
IRF2BP2 1 4.85E-05 2.06 (1.45, 2.92) 0.30% 1.12 1.42
IRF2BP2 1 4.85E-05 2.06 (1.45, 2.92) 0.30% 1.12 1.42
ITLN2 1 5.74E-05 1.91 (1.40, 2.63) 0.40% 1.12 1.41
KLHL23 -1 3.95E-05 0.51 (0.37, 0.70) 0.30% 1.12 1.44
KLHL23 -1 3.95E-05 0.51 (0.37, 0.70) 0.30% 1.12 1.44
LCE1C 1 3.13E-06 1.48 (1.26, 1.74) 0.10% 1.12 1.37
MTCH1 1 1.38E-06 1.45 (1.24, 1.68) <0.1% 1.12 1.36
MYOF -1 1.35E-05 0.62 (0.50, 0.77) 0.10% 1.12 1.42
MYOF -1 1.35E-05 0.62 (0.50, 0.77) 0.10% 1.12 1.42
NHSL1 1 3.34E-05 1.87 (1.39, 2.51) 0.30% 1.12 1.43
NHSL1 1 3.34E-05 1.87 (1.39, 2.51) 0.30% 1.12 1.43
NRM -1 5.27E-05 0.52 (0.38, 0.71) 0.40% 1.12 1.43
NSD1 1 1.13E-06 1.49 (1.27, 1.74) <0.1% 1.12 1.38
NSD1 1 1.13E-06 1.49 (1.27, 1.74) <0.1% 1.12 1.38
NUP54 1 1.51E-06 1.47 (1.26, 1.73) <0.1% 1.12 1.37
PDXDC2P 1 6.41E-05 1.94 (1.40, 2.69) 0.40% 1.12 1.41
PIR 1 4.31E-05 1.96 (1.42, 2.70) 0.30% 1.12 1.42
PIR 1 4.31E-05 1.96 (1.42, 2.70) 0.30% 1.12 1.42
PLEKHM1P 1 7.39E-06 1.54 (1.28, 1.86) 0.10% 1.12 1.39
PRRC1 1 6.79E-05 2.10 (1.46, 3.02) 0.40% 1.12 1.41
PSMG3 1 0.000078564 2.30 (1.52, 3.48) 0.50% 1.12 1.4
PSMG3 1 0.000078564 2.30 (1.52, 3.48) 0.50% 1.12 1.4
PYY -1 5.43E-05 0.49 (0.34, 0.69) 0.40% 1.12 1.44
RAX 1 3.33E-05 1.75 (1.35, 2.29) 0.30% 1.12 1.42
RTN1 -1 5.29E-05 0.47 (0.33, 0.68) 0.40% 1.12 1.44
RTN1 -1 5.29E-05 0.47 (0.33, 0.68) 0.40% 1.12 1.44
RTN1 -1 5.29E-05 0.47 (0.33, 0.68) 0.40% 1.12 1.44
SLC35D2 -1 6.31E-06 0.62 (0.51, 0.77) 0.10% 1.12 1.42
SLC7A5 1 3.32E-05 1.88 (1.40, 2.53) 0.30% 1.12 1.43
SQSTM1 1 2.49E-05 1.78 (1.36, 2.33) 0.20% 1.12 1.43
SQSTM1 1 2.49E-05 1.78 (1.36, 2.33) 0.20% 1.12 1.43
SQSTM1 1 2.49E-05 1.78 (1.36, 2.33) 0.20% 1.12 1.43
TBX4 1 3.19E-05 1.81 (1.37, 2.39) 0.30% 1.12 1.42
TKT 1 4.20E-05 1.81 (1.36, 2.41) 0.30% 1.12 1.42
TKT 1 4.20E-05 1.81 (1.36, 2.41) 0.30% 1.12 1.42
TMEM26 -1 2.62E-05 0.55 (0.41, 0.73) 0.20% 1.12 1.44
TMEM8B -1 0.000067009 0.50 (0.36, 0.70) 0.40% 1.12 1.43
TMEM8B -1 0.000067009 0.50 (0.36, 0.70) 0.40% 1.12 1.43
TMEM8B -1 0.000067009 0.50 (0.36, 0.70) 0.40% 1.12 1.43
USP8 1 3.60E-09 1.29 (1.18, 1.40) <0.1% 1.12 1.27
USP8 1 3.60E-09 1.29 (1.18, 1.40) <0.1% 1.12 1.27
USP8 1 3.60E-09 1.29 (1.18, 1.40) <0.1% 1.12 1.27
WDR70 1 4.01E-05 1.98 (1.43, 2.73) 0.30% 1.12 1.42
WDR78 -1 1.82E-05 0.58 (0.45, 0.74) 0.20% 1.12 1.44
WDR78 -1 1.82E-05 0.58 (0.45, 0.74) 0.20% 1.12 1.44
ZNF433 -1 4.82E-06 0.63 (0.52, 0.77) 0.10% 1.12 1.42
ZNF563 -1 1.21E-05 0.59 (0.47, 0.75) 0.10% 1.12 1.44
ZNF788 -1 2.72E-05 0.59 (0.46, 0.75) 0.20% 1.12 1.43
ZNF836 -1 4.08E-05 0.51 (0.37, 0.71) 0.30% 1.12 1.44
AK8 -1 5.55E-05 0.54 (0.40, 0.73) 0.40% 1.11 1.43
C11orf70 -1 0.000056385 0.59 (0.46, 0.76) 0.40% 1.11 1.41
C11orf70 -1 0.000056385 0.59 (0.46, 0.76) 0.40% 1.11 1.41
C15orf23 1 0.000143369 2.27 (1.49, 3.46) 0.70% 1.11 1.38
C15orf23 1 0.000143369 2.27 (1.49, 3.46) 0.70% 1.11 1.38
C15orf23 1 0.000143369 2.27 (1.49, 3.46) 0.70% 1.11 1.38
C16orf52 -1 8.04E-05 0.54 (0.40, 0.73) 0.50% 1.11 1.42
C1orf168 -1 0.000132664 0.50 (0.35, 0.71) 0.70% 1.11 1.41
C20orf26 -1 0.000125264 0.46 (0.31, 0.69) 0.60% 1.11 1.41
C20orf26 -1 0.000125264 0.46 (0.31, 0.69) 0.60% 1.11 1.41
CX3CR1 -1 6.03E-05 0.54 (0.40, 0.73) 0.40% 1.11 1.43
CX3CR1 -1 6.03E-05 0.54 (0.40, 0.73) 0.40% 1.11 1.43
CX3CR1 -1 6.03E-05 0.54 (0.40, 0.73) 0.40% 1.11 1.43
CX3CR1 -1 6.03E-05 0.54 (0.40, 0.73) 0.40% 1.11 1.43
DAB1 -1 0.000102041 0.52 (0.38, 0.73) 0.60% 1.11 1.42
DMRTC2 1 5.88E-05 1.70 (1.31, 2.20) 0.40% 1.11 1.4
FAM98A 1 0.000152723 2.15 (1.45, 3.20) 0.70% 1.11 1.38
FAM9C 1 7.08E-07 1.39 (1.22, 1.58) <0.1% 1.11 1.33
FBXO15 -1 0.00014207 0.49 (0.34, 0.71) 0.70% 1.11 1.41
FBXO15 -1 0.00014207 0.49 (0.34, 0.71) 0.70% 1.11 1.41
GABPB1 1 3.07E-07 1.32 (1.19, 1.47) <0.1% 1.11 1.29
GABPB1 1 3.07E-07 1.32 (1.19, 1.47) <0.1% 1.11 1.29
GABPB1 1 3.07E-07 1.32 (1.19, 1.47) <0.1% 1.11 1.29
GABPB1 1 3.07E-07 1.32 (1.19, 1.47) <0.1% 1.11 1.29
GABPB1 1 3.07E-07 1.32 (1.19, 1.47) <0.1% 1.11 1.29
GARS 1 0.000025817 1.62 (1.29, 2.03) 0.20% 1.11 1.4
GLRA1 1 4.64E-05 1.66 (1.30, 2.12) 0.30% 1.11 1.4
GLRA1 1 4.64E-05 1.66 (1.30, 2.12) 0.30% 1.11 1.4
GOLPH3 1 0.000116993 1.95 (1.39, 2.74) 0.60% 1.11 1.39
GP9 1 1.93E-07 1.34 (1.20, 1.49) <0.1% 1.11 1.3
GPRIN1 1 9.56E-05 2.00 (1.41, 2.84) 0.50% 1.11 1.4
IGFBP3 1 0.000195883 2.33 (1.49, 3.64) 0.90% 1.11 1.36
IGFBP3 1 0.000195883 2.33 (1.49, 3.64) 0.90% 1.11 1.36
KCNJ5 -1 9.79E-05 0.50 (0.35, 0.71) 0.50% 1.11 1.42
KLHL5 -1 0.000134571 0.49 (0.34, 0.71) 0.70% 1.11 1.41
KLHL5 -1 0.000134571 0.49 (0.34, 0.71) 0.70% 1.11 1.41
KLHL5 -1 0.000134571 0.49 (0.34, 0.71) 0.70% 1.11 1.41
KLHL5 -1 0.000134571 0.49 (0.34, 0.71) 0.70% 1.11 1.41
KRT27 1 1.79E-05 1.54 (1.27, 1.88) 0.20% 1.11 1.38
LMAN1L 1 0.000147619 2.05 (1.41, 2.96) 0.70% 1.11 1.38
LOC100271722 -1 2.89E-05 0.64 (0.52, 0.79) 0.20% 1.11 1.39
LYL1 -1 4.58E-05 0.58 (0.45, 0.75) 0.30% 1.11 1.42
MAD1L1 1 0.000102969 1.87 (1.36, 2.56) 0.60% 1.11 1.4
MAD1L1 1 0.000102969 1.87 (1.36, 2.56) 0.60% 1.11 1.4
MAD1L1 1 0.000102969 1.87 (1.36, 2.56) 0.60% 1.11 1.4
MAPK6 1 1.97E-07 1.33 (1.20, 1.48) <0.1% 1.11 1.3
MRPS26 -1 6.20E-06 0.70 (0.60, 0.82) 0.10% 1.11 1.35
NAGS -1 0.00010598 0.50 (0.36, 0.71) 0.60% 1.11 1.42
OTP 1 3.84E-05 1.62 (1.29, 2.05) 0.30% 1.11 1.39
PINK1 -1 7.63E-05 0.53 (0.39, 0.73) 0.50% 1.11 1.42
RESP18 1 6.15E-06 1.46 (1.24, 1.72) 0.10% 1.11 1.36
SLC22A6 1 5.02E-05 1.82 (1.36, 2.42) 0.30% 1.11 1.41
SLC22A6 1 5.02E-05 1.82 (1.36, 2.42) 0.30% 1.11 1.41
SLC22A6 1 5.02E-05 1.82 (1.36, 2.42) 0.30% 1.11 1.41
SLC22A6 1 5.02E-05 1.82 (1.36, 2.42) 0.30% 1.11 1.41
SPATC1 1 0.000142376 2.22 (1.47, 3.36) 0.70% 1.11 1.38
SPATC1 1 0.000142376 2.22 (1.47, 3.36) 0.70% 1.11 1.38
TBX19 1 5.35E-05 1.76 (1.34, 2.32) 0.40% 1.11 1.41
TNFRSF14 -1 0.000166546 0.47 (0.31, 0.69) 0.80% 1.11 1.4
TRPM7 1 7.91E-09 1.27 (1.17, 1.38) <0.1% 1.11 1.25
TSC22D1 1 0.000124731 2.10 (1.44, 3.07) 0.60% 1.11 1.39
TSC22D1 1 0.000124731 2.10 (1.44, 3.07) 0.60% 1.11 1.39
WWP2 1 2.60E-05 1.60 (1.29, 2.00) 0.20% 1.11 1.39
WWP2 1 2.60E-05 1.60 (1.29, 2.00) 0.20% 1.11 1.39
WWP2 1 2.60E-05 1.60 (1.29, 2.00) 0.20% 1.11 1.39
ZNF136 -1 0.000105463 0.49 (0.35, 0.71) 0.60% 1.11 1.42
ZNF175 -1 5.57E-05 0.56 (0.42, 0.74) 0.40% 1.11 1.42
ZNF396 -1 2.46E-05 0.61 (0.48, 0.76) 0.20% 1.11 1.42
ZNF429 -1 0.000110212 0.51 (0.36, 0.72) 0.60% 1.11 1.41
ZNF491 -1 1.25E-05 0.66 (0.55, 0.80) 0.10% 1.11 1.38
ZNF721 -1 6.35E-05 0.57 (0.43, 0.75) 0.40% 1.11 1.42
ZNF79 -1 1.31E-05 0.64 (0.53, 0.78) 0.10% 1.11 1.4
ACSBG2 -1 0.000112734 0.58 (0.44, 0.76) 0.60% 1.1 1.4
ADCK5 1 0.000108958 1.77 (1.33, 2.37) 0.60% 1.1 1.39
ANKS6 1 0.000189078 1.98 (1.38, 2.83) 0.90% 1.1 1.38
ARMC9 -1 4.50E-05 0.62 (0.49, 0.78) 0.30% 1.1 1.4
ATP1A3 1 0.000078271 1.65 (1.29, 2.12) 0.50% 1.1 1.38
ATP7B -1 8.98E-05 0.59 (0.45, 0.77) 0.50% 1.1 1.4
ATP7B -1 8.98E-05 0.59 (0.45, 0.77) 0.50% 1.1 1.4
BGN -1 4.71E-05 0.65 (0.53, 0.80) 0.30% 1.1 1.38
C1orf146 -1 7.80E-05 0.59 (0.45, 0.76) 0.50% 1.1 1.41
CFHR5 1 0.000144896 1.85 (1.35, 2.54) 0.70% 1.1 1.39
CREB3 -1 4.27E-05 0.64 (0.52, 0.79) 0.30% 1.1 1.38
CROCC -1 0.000170204 0.52 (0.37, 0.73) 0.80% 1.1 1.4
DNAH7 -1 9.52E-05 0.56 (0.41, 0.75) 0.50% 1.1 1.41
DSCR4 1 5.00E-05 1.64 (1.29, 2.09) 0.30% 1.1 1.39
EGLN1 1 9.70E-05 1.80 (1.34, 2.41) 0.50% 1.1 1.39
GGCT 1 0.000050126 1.56 (1.26, 1.94) 0.30% 1.1 1.37
GGCT 1 0.000050126 1.56 (1.26, 1.94) 0.30% 1.1 1.37
GGCT 1 0.000050126 1.56 (1.26, 1.94) 0.30% 1.1 1.37
GGCT 1 0.000050126 1.56 (1.26, 1.94) 0.30% 1.1 1.37
GGCT 1 0.000050126 1.56 (1.26, 1.94) 0.30% 1.1 1.37
GRHL2 1 0.000165793 2.03 (1.40, 2.93) 0.80% 1.1 1.38
GRIK4 -1 0.000250003 0.43 (0.27, 0.67) 1.00% 1.1 1.38
HIP1 -1 4.88E-05 0.63 (0.50, 0.79) 0.30% 1.1 1.39
INCENP 1 0.000223059 2.03 (1.39, 2.96) 0.90% 1.1 1.37
INCENP 1 0.000223059 2.03 (1.39, 2.96) 0.90% 1.1 1.37
KCNH7 1 1.43E-05 1.45 (1.23, 1.72) 0.10% 1.1 1.35
KCNH7 1 1.43E-05 1.45 (1.23, 1.72) 0.10% 1.1 1.35
KMO 1 0.000124999 1.75 (1.32, 2.33) 0.60% 1.1 1.39
LCE3E 1 1.98E-06 1.35 (1.19, 1.53) <0.1% 1.1 1.3
LOC100130950 -1 0.000224114 0.48 (0.33, 0.71) 1.00% 1.1 1.39
LYPD6B -1 0.000130737 0.56 (0.41, 0.75) 0.70% 1.1 1.4
MAGEA5 1 2.64E-05 1.50 (1.24, 1.81) 0.20% 1.1 1.36
MYO1C -1 0.000148018 0.52 (0.37, 0.73) 0.70% 1.1 1.41
MYO1C -1 0.000148018 0.52 (0.37, 0.73) 0.70% 1.1 1.41
MYO1C -1 0.000148018 0.52 (0.37, 0.73) 0.70% 1.1 1.41
NDRG1 1 0.00006342 1.60 (1.27, 2.02) 0.40% 1.1 1.38
NDRG1 1 0.00006342 1.60 (1.27, 2.02) 0.40% 1.1 1.38
ONECUT2 1 0.000116006 1.87 (1.36, 2.57) 0.60% 1.1 1.39
PAIP1 1 3.95E-05 1.61 (1.28, 2.02) 0.30% 1.1 1.39
PAIP1 1 3.95E-05 1.61 (1.28, 2.02) 0.30% 1.1 1.39
PAIP1 1 3.95E-05 1.61 (1.28, 2.02) 0.30% 1.1 1.39
RAPGEF5 1 7.22E-05 1.71 (1.31, 2.22) 0.40% 1.1 1.39
RNASE2 1 1.62E-05 1.48 (1.24, 1.76) 0.20% 1.1 1.36
SCARB2 1 2.26E-05 1.47 (1.23, 1.77) 0.20% 1.1 1.35
SEC14L3 1 1.41E-05 1.47 (1.23, 1.74) 0.10% 1.1 1.35
SELO 1 3.85E-06 1.37 (1.20, 1.57) 0.10% 1.1 1.31
SLC15A1 1 0.000192161 2.05 (1.41, 2.99) 0.90% 1.1 1.38
SUTRK5 1 0.000119475 1.86 (1.35, 2.55) 0.60% 1.1 1.39
SPINK5 1 0.00014485 1.79 (1.33, 2.42) 0.70% 1.1 1.38
SPINK5 1 0.00014485 1.79 (1.33, 2.42) 0.70% 1.1 1.38
SPINK5 1 0.00014485 1.79 (1.33, 2.42) 0.70% 1.1 1.38
TMEM164 -1 0.000184554 0.51 (0.36, 0.72) 0.80% 1.1 1.4
TMEM164 -1 0.000184554 0.51 (0.36, 0.72) 0.80% 1.1 1.4
TMOD3 1 4.02E-08 1.27 (1.17, 1.38) <0.1% 1.1 1.25
TRIM32 -1 0.000162106 0.53 (0.38, 0.74) 0.80% 1.1 1.4
TRIM32 -1 0.000162106 0.53 (0.38, 0.74) 0.80% 1.1 1.4
TRIP13 1 0.00024036 2.25 (1.46, 3.47) 1.00% 1.1 1.36
TRIP13 1 0.00024036 2.25 (1.46, 3.47) 1.00% 1.1 1.36
ZNF347 -1 0.000123774 0.55 (0.40, 0.74) 0.60% 1.1 1.41
ZNF347 -1 0.000123774 0.55 (0.40, 0.74) 0.60% 1.1 1.41
ZNF347 -1 0.000123774 0.55 (0.40, 0.74) 0.60% 1.1 1.41
BCAR3 -1 0.000312727 0.49 (0.33, 0.72) 1.20% 1.09 1.38
BCL2 -1 0.000271683 0.53 (0.38, 0.75) 1.10% 1.09 1.39
BCL2 -1 0.000271683 0.53 (0.38, 0.75) 1.10% 1.09 1.39
BCL7C -1 0.00023086 0.53 (0.38, 0.74) 1.00% 1.09 1.39
BICD2 -1 0.000133159 0.57 (0.43, 0.76) 0.70% 1.09 1.4
BICD2 -1 0.000133159 0.57 (0.43, 0.76) 0.70% 1.09 1.4
C18orf54 1 0.000202177 1.74 (1.30, 2.34) 0.90% 1.09 1.37
CA10 1 1.34E-05 1.37 (1.19, 1.57) 0.10% 1.09 1.3
CA10 1 1.34E-05 1.37 (1.19, 1.57) 0.10% 1.09 1.3
CA10 1 1.34E-05 1.37 (1.19, 1.57) 0.10% 1.09 1.3
CLIC6 -1 0.000542023 0.38 (0.22, 0.66) 1.70% 1.09 1.33
EFCAB6 -1 0.000168016 0.59 (0.44, 0.77) 0.80% 1.09 1.39
EFCAB6 -1 0.000168016 0.59 (0.44, 0.77) 0.80% 1.09 1.39
EIF2B2 -1 0.000117388 0.59 (0.45, 0.77) 0.60% 1.09 1.4
ENO2 -1 0.000134221 0.58 (0.44, 0.77) 0.70% 1.09 1.4
FAM66C -1 0.000163471 0.59 (0.45, 0.78) 0.80% 1.09 1.39
FANK1 -1 0.000257189 0.54 (0.39, 0.75) 1.00% 1.09 1.39
FGFRL1 -1 0.000111716 0.60 (0.46, 0.78) 0.60% 1.09 1.39
FGFRL1 -1 0.000111716 0.60 (0.46, 0.78) 0.60% 1.09 1.39
FGFRL1 -1 0.000111716 0.60 (0.46, 0.78) 0.60% 1.09 1.39
FOXH1 1 2.16E-05 1.39 (1.20, 1.62) 0.20% 1.09 1.32
HIF1A 1 0.000181495 1.79 (1.32, 2.43) 0.80% 1.09 1.38
HIF1A 1 0.000181495 1.79 (1.32, 2.43) 0.80% 1.09 1.38
HJURP 1 0.000352551 2.12 (1.40, 3.20) 1.30% 1.09 1.35
LOC642345 1 0.000195592 1.75 (1.30, 2.35) 0.90% 1.09 1.37
LOX 1 0.000192189 1.82 (1.33, 2.50) 0.90% 1.09 1.38
LOX 1 0.000192189 1.82 (1.33, 2.50) 0.90% 1.09 1.38
LRIT2 1 2.01E-06 1.31 (1.17, 1.46) <0.1% 1.09 1.27
MYF5 1 7.41E-06 1.34 (1.18, 1.52) 0.10% 1.09 1.29
MYH2 -1 7.14E-05 0.63 (0.51, 0.79) 0.40% 1.09 1.38
MYH2 -1 7.14E-05 0.63 (0.51, 0.79) 0.40% 1.09 1.38
NAA35 -1 0.000347317 0.48 (0.32, 0.72) 1.30% 1.09 1.38
NCRNA00221 1 3.23E-05 1.42 (1.20, 1.67) 0.30% 1.09 1.33
NINJ1 -1 0.000222676 0.54 (0.38, 0.75) 0.90% 1.09 1.39
NPY1R -1 0.000241391 0.51 (0.35, 0.73) 1.00% 1.09 1.39
NR1I2 -1 0.000242263 0.55 (0.40, 0.75) 1.00% 1.09 1.39
NR1I2 -1 0.000242263 0.55 (0.40, 0.75) 1.00% 1.09 1.39
NR1I2 -1 0.000242263 0.55 (0.40, 0.75) 1.00% 1.09 1.39
NUP205 1 0.000108468 1.57 (1.25, 1.96) 0.60% 1.09 1.36
RAI2 -1 0.000402941 0.44 (0.28, 0.70) 1.40% 1.09 1.36
RAI2 -1 0.000402941 0.44 (0.28, 0.70) 1.40% 1.09 1.36
RAI2 -1 0.000402941 0.44 (0.28, 0.70) 1.40% 1.09 1.36
RAI2 -1 0.000402941 0.44 (0.28, 0.70) 1.40% 1.09 1.36
RAI2 -1 0.000402941 0.44 (0.28, 0.70) 1.40% 1.09 1.36
RAI2 -1 0.000402941 0.44 (0.28, 0.70) 1.40% 1.09 1.36
RDH10 1 0.000149274 1.79 (1.33, 2.42) 0.70% 1.09 1.38
RP1-177G6-2 1 2.00E-06 1.29 (1.16, 1.43) <0.1% 1.09 1.26
RP1-177G6-2 1 2.00E-06 1.29 (1.16, 1.43) <0.1% 1.09 1.26
SCD 1 0.000258891 2.04 (1.39, 2.99) 1.00% 1.09 1.37
SREBF2 1 0.000116715 1.66 (1.28, 2.15) 0.60% 1.09 1.38
TCEA3 -1 0.000146171 0.60 (0.46, 0.78) 0.70% 1.09 1.39
TROAP 1 0.000469135 2.65 (1.53, 4.57) 1.60% 1.09 1.31
TROAP 1 0.000469135 2.65 (1.53, 4.57) 1.60% 1.09 1.31
UIMC1 1 4.35E-05 1.47 (1.22, 1.77) 0.30% 1.09 1.34
UIMC1 1 4.35E-05 1.47 (1.22, 1.77) 0.30% 1.09 1.34
UIMC1 1 4.35E-05 1.47 (1.22, 1.77) 0.30% 1.09 1.34
XPA -1 0.000185424 0.57 (0.43, 0.77) 0.80% 1.09 1.39
XPA -1 0.000185424 0.57 (0.43, 0.77) 0.80% 1.09 1.39
YWHAZ 1 0.000084608 1.54 (1.24, 1.91) 0.50% 1.09 1.36
YWHAZ 1 0.000084608 1.54 (1.24, 1.91) 0.50% 1.09 1.36
YWHAZ 1 0.000084608 1.54 (1.24, 1.91) 0.50% 1.09 1.36
YWHAZ 1 0.000084608 1.54 (1.24, 1.91) 0.50% 1.09 1.36
YWHAZ 1 0.000084608 1.54 (1.24, 1.91) 0.50% 1.09 1.36
YWHAZ 1 0.000084608 1.54 (1.24, 1.91) 0.50% 1.09 1.36
ZNF626 -1 0.000106466 0.61 (0.48, 0.78) 0.60% 1.09 1.39
ZNF626 -1 0.000106466 0.61 (0.48, 0.78) 0.60% 1.09 1.39
ZNF709 -1 0.000178037 0.56 (0.41, 0.76) 0.80% 1.09 1.4
ADHFE1 -1 0.000429195 0.51 (0.35, 0.74) 1.50% 1.08 1.37
AP1G1 1 0.000239608 1.74 (1.29, 2.33) 1.00% 1.08 1.37
AP1G1 1 0.000239608 1.74 (1.29, 2.33) 1.00% 1.08 1.37
AP4E1 1 6.06E-06 1.28 (1.15, 1.42) 0.10% 1.08 1.25
BRD7 1 0.000271783 1.72 (1.29, 2.31) 1.10% 1.08 1.36
BRD7 1 0.000271783 1.72 (1.29, 2.31) 1.10% 1.08 1.36
C11orf24 1 0.000366903 1.84 (1.32, 2.57) 1.30% 1.08 1.36
C11orf40 1 0.00012651 1.53 (1.23, 1.91) 0.60% 1.08 1.35
C15orf42 1 0.000366951 1.89 (1.33, 2.68) 1.30% 1.08 1.36
C17orf68 -1 0.000267187 0.55 (0.40, 0.76) 1.10% 1.08 1.39
C17orf85 -1 0.000408898 0.49 (0.33, 0.73) 1.40% 1.08 1.37
C17orf85 -1 0.000408898 0.49 (0.33, 0.73) 1.40% 1.08 1.37
C18orf26 1 0.000269333 1.73 (1.29, 2.33) 1.10% 1.08 1.36
C2orf34 1 0.000480591 2.01 (1.36, 2.96) 1.60% 1.08 1.35
CALHM2 -1 0.000105504 0.65 (0.53, 0.81) 0.60% 1.08 1.36
CALHM2 -1 0.000105504 0.65 (0.53, 0.81) 0.60% 1.08 1.36
CNGB3 1 0.000314415 1.85 (1.32, 2.58) 1.20% 1.08 1.36
FLJ21408 -1 0.00017901 0.61 (0.47, 0.79) 0.80% 1.08 1.38
GALK2 1 0.000248814 1.80 (1.31, 2.47) 1.00% 1.08 1.37
GALK2 1 0.000248814 1.80 (1.31, 2.47) 1.00% 1.08 1.37
GNB2L1 1 0.000244751 1.77 (1.30, 2.40) 1.00% 1.08 1.37
HAUS1 -1 0.000455791 0.46 (0.30, 0.71) 1.50% 1.08 1.36
HAUS1 -1 0.000455791 0.46 (0.30, 0.71) 1.50% 1.08 1.36
IL17F 1 7.09E-05 1.42 (1.19, 1.69) 0.40% 1.08 1.32
KIAA0174 1 0.000369657 1.91 (1.34, 2.73) 1.30% 1.08 1.36
KLF3 1 0.000371138 1.81 (1.31, 2.52) 1.30% 1.08 1.36
LDLRAD3 -1 0.00028695 0.55 (0.39, 0.76) 1.10% 1.08 1.38
LOC100302640 -1 0.000386012 0.50 (0.35, 0.74) 1.40% 1.08 1.38
MAP3K14 -1 0.000279615 0.55 (0.40, 0.76) 1.10% 1.08 1.38
MVP -1 0.000337882 0.55 (0.40, 0.76) 1.20% 1.08 1.38
MVP -1 0.000337882 0.55 (0.40, 0.76) 1.20% 1.08 1.38
NEUROD2 1 8.72E-05 1.49 (1.22, 1.82) 0.50% 1.08 1.34
NFXL1 1 9.20E-05 1.51 (1.23, 1.86) 0.50% 1.08 1.35
NXF5 -1 0.000312889 0.54 (0.39, 0.76) 1.20% 1.08 1.38
NXF5 -1 0.000312889 0.54 (0.39, 0.76) 1.20% 1.08 1.38
PABPN1L 1 7.99E-05 1.46 (1.21, 1.76) 0.50% 1.08 1.33
PACSIN2 1 0.000313177 1.80 (1.31, 2.48) 1.20% 1.08 1.36
PACSIN2 1 0.000313177 1.80 (1.31, 2.48) 1.20% 1.08 1.36
PACSIN2 1 0.000313177 1.80 (1.31, 2.48) 1.20% 1.08 1.36
PLCD3 -1 0.00020193 0.63 (0.49, 0.80) 0.90% 1.08 1.37
PRSS41 1 5.10E-05 1.45 (1.21, 1.73) 0.30% 1.08 1.33
RGPD2 1 0.000329641 1.83 (1.32, 2.55) 1.20% 1.08 1.36
RGPD2 1 0.000329641 1.83 (1.32, 2.55) 1.20% 1.08 1.36
RIPK4 1 0.000629791 2.40 (1.45, 3.96) 1.80% 1.08 1.31
RPF1 -1 0.000340725 0.52 (0.36, 0.74) 1.20% 1.08 1.38
SLCO6A1 1 0.000282574 1.72 (1.28, 2.31) 1.10% 1.08 1.36
SPTAN1 -1 0.000302919 0.55 (0.40, 0.76) 1.20% 1.08 1.38
SPTAN1 -1 0.000302919 0.55 (0.40, 0.76) 1.20% 1.08 1.38
SPTAN1 -1 0.000302919 0.55 (0.40, 0.76) 1.20% 1.08 1.38
ST8SIA3 1 3.00E-07 1.24 (1.14, 1.34) <0.1% 1.08 1.22
TMEM106A -1 0.000264069 0.57 (0.42, 0.77) 1.10% 1.08 1.38
VCX3B 1 3.69E-05 1.41 (1.20, 1.66) 0.30% 1.08 1.32
ADAMTSL2 -1 0.000193672 0.65 (0.52, 0.82) 0.90% 1.07 1.35
ADAMTSL2 -1 0.000193672 0.65 (0.52, 0.82) 0.90% 1.07 1.35
ALG14 -1 0.000562384 0.52 (0.36, 0.75) 1.70% 1.07 1.36
ANLN 1 0.000800701 2.41 (1.44, 4.02) 2.10% 1.07 1.3
ANUBL1 -1 0.000562446 0.50 (0.34, 0.74) 1.70% 1.07 1.36
ANUBL1 -1 0.000562446 0.50 (0.34, 0.74) 1.70% 1.07 1.36
ARRDC3 1 0.000609525 1.87 (1.31, 2.67) 1.80% 1.07 1.34
ATG5 1 6.58E-05 1.31 (1.15, 1.49) 0.40% 1.07 1.26
ATP1A1OS -1 0.00067514 0.44 (0.27, 0.70) 1.90% 1.07 1.34
ATP1A1OS -1 0.00067514 0.44 (0.27, 0.70) 1.90% 1.07 1.34
ATP1A1OS -1 0.00067514 0.44 (0.27, 0.70) 1.90% 1.07 1.34
ATP1A1OS -1 0.00067514 0.44 (0.27, 0.70) 1.90% 1.07 1.34
ATP1A1OS -1 0.00067514 0.44 (0.27, 0.70) 1.90% 1.07 1.34
AURKA 1 0.000564508 1.96 (1.34, 2.86) 1.70% 1.07 1.34
AURKA 1 0.000564508 1.96 (1.34, 2.86) 1.70% 1.07 1.34
AURKA 1 0.000564508 1.96 (1.34, 2.86) 1.70% 1.07 1.34
AURKA 1 0.000564508 1.96 (1.34, 2.86) 1.70% 1.07 1.34
AURKA 1 0.000564508 1.96 (1.34, 2.86) 1.70% 1.07 1.34
AURKA 1 0.000564508 1.96 (1.34, 2.86) 1.70% 1.07 1.34
BRD1 1 0.000134308 1.37 (1.17, 1.62) 0.70% 1.07 1.29
C20orf191 1 0.00028668 1.50 (1.20, 1.86) 1.10% 1.07 1.33
C2orf77 -1 0.000330919 0.58 (0.43, 0.78) 1.20% 1.07 1.37
C5 -1 0.000477055 0.56 (0.41, 0.78) 1.60% 1.07 1.37
C6orf103 -1 0.00075103 0.49 (0.32, 0.74) 2.10% 1.07 1.35
CAMTA2 -1 0.000585964 0.54 (0.38, 0.77) 1.80% 1.07 1.36
CAMTA2 -1 0.000585964 0.54 (0.38, 0.77) 1.80% 1.07 1.36
CAMTA2 -1 0.000585964 0.54 (0.38, 0.77) 1.80% 1.07 1.36
CAMTA2 -1 0.000585964 0.54 (0.38, 0.77) 1.80% 1.07 1.36
CCDC40 -1 0.000595988 0.55 (0.39, 0.77) 1.80% 1.07 1.36
CENPP -1 0.00100693 0.39 (0.22, 0.68) 2.50% 1.07 1.31
CHRNA6 -1 0.000417968 0.60 (0.45, 0.80) 1.40% 1.07 1.36
CHRNA6 -1 0.000417968 0.60 (0.45, 0.80) 1.40% 1.07 1.36
DCTN3 -1 0.000423018 0.59 (0.44, 0.79) 1.50% 1.07 1.37
DCTN3 -1 0.000423018 0.59 (0.44, 0.79) 1.50% 1.07 1.37
DDX5 1 0.000330009 1.53 (1.21, 1.92) 1.20% 1.07 1.33
DNAJC24 -1 0.000858705 0.38 (0.21, 0.67) 2.20% 1.07 1.31
EBF4 -1 0.000723231 0.52 (0.36, 0.76) 2.00% 1.07 1.35
ENO1 1 0.000286748 1.61 (1.25, 2.09) 1.10% 1.07 1.35
ESRP1 1 0.000526689 1.83 (1.30, 2.58) 1.70% 1.07 1.35
ESRP1 1 0.000526689 1.83 (1.30, 2.58) 1.70% 1.07 1.35
ESRP1 1 0.000526689 1.83 (1.30, 2.58) 1.70% 1.07 1.35
ESRP1 1 0.000526689 1.83 (1.30, 2.58) 1.70% 1.07 1.35
ESRP1 1 0.000526689 1.83 (1.30, 2.58) 1.70% 1.07 1.35
EVX1 1 0.000155183 1.47 (1.21, 1.80) 0.70% 1.07 1.33
EXO1 1 0.000815942 2.21 (1.39, 3.52) 2.10% 1.07 1.31
EXO1 1 0.000815942 2.21 (1.39, 3.52) 2.10% 1.07 1.31
EXO1 1 0.000815942 2.21 (1.39, 3.52) 2.10% 1.07 1.31
FAHD1 -1 0.000285382 0.63 (0.49, 0.81) 1.10% 1.07 1.36
FAHD1 -1 0.000285382 0.63 (0.49, 0.81) 1.10% 1.07 1.36
FTSJ3 1 0.000250886 1.56 (1.23, 1.98) 1.00% 1.07 1.35
GJB6 1 0.000361532 1.59 (1.23, 2.05) 1.30% 1.07 1.34
GJB6 1 0.000361532 1.59 (1.23, 2.05) 1.30% 1.07 1.34
GJB6 1 0.000361532 1.59 (1.23, 2.05) 1.30% 1.07 1.34
GJB6 1 0.000361532 1.59 (1.23, 2.05) 1.30% 1.07 1.34
GTF2IRD2B -1 0.000489747 0.53 (0.37, 0.76) 1.60% 1.07 1.37
HIBADH 1 7.51E-05 1.41 (1.19, 1.67) 0.50% 1.07 1.31
HIVEP3 -1 0.000580798 0.50 (0.34, 0.74) 1.80% 1.07 1.36
HIVEP3 -1 0.000580798 0.50 (0.34, 0.74) 1.80% 1.07 1.36
HMGCL -1 0.00045336 0.56 (0.41, 0.78) 1.50% 1.07 1.37
HMGCL -1 0.00045336 0.56 (0.41, 0.78) 1.50% 1.07 1.37
HSBP1 1 0.000764687 2.07 (1.36, 3.17) 2.10% 1.07 1.32
INTS1 1 0.000425057 1.59 (1.23, 2.06) 1.50% 1.07 1.34
KIAA1274 -1 0.000322419 0.62 (0.48, 0.80) 1.20% 1.07 1.36
KIF4A 1 0.000565152 2.01 (1.35, 2.99) 1.70% 1.07 1.34
KLHL28 -1 0.000499515 0.52 (0.36, 0.75) 1.60% 1.07 1.37
KPNA2 1 0.000366643 1.80 (1.30, 2.49) 1.30% 1.07 1.36
KRT81 1 0.000377924 1.69 (1.27, 2.26) 1.30% 1.07 1.35
LOC100128881 1 0.000625392 2.08 (1.37, 3.16) 1.80% 1.07 1.33
LOC100129636 1 0.000323962 1.68 (1.27, 2.23) 1.20% 1.07 1.36
LOC284276 -1 0.000423828 0.57 (0.42, 0.78) 1.50% 1.07 1.37
LOXL1 -1 0.000510308 0.59 (0.44, 0.79) 1.60% 1.07 1.36
LRP8 1 0.000675065 2.00 (1.34, 2.98) 1.90% 1.07 1.33
LRP8 1 0.000675065 2.00 (1.34, 2.98) 1.90% 1.07 1.33
LRP8 1 0.000675065 2.00 (1.34, 2.98) 1.90% 1.07 1.33
LRP8 1 0.000675065 2.00 (1.34, 2.98) 1.90% 1.07 1.33
LRRC8A -1 0.00053552 0.51 (0.35, 0.75) 1.70% 1.07 1.36
LRRC8A -1 0.00053552 0.51 (0.35, 0.75) 1.70% 1.07 1.36
LRRC8A -1 0.00053552 0.51 (0.35, 0.75) 1.70% 1.07 1.36
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MAP7 1 0.000510806 1.69 (1.26, 2.26) 1.60% 1.07 1.34
MGC3771 -1 0.000568687 0.55 (0.39, 0.77) 1.70% 1.07 1.36
MGC3771 -1 0.000568687 0.55 (0.39, 0.77) 1.70% 1.07 1.36
MT1G 1 0.000312285 1.56 (1.22, 1.98) 1.20% 1.07 1.34
NGRN 1 0.000282469 1.57 (1.23, 2.01) 1.10% 1.07 1.35
NGRN 1 0.000282469 1.57 (1.23, 2.01) 1.10% 1.07 1.35
NLRP8 -1 0.000622004 0.50 (0.34, 0.74) 1.80% 1.07 1.36
NPHP1 -1 0.000473665 0.54 (0.38, 0.76) 1.60% 1.07 1.37
NPHP1 -1 0.000473665 0.54 (0.38, 0.76) 1.60% 1.07 1.37
NPHP1 -1 0.000473665 0.54 (0.38, 0.76) 1.60% 1.07 1.37
NPHP1 -1 0.000473665 0.54 (0.38, 0.76) 1.60% 1.07 1.37
NPY 1 0.00011211 1.35 (1.16, 1.57) 0.60% 1.07 1.28
PGK1 1 0.000239238 1.59 (1.24, 2.04) 1.00% 1.07 1.35
PGR -1 0.000509769 0.53 (0.37, 0.76) 1.60% 1.07 1.37
PIH1D2 -1 0.000210904 0.65 (0.52, 0.82) 0.90% 1.07 1.35
PIH1D2 -1 0.000210904 0.65 (0.52, 0.82) 0.90% 1.07 1.35
PLA2G2E 1 0.000289748 1.57 (1.23, 2.00) 1.10% 1.07 1.34
PLD2 -1 0.000493619 0.57 (0.42, 0.78) 1.60% 1.07 1.37
PLEKHA8 1 0.000432361 1.63 (1.24, 2.13) 1.50% 1.07 1.34
PLEKHA8 1 0.000432361 1.63 (1.24, 2.13) 1.50% 1.07 1.34
PLEKHA8 1 0.000432361 1.63 (1.24, 2.13) 1.50% 1.07 1.34
PMAIP1 -1 0.000483779 0.54 (0.39, 0.77) 1.60% 1.07 1.37
PRC1 1 0.000661503 1.87 (1.30, 2.67) 1.90% 1.07 1.34
PRC1 1 0.000661503 1.87 (1.30, 2.67) 1.90% 1.07 1.34
PRC1 1 0.000661503 1.87 (1.30, 2.67) 1.90% 1.07 1.34
PRKAG2 -1 0.000805839 0.48 (0.31, 0.74) 2.10% 1.07 1.35
PRKAG2 -1 0.000805839 0.48 (0.31, 0.74) 2.10% 1.07 1.35
PRKAG2 -1 0.000805839 0.48 (0.31, 0.74) 2.10% 1.07 1.35
PRR7 1 0.000736074 2.09 (1.36, 3.21) 2.00% 1.07 1.33
PRR7 1 0.000736074 2.09 (1.36, 3.21) 2.00% 1.07 1.33
PRR7 1 0.000736074 2.09 (1.36, 3.21) 2.00% 1.07 1.33
SARNP 1 0.000200909 1.48 (1.20, 1.83) 0.90% 1.07 1.33
SARNP 1 0.000200909 1.48 (1.20, 1.83) 0.90% 1.07 1.33
SARNP 1 0.000200909 1.48 (1.20, 1.83) 0.90% 1.07 1.33
SCUBE2 -1 0.000658247 0.48 (0.32, 0.73) 1.90% 1.07 1.35
SCUBE2 -1 0.000658247 0.48 (0.32, 0.73) 1.90% 1.07 1.35
SEC31A 1 0.000358109 1.68 (1.26, 2.23) 1.30% 1.07 1.35
SEC31A 1 0.000358109 1.68 (1.26, 2.23) 1.30% 1.07 1.35
SEC31A 1 0.000358109 1.68 (1.26, 2.23) 1.30% 1.07 1.35
SEC31A 1 0.000358109 1.68 (1.26, 2.23) 1.30% 1.07 1.35
SEC31A 1 0.000358109 1.68 (1.26, 2.23) 1.30% 1.07 1.35
SEC31A 1 0.000358109 1.68 (1.26, 2.23) 1.30% 1.07 1.35
SEMA4B 1 0.000291864 1.53 (1.21, 1.92) 1.10% 1.07 1.34
SEMA4B 1 0.000291864 1.53 (1.21, 1.92) 1.10% 1.07 1.34
SERPINB3 1 4..56E-05 1.34 (1.17, 1.55) 0.30% 1.07 1.28
SEZ6L -1 0.00098828 0.42 (0.25, 0.70) 2.40% 1.07 1.32
SEZ6L -1 0.00098828 0.42 (0.25, 0.70) 2.40% 1.07 1.32
SEZ6L -1 0.00098828 0.42 (0.25, 0.70) 2.40% 1.07 1.32
SEZ6L -1 0.00098828 0.42 (0.25, 0.70) 2.40% 1.07 1.32
SEZ6L -1 0.00098828 0.42 (0.25, 0.70) 2.40% 1.07 1.32
SEZ6L -1 0.00098828 0.42 (0.25, 0.70) 2.40% 1.07 1.32
SH3GLB2 -1 0.000498384 0.57 (0.41, 0.78) 1.60% 1.07 1.37
SLC10A7 1 0.000332852 1.59 (1.23, 2.05) 1.20% 1.07 1.34
SLC10A7 1 0.000332852 1.59 (1.23, 2.05) 1.20% 1.07 1.34
SLC12A1 1 0.000204056 1.49 (1.21, 1.83) 0.90% 1.07 1.33
SLC12A1 1 0.000204056 1.49 (1.21, 1.83) 0.90% 1.07 1.33
SLC6A17 1 0.000424003 1.66 (1.25, 2.19) 1.50% 1.07 1.35
SND1 1 0.000527599 1.82 (1.30, 2.55) 1.70% 1.07 1.35
SPATA4 -1 0.000630371 0.51 (0.35, 0.75) 1.80% 1.07 1.36
SPPL2A 1 5.23E-06 1.25 (1.14, 1.38) 0.10% 1.07 1.23
SURF1 -1 0.000200776 0.64 (0.51, 0.81) 0.90% 1.07 1.36
SYT9 -1 0.000684006 0.54 (0.38, 0.77) 1.90% 1.07 1.36
TBRG4 1 0.000200243 1.49 (1.21, 1.85) 0.90% 1.07 1.33
TBRG4 1 0.000200243 1.49 (1.21, 1.85) 0.90% 1.07 1.33
TBRG4 1 0.000200243 1.49 (1.21, 1.85) 0.90% 1.07 1.33
TFRC 1 0.000315917 1.71 (1.28, 2.29) 1.20% 1.07 1.36
TFRC 1 0.000315917 1.71 (1.28, 2.29) 1.20% 1.07 1.36
TRABD 1 0.000122576 1.47 (1.21, 1.79) 0.60% 1.07 1.33
TSTD2 -1 0.000818708 0.48 (0.31, 0.74) 2.10% 1.07 1.34
TUG1 1 0.000491525 1.91 (1.33, 2.76) 1.60% 1.07 1.35
UCA1 -1 0.000575028 0.54 (0.38, 0.76) 1.80% 1.07 1.36
UGT2A1 1 0.000173025 1.43 (1.19, 1.73) 0.80% 1.07 1.32
ULBP3 1 0.000274042 1.57 (1.23, 2.00) 1.10% 1.07 1.35
USP39 1 0.000493416 1.78 (1.29, 2.47) 1.60% 1.07 1.35
VPS41 1 0.000370817 1.62 (1.24, 2.12) 1.30% 1.07 1.35
VPS41 1 0.000370817 1.62 (1.24, 2.12) 1.30% 1.07 1.35
WDR19 -1 0.000547998 0.54 (0.38, 0.77) 1.70% 1.07 1.36
XAB2 -1 0.000225163 0.68 (0.55, 0.83) 1.00% 1.07 1.34
ZNF516 -1 0.000417543 0.53 (0.38, 0.76) 1.40% 1.07 1.37
ZNF665 -1 0.000397142 0.57 (0.42, 0.78) 1.40% 1.07 1.37
ZNF768 -1 0.00038939 0.60 (0.46, 0.80) 1.40% 1.07 1.36
ZNF782 -1 0.000573696 0.57 (0.41, 0.78) 1.80% 1.07 1.36
ZSCAN30 -1 0.000437804 0.55 (0.39, 0.77) 1.50% 1.07 1.37
ZSCAN30 -1 0.000437804 0.55 (0.39, 0.77) 1.50% 1.07 1.37
ADC -1 0.00054168 0.63 (0.48, 0.82) 1.70% 1.06 1.35
ANKRD30A -1 0.000861337 0.55 (0.39, 0.78) 2.20% 1.06 1.35
ANKRD5 -1 0.000461483 0.63 (0.48, 0.81) 1.50% 1.06 1.35
ANKRD5 -1 0.000461483 0.63 (0.48, 0.81) 1.50% 1.06 1.35
ARMCX4 -1 0.000894017 0.53 (0.36, 0.77) 2.30% 1.06 1.35
ATP5S -1 0.000805348 0.52 (0.35, 0.76) 2.10% 1.06 1.35
ATP5S -1 0.000805348 0.52 (0.35, 0.76) 2.10% 1.06 1.35
ATP5S -1 0.000805348 0.52 (0.35, 0.76) 2.10% 1.06 1.35
ATP5S -1 0.000805348 0.52 (0.35, 0.76) 2.10% 1.06 1.35
AZI2 1 0.000790058 1.85 (1.29, 2.65) 2.10% 1.06 1.33
AZI2 1 0.000790058 1.85 (1.29, 2.65) 2.10% 1.06 1.33
AZI2 1 0.000790058 1.85 (1.29, 2.65) 2.10% 1.06 1.33
BCAS3 1 0.000602033 1.60 (1.22, 2.10) 1.80% 1.06 1.33
BCAS3 1 0.000602033 1.60 (1.22, 2.10) 1.80% 1.06 1.33
C16orf71 -1 0.000979549 0.51 (0.34, 0.76) 2.40% 1.06 1.34
C1orf173 -1 0.000725234 0.54 (0.37, 0.77) 2.00% 1.06 1.36
C1orf198 1 0.000803782 1.80 (1.28, 2.54) 2.10% 1.06 1.33
C1orf198 1 0.000803782 1.80 (1.28, 2.54) 2.10% 1.06 1.33
C1orf198 1 0.000803782 1.80 (1.28, 2.54) 2.10% 1.06 1.33
C2orf78 1 0.000483098 1.58 (1.22, 2.04) 1.60% 1.06 1.33
C4orf45 1 0.000764755 1.79 (1.28, 2.51) 2.10% 1.06 1.34
CALCOCO2 1 0.00019697 1.33 (1.15, 1.55) 0.90% 1.06 1.27
CDCA8 1 0.001355782 2.59 (1.45, 4.65) 2.90% 1.06 1.27
CEP110 -1 0.00077961 0.52 (0.36, 0.76) 2.10% 1.06 1.35
CGRRF1 -1 0.000645901 0.60 (0.45, 0.81) 1.90% 1.06 1.35
CNTNAP1 -1 0.000689153 0.60 (0.45, 0.81) 2.00% 1.06 1.35
COL11A2 1 0.00025518 1.37 (1.16, 1.62) 1.00% 1.06 1.29
COL11A2 1 0.00025518 1.37 (1.16, 1.62) 1.00% 1.06 1.29
COL11A2 1 0.00025518 1.37 (1.16, 1.62) 1.00% 1.06 1.29
COL11A2 1 0.00025518 1.37 (1.16, 1.62) 1.00% 1.06 1.29
COPB1 1 0.000543696 1.69 (1.26, 2.28) 1.70% 1.06 1.34
COPB1 1 0.000543696 1.69 (1.26, 2.28) 1.70% 1.06 1.34
COPB1 1 0.000543696 1.69 (1.26, 2.28) 1.70% 1.06 1.34
CREB3L2 1 0.00060177 1.72 (1.26, 2.35) 1.80% 1.06 1.34
DCDC1 -1 0.000539347 0.59 (0.44, 0.80) 1.70% 1.06 1.36
EFNA5 1 0.000714322 1.71 (1.25, 2.34) 2.00% 1.06 1.34
EIF3B 1 0.000597068 1.67 (1.25, 2.24) 1.80% 1.06 1.34
EIF3B 1 0.000597068 1.67 (1.25, 2.24) 1.80% 1.06 1.34
ELOVL2 -1 0.000664075 0.56 (0.40, 0.78) 1.90% 1.06 1.36
FBXO8 -1 0.000806276 0.56 (0.40, 0.79) 2.10% 1.06 1.35
FGD3 -1 0.000941348 0.49 (0.32, 0.75) 2.40% 1.06 1.34
FGD3 -1 0.000941348 0.49 (0.32, 0.75) 2.40% 1.06 1.34
GALNT5 -1 0.000684822 0.55 (0.39, 0.78) 1.90% 1.06 1.36
GTSE1 1 0.000929866 2.10 (1.35, 3.26) 2.40% 1.06 1.32
INHBE 1 0.000208267 1.37 (1.16, 1.61) 0.90% 1.06 1.29
IPMK 1 0.00077886 1.67 (1.24, 2.24) 2.10% 1.06 1.33
KRT4 1 0.00047149 1.55 (1.21, 1.98) 1.60% 1.06 1.33
LDLR 1 0.000708045 1.70 (1.25, 2.31) 2.00% 1.06 1.34
LDLR 1 0.000708045 1.70 (1.25, 2.31) 2.00% 1.06 1.34
LDLR 1 0.000708045 1.70 (1.25, 2.31) 2.00% 1.06 1.34
LDLR 1 0.000708045 1.70 (1.25, 2.31) 2.00% 1.06 1.34
LDLR 1 0.000708045 1.70 (1.25, 2.31) 2.00% 1.06 1.34
LDLR 1 0.000708045 1.70 (1.25, 2.31) 2.00% 1.06 1.34
LIN28A 1 0.000535605 1.50 (1.19, 1.88) 1.70% 1.06 1.32
LOC100128788 -1 0.001181148 0.48 (0.31, 0.75) 2.70% 1.06 1.33
LOC100128788 -1 0.001181148 0.48 (0.31, 0.75) 2.70% 1.06 1.33
LOC283038 -1 0.000583488 0.60 (0.45, 0.80) 1.80% 1.06 1.36
MAPT -1 0.000668769 0.59 (0.43, 0.80) 1.90% 1.06 1.35
MAPT -1 0.000668769 0.59 (0.43, 0.80) 1.90% 1.06 1.35
MAPT -1 0.000668769 0.59 (0.43, 0.80) 1.90% 1.06 1.35
MAPT -1 0.000668769 0.59 (0.43, 0.80) 1.90% 1.06 1.35
MAPT -1 0.000668769 0.59 (0.43, 0.80) 1.90% 1.06 1.35
MAPT -1 0.000668769 0.59 (0.43, 0.80) 1.90% 1.06 1.35
MATN3 -1 0.000797381 0.59 (0.43, 0.80) 2.10% 1.06 1.35
MKI67 1 0.001246003 2.15 (1.35, 3.41) 2.80% 1.06 1.3
MKI67 1 0.001246003 2.15 (1.35, 3.41) 2.80% 1.06 1.3
MORC2 1 0.000833522 1.86 (1.29, 2.68) 2.20% 1.06 1.33
NLGN2 -1 0.000244843 0.71 (0.59, 0.85) 1.00% 1.06 1.31
NT5C2 1 0.000631267 1.73 (1.26, 2.37) 1.80% 1.06 1.34
NT5C2 1 0.000631267 1.73 (1.26, 2.37) 1.80% 1.06 1.34
OSBP2 1 0.000812952 1.71 (1.25, 2.33) 2.10% 1.06 1.33
PDE11A -1 0.000734955 0.57 (0.42, 0.79) 2.00% 1.06 1.35
PDE11A -1 0.000734955 0.57 (0.42, 0.79) 2.00% 1.06 1.35
PDE11A -1 0.000734955 0.57 (0.42, 0.79) 2.00% 1.06 1.35
PDE11A -1 0.000734955 0.57 (0.42, 0.79) 2.00% 1.06 1.35
PI3 1 0.000476303 1.49 (1.19, 1.86) 1.60% 1.06 1.32
PIGG -1 0.000571553 0.60 (0.45, 0.80) 1.70% 1.06 1.36
PIGG -1 0.000571553 0.60 (0.45, 0.80) 1.70% 1.06 1.36
POLDIP3 1 0.000528218 1.55 (1.21, 1.98) 1.70% 1.06 1.33
POLDIP3 1 0.000528218 1.55 (1.21, 1.98) 1.70% 1.06 1.33
POU4F3 1 0.000229501 1.40 (1.17, 1.67) 1.00% 1.06 1.3
PRDX6 1 0.000780619 1.70 (1.25, 2.32) 2.10% 1.06 1.33
PRKD1 1 0.000548992 1.50 (1.19, 1.89) 1.70% 1.06 1.32
PSMD7 1 0.000563721 1.68 (1.25, 2.25) 1.70% 1.06 1.34
RILPL2 -1 0.000768058 0.57 (0.41, 0.79) 2.10% 1.06 1.35
RORB -1 0.000604719 0.59 (0.44, 0.80) 1.80% 1.06 1.36
RPS3 1 0.000337452 1.44 (1.18, 1.75) 1.20% 1.06 1.31
RTN4RL1 -1 0.000608443 0.63 (0.49, 0.82) 1.80% 1.06 1.34
SC4MOL 1 0.000437147 1.51 (1.20, 1.89) 1.50% 1.06 1.32
SC4MOL 1 0.000437147 1.51 (1.20, 1.89) 1.50% 1.06 1.32
SLC40A1 -1 0.001006056 0.51 (0.34, 0.76) 2.50% 1.06 1.34
SLC9A6 1 0.00076266 1.81 (1.28, 2.56) 2.10% 1.06 1.34
SLC9A6 1 0.00076266 1.81 (1.28, 2.56) 2.10% 1.06 1.34
SLC9A6 1 0.00076266 1.81 (1.28, 2.56) 2.10% 1.06 1.34
TAX1BP1 1 0.000335077 1.39 (1.16, 1.66) 1.20% 1.06 1.29
TAX1BP1 1 0.000335077 1.39 (1.16, 1.66) 1.20% 1.06 1.29
TMEM39A 1 0.000692396 1.77 (1.27, 2.47) 2.00% 1.06 1.34
TMEM5 -1 0.000852491 0.56 (0.40, 0.79) 2.20% 1.06 1.35
TMOD2 1 0.000221131 1.43 (1.18, 1.72) 0.90% 1.06 1.31
TMOD2 1 0.000221131 1.43 (1.18, 1.72) 0.90% 1.06 1.31
TMPRSS11E 1 0.000771096 1.72 (1.25, 2.36) 2.10% 1.06 1.33
TNFAIP8L2 -1 0.000648477 0.57 (0.41, 0.79) 1.90% 1.06 1.36
TNFSF12-TNFSF13 -1 0.000593768 0.58 (0.43, 0.79) 1.80% 1.06 1.36
TRAF3IP1 -1 0.000786338 0.56 (0.40, 0.79) 2.10% 1.06 1.35
TRAF3IP1 -1 0.000786338 0.56 (0.40, 0.79) 2.10% 1.06 1.35
TRIM10 1 0.000210243 1.33 (1.14, 1.55) 0.90% 1.06 1.27
TRIM10 1 0.000210243 1.33 (1.14, 1.55) 0.90% 1.06 1.27
VILL -1 0.000741792 0.60 (0.44, 0.81) 2.10% 1.06 1.35
ZFHX2 -1 0.000723459 0.55 (0.39, 0.78) 2.00% 1.06 1.36
ZNF652 1 0.000337669 1.51 (1.20, 1.89) 1.20% 1.06 1.33
ZNF652 1 0.000337669 1.51 (1.20, 1.89) 1.20% 1.06 1.33
ACCN5 1 0.001052716 1.88 (1.29, 2.74) 2.50% 1.05 1.32
ACTL8 1 0.000978531 1.78 (1.26, 2.52) 2.40% 1.05 1.33
AGTR1 -1 0.001529539 0.50 (0.32, 0.77) 3.10% 1.05 1.32
AGTR1 -1 0.001529539 0.50 (0.32, 0.77) 3.10% 1.05 1.32
AGTR1 -1 0.001529539 0.50 (0.32, 0.77) 3.10% 1.05 1.32
AGTR1 -1 0.001529539 0.50 (0.32, 0.77) 3.10% 1.05 1.32
AGTR1 -1 0.001529539 0.50 (0.32, 0.77) 3.10% 1.05 1.32
APOF 1 0.000357244 1.36 (1.15, 1.61) 1.30% 1.05 1.28
ARPP19 1 0.000140299 1.23 (1.11, 1.37) 0.70% 1.05 1.21
ATN1 -1 0.00113338 0.57 (0.41, 0.80) 2.60% 1.05 1.34
ATN1 -1 0.00113338 0.57 (0.41, 0.80) 2.60% 1.05 1.34
BIRC6 1 0.001242408 1.68 (1.23, 2.30) 2.80% 1.05 1.32
BTG3 1 0.00134171 1.79 (1.25, 2.55) 2.90% 1.05 1.32
BTG3 1 0.00134171 1.79 (1.25, 2.55) 2.90% 1.05 1.32
C10orf79 -1 0.001408252 0.59 (0.42, 0.81) 3.00% 1.05 1.33
C14orf105 1 0.001588324 1.90 (1.27, 2.82) 3.20% 1.05 1.31
C14orf135 -1 0.001008184 0.60 (0.44, 0.81) 2.50% 1.05 1.34
C16orf61 1 0.001288809 1.78 (1.25, 2.53) 2.90% 1.05 1.32
C17orf102 1 0.000181996 1.24 (1.11, 1.39) 0.80% 1.05 1.21
C17orf64 1 0.00063311 1.48 (1.18, 1.86) 1.80% 1.05 1.31
C20orf132 -1 0.00106845 0.53 (0.36, 0.77) 2.60% 1.05 1.34
C20orf132 -1 0.00106845 0.53 (0.36, 0.77) 2.60% 1.05 1.34
C20orf132 -1 0.00106845 0.53 (0.36, 0.77) 2.60% 1.05 1.34
C21orf29 1 0.001264027 1.74 (1.24, 2.44) 2.80% 1.05 1.32
C6orf155 -1 0.001092707 0.53 (0.36, 0.78) 2.60% 1.05 1.34
C9orf102 -1 0.001523324 0.50 (0.33, 0.77) 3.10% 1.05 1.32
C9orf156 -1 0.001347547 0.52 (0.34, 0.77) 2.90% 1.05 1.33
C9orf43 -1 0.001198516 0.60 (0.44, 0.82) 2.70% 1.05 1.34
CASC1 -1 0.000936736 0.59 (0.43, 0.81) 2.40% 1.05 1.34
CASC1 -1 0.000936736 0.59 (0.43, 0.81) 2.40% 1.05 1.34
CASC1 -1 0.000936736 0.59 (0.43, 0.81) 2.40% 1.05 1.34
CASK 1 0.001007193 1.81 (1.27, 2.57) 2.50% 1.05 1.33
CASK 1 0.001007193 1.81 (1.27, 2.57) 2.50% 1.05 1.33
CASK 1 0.001007193 1.81 (1.27, 2.57) 2.50% 1.05 1.33
CBFB 1 0.001037169 1.65 (1.22, 2.23) 2.50% 1.05 1.32
CBFB 1 0.001037169 1.65 (1.22, 2.23) 2.50% 1.05 1.32
CCNB2 1 0.001408285 1.72 (1.23, 2.40) 3.00% 1.05 1.32
CDK13 1 7.62E-05 1.22 (1.11, 1.35) 0.50% 1.05 1.2
CDK13 1 7.62E-05 1.22 (1.11, 1.35) 0.50% 1.05 1.2
CEP72 1 0.001459446 1.82 (1.26, 2.63) 3.10% 1.05 1.31
CKAP2L 1 0.001319145 2.12 (1.34, 3.35) 2.90% 1.05 1.3
CLTC 1 0.000745682 1.49 (1.18, 1.88) 2.10% 1.05 1.31
COX5A 1 0.000669975 1.51 (1.19, 1.91) 1.90% 1.05 1.32
CRNN 1 0.000789381 1.45 (1.17, 1.80) 2.10% 1.05 1.3
CYP19A1 1 0.001318685 1.75 (1.24, 2.47) 2.90% 1.05 1.32
CYP19A1 1 0.001318685 1.75 (1.24, 2.47) 2.90% 1.05 1.32
DCHS1 -1 0.001479235 0.56 (0.39, 0.80) 3.10% 1.05 1.33
DET1 -1 0.000618527 0.72 (0.59, 0.87) 1.80% 1.05 1.29
DET1 -1 0.000618527 0.72 (0.59, 0.87) 1.80% 1.05 1.29
DET1 -1 0.000618527 0.72 (0.59, 0.87) 1.80% 1.05 1.29
DNAJA1 -1 0.001074517 0.64 (0.49, 0.84) 2.60% 1.05 1.33
EPGN 1 0.001109057 1.71 (1.24, 2.36) 2.60% 1.05 1.32
ERBB4 -1 0.001313858 0.59 (0.42, 0.81) 2.90% 1.05 1.33
ERBB4 -1 0.001313858 0.59 (0.42, 0.81) 2.90% 1.05 1.33
EXOC3L 1 0.001576091 2.03 (1.31, 3.14) 3.20% 1.05 1.3
FBN3 1 0.000998771 1.55 (1.19, 2.02) 2.50% 1.05 1.31
FBXO22 1 0.000970814 1.79 (1.27, 2.53) 2.40% 1.05 1.33
FBXO22 1 0.000970814 1.79 (1.27, 2.53) 2.40% 1.05 1.33
FBXO22 1 0.000970814 1.79 (1.27, 2.53) 2.40% 1.05 1.33
FBXO36 -1 0.000983445 0.56 (040, 0.79) 2.40% 1.05 1.35
FU26245 1 0.000549548 1.46 (1.18, 1.81) 1.70% 1.05 1.31
FU46361 1 0.000467876 1.42 (1.17, 1.73) 1.60% 1.05 1.3
GALNT13 1 0.001008619 1.66 (1.23, 2.24) 2.50% 1.05 1.32
GALNTL1 -1 0.001388679 0.54 (0.37, 0.79) 3.00% 1.05 1.33
GALNTL1 -1 0.001388679 0.54 (0.37, 0.79) 3.00% 1.05 1.33
GPR107 -1 0.001371972 0.46 (0.29, 0.74) 2.90% 1.05 1.32
GPR107 -1 0.001371972 0.46 (0.29, 0.74) 2.90% 1.05 1.32
GPR107 -1 0.001371972 0.46 (0.29, 0.74) 2.90% 1.05 1.32
GSTA5 1 0.000405719 1.37 (1.15, 1.62) 1.40% 1.05 1.28
HHLA3 -1 0.001094742 0.58 (0.42, 0.80) 2.60% 1.05 1.34
HHLA3 -1 0.001094742 0.58 (0.42, 0.80) 2.60% 1.05 1.34
HHLA3 -1 0.001094742 0.58 (0.42, 0.80) 2.60% 1.05 1.34
HHLA3 -1 0.001094742 0.58 (0.42, 0.80) 2.60% 1.05 1.34
HINFP -1 0.000768103 0.65 (0.50, 0.84) 2.10% 1.05 1.33
HINFP -1 0.000768103 0.65 (0.50, 0.84) 2.10% 1.05 1.33
HMGCR 1 0.000609854 1.48 (1.18, 1.85) 1.80% 1.05 1.31
HMGCR 1 0.000609854 1.48 (1.18, 1.85) 1.80% 1.05 1.31
HYDIN -1 0.001297953 0.58 (0.42, 0.81) 2.90% 1.05 1.34
HYDIN -1 0.001297953 0.58 (0.42, 0.81) 2.90% 1.05 1.34
HYDIN -1 0.001297953 0.58 (0.42, 0.81) 2.90% 1.05 1.34
HYDIN -1 0.001297953 0.58 (0.42, 0.81) 2.90% 1.05 1.34
IARS2 1 0.001187981 1.68 (1.23, 2.30) 2.70% 1.05 1.32
IFT88 -1 0.001402791 0.57 (0.40, 0.80) 3.00% 1.05 1.33
IFT88 -1 0.001402791 0.57 (0.40, 0.80) 3.00% 1.05 1.33
IGF2BP1 1 0.000806815 1.61 (1.22, 2.13) 2.10% 1.05 1.33
IGF2BP1 1 0.000806815 1.61 (1.22, 2.13) 2.10% 1.05 1.33
IL1F10 1 0.000806465 1.47 (1.17, 1.84) 2.10% 1.05 1.3
IL1F10 1 0.000806465 1.47 (1.17, 1.84) 2.10% 1.05 1.3
INTU -1 0.000791038 0.64 (0.49, 0.83) 2.10% 1.05 1.34
IQGAP3 1 0.001269109 2.03 (1.32, 3.13) 2.80% 1.05 1.31
KYNU 1 0.000833126 1.48 (1.18, 1.87) 2.20% 1.05 1.31
KYNU 1 0.000833126 1.48 (1.18, 1.87) 2.20% 1.05 1.31
KYNU 1 0.000833126 1.48 (1.18, 1.87) 2.20% 1.05 1.31
LEKR1 -1 0.001095433 0.55 (0.39, 0.79) 2.60% 1.05 1.34
LEKR1 -1 0.001095433 0.55 (0.39, 0.79) 2.60% 1.05 1.34
LOC100129046 -1 0.001505992 0.56 (0.40, 0.80) 3.10% 1.05 1.33
LOC100130015 1 0.000973928 1.60 (1.21, 2.11) 2.40% 1.05 1.32
LOC100130015 1 0.000973928 1.60 (1.21, 2.11) 2.40% 1.05 1.32
LOC386758 -1 0.001056927 0.60 (0.44, 0.82) 2.50% 1.05 1.34
LOC386758 -1 0.001056927 0.60 (0.44, 0.82) 2.50% 1.05 1.34
LOC386758 -1 0.001056927 0.60 (0.44, 0.82) 2.50% 1.05 1.34
LOC389765 -1 0.001342509 0.56 (0.39, 0.80) 2.90% 1.05 1.34
LOC401242 1 0.000156056 1.27 (1.12, 1.43) 0.70% 1.05 1.23
LRRC48 -1 0.001316854 0.54 (0.38, 0.79) 2.90% 1.05 1.34
LRRC48 -1 0.001316854 0.54 (0.38, 0.79) 2.90% 1.05 1.34
LRRC48 -1 0.001316854 0.54 (0.38, 0.79) 2.90% 1.05 1.34
LRRC48 -1 0.001316854 0.54 (0.38, 0.79) 2.90% 1.05 1.34
MAGEA12 1 0.000281529 1.29 (1.12, 1.48) 1.10% 1.05 1.24
MAGEA12 1 0.000281529 1.29 (1.12, 1.48) 1.10% 1.05 1.24
MAGEA12 1 0.000281529 1.29 (1.12, 1.48) 1.10% 1.05 1.24
MLF1IP 1 0.00175043 1.95 (1.28, 2.97) 3.40% 1.05 1.3
MRPL54 -1 0.001508008 0.52 (0.35, 0.78) 3.10% 1.05 1.33
MTNR1A 1 0.001122268 1.71 (1.24, 2.36) 2.60% 1.05 1.32
MYBL2 1 0.001307241 1.82 (1.26, 2.63) 2.90% 1.05 1.32
NBPF1 -1 0.001260206 0.58 (0.41, 0.81) 2.80% 1.05 1.34
NCBP1 -1 0.001356126 0.57 (0.41, 0.80) 2.90% 1.05 1.33
NCOA5 -1 0.001192077 0.55 (0.39, 0.79) 2.70% 1.05 1.34
NUBP1 -1 0.000937501 0.59 (0.43, 0.81) 2.40% 1.05 1.34
NUP155 1 0.00100456 1.82 (1.27, 2.59) 2.50% 1.05 1.33
NUP155 1 0.00100456 1.82 (1.27, 2.59) 2.50% 1.05 1.33
OPN3 1 0.001078316 1.89 (1.29, 2.78) 2.60% 1.05 1.32
PABPC1 1 0.001122107 1.62 (1.21, 2.17) 2.60% 1.05 1.32
PACRGL -1 0.000964235 0.59 (0.43, 0.81) 2.40% 1.05 1.34
PACRGL -1 0.000964235 0.59 (0.43, 0.81) 2.40% 1.05 1.34
PALM -1 0.000885604 0.59 (0.43, 0.80) 2.30% 1.05 1.35
PALM -1 0.000885604 0.59 (0.43, 0.80) 2.30% 1.05 1.35
PHF2 -1 0.001491851 0.58 (0.41, 0.81) 3.10% 1.05 1.33
PIF1 1 0.001559389 2.22 (1.35, 3.64) 3.20% 1.05 1.29
PLA2G16 -1 0.001171353 0.52 (0.35, 0.77) 2.70% 1.05 1.34
PLA2G16 -1 0.001171353 0.52 (0.35, 0.77) 2.70% 1.05 1.34
PNPLA4 -1 0.001295225 0.55 (0.38, 0.79) 2.90% 1.05 1.34
PNPLA4 -1 0.001295225 0.55 (0.38, 0.79) 2.90% 1.05 1.34
PNPLA4 -1 0.001295225 0.55 (0.38, 0.79) 2.90% 1.05 1.34
PPIA 1 0.000543774 1.42 (1.16, 1.73) 1.70% 1.05 1.3
PPM1M -1 0.000929062 0.67 (0.52, 0.85) 2.40% 1.05 1.32
PPM1M -1 0.000929062 0.67 (0.52, 0.85) 2.40% 1.05 1.32
PPP1CB 1 0.001307362 1.75 (1.24, 2.45) 2.90% 1.05 1.32
PPP1CB 1 0.001307362 1.75 (1.24, 2.45) 2.90% 1.05 1.32
PRRG1 1 0.001335665 2.05 (1.32, 3.17) 2.90% 1.05 1.3
PRRG1 1 0.001335665 2.05 (1.32, 3.17) 2.90% 1.05 1.3
PRRG1 1 0.001335665 2.05 (1.32, 3.17) 2.90% 1.05 1.3
PRRG1 1 0.001335665 2.05 (1.32, 3.17) 2.90% 1.05 1.3
PRRG1 1 0.001335665 2.05 (1.32, 3.17) 2.90% 1.05 1.3
PYGO1 -1 0.000933796 0.59 (0.43, 0.80) 2.40% 1.05 1.35
RASGEF1C 1 0.000782881 1.63 (1.23, 2.17) 2.10% 1.05 1.33
RBBP6 -1 0.001298068 0.53 (0.36, 0.78) 2.90% 1.05 1.33
RBBP6 -1 0.001298068 0.53 (0.36, 0.78) 2.90% 1.05 1.33
RBBP6 -1 0.001298068 0.53 (0.36, 0.78) 2.90% 1.05 1.33
RBM24 -1 0.00141751 0.54 (0.37, 0.79) 3.00% 1.05 1.33
RBM24 -1 0.00141751 0.54 (0.37, 0.79) 3.00% 1.05 1.33
RBM24 -1 0.00141751 0.54 (0.37, 0.79) 3.00% 1.05 1.33
REM2 -1 0.000882487 0.63 (0.48, 0.83) 2.30% 1.05 1.34
SEPSECS -1 0.001221472 0.59 (0.43, 0.81) 2.80% 1.05 1.34
SHCBP1 1 0.001555367 1.94 (1.29, 2.93) 3.20% 1.05 1.3
SLC25A12 -1 0.001161342 0.53 (0.36, 0.78) 2.70% 1.05 1.34
SRP9 1 0.001180657 1.64 (1.22, 2.22) 2.70% 1.05 1.32
SRP9 1 0.001180657 1.64 (1.22, 2.22) 2.70% 1.05 1.32
SYT6 -1 0.00123582 0.51 (0.34, 0.77) 2.80% 1.05 1.33
TARBP2 -1 0.000916321 0.62 (0.47, 0.82) 2.30% 1.05 1.34
TARBP2 -1 0.000916321 0.62 (0.47, 0.82) 2.30% 1.05 1.34
TARBP2 -1 0.000916321 0.62 (0.47, 0.82) 2.30% 1.05 1.34
TCAM1P 1 0.000940114 1.64 (1.22, 2.20) 2.40% 1.05 1.32
THAP4 -1 0.001221209 0.55 (0.38, 0.79) 2.80% 1.05 1.34
THAP4 -1 0.001221209 0.55 (0.38, 0.79) 2.80% 1.05 1.34
TLR3 -1 0.001127044 0.59 (0.43, 0.81) 2.60% 1.05 1.34
TMEM127 -1 0.000890354 0.59 (0.43, 0.81) 2.30% 1.05 1.35
TMEM127 -1 0.000890354 0.59 (0.43, 0.81) 2.30% 1.05 1.35
TPTE 1 0.000758552 1.57 (1.21, 2.04) 2.10% 1.05 1.32
TPTE 1 0.000758552 1.57 (1.21, 2.04) 2.10% 1.05 1.32
TPTE 1 0.000758552 1.57 (1.21, 2.04) 2.10% 1.05 1.32
TRNP1 -1 0.001093981 0.62 (0.46, 0.83) 2.60% 1.05 1.33
TRPV1 -1 0.001166172 0.51 (0.34, 0.77) 2.70% 1.05 1.34
TRPV1 -1 0.001166172 0.51 (0.34, 0.77) 2.70% 1.05 1.34
TRPV1 -1 0.001166172 0.51 (0.34, 0.77) 2.70% 1.05 1.34
TRPV1 -1 0.001166172 0.51 (0.34, 0.77) 2.70% 1.05 1.34
TTC23L -1 0.001233032 0.57 (0.41, 0.80) 2.80% 1.05 1.34
TTC26 -1 0.000762816 0.66 (0.52, 0.84) 2.10% 1.05 1.33
TTC26 -1 0.000762816 0.66 (0.52, 0.84) 2.10% 1.05 1.33
TTC26 -1 0.000762816 0.66 (0.52, 0.84) 2.10% 1.05 1.33
UNC5B -1 0.001174314 0.61 (0.46, 0.82) 2.70% 1.05 1.33
USP9X 1 0.001402489 1.73 (1.24, 2.43) 3.00% 1.05 1.32
USP9X 1 0.001402489 1.73 (1.24, 2.43) 3.00% 1.05 1.32
WDR16 -1 0.001158488 0.53 (0.36, 0.78) 2.70% 1.05 1.34
WDR16 -1 0.001158488 0.53 (0.36, 0.78) 2.70% 1.05 1.34
YWHAE -1 0.001115707 0.52 (0.35, 0.77) 2.60% 1.05 1.34
YWHAE -1 0.001115707 0.52 (0.35, 0.77) 2.60% 1.05 1.34
ZBTB26 -1 0.001225918 0.59 (0.43, 0.81) 2.80% 1.05 1.34
ZFP112 -1 0.00123204 0.54 (0.37, 0.78) 2.80% 1.05 1.34
ZFP112 -1 0.00123204 0.54 (0.37, 0.78) 2.80% 1.05 1.34
ZFP28 -1 0.000981399 0.58 (0.42, 0.80) 2.40% 1.05 1.34
ZFP3 -1 0.001069592 0.56 (0.40, 0.79) 2.60% 1.05 1.34
ZNF358 -1 0.000693963 0.66 (0.52, 0.84) 2.00% 1.05 1.33
ZNF420 -1 0.001324154 0.57 (0.40, 0.80) 2.90% 1.05 1.34
ZNF597 -1 0.000903345 0.59 (0.44, 0.81) 2.30% 1.05 1.34
ZNF610 -1 0.001280906 0.60 (0.44, 0.82) 2.80% 1.05 1.33
ZNF610 -1 0.001280906 0.60 (0.44, 0.82) 2.80% 1.05 1.33
ZNF610 -1 0.001280906 0.60 (0.44, 0.82) 2.80% 1.05 1.33
ZNF610 -1 0.001280906 0.60 (0.44, 0.82) 2.80% 1.05 1.33
ZNF862 -1 0.00105257 0.55 (0.39, 0.79) 2.50% 1.05 1.34
ABCA12 1 0.002161248 1.74 (1.22, 2.47) 3.90% 1.04 1.3
ABCA12 1 0.002161248 1.74 (1.22, 2.47) 3.90% 1.04 1.3
ACSMS -1 0.002054386 0.56 (0.39, 0.81) 3.80% 1.04 1.32
ADM2 1 0.001274536 1.46 (1.16, 1.84) 2.80% 1.04 1.29
AMDHD1 -1 0.001536666 0.61 (0.45, 0.83) 3.10% 1.04 1.33
AMN1 -1 0.002178846 0.52 (0.35, 0.79) 3.90% 1.04 1.31
AMN1 -1 0.002178846 0.52 (0.35, 0.79) 3.90% 1.04 1.31
ANKAR -1 0.002007581 0.62 (0.46, 0.84) 3.70% 1.04 1.32
B3GNT8 -1 0.001926614 0.55 (0.38, 0.80) 3.60% 1.04 1.32
BBS5 -1 0.001546773 0.60 (0.44, 0.82) 3.20% 1.04 1.33
BDNF-AS1 -1 0.001646972 0.64 (0.48, 0.84) 3.30% 1.04 1.32
BDNF-AS1 -1 0.001646972 0.64 (0.48, 0.84) 3.30% 1.04 1.32
BDNF-AS1 -1 0.001646972 0.64 (0.48, 0.84) 3.30% 1.04 1.32
BDNF-AS1 -1 0.001646972 0.64 (0.48, 0.84) 3.30% 1.04 1.32
BDNF-AS1 -1 0.001646972 0.64 (0.48, 0.84) 3.30% 1.04 1.32
BZRAP1 -1 0.001603336 0.58 (0.41, 0.81) 3.20% 1.04 1.33
BZRAP1 -1 0.001603336 0.58 (0.41, 0.81) 3.20% 1.04 1.33
C22orf9 -1 0.001457169 0.59 (0.42, 0.81) 3.10% 1.04 1.33
C22orf9 -1 0.001457169 0.59 (0.42, 0.81) 3.10% 1.04 1.33
C5orf22 1 0.00164001 1.82 (1.25, 2.64) 3.30% 1.04 1.31
C7orf30 1 0.001468584 1.43 (1.15, 1.79) 3.10% 1.04 1.28
C7orf53 1 0.00256683 1.97 (1.27, 3.06) 4.30% 1.04 1.28
C7orf53 1 0.00256683 1.97 (1.27, 3.06) 4.30% 1.04 1.28
C8orf75 1 0.001454158 1.62 (1.20, 2.19) 3.10% 1.04 1.31
C9orf89 -1 0.001984738 0.52 (0.34, 0.78) 3.70% 1.04 1.32
CBX3 1 0.001431883 1.40 (1.14, 1.72) 3.00% 1.04 1.27
CBX3 1 0.001431883 1.40 (1.14, 1.72) 3.00% 1.04 1.27
CELA2B -1 0.001884979 0.56 (0.39, 0.81) 3.60% 1.04 1.32
CENPF 1 0.002672209 2.01 (1.28, 3.18) 4.40% 1.04 1.28
CENPI 1 0.00200314 1.76 (1.23, 2.52) 3.70% 1.04 1.3
CLRN1 -1 0.001811077 0.59 (0.42, 0.82) 3.50% 1.04 1.32
CLRN1 -1 0.001811077 0.59 (0.42, 0.82) 3.50% 1.04 1.32
CLRN1 -1 0.001811077 0.59 (0.42, 0.82) 3.50% 1.04 1.32
CNOT1 1 0.002044545 1.67 (1.20, 2.31) 3.80% 1.04 1.3
CNOT1 1 0.002044545 1.67 (1.20, 2.31) 3.80% 1.04 1.3
COX4I1 1 0.001837639 1.78 (1.24, 2.56) 3.50% 1.04 1.31
CREBBP -1 0.002076809 0.56 (0.39, 0.81) 3.80% 1.04 1.32
CREBBP -1 0.002076809 0.56 (0.39, 0.81) 3.80% 1.04 1.32
DCP1B -1 0.002232642 0.55 (0.37, 0.81) 4.00% 1.04 1.32
DEGS2 -1 0.002313022 0.58 (0.41, 0.83) 4.10% 1.04 1.32
DNAH6 -1 0.001467242 0.62 (0.46, 0.83) 3.10% 1.04 1.33
DYNLRB2 -1 0.001832614 0.62 (0.46, 0.84) 3.50% 1.04 1.32
EIF3E 1 0.001989926 1.72 (1.22, 2.42) 3.70% 1.04 1.3
EPRS 1 0.002365345 1.81 (1.24, 2.67) 4.10% 1.04 1.29
ETFDH -1 0.00230326 0.58 (0.41, 0.82) 4.10% 1.04 1.32
FAM131C 1 0.002298543 1.77 (1.23, 2.55) 4.10% 1.04 1.3
GALC -1 0.001803912 0.61 (0.44, 0.83) 3.50% 1.04 1.32
GALC -1 0.001803912 0.61 (0.44, 0.83) 3.50% 1.04 1.32
GALNT14 1 0.001837704 1.76 (1.23, 2.52) 3.50% 1.04 1.31
HEATR2 1 0.001823293 1.54 (1.18, 2.03) 3.50% 1.04 1.3
HEATR3 1 0.001554545 1.73 (1.23, 2.42) 3.20% 1.04 1.31
HEATR7A 1 0.001790133 1.61 (1.19, 2.18) 3.50% 1.04 1.3
HEATR7A 1 0.001790133 1.61 (1.19, 2.18) 3.50% 1.04 1.3
HEATR7A 1 0.001790133 1.61 (1.19, 2.18) 3.50% 1.04 1.3
HMGCS1 1 0.001069341 1.47 (1.17, 1.85) 2.60% 1.04 1.3
HMGCS1 1 0.001069341 1.47 (1.17, 1.85) 2.60% 1.04 1.3
HOXB9 1 0.001509092 1.61 (1.20, 2.17) 3.10% 1.04 1.31
IFT74 -1 0.001765925 0.58 (0.42, 0.82) 3.40% 1.04 1.33
IFT74 -1 0.001765925 0.58 (0.42, 0.82) 3.40% 1.04 1.33
IFT74 -1 0.001765925 0.58 (0.42, 0.82) 3.40% 1.04 1.33
IFT74 -1 0.001765925 0.58 (0.42, 0.82) 3.40% 1.04 1.33
KCNK5 1 0.001161172 1.52 (1.18, 1.97) 2.70% 1.04 1.31
KDELR2 1 0.001508021 1.70 (1.22, 2.35) 3.10% 1.04 1.31
KDELR2 1 0.001508021 1.70 (1.22, 2.35) 3.10% 1.04 1.31
KDM4B -1 0.001823372 0.53 (0.35, 0.79) 3.50% 1.04 1.32
KIAA0226 1 0.001751246 1.55 (1.18, 2.04) 3.40% 1.04 1.3
KIAA0226 1 0.001751246 1.55 (1.18, 2.04) 3.40% 1.04 1.3
KIAA1737 -1 0.002117405 0.59 (0.42, 0.83) 3.90% 1.04 1.32
LOC100130581 -1 0.00105557 0.72 (0.59, 0.88) 2.50% 1.04 1.29
LOC100130581 -1 0.00105557 0.72 (0.59, 0.88) 2.50% 1.04 1.29
LOC100288730 -1 0.002074681 0.55 (0.37, 0.80) 3.80% 1.04 1.32
LOC285629 1 0.001639129 1.47 (1.16, 1.87) 3.30% 1.04 1.29
LOC348021 1 0.000629483 1.26 (1.10, 1.44) 1.80% 1.04 1.22
LOC389033 -1 0.001863566 0.56 (0.38, 0.81) 3.50% 1.04 1.32
LOC494141 1 0.001552204 1.50 (1.17, 1.92) 3.20% 1.04 1.3
LOC494141 1 0.001552204 1.50 (1.17,1.92) 3.20% 1.04 1.3
LOC494141 1 0.001552204 1.50 (1.17, 1.92) 3.20% 1.04 1.3
LPPR2 -1 0.001724289 0.62 (0.45, 0.83) 3.40% 1.04 1.32
LPPR2 -1 0.001724289 0.62 (0.45, 0.83) 3.40% 1.04 1.32
LRP12 1 0.001577381 1.60 (1.20, 2.15) 3.20% 1.04 1.31
LRP12 1 0.001577381 1.60 (1.20, 2.15) 3.20% 1.04 1.31
LRP2 -1 0.001813236 0.55 (0.38, 0.80) 3.50% 1.04 1.32
LYPD2 1 0.001349535 1.39 (1.14, 1.70) 2.90% 1.04 1.27
MAP7D1 -1 0.001687535 0.57 (0.40, 0.81) 3.30% 1.04 1.33
MED16 -1 0.001899319 0.59 (0.42, 0.82) 3.60% 1.04 1.32
MEMO1 1 0.002174585 2.05 (1.29, 3.24) 3.90% 1.04 1.28
MEMO1 1 0.002174585 2.05 (1.29, 3.24) 3.90% 1.04 1.28
MICAL3 1 0.001535676 1.71 (1.23, 2.38) 3.10% 1.04 1.31
MICAL3 1 0.001535676 1.71 (1.23, 2.38) 3.10% 1.04 1.31
MICAL3 1 0.001535676 1.71 (1.23, 2.38) 3.10% 1.04 1.31
MIP 1 0.000829718 1.39 (1.15, 1.70) 2.20% 1.04 1.28
MKL2 -1 0.001781182 0.53 (0.36, 0.79) 3.50% 1.04 1.32
MPHOSPH6 1 0.001626864 1.51 (1.17, 1.96) 3.30% 1.04 1.3
MSRA -1 0.001531353 0.61 (0.44, 0.83) 3.10% 1.04 1.33
MSRA -1 0.001531353 0.61 (0.44, 0.83) 3.10% 1.04 1.33
MSRA -1 0.001531353 0.61 (0.44, 0.83) 3.10% 1.04 1.33
MSRA -1 0.001531353 0.61 (0.44, 0.83) 3.10% 1.04 1.33
MTIF3 -1 0.002132573 0.58 (0.41, 0.82) 3.90% 1.04 1.32
MTIF3 -1 0.002132573 0.58 (0.41, 0.82) 3.90% 1.04 1.32
MTIF3 -1 0.002132573 0.58 (0.41, 0.82) 3.90% 1.04 1.32
MTIF3 -1 0.002132573 0.58 (0.41, 0.82) 3.90% 1.04 1.32
MUM1L1 -1 0.001404473 0.61 (0.45, 0.82) 3.00% 1.04 1.33
MUM1L1 -1 0.001404473 0.61 (0.45, 0.82) 3.00% 1.04 1.33
NCALD 1 0.00188018 1.65 (1.20, 2.25) 3.60% 1.04 1.3
NCALD 1 0.00188018 1.65 (1.20, 2.25) 3.60% 1.04 1.3
NCALD 1 0.00188018 1.65 (1.20, 2.25) 3.60% 1.04 1.3
NCALD 1 0.00188018 1.65 (1.20, 2.25) 3.60% 1.04 1.3
NCALD 1 0.00188018 1.65 (1.20, 2.25) 3.60% 1.04 1.3
NCALD 1 0.00188018 1.65 (1.20, 2.25) 3.60% 1.04 1.3
NCALD 1 0.00188018 1.65 (1.20, 2.25) 3.60% 1.04 1.3
NCALD 1 0.00188018 1.65 (1.20, 2.25) 3.60% 1.04 1.3
NCRNA00094 1 0.001484442 1.64 (1.21, 2.22) 3.10% 1.04 1.31
NDUFA12 -1 0.001796493 0.67 (0.52, 0.86) 3.50% 1.04 1.3
NME1-NME2 1 0.001608921 1.59 (1.19, 2.12) 3.20% 1.04 1.31
NME1-NME2 1 0.001608921 1.59 (1.19, 2.12) 3.20% 1.04 1.31
NUP93 1 0.001568961 1.63 (1.20, 2.20) 3.20% 1.04 1.31
NUTF2 1 0.002638761 2.03 (1.28, 3.21) 4.40% 1.04 1.28
PARP11 -1 0.001639941 0.56 (0.39, 0.80) 3.30% 1.04 1.33
PCDH12 -1 0.002217348 0.54 (0.36, 0.80) 4.00% 1.04 1.32
PCOLCE -1 0.001169185 0.69 (0.55, 0.86) 2.70% 1.04 1.3
PIGA 1 0.001611291 1.71 (1.23, 2.39) 3.20% 1.04 1.31
PIGA 1 0.001611291 1.71 (1.23, 2.39) 3.20% 1.04 1.31
PIGA 1 0.001611291 1.71 (1.23, 2.39) 3.20% 1.04 1.31
PIGA 1 0.001611291 1.71 (1.23, 2.39) 3.20% 1.04 1.31
PRAMEF11 1 0.001218956 1.49 (1.17, 1.89) 2.80% 1.04 1.3
PRDM4 -1 0.002295022 0.57 (0.39, 0.82) 4.10% 1.04 1.32
PRR11 1 0.001592327 1.68 (1.22, 2.31) 3.20% 1.04 1.31
PRR25 -1 0.00181547 0.61 (0.45, 0.83) 3.50% 1.04 1.32
PVRL4 1 0.002362673 1.76 (1.22, 2.54) 4.10% 1.04 1.3
RAD52 -1 0.001826287 0.58 (0.42, 0.82) 3.50% 1.04 1.32
RBM19 -1 0.001710729 0.58 (0.41, 0.81) 3.40% 1.04 1.33
RBM19 -1 0.001710729 0.58 (0.41, 0.81) 3.40% 1.04 1.33
RBM19 -1 0.001710729 0.58 (0.41, 0.81) 3.40% 1.04 1.33
RCHY1 1 0.001382457 1.40 (1.14, 1.71) 3.00% 1.04 1.28
RCHY1 1 0.001382457 1.40 (1.14, 1.71) 3.00% 1.04 1.28
RCHY1 1 0.001382457 1.40 (1.14, 1.71) 3.00% 1.04 1.28
RGS12 -1 0.00204249 0.62 (0.46, 0.84) 3.80% 1.04 1.32
RGS12 -1 0.00204249 0.62 (0.46, 0.84) 3.80% 1.04 1.32
RGS12 -1 0.00204249 0.62 (0.46, 0.84) 3.80% 1.04 1.32
RHOV 1 0.002052837 1.61 (1.19, 2.17) 3.80% 1.04 1.3
RPL17-C180RF32 1 0.002254262 1.78 (1.23, 2.58) 4.00% 1.04 1.3
RPL17-C18ORF32 1 0.002254262 1.78 (1.23, 2.58) 4.00% 1.04 1.3
SCFD1 1 0.001110852 1.39 (1.14, 1.69) 2.60% 1.04 1.28
SCFD1 1 0.001110852 1.39 (1.14, 1.69) 2.60% 1.04 1.28
SENP5 1 0.001328803 1.44 (1.15, 1.80) 2.90% 1.04 1.29
SERPINF1 -1 0.001927763 0.58 (0.41, 0.82) 3.60% 1.04 1.32
SGOL2 1 0.001766454 1.62 (1.20, 2.20) 3.40% 1.04 1.31
SGOL2 1 0.001766454 1.62 (1.20, 2.20) 3.40% 1.04 1.31
SGOL2 1 0.001766454 1.62 (1.20, 2.20) 3.40% 1.04 1.31
SLC43A1 -1 0.002668902 0.51 (0.33, 0.79) 4.40% 1.04 1.3
SLC43A1 -1 0.002668902 0.51 (0.33, 0.79) 4.40% 1.04 1.3
SMPDL3A 1 0.00123104 1.52 (1.18, 1.95) 2.80% 1.04 1.3
SOX8 1 0.000931789 1.46 (1.17, 1.82) 2.40% 1.04 1.3
SPRR1B 1 0.000777744 1.29 (1.11, 1.50) 2.10% 1.04 1.24
STX1B -1 0.002150231 0.58 (0.41, 0.82) 3.90% 1.04 1.32
SYNPO2L -1 0.001652246 0.62 (0.45, 0.83) 3.30% 1.04 1.32
SYNPO2L -1 0.001652246 0.62 (0.45, 0.83) 3.30% 1.04 1.32
TBCEL -1 0.001739503 0.67 (0.52, 0.86) 3.40% 1.04 1.31
TBCEL -1 0.001739503 0.67 (0.52, 0.86) 3.40% 1.04 1.31
TECTA -1 0.00137001 0.68 (0.54, 0.86) 2.90% 1.04 1.31
TMEM229B -1 0.001467076 0.59 (0.43, 0.82) 3.10% 1.04 1.33
TOR1A -1 0.001857485 0.51 (0.33, 0.78) 3.50% 1.04 1.32
TRIM15 1 0.001090987 1.36 (1.13, 1.64) 2.60% 1.04 1.27
TYW3 -1 0.001970278 0.62 (0.46, 0.84) 3.70% 1.04 1.32
TYW3 -1 0.001970278 0.62 (0.46, 0.84) 3.70% 1.04 1.32
TYW3 -1 0.001970278 0.62 (0.46, 0.84) 3.70% 1.04 1.32
UBA6 1 0.001190224 1.54 (1.19, 2.00) 2.70% 1.04 1.31
UBXN11 -1 0.002331967 0.58 (0.41, 0.82) 4.10% 1.04 1.32
UBXN11 -1 0.002331967 0.58 (0.41, 0.82) 4.10% 1.04 1.32
UBXN11 -1 0.002331967 0.58 (0.41, 0.82) 4.10% 1.04 1.32
USP28 -1 0.001429182 0.60 (0.44, 0.82) 3.00% 1.04 1.33
VSTM2B 1 0.001630655 1.53 (1.18, 2.00) 3.30% 1.04 1.3
WDR62 1 0.002082929 1.75 (1.22, 2.49) 3.80% 1.04 1.3
WDR62 1 0.002082929 1.75 (1.22, 2.49) 3.80% 1.04 1.3
WFDC12 1 0.001028037 1.38 (1.14, 1.67) 2.50% 1.04 1.27
WFS1 -1 0.001502849 0.62 (0.47, 0.84) 3.10% 1.04 1.32
WFS1 -1 0.001502849 0.62 (0.47, 0.84) 3.10% 1.04 1.32
ZNF564 -1 0.001983109 0.56 (0.39, 0.81) 3.70% 1.04 1.32
ZNF627 -1 0.001961641 0.59 (0A2, 0.82) 3.70% 1.04 1.32
ZNF799 -1 0.001796488 0.54 (0.37, 0.80) 3.50% 1.04 1.32
ACBD3 1 0.003108527 1.67 (1.19, 2.34) 4.80% 1.03 1.29
ACRBP -1 0.002527232 0.59 (0A2, 0.83) 4.30% 1.03 1.31
ADAM17 1 0.002756749 1.73 (1.21, 2.47) 4.50% 1.03 1.29
AHCTF1 1 0.002833846 1.82 (1.23, 2.68) 4.60% 1.03 1.29
AIDA 1 0.002305105 1.42 (1.13, 1.77) 4.10% 1.03 1.27
AK7 -1 0.002397849 0.60 (0.43, 0.84) 4.20% 1.03 1.31
AKD1 -1 0.003540384 0.55 (0.37, 0.82) 5.20% 1.03 1.3
AKD1 -1 0.003540384 0.55 (0.37, 0.82) 5.20% 1.03 1.3
ALB 1 0.002271626 1.60 (1.18, 2.16) 4.10% 1.03 1.3
ANKMY1 -1 0.003302577 0.59 (0.42, 0.84) 4.90% 1.03 1.3
ANKMY1 -1 0.003302577 0.59 (042, 0.84) 4.90% 1.03 1.3
ANKRD24 -1 0.002274319 0.62 (0.46, 0.84) 4.10% 1.03 1.31
ANKRD37 1 0.003334199 2.07 (1.27, 3.38) 5.00% 1.03 1.26
ARHGEF6 -1 0.003627718 0.60 (0.43, 0.85) 5.30% 1.03 1.3
ASB18 1 0.002578858 1.74 (1.21, 2.48) 4.40% 1.03 1.29
ATP2A2 1 0.003253492 1.60 (1.17, 2.18) 4.90% 1.03 1.29
ATP2A2 1 0.003253492 1.60 (1.17, 2.18) 4.90% 1.03 1.29
ATP2A2 1 0.003253492 1.60 (1.17, 2.18) 4.90% 1.03 1.29
BAI2 -1 0.003578065 0.60 (0.43, 0.85) 5.20% 1.03 1.3
BANP 1 0.003069281 1.50 (1.15, 1.96) 4.80% 1.03 1.28
BANP 1 0.003069281 1.50 (1.15, 1.96) 4.80% 1.03 1.28
BANP 1 0.003069281 1.50 (1.15, 1.96) 4.80% 1.03 1.28
BANP 1 0.003069281 1.50 (1.15, 1.96) 4.80% 1.03 1.28
BANP 1 0.003069281 1.50 (1.15, 1.96) 4.80% 1.03 1.28
BANP 1 0.003069281 1.50 (1.15, 1.96) 4.80% 1.03 1.28
BANP 1 0.003069281 1.50 (1.15, 1.96) 4.80% 1.03 1.28
BLM 1 0.003819008 1.79 (1.21, 2.65) 5.40% 1.03 1.28
C10orf82 -1 0.00290893 0.53 (0.35, 0.81) 4.60% 1.03 1.3
C11orf34 -1 0.003273096 0.60 (0.43, 0.84) 4.90% 1.03 1.3
C12orf35 -1 0.003559999 0.52 (0.33, 0.81) 5.20% 1.03 1.29
C19orf76 1 0.002020895 1.50 (1.16, 1.94) 3.70% 1.03 1.29
C1orf106 1 0.003304843 1.94 (1.25, 3.01) 4.90% 1.03 1.27
C1orf106 1 0.003304843 1.94 (1.25, 3.01) 4.90% 1.03 1.27
C20orf185 1 0.003007008 1.45 (1.13, 1.85) 4.70% 1.03 1.27
C2orf65 -1 0.002411185 0.61 (0.44, 0.84) 4.20% 1.03 1.31
C4orf32 -1 0.003456897 0.56 (0.38, 0.82) 5.10% 1.03 1.3
C6orf124 1 0.002597838 1.72 (1.21, 2.46) 4.40% 1.03 1.29
C9orf130 -1 0.003706858 0.57 (0.39, 0.83) 5.30% 1.03 1.3
C9orf130 -1 0.003706858 0.57 (0.39, 0.83) 5.30% 1.03 1.3
CADM4 -1 0.002653642 0.63 (0.47, 0.85) 4.40% 1.03 1.31
CALCOCO1 -1 0.003000491 0.63 (0.46, 0.85) 4.70% 1.03 1.3
CALCOCO1 -1 0.003000491 0.63 (0.46, 0.85) 4.70% 1.03 1.3
CALCOCO1 -1 0.003000491 0.63 (0.46, 0.85) 4.70% 1.03 1.3
CCDC144NL 1 0.002348542 1.56 (1.17, 2.08) 4.10% 1.03 1.29
CCDC76 -1 0.004138708 0.53 (0.34, 0.82) 5.60% 1.03 1.29
CCDC92 -1 0.002468024 0.57 (0.40, 0.82) 4.20% 1.03 1.31
CD300C -1 0.002609931 0.60 (0.43, 0.84) 4.40% 1.03 1.31
CD33 -1 0.003435908 0.59 (0.42, 0.84) 5.10% 1.03 1.3
CD33 -1 0.003435908 0.59 (0.42, 0.84) 5.10% 1.03 1.3
CD33 -1 0.003435908 0.59 (0.42, 0.84) 5.10% 1.03 1.3
CDC45 1 0.002832865 1.82 (1.23, 2.70) 4.60% 1.03 1.29
CDC45 1 0.002832865 1.82 (1.23, 2.70) 4.60% 1.03 1.29
CDC45 1 0.002832865 1.82 (1.23, 2.70) 4.60% 1.03 1.29
CENPN 1 0.003679416 1.73 (1.19, 2.50) 5.30% 1.03 1.28
CENPN 1 0.003679416 1.73 (1.19, 2.50) 5.30% 1.03 1.28
CENPN 1 0.003679416 1.73 (1.19, 2.50) 5.30% 1.03 1.28
CENPV -1 0.002354532 0.64 (0.49, 0.86) 4.10% 1.03 1.31
CFHR1 1 0.001445939 1.29 (1.10, 1.51) 3.10% 1.03 1.23
CHKA 1 0.003263824 1.71 (1.20, 2.46) 4.90% 1.03 1.29
CHKA 1 0.003263824 1.71 (1.20, 2.46) 4.90% 1.03 1.29
CLEC4A -1 0.003825871 0.58 (0.40, 0.84) 5.40% 1.03 1.3
CLEC4A -1 0.003825871 0.58 (0.40, 0.84) 5.40% 1.03 1.3
CLEC4A -1 0.003825871 0.58 (0.40, 0.84) 5.40% 1.03 1.3
CLEC4A -1 0.003825871 0.58 (0.40, 0.84) 5.40% 1.03 1.3
CLPTM1 -1 0.00357314 0.60 (0.42, 0.85) 5.20% 1.03 1.3
CLPTM1 -1 0.00357314 0.60 (0.42, 0.85) 5.20% 1.03 1.3
COL20A1 1 0.002174665 1.59 (1.18, 2.13) 3.90% 1.03 1.3
COQ9 1 0.003239597 2.01 (1.26, 3.20) 4.90% 1.03 1.27
CRYZ -1 0.002899901 0.59 (0.42,0.84) 4.60% 1.03 1.31
CRYZ -1 0.002899901 0.59 (0.42, 0.84) 4.60% 1.03 1.31
CRYZ -1 0.002899901 0.59 (0.42, 0.84) 4.60% 1.03 1.31
CRYZ -1 0.002899901 0.59 (0.42, 0.84) 4.60% 1.03 1.31
CYB5D1 -1 0.003353239 0.67 (0.51, 0.87) 5.00% 1.03 1.29
DCDC2 -1 0.00250085 0.59 (0.42, 0.83) 4.30% 1.03 1.31
DCDC2 -1 0.00250085 0.59 (0.42, 0.83) 4.30% 1.03 1.31
DEFB112 1 0.00201406 1.43 (1.14,1.79) 3.70% 1.03 1.28
DFNA5 1 0.002721206 1.53 (1.16, 2.02) 4.50% 1.03 1.29
DFNA5 1 0.002721206 1.53 (1.16, 2.02) 4.50% 1.03 1.29
DFNA5 1 0.002721206 1.53 (1.16, 2.02) 4.50% 1.03 1.29
DIO1 -1 0.002787562 0.63 (0.46, 0.85) 4.50% 1.03 1.31
DIO1 -1 0.002787562 0.63 (0.46, 0.85) 4.50% 1.03 1.31
DIO1 -1 0.002787562 0.63 (0.46, 0.85) 4.50% 1.03 1.31
DIO1 -1 0.002787562 0.63 (0.46, 0.85) 4.50% 1.03 1.31
DIS3L -1 0.003001161 0.56 (0.38, 0.82) 4.70% 1.03 1.31
DIS3L -1 0.003001161 0.56 (0.38, 0.82) 4.70% 1.03 1.31
DLGAP5 1 0.00278647 1.94 (1.26, 2.99) 4.50% 1.03 1.28
DLGAP5 1 0.00278647 1.94 (1.26, 2.99) 4.50% 1.03 1.28
DLX4 1 0.00416168 1.88 (1.22, 2.89) 5.60% 1.03 1.27
DLX4 1 0.00416168 1.88 (1.22, 2.89) 5.60% 1.03 1.27
DNMT3B 1 0.002143803 1.59 (1.18, 2.13) 3.90% 1.03 1.3
DNMT3B 1 0.002143803 1.59 (1.18, 2.13) 3.90% 1.03 1.3
DNMT3B 1 0.002143803 1.59 (1.18, 2.13) 3.90% 1.03 1.3
DNMT3B 1 0.002143803 1.59 (1.18, 2.13) 3.90% 1.03 1.3
DPM3 1 0.003717491 1.78 (1.21, 2.63) 5.30% 1.03 1.28
DROSHA 1 0.002278248 1.67 (1.20, 2.33) 4.10% 1.03 1.3
DROSHA 1 0.002278248 1.67 (1.20, 2.33) 4.10% 1.03 1.3
DYNC1LI2 1 0.002945366 1.68 (1.19, 2.36) 4.70% 1.03 1.29
DYX1C1 -1 0.003170085 0.66 (0.50, 0.87) 4.90% 1.03 1.3
DYX1C1 -1 0.003170085 0.66 (0.50, 0.87) 4.90% 1.03 1.3
DYX1C1 -1 0.003170085 0.66 (0.50, 0.87) 4.90% 1.03 1.3
ECEL1 1 0.001529034 1.25 (1.09, 1.44) 3.10% 1.03 1.21
ENDOG -1 0.002977538 0.60 (0.43, 0.84) 4.70% 1.03 1.31
EPOR -1 0.002953308 0.65 (0.49, 0.86) 4.70% 1.03 1.3
EPOR -1 0.002953308 0.65 (0.49, 0.86) 4.70% 1.03 1.3
ESRP2 1 0.00358533 1.74 (1.20, 2.53) 5.20% 1.03 1.28
FAM149A -1 0.003077443 0.60 (0.43, 0.84) 4.80% 1.03 1.31
FAM149A -1 0.003077443 0.60 (0.43, 0.84) 4.80% 1.03 1.31
FAM35A -1 0.003261698 0.62 (0.45, 0.85) 4.90% 1.03 1.3
FAM38B -1 0.003890881 0.43 (0.24, 0.76) 5.40% 1.03 1.26
FAM73A -1 0.003419709 0.47 (0.29, 0.78) 5.10% 1.03 1.28
FBX05 1 0.002655563 1.89 (1.25, 2.86) 4.40% 1.03 1.29
FBX05 1 0.002655563 1.89 (1.25, 2.86) 4.40% 1.03 1.29
FGG 1 0.002203049 1.41 (1.13, 1.76) 4.00% 1.03 1.27
FGG 1 0.002203049 1.41 (1.13, 1.76) 4.00% 1.03 1.27
FU14186 1 0.002707068 1.37 (1.12, 1.68) 4.50% 1.03 1.26
FU42969 1 0.002377951 1.52 (1.16, 2.00) 4.10% 1.03 1.29
FSTL3 -1 0.003015843 0.60 (0.43, 0.84) 4.70% 1.03 1.31
GFOD2 1 0.00388773 1.92 (1.23, 2.98) 5.40% 1.03 1.27
GFOD2 1 0.00388773 1.92 (1.23, 2.98) 5.40% 1.03 1.27
GFOD2 1 0.00388773 1.92 (1.23, 2.98) 5.40% 1.03 1.27
GJC3 -1 0.002130385 0.66 (0.51, 0.86) 3.90% 1.03 1.31
GLG1 1 0.00232853 1.60 (1.18, 2.15) 4.10% 1.03 1.3
GLG1 1 0.00232853 1.60 (1.18, 2.15) 4.10% 1.03 1.3
GLG1 1 0.00232853 1.60 (1.18, 2.15) 4.10% 1.03 1.3
GLG1 1 0.00232853 1.60 (1.18, 2.15) 4.10% 1.03 1.3
GLG1 1 0.00232853 1.60 (1.18, 2.15) 4.10% 1.03 1.3
GMPR2 -1 0.002889811 0.61 (0.44, 0.84) 4.60% 1.03 1.31
GMPR2 -1 0.002889811 0.61 (0.44, 0.84) 4.60% 1.03 1.31
GMPR2 -1 0.002889811 0.61 (0.44, 0.84) 4.60% 1.03 1.31
GMPR2 -1 0.002889811 0.61 (0.44, 0.84) 4.60% 1.03 1.31
GNPDA2 -1 0.003200059 0.57 (0.39, 0.83) 4.90% 1.03 1.3
GPR78 1 0.001899031 1.30 (1.10, 1.54) 3.60% 1.03 1.23
HDGFRP2 -1 0.002470922 0.58 (0.41, 0.82) 4.20% 1.03 1.31
HDGFRP2 -1 0.002470922 0.58 (0.41, 0.82) 4.20% 1.03 1.31
HDGFRP3 -1 0.002866543 0.58 (0.41, 0.83) 4.60% 1.03 1.31
HLA-DQB2 -1 0.002601447 0.61 (0.44, 0.84) 4.40% 1.03 1.31
HMX2 1 0.001633074 1.36 (1.12, 1.66) 3.30% 1.03 1.26
IVNS1ABP 1 0.003215304 1.62 (1.17, 2.22) 4.90% 1.03 1.29
JKAMP -1 0.002816042 0.58 (0.40, 0.83) 4.60% 1.03 1.31
JKAMP -1 0.002816042 0.58 (0.40, 0.83) 4.60% 1.03 1.31
KCNMB2 1 0.002365787 1.55 (1.17, 2.05) 4.10% 1.03 1.29
KCNMB2 1 0.002365787 1.55 (1.17, 2.05) 4.10% 1.03 1.29
KIAA0182 1 0.00400237 1.79 (1.21, 2.67) 5.50% 1.03 1.27
KIAA0182 1 0.00400237 1.79 (1.21, 2.67) 5.50% 1.03 1.27
KIAA1524 1 0.002658234 1.76 (1.22, 2.56) 4.40% 1.03 1.29
KIAA1609 1 0.003411463 1.72 (1.20, 247) 5.10% 1.03 1.28
KIF14 1 0.002967379 1.90 (1.24, 2.91) 4.70% 1.03 1.28
KIF15 1 0.002847341 1.91 (1.25, 2.92) 4.60% 1.03 1.28
KIR3DL1 1 0.002292839 1.39 (1.12, 1.72) 4.10% 1.03 1.27
LILRA2 -1 0.003038167 0.62 (0.46, 0.85) 4.70% 1.03 1.3
LILRA2 -1 0.003038167 0.62 (0.46, 0.85) 4.70% 1.03 1.3
LMO2 -1 0.002944661 0.65 (0.48, 0.86) 4.70% 1.03 1.3
LMO2 -1 0.002944661 0.65 (0.48, 0.86) 4.70% 1.03 1.3
LMO2 -1 0.002944661 0.65 (0.48, 0.86) 4.70% 1.03 1.3
LOC100132707 -1 0.002472978 0.62 (0.45, 0.84) 4.20% 1.03 1.31
LOC100132707 -1 0.002472978 0.62 (0.45, 0.84) 4.20% 1.03 1.31
LOC100289187 -1 0.002804418 0.66 (0.50, 0.87) 4.60% 1.03 1.3
LOC100289187 -1 0.002804418 0.66 (0.50, 0.87) 4.60% 1.03 1.3
LOC100289187 -1 0.002804418 0.66 (0.50, 0.87) 4.60% 1.03 1.3
LOC146880 1 0.002469876 1.45 (1.14, 1.85) 4.20% 1.03 1.28
LOC146880 1 0.002469876 1.45 (1.14, 1.85) 4.20% 1.03 1.28
LOC283033 -1 0.002659531 0.60 (0.43, 0.84) 4.40% 1.03 1.31
LOC375190 -1 0.002118296 0.64 (0.48, 0.85) 3.90% 1.03 1.31
LOC401431 -1 0.002536678 0.65 (0.50, 0.86) 4.30% 1.03 1.3
LOC728606 -1 0.003271325 0.60 (0.42, 0.84) 4.90% 1.03 1.3
LOC730441 1 0.00284141 1.55 (1.16, 2.06) 4.60% 1.03 1.29
LRP11 1 0.002676431 1.85 (1.24, 2.77) 4.40% 1.03 1.29
LRRC49 -1 0.004003969 0.52 (0.33, 0.81) 5.50% 1.03 1.29
LRRC49 -1 0.004003969 0.52 (0.33, 0.81) 5.50% 1.03 1.29
LRRC49 -1 0.004003969 0.52 (0.33, 0.81) 5.50% 1.03 1.29
LRRC50 -1 0.003723262 0.57 (0.39, 0.83) 5.30% 1.03 1.3
LRRC69 1 0.00326634 1.64 (1.18, 2.28) 4.90% 1.03 1.29
LYPD1 -1 0.003495354 0.57 (0.39, 0.83) 5.10% 1.03 1.3
LYPD1 -1 0.003495354 0.57 (0.39, 0.83) 5.10% 1.03 1.3
MDGA2 1 0.002999416 1.51 (1.15, 1.98) 4.70% 1.03 1.28
MDGA2 1 0.002999416 1.51 (1.15, 1.98) 4.70% 1.03 1.28
MED13 1 0.001791043 1.40 (1.13, 1.73) 3.50% 1.03 1.27
MED23 1 0.002771728 1.43 (1.13, 1.80) 4.50% 1.03 1.27
MED23 1 0.002771728 1.43 (1.13, 1.80) 4.50% 1.03 1.27
MRPL33 -1 0.002810203 0.56 (0.39, 0.82) 4.60% 1.03 1.31
MRPL33 -1 0.002810203 0.56 (0.39, 0.82) 4.60% 1.03 1.31
MRPS25 1 0.00232796 1.57 (1.18, 2.11) 4.10% 1.03 1.29
NAALADL1 -1 0.003229161 0.59 (0.42, 0.84) 4.90% 1.03 1.3
NCOA2 1 0.0028789 1.57 (1.17, 2.11) 4.60% 1.03 1.29
NDC80 1 0.004332624 2.09 (1.26, 3.47) 5.70% 1.03 1.25
NEGR1 -1 0.003356882 0.60 (0.43, 0.84) 5.00% 1.03 1.3
NEK2 1 0.004390513 2.20 (1.28, 3.77) 5.80% 1.03 1.24
NEURL4 -1 0.002512267 0.61 (0.45, 0.84) 4.30% 1.03 1.31
NEURL4 -1 0.002512267 0.61 (0.45, 0.84) 4.30% 1.03 1.31
NIPBL 1 0.003678237 1.81 (1.21, 2.69) 5.30% 1.03 1.28
NIPBL 1 0.003678237 1.81 (1.21, 2.69) 5.30% 1.03 1.28
NKX2-3 1 0.00288716 1.51 (1.15, 1.98) 4.60% 1.03 1.28
NRIP3 -1 0.003165915 0.55 (0.37, 0.82) 4.90% 1.03 1.3
NSMCE1 -1 0.00397664 0.52 (0.33, 0.81) 5.50% 1.03 1.29
OGDHL 1 0.00273305 1.84 (1.24, 2.75) 4.50% 1.03 1.29
OGDHL 1 0.00273305 1.84 (1.24, 2.75) 4.50% 1.03 1.29
OGDHL 1 0.00273305 1.84 (1.24, 2.75) 4.50% 1.03 1.29
OMA1 -1 0.003329284 0.61 (0.44, 0.85) 5.00% 1.03 1.3
ORC6 1 0.002725216 1.84 (1.24, 2.75) 4.50% 1.03 1.29
OSCP1 -1 0.002803854 0.65 (0.48, 0.86) 4.60% 1.03 1.3
OSCP1 -1 0.002803854 0.65 (0.48, 0.86) 4.60% 1.03 1.3
P2RX4 -1 0.003773817 0.54 (0.35, 0.82) 5.40% 1.03 1.29
P4HA1 1 0.002479967 1.46 (1.14, 1.86) 4.20% 1.03 1.28
P4HA1 1 0.002479967 1.46 (1.14, 1.86) 4.20% 1.03 1.28
P4HA1 1 0.002479967 1.46 (1.14, 1.86) 4.20% 1.03 1.28
P4HA1 1 0.002479967 1.46 (1.14, 1.86) 4.20% 1.03 1.28
PCGF3 -1 0.002417253 0.66 (0.50, 0.86) 4.20% 1.03 1.3
PDE8A 1 0.002954651 1.58 (1.17, 2.13) 4.70% 1.03 1.29
PDE8A 1 0.002954651 1.58 (1.17, 2.13) 4.70% 1.03 1.29
PDIA5 1 0.003793083 1.64 (1.17, 2.28) 5.40% 1.03 1.28
PDIA5 1 0.003793083 1.64 (1.17, 2.28) 5.40% 1.03 1.28
PDSS2 1 0.002270205 1.30 (1.10, 1.53) 4.10% 1.03 1.23
PHACTR2 1 0.003548548 1.77 (1.20, 2.59) 5.20% 1.03 1.28
PHACTR2 1 0.003548548 1.77 (1.20, 2.59) 5.20% 1.03 1.28
PHACTR2 1 0.003548548 1.77 (1.20, 2.59) 5.20% 1.03 1.28
PHACTR2 1 0.003548548 1.77 (1.20, 2.59) 5.20% 1.03 1.28
PHYHD1 -1 0.002869757 0.57 (0.39, 0.82) 4.60% 1.03 1.31
PHYHD1 -1 0.002869757 0.57 (0.39, 0.82) 4.60% 1.03 1.31
PHYHD1 -1 0.002869757 0.57 (0.39, 0.82) 4.60% 1.03 1.31
PNKP -1 0.002981421 0.55 (0.37, 0.81) 4.70% 1.03 1.31
PNMA2 -1 0.00372139 0.61 (0.44, 0.85) 5.30% 1.03 1.3
PODXL2 1 0.003649098 1.84 (1.22, 2.77) 5.30% 1.03 1.28
POLQ 1 0.002981188 1.84 (1.23, 2.76) 4.70% 1.03 1.28
POLR2D -1 0.002769807 0.69 (0.55, 0.88) 4.50% 1.03 1.29
PRPF31 -1 0.003398135 0.50 (0.31, 0.79) 5.00% 1.03 1.29
PRSS23 -1 0.003988776 0.54 (0.35, 0.82) 5.50% 1.03 1.29
PSMA1 1 0.003851406 1.70 (1.19, 2.43) 5.40% 1.03 1.28
PSMA1 1 0.003851406 1.70 (1.19, 2.43) 5.40% 1.03 1.28
PSMA1 1 0.003851406 1.70 (1.19, 2.43) 5.40% 1.03 1.28
PTCD3 1 0.002483485 1.72 (1.21, 2.43) 4.20% 1.03 1.3
PTPRK 1 0.003767173 1.70 (1.19, 2.44) 5.40% 1.03 1.28
PTPRK 1 0.003767173 1.70 (1.19, 2.44) 5.40% 1.03 1.28
RAB11B -1 0.003087506 0.59 (0.41, 0.83) 4.80% 1.03 1.31
RAB14 -1 0.002933672 0.60 (0.42, 0.84) 4.70% 1.03 1.31
RAB3GAP2 1 0.002212459 1.62 (1.19, 2.20) 4.00% 1.03 1.3
RAD51 1 0.003473055 1.82 (1.22, 2.71) 5.10% 1.03 1.28
RAD51 1 0.003473055 1.82 (1.22, 2.71) 5.10% 1.03 1.28
RAD51 1 0.003473055 1.82 (1.22, 2.71) 5.10% 1.03 1.28
RAD51 1 0.003473055 1.82 (1.22, 2.71) 5.10% 1.03 1.28
RALGPS1 -1 0.003164278 0.62 (0.45, 0.85) 4.90% 1.03 1.3
RALGPS1 -1 0.003164278 0.62 (0.45, 0.85) 4.90% 1.03 1.3
RALGPS1 -1 0.003164278 0.62 (0.45, 0.85) 4.90% 1.03 1.3
RALGPS1 -1 0.003164278 0.62 (0.45, 0.85) 4.90% 1.03 1.3
RASAL1 1 0.002891275 1.81 (1.22, 2.67) 4.60% 1.03 1.29
RASAL1 1 0.002891275 1.81 (1.22, 2.67) 4.60% 1.03 1.29
RASAL1 1 0.002891275 1.81 (1.22, 2.67) 4.60% 1.03 1.29
RBKS -1 0.002599049 0.58 (0.41, 0.83) 4.40% 1.03 1.31
RETNLB 1 0.00184757 1.34 (1.11, 1.61) 3.50% 1.03 1.25
RG9MTD3 -1 0.003210008 0.60 (0.43, 0.84) 4.90% 1.03 1.3
RHCG 1 0.003916067 1.97 (1.24, 3.13) 5.40% 1.03 1.26
RIPK3 -1 0.003278775 0.65 (0.48, 0.86) 4.90% 1.03 1.3
RNF168 1 0.002917142 1.56 (1.16, 2.09) 4.60% 1.03 1.29
RNF19A 1 0.00310618 1.56 (1.16, 2.08) 4.80% 1.03 1.28
RNF19A 1 0.00310618 1.56 (1.16, 2.08) 4.80% 1.03 1.28
ROBO1 1 0.002242507 1.48 (1.15, 1.90) 4.00% 1.03 1.29
R0BO1 1 0.002242507 1.48 (1.15, 1.90) 4.00% 1.03 1.29
ROBO1 1 0.002242507 1.48 (1.15, 1.90) 4.00% 1.03 1.29
RPGR -1 0.003675682 0.56 (0.38, 0.83) 5.30% 1.03 1.3
RPGR -1 0.003675682 0.56 (0.38, 0.83) 5.30% 1.03 1.3
RPGRIP1 -1 0.002745549 0.58 (040, 0.83) 4.50% 1.03 1.31
SETBP1 -1 0.003662366 0.54 (0.35, 0.82) 5.30% 1.03 1.3
SETBP1 -1 0.003662366 0.54 (0.35, 0.82) 5.30% 1.03 1.3
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SGOL1 1 0.003377474 1.92 (1.24, 2.96) 5.00% 1.03 1.27
SIX5 -1 0.002411377 0.60 (0.43, 0.84) 4.20% 1.03 1.31
SLC25A32 1 0.002217418 1.60 (1.18, 2.16) 4.00% 1.03 1.3
SLC26A6 1 0.002285648 1.55 (1.17, 2.04) 4.10% 1.03 1.29
SLC26A6 1 0.002285648 1.55 (1.17, 2.04) 4.10% 1.03 1.29
SLC26A6 1 0.002285648 1.55 (1.17, 2.04) 4.10% 1.03 1.29
SLC26A6 1 0.002285648 1.55 (1.17, 2.04) 4.10% 1.03 1.29
SLC34A1 1 0.002879478 1.64 (1.18, 2.27) 4.60% 1.03 1.29
SLC34A1 1 0.002879478 1.64 (1.18, 2.27) 4.60% 1.03 1.29
SLC3A2 1 0.003758233 1.76 (1.20, 2.58) 5.40% 1.03 1.28
SLC3A2 1 0.003758233 1.76 (1.20, 2.58) 5.40% 1.03 1.28
SLC3A2 1 0.003758233 1.76 (1.20, 2.58) 5.40% 1.03 1.28
SLC3A2 1 0.003758233 1.76 (1.20, 2.58) 5.40% 1.03 1.28
SLC3A2 1 0.003758233 1.76 (1.20, 2.58) 5.40% 1.03 1.28
SLC3A2 1 0.003758233 1.76 (1.20, 2.58) 5.40% 1.03 1.28
SLC3A2 1 0.003758233 1.76 (1.20, 2.58) 5.40% 1.03 1.28 1.29
SNHG9 1 0.002692923 1.60 (1.18, 2.18) 4.50% 1.03 1.31
SORBS3 -1 0.002232728 0.62 (0.46, 0.84) 4.00% 1.03
SORBS3 -1 0.002232728 0.62 (0.46, 0.84) 4.00% 1.03 1.31 1.29
SOST 1 0.002828316 1.57 (1.17, 2.10) 4.60% 1.03 1.3
SREK1IP1 -1 0.00381954 0.56 (0.38, 0.83) 5.40% 1.03 1.29
SRP72 1 0.001984343 1.47 (1.15, 1.87) 3.70% 1.03 1.28
STRADA 1 0.001851162 1.44 (1.15, 1.82) 3.50% 1.03 1.28
STRADA 1 0.001851162 1.44 (1.15, 1.82) 3.50% 1.03 1.28
STRADA 1 0.001851162 1.44 (1.15, 1.82) 3.50% 1.03 1.28
STRADA 1 0.001851162 1.44 (1.15, 1.82) 3.50% 1.03 1.28
STRADA 1 0.001851162 1.44 (1.15, 1.82) 3.50% 1.03 1.28
STRADA 1 0.001851162 1.44 (1.15, 1.82) 3.50% 1.03 1.3
SVIP -1 0.00233855 0.67 (0.52, 0.87) 4.10% 1.03 1.27
TAF9B 1 0.003841595 1.82 (1.21, 2.74) 5.40% 1.03 1.29
TALDO1 1 0.002598718 1.82 (1.23, 2.68) 4.40% 1.03 1.29
TARS 1 0.003276379 1.71 (1.20, 2.44) 4.90% 1.03 1.31
TBC1D19 -1 0.003039839 0.59 (0.41, 0.83) 4.70% 1.03 1.3
TEKT3 -1 0.003310535 0.57 (0.39, 0.83) 4.90% 1.03 1.29
TIGD7 -1 0.003861327 0.54 (0.35, 0.82) 5.40% 1.03 1.29
TJP1 1 0.003251585 1.62 (1.17, 2.23) 4.90% 1.03 1.29
TJP1 1 0.003251585 1.62 (1.17, 2.23) 4.90% 1.03 1.29
TLE1 1 0.00347973 1.85 (1.22, 2.80) 5.10% 1.03 1.28
TMEM221 -1 0.003086562 0.60 (0.43, 0.84) 4.80% 1.03 1.31
TNFAIP8L3 1 0.003178113 1.67 (1.19, 2.35) 4.90% 1.03 1.29
TOMM7 1 0.002338876 1.53 (1.16, 2.02) 4.10% 1.03 1.29
TPPP2 1 0.003263204 1.53 (1.15, 2.03) 4.90% 1.03 1.28
TPX2 1 0.003467271 2.06 (1.27, 3.35) 5.10% 1.03 1.26
TRIM8 -1 0.002552093 0.58 (0.40, 0.82) 4.30% 1.03 1.31
TTK 1 0.003825485 1.94 (1.24, 3.05) 5.40% 1.03 1.27
TTK 1 0.003825485 1.94 (1.24, 3.05) 5.40% 1.03 1.27
UBE2E2 1 0.003261146 1.77 (1.21, 2.59) 4.90% 1.03 1.28
UQCRB 1 0.003918973 2.01 (1.25, 3.24) 5.40% 1.03 1.26
UQCRB 1 0.003918973 2.01 (1.25, 3.24) 5.40% 1.03 1.26
USH1G 1 0.002435828 1.52 (1.16, 1.99) 4.20% 1.03 1.29
VAMP1 -1 0.003323775 0.55 (0.36, 0.82) 5.00% 1.03 1.3
VAMP1 -1 0.003323775 0.55 (0.36, 0.82) 5.00% 1.03 1.3
VAMP1 -1 0.003323775 0.55 (0.36, 0.82) 5.00% 1.03 1.3
VNN3 1 0.002945726 1.57 (1.17, 2.11) 4.70% 1.03 1.29
VNN3 1 0.002945726 1.57 (1.17, 2.11) 4.70% 1.03 1.29
WBSCR17 1 0.002745076 1.51 (1.15, 1.97) 4.50% 1.03 1.28
ZBTB34 -1 0.002143612 0.63 (0.47, 0.85) 3.90% 1.03 1.31
ZMYND10 -1 0.003201542 0.62 (0.45, 0.85) 4.90% 1.03 1.3
ZNF132 -1 0.002418386 0.70 (0.56, 0.88) 4.20% 1.03 1.28
ZNF137P -1 0.002738324 0.66 (0.51, 0.87) 4.50% 1.03 1.3
ZNF142 -1 0.002752334 0.52 (0.34, 0.80) 4.50% 1.03 1.31
ZNF143 1 0.003902798 1.78 (1.20, 2.62) 5.40% 1.03 1.28
ZNF284 -1 0.001742621 0.72 (0.58, 0.88) 3.40% 1.03 1.28
ZNF343 -1 0.002492691 0.67 (0.52, 0.87) 4.30% 1.03 1.3
ZNF510 -1 0.003447286 0.63 (0.46, 0.86) 5.10% 1.03 1.3
ZNF85 -1 0.00269138 0.59 (0.42, 0.83) 4.50% 1.03 1.31
ZNF85 -1 0.00269138 0.59 (0.42,0.83) 4.50% 1.03 1.31
ACER2 -1 0.005258002 0.59 (0.41, 0.86) 6.30% 1.02 1.29
AFF3 -1 0.006224386 0.61 (0.43, 0.87) 6.90% 1.02 1.28
AFF3 -1 0.006224386 0.61 (0.43, 0.87) 6.90% 1.02 1.28
AGBL4 -1 0.004756402 0.59 (0.41, 0.85) 6.10% 1.02 1.29
AGTR2 1 0.004593311 1.31 (1.09, 1.58) 5.90% 1.02 1.23
ALDH3A1 1 0.005741471 1.47 (1.12, 1.93) 6.60% 1.02 1.26
ALDH3A1 1 0.005741471 1.47 (1.12, 1.93) 6.60% 1.02 1.26
ALDH3A1 1 0.005741471 1.47 (1.12, 1.93) 6.60% 1.02 1.26
ALG1L 1 0.005751645 1.64 (1.15, 2.32) 6.60% 1.02 1.27
ALG1L 1 0.005751645 1.64 (1.15, 2.32) 6.60% 1.02 1.27
ALKBH5 -1 0.005864328 0.54 (0.35, 0.84) 6.70% 1.02 1.28
ANKK1 -1 0.004982445 0.56 (0.37, 0.84) 6.20% 1.02 1.29
ANKRD11 1 0.00420042 1.58 (1.16, 2.16) 5.60% 1.02 1.28
ANKZF1 -1 0.003835427 0.62 (0.45, 0.86) 5.40% 1.02 1.3
ANKZF1 -1 0.003835427 0.62 (0.45, 0.86) 5.40% 1.02 1.3
ANO10 1 0.005187033 1.81 (1.19, 2.74) 6.30% 1.02 1.26
ATP6VOC -1 0.004151532 0.59 (0.42, 0.85) 5.60% 1.02 1.3
ATP6VOC -1 0.004151532 0.59 (0.42, 0.85) 5.60% 1.02 1.3
B3GALNT2 1 0.004947216 1.81 (1.20, 2.75) 6.20% 1.02 1.26
B9D2 -1 0.004413471 0.64 (0.47, 0.87) 5.80% 1.02 1.29
BAGE 1 0.003883658 1.52 (1.14, 2.03) 5.40% 1.02 1.28
BBS12 -1 0.004913742 0.61 (0.43, 0.86) 6.20% 1.02 1.29
BBS12 -1 0.004913742 0.61 (0.43, 0.86) 6.20% 1.02 1.29
BUB1 1 0.004514942 1.93 (1.23, 3.03) 5.90% 1.02 1.26
C12orf26 -1 0.006126167 0.54 (0.35, 0.84) 6.90% 1.02 1.28
C12orf47 -1 0.005171331 0.67 (0.50, 0.89) 6.30% 1.02 1.28
C12orf48 1 0.004544654 1.76 (1.19, 2.60) 5.90% 1.02 1.27
C12orf5 -1 0.004934346 0.61 (0.44, 0.86) 6.20% 1.02 1.29
C12orfS7 -1 0.00493224 0.70 (0.54, 0.90) 6.20% 1.02 1.27
C16orf58 -1 0.005936891 0.61 (0.43, 0.87) 6.80% 1.02 1.28
C18orf62 1 0.004064416 1.63 (1.17, 2.28) 5.60% 1.02 1.28
C19orf20 -1 0.005286341 0.65 (0.48, 0.88) 6.30% 1.02 1.28
C5orf30 -1 0.005136301 0.60 (0.42, 0.86) 6.20% 1.02 1.29
C6orf58 1 0.004731205 1.47 (1.13, 1.92) 6.00% 1.02 1.27
C9orf80 -1 0.004122841 0.61 (0.43, 0.85) 5.60% 1.02 1.3
C9orf9 -1 0.00449506 0.68 (0.52, 0.89) 5.90% 1.02 1.28
CASC5 1 0.005050283 2.06 (1.24, 3.41) 6.20% 1.02 1.25
CASC5 1 0.005050283 2.06 (1.24, 3.41) 6.20% 1.02 1.25
CBLN4 -1 0.005236558 0.55 (0.37, 0.84) 6.30% 1.02 1.28
CDKN3 1 0.00470614 1.56 (1.15, 2.11) 6.00% 1.02 1.27
CDKN3 1 0.00470614 1.56 (1.15, 2.11) 6.00% 1.02 1.27
CENPE 1 0.005043144 1.82 (1.20, 2.76) 6.20% 1.02 1.26
CHP 1 0.00474853 1.71 (1.18, 2.47) 6.10% 1.02 1.27
CHRM3 1 0.004463794 1.55 (1.14, 2.09) 5.80% 1.02 1.27
CLDN6 1 0.003130215 1.42 (1.13, 1.80) 4.80% 1.02 1.27
CLEC10A -1 0.005671891 0.56 (0.37, 0.85) 6.60% 1.02 1.28
CLEC10A -1 0.005671891 0.56 (0.37, 0.85) 6.60% 1.02 1.28
COL4A5 -1 0.005952194 0.63 (0.45, 0.88) 6.80% 1.02 1.28
COL4A5 -1 0.005952194 0.63 (0.45, 0.88) 6.80% 1.02 1.28
COMP -1 0.005307774 0.65 (0.48, 0.88) 6.30% 1.02 1.28
CPA3 -1 0.004401849 0.64 (0.47, 0.87) 5.80% 1.02 1.29
CPLX3 1 0.003893832 1.47 (1.13, 1.90) 5.40% 1.02 1.27
CT62 -1 0.004298148 0.60 (0.43, 0.85) 5.70% 1.02 1.29
CTDSP1 -1 0.004831508 0.65 (0.48, 0.88) 6.10% 1.02 1.29
CTDSP1 -1 0.004831508 0.65 (0.48, 0.88) 6.10% 1.02 1.29
CTXN2 1 0.004461247 1.53 (1.14, 2.06) 5.80% 1.02 1.27
CYB5R1 -1 0.005236004 0.67 (0.50, 0.89) 6.30% 1.02 1.28
CYBRD1 -1 0.00448011 0.61 (0.44, 0.86) 5.80% 1.02 1.29
CYBRD1 -1 0.00448011 0.61 (0.44, 0.86) 5.80% 1.02 1.29
CYP4B1 -1 0.006117908 0.62 (0.44, 0.87) 6.90% 1.02 1.28
CYP4B1 -1 0.006117908 0.62 (0.44, 0.87) 6.90% 1.02 1.28
DAR52 -1 0.004193228 0.61 (0.43, 0.86) 5.60% 1.02 1.3
DCTD -1 0.004336513 0.65 (0.48, 0.87) 5.70% 1.02 1.29
DCTD -1 0.004336513 0.65 (0.48, 0.87) 5.70% 1.02 1.29
DDIT4 1 0.006657073 2.06 (1.22, 3.46) 7.10% 1.02 1.23
DDX12 1 0.005232168 1.71 (1.17, 2.50) 6.30% 1.02 1.27
DDX19A 1 0.005506264 1.72 (1.17, 2.51) 6.40% 1.02 1.27
DEPDC1B 1 0.005895254 1.80 (1.18, 2.73) 6.70% 1.02 1.26
DEPDC1B 1 0.005895254 1.80 (1.18, 2.73) 6.70% 1.02 1.26
DHCR7 1 0.004895545 1.61 (1.16, 2.25) 6.10% 1.02 1.27
DHCR7 1 0.004895545 1.61 (1.16, 2.25) 6.10% 1.02 1.27
DMWD -1 0.004951827 0.70 (0.54, 0.90) 6.20% 1.02 1.27
DNAJC16 -1 0.005555333 0.61 (0.43, 0.87) 6.50% 1.02 1.29
DNAJC5 1 0.004961512 1.58 (1.15, 2.17) 6.20% 1.02 1.27
DNAL1 -1 0.005480966 0.62 (0.45, 0.87) 6.40% 1.02 1.29
DSG4 1 0.005276336 1.58 (1.15, 2.19) 6.30% 1.02 1.27
DSG4 1 0.005276336 1.58 (1.15, 2.19) 6.30% 1.02 1.27
DYNLL1 -1 0.005877927 0.58 (0.40, 0.86) 6.70% 1.02 1.28
DYNLL1 -1 0.005877927 0.58 (0.40, 0.86) 6.70% 1.02 1.28
DYNLL1 -1 0.005877927 0.58 (0.40, 0.86) 6.70% 1.02 1.28
E2F8 1 0.006071337 2.36 (1.28, 4.36) 6.90% 1.02 1.22
EFNA2 1 0.004879866 1.55 (1.14, 2.11) 6.10% 1.02 1.27
EGFEM1P -1 0.006582566 0.53 (0.33, 0.84) 7.10% 1.02 1.27
ELL3 1 0.005132124 2.00 (1.23, 3.26) 6.20% 1.02 1.25
ERRFI1 1 0.004022383 1.57 (1.15, 2.13) 5.50% 1.02 1.28
EXD2 -1 0.004992909 0.62 (0.44, 0.87) 6.20% 1.02 1.29
EXD2 -1 0.004992909 0.62 (0.44, 0.87) 6.20% 1.02 1.29
EXD2 -1 0.004992909 0.62 (0.44, 0.87) 6.20% 1.02 1.29
EXD2 -1 0.004992909 0.62 (0.44, 0.87) 6.20% 1.02 1.29
EXD2 -1 0.004992909 0.62 (0.44, 0.87) 6.20% 1.02 1.29
EXD2 -1 0.004992909 0.62 (0.44, 0.87) 6.20% 1.02 1.29
EXD2 -1 0.004992909 0.62 (0.44, 0.87) 6.20% 1.02 1.29
FADS2 1 0.00451137 1.85 (1.21, 2.82) 5.90% 1.02 1.27
FAM19A1 1 0.004486786 1.72 (1.18, 2.51) 5.80% 1.02 1.27
FAM24A 1 0.003464128 1.48 (1.14, 1.93) 5.10% 1.02 1.28
FAM75C1 1 0.003067161 1.29 (1.09, 1.52) 4.80% 1.02 1.22
FAM83D 1 0.005258982 2.10 (1.25, 3.55) 6.30% 1.02 1.24
FANCA 1 0.006453602 1.74 (1.17, 2.60) 7.10% 1.02 1.26
FANCA 1 0.006453602 1.74 (1.17, 2.60) 7.10% 1.02 1.26
FARP2 -1 0.00480468 0.61 (0.43, 0.86) 6.10% 1.02 1.29
FCGBP -1 0.005135347 0.61 (0.43, 0.86) 6.20% 1.02 1.29
FGF12 1 0.00508741 1.49 (1.13, 1.97) 6.20% 1.02 1.27
FGF12 1 0.00508741 1.49 (1.13, 1.97) 6.20% 1.02 1.27
FU31306 -1 0.005207343 0.56 (0.38, 0.84) 6.30% 1.02 1.29
FLJ31306 -1 0.005207343 0.56 (0.38, 0.84) 6.30% 1.02 1.29
FLYWCH2 -1 0.00602473 0.63 (0.45, 0.88) 6.80% 1.02 1.28
FLYWCH2 -1 0.00602473 0.63 (0.45, 0.88) 6.80% 1.02 1.28
FLYWCH2 -1 0.00602473 0.63 (0.45, 0.88) 6.80% 1.02 1.28
FRMD8 1 0.005100953 1.53 (1.14, 2.07) 6.20% 1.02 1.27
GDAP1L1 -1 0.004064739 0.64 (0.48, 0.87) 5.60% 1.02 1.29
GLIPR1L2 -1 0.004844215 0.67 (0.51, 0.88) 6.10% 1.02 1.28
GNAI1 1 0.004921212 1.52 (1.14, 2.03) 6.20% 1.02 1.27
GNN -1 0.00547683 0.55 (0.36, 0.84) 6.40% 1.02 1.28
GOT1L1 1 0.005030656 1.50 (1.13, 2.00) 6.20% 1.02 1.27
GPR56 1 0.005127944 1.67 (1.17, 2.39) 6.20% 1.02 1.27
GPR56 1 0.005127944 1.67 (1.17, 2.39) 6.20% 1.02 1.27
GPR56 1 0.005127944 1.67 (1.17, 2.39) 6.20% 1.02 1.27
GPR56 1 0.005127944 1.67 (1.17, 2.39) 6.20% 1.02 1.27
GPR56 1 0.005127944 1.67 (1.17, 2.39) 6.20% 1.02 1.27
GPR56 1 0.005127944 1.67 (1.17, 2.39) 6.20% 1.02 1.27
GPR56 1 0.005127944 1.67 (1.17, 2.39) 6.20% 1.02 1.27
GPR56 1 0.005127944 1.67 (1.17, 2.39) 6.20% 1.02 1.27
GTF2F1 -1 0.004162542 0.65 (0.49, 0.87) 5.60% 1.02 1.29
HDAC7 -1 0.004641148 0.64 (0.46, 0.87) 6.00% 1.02 1.29
HDAC7 -1 0.004641148 0.64 (0.46, 0.87) 6.00% 1.02 1.29
HERV-V2 1 0.003227481 1.41 (1.12, 1.76) 4.90% 1.02 1.26
HHEX -1 0.005145369 0.65 (0.48, 0.88) 6.20% 1.02 1.28
HMMR 1 0.005103266 1.91 (1.22, 3.02) 6.20% 1.02 1.26
HMMR 1 0.005103266 1.91 (1.22, 3.02) 6.20% 1.02 1.26
HMMR 1 0.005103266 1.91 (1.22, 3.02) 6.20% 1.02 1.26
HMMR 1 0.005103266 1.91 (1.22, 3.02) 6.20% 1.02 1.26
HN1 1 0.005386748 1.69 (1.17, 2.46) 6.40% 1.02 1.27
HN1 1 0.005386748 1.69 (1.17, 2.46) 6.40% 1.02 1.27
HN1 1 0.005386748 1.69 (1.17, 2.46) 6.40% 1.02 1.27
HRNR -1 0.005968075 0.65 (0.48, 0.88) 6.80% 1.02 1.28
HS3ST1 1 0.005320771 1.50 (1.13, 2.00) 6.30% 1.02 1.27
HSPA9 1 0.005701331 1.64 (1.15, 2.32) 6.60% 1.02 1.27
IBSP 1 0.004575031 1.59 (1.15, 2.18) 5.90% 1.02 1.27
ICA1L -1 0.005336018 0.59 (0.41, 0.85) 6.30% 1.02 1.29
ICA1L -1 0.005336018 0.59 (0.41, 0.85) 6.30% 1.02 1.29
IFRD1 1 0.005335466 1.56 (1.14, 2.14) 6.30% 1.02 1.27
IFRD1 1 0.005335466 1.56 (1.14, 2.14) 6.30% 1.02 1.27
IFRD1 1 0.005335466 1.56 (1.14, 2.14) 6.30% 1.02 1.27
IFRD1 1 0.005335466 1.56 (1.14, 2.14) 6.30% 1.02 1.27
IFRD2 -1 0.004620541 0.68 (0.52, 0.89) 6.00% 1.02 1.28
IL6ST -1 0.004669167 0.56 (0.37, 0.84) 6.00% 1.02 1.29
IL6ST -1 0.004669167 0.56 (0.37, 0.84) 6.00% 1.02 1.29
IL6ST -1 0.004669167 0.56 (0.37, 0.84) 6.00% 1.02 1.29
INCA1 -1 0.003958143 0.61 (0.43, 0.85) 5.50% 1.02 1.3
INCA1 -1 0.003958143 0.61 (0.43, 0.85) 5.50% 1.02 1.3
INCA1 -1 0.003958143 0.61 (0.43, 0.85) 5.50% 1.02 1.3
INCA1 -1 0.003958143 0.61 (0.43, 0.85) 5.50% 1.02 1.3
INO80 1 0.004710879 1.77 (1.19, 2.62) 6.00% 1.02 1.27
ISOC2 -1 0.006176895 0.61 (0.43, 0.87) 6.90% 1.02 1.28
ISOC2 -1 0.006176895 0.61 (0.43, 0.87) 6.90% 1.02 1.28
ISOC2 -1 0.006176895 0.61 (0.43, 0.87) 6.90% 1.02 1.28
KCNA4 1 0.004433861 1.41 (1.11, 1.79) 5.80% 1.02 1.26
KIAA1324 -1 0.005588146 0.68 (0.52, 0.89) 6.50% 1.02 1.27
KIF18A 1 0.005735098 1.80 (1.19, 2.72) 6.60% 1.02 1.26
KIF23 1 0.006540193 1.78 (1.17, 2.69) 7.10% 1.02 1.25
KIF23 1 0.006540193 1.78 (1.17, 2.69) 7.10% 1.02 1.25
KIF2C 1 0.005175206 1.97 (1.22, 3.17) 6.30% 1.02 1.25
KRCC1 -1 0.004567679 0.63 (0.46, 0.87) 5.90% 1.02 1.29
KRT16 1 0.004086786 1.43 (1.12, 1.83) 5.60% 1.02 1.26
KRT84 1 0.004004984 1.49 (1.14, 1.96) 5.50% 1.02 1.27
LACTB -1 0.006101678 0.61 (0.43, 0.87) 6.90% 1.02 1.28
LACTB -1 0.006101678 0.61 (0.43, 0.87) 6.90% 1.02 1.28
LAG3 -1 0.005742967 0.62 (0.45, 0.87) 6.60% 1.02 1.28
LIN9 1 0.004469851 1.73 (1.19, 2.53) 5.80% 1.02 1.27
LOC100190938 -1 0.005127469 0.64 (0.47, 0.88) 6.20% 1.02 1.29
LOC100190938 -1 0.005127469 0.64 (0.47, 0.88) 6.20% 1.02 1.29
LOC154860 1 0.004106036 1.50 (1.14, 1.98) 5.60% 1.02 1.27
LOC285735 1 0.003944073 1.43 (1.12, 1.82) 5.50% 1.02 1.26
LOC400643 1 0.004781617 1.30 (1.08, 1.55) 6.10% 1.02 1.22
LOC400657 -1 0.004993934 0.67 (0.50, 0.88) 6.20% 1.02 1.28
LY6D 1 0.004888422 1.46 (1.12, 1.90) 6.10% 1.02 1.26
LY6H 1 0.004151007 1.39 (1.11, 1.75) 5.60% 1.02 1.25
LY6H 1 0.004151007 1.39 (1.11, 1.75) 5.60% 1.02 1.25
LY6H 1 0.004151007 1.39 (1.11, 1.75) 5.60% 1.02 1.25
MAP2K2 -1 0.005892515 0.63 (0.46, 0.88) 6.70% 1.02 1.28
MAP3K4 1 0.004985634 1.43 (1.11, 1.84) 6.20% 1.02 1.26
MAP3K4 1 0.004985634 1.43 (1.11, 1.84) 6.20% 1.02 1.26
MAP7D2 1 0.005695576 1.53 (1.13, 2.06) 6.60% 1.02 1.26
MAP7D2 1 0.005695576 1.53 (1.13, 2.06) 6.60% 1.02 1.26
MAP7D2 1 0.005695576 1.53 (1.13, 2.06) 6.60% 1.02 1.26
MAP7D2 1 0.005695576 1.53 (1.13, 2.06) 6.60% 1.02 1.26
MCCC1 1 0.006217752 1.59 (1.14, 2.22) 6.90% 1.02 1.26
ME3 -1 0.005503433 0.61 (0.43, 0.86) 6.40% 1.02 1.29
ME3 -1 0.005503433 0.61 (0.43, 0.86) 6.40% 1.02 1.29
ME3 -1 0.005503433 0.61 (0.43, 0.86) 6.40% 1.02 1.29
MELK 1 0.006465586 1.77 (1.17, 2.66) 7.10% 1.02 1.26
MMP15 1 0.005850262 1.85 (1.19, 2.86) 6.70% 1.02 1.25
MOV10 -1 0.005238498 0.58 (0.39, 0.85) 6.30% 1.02 1.29
MOV10 -1 0.005238498 0.58 (0.39, 0.85) 6.30% 1.02 1.29
MRPL39 -1 0.003894605 0.61 (0.44, 0.85) 5.40% 1.02 1.3
MRPL39 -1 0.003894605 0.61 (0.44, 0.85) 5.40% 1.02 1.3
MSL3L2 1 0.005035426 1.60 (1.15, 2.23) 6.20% 1.02 1.27
MTBP 1 0.005853811 1.63 (1.15, 2.30) 6.70% 1.02 1.27
MTFR1 1 0.005110758 1.55 (1.14, 2.11) 6.20% 1.02 1.27
MTFR1 1 0.005110758 1.55 (1.14, 2.11) 6.20% 1.02 1.27
MTFR1 1 0.005110758 1.55 (1.14, 2.11) 6.20% 1.02 1.27
MTSS1L 1 0.004990967 1.65 (1.16, 2.34) 6.20% 1.02 1.27
MYOM3 -1 0.00522092 0.63 (0.46, 0.87) 6.30% 1.02 1.29
NCRNA00263 1 0.004190387 1.65 (1.17, 2.33) 5.60% 1.02 1.28
NDUFB10 -1 0.005128156 0.69 (0.54, 0.90) 6.20% 1.02 1.27
NEIL3 1 0.006472151 1.95 (1.21, 3.15) 7.10% 1.02 1.24
NKG7 1 0.003249298 1.34 (1.10, 1.62) 4.90% 1.02 1.24
NMNAT3 -1 0.004403783 0.56 (0.37, 0.83) 5.80% 1.02 1.29
NOD1 1 0.003051661 1.40 (1.12, 1.75) 4.70% 1.02 1.26
NPM1 1 0.004274784 1.78 (1.20, 2.66) 5.70% 1.02 1.27
NPM1 1 0.004274784 1.78 (1.20, 2.66) 5.70% 1.02 1.27
NPM1 1 0.004274784 1.78 (1.20, 2.66) 5.70% 1.02 1.27
NPY5R -1 0.005397335 0.56 (0.37, 0.84) 6.40% 1.02 1.28
NRG2 1 0.005368867 1.65 (1.16, 2.34) 6.40% 1.02 1.27
NRG2 1 0.005368867 1.65 (1.16, 2.34) 6.40% 1.02 1.27
NRG2 1 0.005368867 1.65 (1.16, 2.34) 6.40% 1.02 1.27
NRG2 1 0.005368867 1.65 (1.16, 2.34) 6.40% 1.02 1.27
NRG2 1 0.005368867 1.65 (1.16, 2.34) 6.40% 1.02 1.27
NUDT16P1 -1 0.004513272 0.59 (0.41, 0.85) 5.90% 1.02 1.29
NUDT16P1 -1 0.004513272 0.59 (0.41, 0.85) 5.90% 1.02 1.29
NUF2 1 0.004146016 1.68 (1.18, 2.41) 5.60% 1.02 1.28
NUF2 1 0.004146016 1.68 (1.18, 2.41) 5.60% 1.02 1.28
NUSAP1 1 0.004608304 1.85 (1.21, 2.83) 6.00% 1.02 1.27
NUSAP1 1 0.004608304 1.85 (1.21, 2.83) 6.00% 1.02 1.27
NUSAP1 1 0.004608304 1.85 (1.21, 2.83) 6.00% 1.02 1.27
OIP5 1 0.00444449 1.74 (1.19, 2.54) 5.80% 1.02 1.27
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PARD3 1 0.00638968 1.81 (1.18, 2.79) 7.10% 1.02 1.25
PCDH11X 1 0.003459139 1.50 (1.14, 1.96) 5.10% 1.02 1.28
PCDH11X 1 0.003459139 1.50 (1.14, 1.96) 5.10% 1.02 1.28
PCDH11X 1 0.003459139 1.50 (1.14, 1.96) 5.10% 1.02 1.28
PCDH11X 1 0.003459139 1.50 (1.14, 1.96) 5.10% 1.02 1.28
PCDH11X 1 0.003459139 1.50 (1.14, 1.96) 5.10% 1.02 1.28
PCDH11X 1 0.003459139 1.50 (1.14, 1.96) 5.10% 1.02 1.28
PCDH11X 1 0.003459139 1.50 (1.14, 1.96) 5.10% 1.02 1.28
PCDH11X 1 0.003459139 1.50 (1.14, 1.96) 5.10% 1.02 1.28
PDZD3 -1 0.004829406 0.57 (0.39, 0.84) 6.10% 1.02 1.29
PDZD3 -1 0.004829406 0.57 (0.39, 0.84) 6.10% 1.02 1.29
PDZD3 -1 0.004829406 0.57 (0.39, 0.84) 6.10% 1.02 1.29
PHIP 1 0.004453412 1.59 (1.16, 2.20) 5.80% 1.02 1.27
PHKB 1 0.00471534 1.49 (1.13, 1.96) 6.00% 1.02 1.27
PHKB 1 0.00471534 1.49 (1.13, 1.96) 6.00% 1.02 1.27
PHKG2 -1 0.006596304 0.52 (0.33, 0.83) 7.10% 1.02 1.27
PHKG2 -1 0.006596304 0.52 (0.33, 0.83) 7.10% 1.02 1.27
PIAS1 1 0.004108295 1.43 (1.12, 1.82) 5.60% 1.02 1.26
PLA2R1 -1 0.004141664 0.65 (0.48, 0.87) 5.60% 1.02 1.29
PLA2R1 -1 0.004141664 0.65 (0.48, 0.87) 5.60% 1.02 1.29
PLA2R1 -1 0.004141664 0.65 (0.48, 0.87) 5.60% 1.02 1.29
PLCD4 -1 0.005641861 0.60 (0.41,0.86) 6.60% 1.02 1.28
POC1A 1 0.005505401 1.66 (1.16, 2.37) 6.40% 1.02 1.27
POC1A 1 0.005505401 1.66 (1.16, 2.37) 6.40% 1.02 1.27
POC1A 1 0.005505401 1.66 (1.16, 2.37) 6.40% 1.02 1.27
POMT2 -1 0.005356899 0.61 (0.43, 0.86) 6.40% 1.02 1.29
PPIL6 -1 0.00393157 0.60 (0.43, 0.85) 5.50% 1.02 1.3
PPIL6 -1 0.00393157 0.60 (0.43, 0.85) 5.50% 1.02 1.3
PPPDE1 1 0.004067992 1.62 (1.17, 2.26) 5.60% 1.02 1.28
PRPF8 -1 0.004322159 0.63 (0.46, 0.87) 5.70% 1.02 1.29
PSMC6 1 0.004415222 1.51 (1.14, 2.00) 5.80% 1.02 1.27
PTDSS1 1 0.005883984 1.64 (1.15, 2.33) 6.70% 1.02 1.26
PTGR1 -1 0.005430957 0.62 (0.44, 0.87) 6.40% 1.02 1.29
PTGR1 -1 0.005430957 0.62 (0.44, 0.87) 6.40% 1.02 1.29
PTGR1 -1 0.005430957 0.62 (0.44, 0.87) 6.40% 1.02 1.29
PTK2 1 0.003632816 1.53 (1.15, 2.04) 5.30% 1.02 1.28
PTK2 1 0.003632816 1.53 (1.15, 2.04) 5.30% 1.02 1.28
PTK2 1 0.003632816 1.53 (1.15, 2.04) 5.30% 1.02 1.28
PTPLB 1 0.003892716 1.62 (1.17, 2.25) 5.40% 1.02 1.28
PTRH2 1 0.004217013 1.50 (1.14, 1.99) 5.60% 1.02 1.27
RAB1A 1 0.005732236 1.58 (1.14, 2.19) 6.60% 1.02 1.27
RAB1A 1 0.005732236 1.58 (1.14, 2.19) 6.60% 1.02 1.27
RAB32 -1 0.004345803 0.68 (0.52, 0.89) 5.70% 1.02 1.28
RAD54B 1 0.004999815 1.60 (1.15, 2.23) 6.20% 1.02 1.27
RBM34 1 0.004614592 1.61 (1.16, 2.24) 6.00% 1.02 1.27
RBM34 1 0.004614592 1.61 (1.16, 2.24) 6.00% 1.02 1.27
RBM34 1 0.004614592 1.61 (1.16, 2.24) 6.00% 1.02 1.27
RERG -1 0.006256771 0.60 (0.41, 0.86) 7.00% 1.02 1.28
RERG -1 0.006256771 0.60 (0.41, 0.86) 7.00% 1.02 1.28
RG9MTD2 -1 0.005451293 0.68 (0.52, 0.89) 6.40% 1.02 1.27
RG9MTD2 -1 0.005451293 0.68 (0.52, 0.89) 6.40% 1.02 1.27
RG9MTD2 -1 0.005451293 0.68 (0.52, 0.89) 6.40% 1.02 1.27
RIBC1 -1 0.005090705 0.63 (0.46, 0.87) 6.20% 1.02 1.29
RIBC1 -1 0.005090705 0.63 (0.46, 0.87) 6.20% 1.02 1.29
RIPK2 1 0.004284645 1.66 (1.17, 2.34) 5.70% 1.02 1.28
RIPPLY2 1 0.00362128 1.39 (1.11, 1.73) 5.30% 1.02 1.26
RNF215 -1 0.003675247 0.65 (0.49, 0.87) 5.30% 1.02 1.29
RPL23AP82 1 0.003704396 1.41 (1.12, 1.78) 5.30% 1.02 1.26
RPL23AP82 1 0.003704396 1.41 (1.12, 1.78) 5.30% 1.02 1.26
RRM2 1 0.00530057 2.12 (1.25, 3.59) 6.30% 1.02 1.24
RRM2 1 0.00530057 2.12 (1.25, 3.59) 6.30% 1.02 1.24
RRP8 -1 0.004670198 0.63 (0.45, 0.87) 6.00% 1.02 1.29
RSPH1 -1 0.005024925 0.63 (0.45, 0.87) 6.20% 1.02 1.29
SAMD14 -1 0.003593798 0.73 (0.59, 0.90) 5.20% 1.02 1.26
SECISBP2 -1 0.00565347 0.56 (0.37, 0.85) 6.60% 1.02 1.28
SEPT1 -1 0.003777972 0.62 (0.45, 0.86) 5.40% 1.02 1.3
SEPT7 1 0.003942003 1.65 (1.17, 2.32) 5.50% 1.02 1.28
SEPT7 1 0.003942003 1.65 (1.17, 2.32) 5.50% 1.02 1.28
SET -1 0.005433028 0.57 (0.39, 0.85) 6.40% 1.02 1.28
SET -1 0.005433028 0.57 (0.39, 0.85) 6.40% 1.02 1.28
SH2B1 -1 0.004950832 0.65 (0.48, 0.88) 6.20% 1.02 1.29
SH2B1 -1 0.004950832 0.65 (0.48, 0.88) 6.20% 1.02 1.29
SH2B1 -1 0.004950832 0.65 (0.48, 0.88) 6.20% 1.02 1.29
SH2B1 -1 0.004950832 0.65 (0.48, 0.88) 6.20% 1.02 1.29
SH2B1 -1 0.004950832 0.65 (0.48, 0.88) 6.20% 1.02 1.29
SH2D6 1 0.004314207 1.42 (1.12, 1.82) 5.70% 1.02 1.26
SI 1 0.005422844 1.39 (1.10, 1.75) 6.40% 1.02 1.25
SIPA1L2 1 0.005953535 1.62 (1.15, 2.28) 6.80% 1.02 1.26
SLC28A1 1 0.005368187 1.71 (1.17, 2.50) 6.40% 1.02 1.27
SLC28A1 1 0.005368187 1.71 (1.17, 2.50) 6.40% 1.02 1.27
SLC6A10P 1 0.004304834 1.34 (1.10, 1.63) 5.70% 1.02 1.24
SLC7A8 -1 0.006012426 0.59 (0.40, 0.86) 6.80% 1.02 1.28
SLC7A8 -1 0.006012426 0.59 (0.40, 0.86) 6.80% 1.02 1.28
SLITRK2 1 0.004114097 1.45 (1.12, 1.86) 5.60% 1.02 1.27
SLITRK2 1 0.004114097 1.45 (1.12, 1.86) 5.60% 1.02 1.27
SLITRK2 1 0.004114097 1.45 (1.12, 1.86) 5.60% 1.02 1.27
SLITRK2 1 0.004114097 1.45 (1.12, 1.86) 5.60% 1.02 1.27
SLITRK2 1 0.004114097 1.45 (1.12, 1.86) 5.60% 1.02 1.27
SLITRK2 1 0.004114097 1.45 (1.12, 1.86) 5.60% 1.02 1.27
SLITRK2 1 0.004114097 1.45 (1.12, 1.86) 5.60% 1.02 1.27
SLITRK2 1 0.004114097 1.45 (1.12, 1.86) 5.60% 1.02 1.27
SMARCC1 1 0.004969555 1.61 (1.15, 2.24) 6.20% 1.02 1.27
SNRPB2 1 0.003112308 1.40 (1.12, 1.75) 4.80% 1.02 1.26
SNRPB2 1 0.003112308 1.40 (1.12, 1.75) 4.80% 1.02 1.26
SOCS6 -1 0.004297582 0.60 (0.42, 0.85) 5.70% 1.02 1.29
SOX17 -1 0.00472738 0.62 (0.44, 0.86) 6.00% 1.02 1.29
SOX2OT -1 0.006142043 0.55 (0.35, 0.84) 6.90% 1.02 1.28
SPA17 -1 0.004800037 0.72 (0.57, 0.90) 6.10% 1.02 1.26
SPAG17 -1 0.006045057 0.60 (0.42, 0.86) 6.80% 1.02 1.28
SPINK8 1 0.005890681 1.59 (1.14, 2.22) 6.70% 1.02 1.27
SRBD1 1 0.003804838 1.55 (1.15, 2.09) 5.40% 1.02 1.28
SRD5A1 1 0.006103365 1.58 (1.14, 2.20) 6.90% 1.02 1.26
SRPRB 1 0.004270811 1.53 (1.14, 2.06) 5.70% 1.02 1.27
STK3 1 0.004308969 1.79 (1.20, 2.67) 5.70% 1.02 1.27
STON2 -1 0.005917452 0.55 (0.36, 0.84) 6.80% 1.02 1.28
TAF2 1 0.00478922 1.48 (1.13, 1.93) 6.10% 1.02 1.27
TBX3 -1 0.004788214 0.60 (0.43, 0.86) 6.10% 1.02 1.29
TBX3 -1 0.004788214 0.60 (0.43, 0.86) 6.10% 1.02 1.29
TDO2 1 0.005420059 1.57 (1.14, 2.16) 6.40% 1.02 1.27
TEKT2 -1 0.005472115 0.61 (0.43, 0.86) 6.40% 1.02 1.29
TEX101 -1 0.004405596 0.57 (0.39, 0.84) 5.80% 1.02 1.29
TEX101 -1 0.004405596 0.57 (0.39, 0.84) 5.80% 1.02 1.29
TFF2 1 0.002565639 1.30 (1.10, 1.53) 4.30% 1.02 1.23
TGFBR3 -1 0.005568795 0.59 (0.40, 0.86) 6.50% 1.02 1.28
TGFBR3 -1 0.005568795 0.59 (040, 0.86) 6.50% 1.02 1.28
TGFBR3 -1 0.005568795 0.59 (0.40, 0.86) 6.50% 1.02 1.28
TGFBR3 -1 0.005568795 0.59 (0.40, 0.86) 6.50% 1.02 1.28
TLX3 1 0.005429471 1.44 (1.11, 1.86) 6.40% 1.02 1.26
TM4SF20 -1 0.005502692 0.61 (0.43, 0.87) 6.40% 1.02 1.29
TMBIM1 -1 0.005802111 0.62 (0.44, 0.87) 6.70% 1.02 1.28
TMC6 1 0.004143969 1.69 (1.18, 2.42) 5.60% 1.02 1.28
TMC6 1 0.004143969 1.69 (1.18, 2.42) 5.60% 1.02 1.28
TMEM132B 1 0.003802933 1.57 (1.16, 2.13) 5.40% 1.02 1.28
TMEM165 1 0.003867527 1.49 (1.14, 1.96) 5.40% 1.02 1.27
TMEM167B -1 0.005258342 0.67 (0.51, 0.89) 6.30% 1.02 1.28
TMEM49 1 0.005254418 1.54 (1.14, 2.09) 6.30% 1.02 1.27
TP5313 -1 0.004119014 0.63 (0.47, 0.87) 5.60% 1.02 1.29
TP5313 -1 0.004119014 0.63 (0.47, 0.87) 5.60% 1.02 1.29
TPH1 -1 0.004144358 0.59 (0.41, 0.85) 5.60% 1.02 1.3
TPRG1 -1 0.004865463 0.54 (0.35, 0.83) 6.10% 1.02 1.28
TRIP10 -1 0.004862787 0.66 (0.50, 0.88) 6.10% 1.02 1.28
TRYX3 1 0.005334529 1.48 (1.12, 1.95) 6.30% 1.02 1.26
TTLL9 -1 0.004802396 0.59 (0.41, 0.85) 6.10% 1.02 1.29
UBTF -1 0.003797859 0.64 (0.48, 0.87) 5.40% 1.02 1.29
UBTF -1 0.003797859 0.64 (0.48, 0.87) 5.40% 1.02 1.29
UBTF -1 0.003797859 0.64 (0.48, 0.87) 5.40% 1.02 1.29
USP10 1 0.004974453 1.60 (1.15, 2.22) 6.20% 1.02 1.27
USP20 -1 0.006090279 0.52 (0.33, 0.83) 6.90% 1.02 1.27
USP20 -1 0.006090279 0.52 (0.33, 0.83) 6.90% 1.02 1.27
USP20 -1 0.006090279 0.52 (0.33, 0.83) 6.90% 1.02 1.27
USP6NL 1 0.005838641 1.62 (1.15, 2.28) 6.70% 1.02 1.27
USP6NL 1 0.005838641 1.62 (1.15, 2.28) 6.70% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VEGFA 1 0.004912488 1.55 (1.14, 2.11) 6.20% 1.02 1.27
VPS13D 1 0.00462902 1.61 (1.16, 2.25) 6.00% 1.02 1.27
VPS13D 1 0.00462902 1.61 (1.16, 2.25) 6.00% 1.02 1.27
WDR91 1 0.004652961 1.64 (1.16, 2.31) 6.00% 1.02 1.27
XPO1 1 0.0059138 1.68 (1.16, 2.43) 6.80% 1.02 1.26
ZNF197 -1 0.004824119 0.64 (0.47, 0.87) 6.10% 1.02 1.29
ZNF197 -1 0.004824119 0.64 (0.47, 0.87) 6.10% 1.02 1.29
ZNF239 -1 0.004350897 0.66 (0.50, 0.88) 5.80% 1.02 1.29
ZNF239 -1 0.004350897 0.66 (0.50, 0.88) 5.80% 1.02 1.29
ZNF239 -1 0.004350897 0.66 (0.50, 0.88) 5.80% 1.02 1.29
ZNF239 -1 0.004350897 0.66 (0.50, 0.88) 5.80% 1.02 1.29
ZNF346 1 0.005370981 1.47 (1.12, 1.94) 6.40% 1.02 1.26
ZNF434 -1 0.004137381 0.58 (0.40, 0.84) 5.60% 1.02 1.3
ZNF616 -1 0.004212388 0.57 (0.39, 0.84) 5.60% 1.02 1.29
ZNF619 -1 0.004847157 0.61 (0.43, 0.86) 6.10% 1.02 1.29
ZNF619 -1 0.004847157 0.61 (0.43, 0.86) 6.10% 1.02 1.29
ZNF619 -1 0.004847157 0.61 (0.43, 0.86) 6.10% 1.02 1.29
ZNF619 -1 0.004847157 0.61 (0.43, 0.86) 6.10% 1.02 1.29
ZNF710 1 0.004198366 1.37 (1.11, 1.71) 5.60% 1.02 1.25
ZNF738 -1 0.005996712 0.64 (0.47, 0.88) 6.80% 1.02 1.28
ZNRF2 1 0.002907072 1.35 (1.11, 1.64) 4.60% 1.02 1.25
ZSCAN16 -1 0.003648245 0.66 (0.50, 0.87) 5.30% 1.02 1.29
ZWILCH 1 0.006215321 1.62 (1.15, 2.28) 6.90% 1.02 1.26
ZWILCH 1 0.006215321 1.62 (1.15, 2.28) 6.90% 1.02 1.26
AARS 1 0.006581854 1.65 (1.15, 2.36) 7.10% 1.01 1.26
ABAT -1 0.008694362 0.53 (0.33, 0.85) 8.20% 1.01 1.26
ABAT -1 0.008694362 0.53 (0.33, 0.85) 8.20% 1.01 1.26
ABAT -1 0.008694362 0.53 (0.33, 0.85) 8.20% 1.01 1.26
ABHD5 1 0.007921655 1.61 (1.13, 2.29) 7.80% 1.01 1.25
ABL1 -1 0.00834792 0.62 (0.44, 0.89) 8.00% 1.01 1.27
ABL1 -1 0.00834792 0.62 (0.44, 0.89) 8.00% 1.01 1.27
ABR -1 0.007662518 0.60 (0.41, 0.87) 7.70% 1.01 1.27
ABR -1 0.007662518 0.60 (0.41, 0.87) 7.70% 1.01 1.27
ABR -1 0.007662518 0.60 (0.41, 0.87) 7.70% 1.01 1.27
ABTB2 1 0.008523209 1.52 (1.11, 2.07) 8.10% 1.01 1.25
ADAMTS8 -1 0.006436924 0.66 (0.48, 0.89) 7.10% 1.01 1.28
AFM 1 0.005145801 1.19 (1.05, 1.35) 6.20% 1.01 1.17
ALDH7A1 1 0.008021584 1.72 (1.15, 2.57) 7.90% 1.01 1.25
ALKBH3 -1 0.009889635 0.61 (042, 0.89) 8.70% 1.01 1.26
ALOX12 -1 0.00634658 0.62 (0.44, 0.88) 7.00% 1.01 1.28
ANTXRL 1 0.00868012 1.56 (1.12, 2.18) 8.20% 1.01 1.25
ARHGEF4 1 0.009414554 1.71 (1.14, 2.56) 8.50% 1.01 1.24
ARHGEF4 1 0.009414554 1.71 (1.14, 2.56) 8.50% 1.01 1.24
ASAH2B -1 0.006655111 0.72 (0.57, 0.91) 7.10% 1.01 1.26
ASB13 -1 0.007573921 0.65 (0.47, 0.89) 7.70% 1.01 1.27
ASB13 -1 0.007573921 0.65 (0.47, 0.89) 7.70% 1.01 1.27
ASB13 -1 0.007573921 0.65 (0.47, 0.89) 7.70% 1.01 1.27
ASPM 1 0.006786143 1.91 (1.20, 3.05) 7.20% 1.01 1.24
ASTN2 -1 0.008824541 0.56 (0.36, 0.86) 8.20% 1.01 1.26
ASTN2 -1 0.008824541 0.56 (0.36, 0.86) 8.20% 1.01 1.26
ASTN2 -1 0.008824541 0.56 (0.36, 0.86) 8.20% 1.01 1.26
ASTN2 -1 0.008824541 0.56 (0.36, 0.86) 8.20% 1.01 1.26
ASTN2 -1 0.008824541 0.56 (0.36, 0.86) 8.20% 1.01 1.26
ASTN2 -1 0.008824541 0.56 (0.36, 0.86) 8.20% 1.01 1.26
ATL2 1 0.008592516 1.47 (1.10, 1.97) 8.10% 1.01 1.25
ATL2 1 0.008592516 1.47 (1.10, 1.97) 8.10% 1.01 1.25
ATL2 1 0.008592516 1.47 (1.10, 1.97) 8.10% 1.01 1.25
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
ATXN3 -1 0.009014078 0.62 (0.43, 0.89) 8.30% 1.01 1.27
AZIN1 1 0.009281268 1.47 (1.10, 1.95) 8.50% 1.01 1.25
AZIN1 1 0.009281268 1.47 (1.10, 1.95) 8.50% 1.01 1.25
BLOC1S1-RDH5 -1 0.00930281 0.62 (0.43, 0.89) 8.50% 1.01 1.27
BRD3 -1 0.008625203 0.58 (0.39, 0.87) 8.10% 1.01 1.27
BRD9 1 0.006755386 1.66 (1.15, 2.41) 7.20% 1.01 1.26
BRD9 1 0.006755386 1.66 (1.15, 2.41) 7.20% 1.01 1.26
BRD9 1 0.006755386 1.66 (1.15, 2.41) 7.20% 1.01 1.26
BUB1B 1 0.007054086 1.95 (1.20, 3.18) 7.30% 1.01 1.24
C12orf52 -1 0.006034719 0.72 (0.57, 0.91) 6.80% 1.01 1.26
C12orf53 -1 0.007888739 0.62 (0.43, 0.88) 7.80% 1.01 1.27
C12orf76 -1 0.006422511 0.60 (0.42, 0.87) 7.10% 1.01 1.28
C14orf132 -1 0.01017781 0.62 (0.43, 0.89) 8.90% 1.01 1.26
C14orf145 1 0.009860907 1.47 (1.10, 1.97) 8.70% 1.01 1.24
C14orf147 1 0.0076906 1.58 (1.13, 2.21) 7.70% 1.01 1.26
C14orf38 -1 0.008239414 0.63 (0.45, 0.89) 8.00% 1.01 1.27
C1orf174 -1 0.008033783 0.66 (0.48, 0.90) 7.90% 1.01 1.27
C1orf38 1 0.008713276 1.58 (1.12, 2.22) 8.20% 1.01 1.25
C1orf38 1 0.008713276 1.58 (1.12, 2.22) 8.20% 1.01 1.25
C1orf38 1 0.008713276 1.58 (1.12, 2.22) 8.20% 1.01 1.25
C1orf9 1 0.008402668 1.56 (1.12, 2.16) 8.10% 1.01 1.25
C1orf9 1 0.008402668 1.56 (1.12, 2.16) 8.10% 1.01 1.25
C1QTNF6 -1 0.006525076 0.67 (0.51, 0.90) 7.10% 1.01 1.27
C1QTNF6 -1 0.006525076 0.67 (0.51, 0.90) 7.10% 1.01 1.27
C4orf44 -1 0.007314886 0.66 (0.49, 0.89) 7.50% 1.01 1.27
C7orf63 -1 0.007739854 0.60 (0.41, 0.87) 7.70% 1.01 1.27
C7orf63 -1 0.007739854 0.60 (0.41, 0.87) 7.70% 1.01 1.27
C8orf73 1 0.00790054 1.92 (1.19, 3.12) 7.80% 1.01 1.24
C9orf46 -1 0.006592071 0.56 (0.37, 0.85) 7.10% 1.01 1.28
C9orf47 1 0.005586283 1.36 (1.09, 1.68) 6.50% 1.01 1.24
C9orf47 1 0.005586283 1.36 (1.09, 1.68) 6.50% 1.01 1.24
CACNA1B 1 0.008323894 1.47 (1.10, 1.97) 8.00% 1.01 1.25
CATSPERG -1 0.0079658 0.62 (0.43, 0.88) 7.90% 1.01 1.27
CCDC101 -1 0.007432279 0.64 (0.46, 0.89) 7.60% 1.01 1.27
CCDC153 -1 0.007781985 0.61 (0.43, 0.88) 7.80% 1.01 1.27
CCDC28B -1 0.009710454 0.62 (0.44, 0.89) 8.70% 1.01 1.26
CCDC66 -1 0.009413964 0.70 (0.54, 0.92) 8.50% 1.01 1.25
CCDC66 -1 0.009413964 0.70 (0.54, 0.92) 8.50% 1.01 1.25
CCDC66 -1 0.009413964 0.70 (0.54, 0.92) 8.50% 1.01 1.25
CCDC68 -1 0.006409628 0.65 (0.48, 0.89) 7.10% 1.01 1.28
CCDC68 -1 0.006409628 0.65 (0.48, 0.89) 7.10% 1.01 1.28
CCDC85A -1 0.006939346 0.57 (0.38, 0.86) 7.30% 1.01 1.27
CCDC97 -1 0.008529916 0.62 (0.43, 0.88) 8.10% 1.01 1.27
CDC73 1 0.008041561 1.69 (1.15, 2.49) 7.90% 1.01 1.25
CDH8 1 0.008791148 1.52 (1.11, 2.08) 8.20% 1.01 1.25
CENPO 1 0.008398103 1.87 (1.17, 2.98) 8.10% 1.01 1.24
CENPO 1 0.008398103 1.87 (1.17, 2.98) 8.10% 1.01 1.24
CENPW 1 0.010108567 1.63 (1.12, 2.36) 8.90% 1.01 1.24
CFDP1 1 0.009181598 1.42 (1.09, 1.84) 8.50% 1.01 1.24
CHCHD10 1 0.007522027 2.38 (1.26, 4.50) 7.70% 1.01 1.2
CHI3L1 1 0.006668226 1.67 (1.15, 2.42) 7.10% 1.01 1.26
CIT 1 0.007377258 1.85 (1.18, 2.89) 7.60% 1.01 1.24
CLASRP -1 0.008231783 0.66 (0.48, 0.90) 8.00% 1.01 1.27
CLCN5 1 0.009310865 1.55 (1.11, 2.16) 8.50% 1.01 1.25
CLCN5 1 0.009310865 1.55 (1.11, 2.16) 8.50% 1.01 1.25
CLCN5 1 0.009310865 1.55 (1.11, 2.16) 8.50% 1.01 1.25
CLEC16A -1 0.010281483 0.56 (0.36, 0.87) 8.90% 1.01 1.26
CMA1 -1 0.008693923 0.61 (0.42, 0.88) 8.20% 1.01 1.27
CNGA1 1 0.00795389 1.47 (1.11, 1.95) 7.90% 1.01 1.25
CNGA1 1 0.00795389 1.47 (1.11, 1.95) 7.90% 1.01 1.25
COMMD9 -1 0.007675478 0.65 (0.48, 0.89) 7.70% 1.01 1.27
COMMD9 -1 0.007675478 0.65 (0.48, 0.89) 7.70% 1.01 1.27
CPLX2 1 0.008558358 1.51 (1.11, 2.05) 8.10% 1.01 1.25
CPLX2 1 0.008558358 1.51 (1.11, 2.05) 8.10% 1.01 1.25
CPLX4 1 0.00691338 1.42 (1.10, 1.84) 7.30% 1.01 1.25
CRABP1 1 0.006626223 1.53 (1.13, 2.09) 7.10% 1.01 1.26
CRMP1 -1 0.007392616 0.64 (0.46, 0.89) 7.60% 1.01 1.27
CRMP1 -1 0.007392616 0.64 (0.46, 0.89) 7.60% 1.01 1.27
CSPG5 1 0.009780303 1.84 (1.16, 2.92) 8.70% 1.01 1.23
CYB5D2 -1 0.006826525 0.64 (0.47, 0.88) 7.20% 1.01 1.28
CYB5D2 -1 0.006826525 0.64 (0.47, 0.88) 7.20% 1.01 1.28
CYB5D2 -1 0.006826525 0.64 (0.47, 0.88) 7.20% 1.01 1.28
CYP4F8 -1 0.006572164 0.56 (0.37, 0.85) 7.10% 1.01 1.28
DBF4 1 0.007605751 1.63 (1.14, 2.33) 7.70% 1.01 1.26
DCAF16 -1 0.006850158 0.56 (0.36, 0.85) 7.20% 1.01 1.27
DEFB126 1 0.009243031 1.35 (1.08, 1.70) 8.50% 1.01 1.23
DERA -1 0.005991399 0.67 (0.51, 0.89) 6.80% 1.01 1.27
DHRS3 1 0.006553888 1.67 (1.15, 2.41) 7.10% 1.01 1.26
DHRS4 -1 0.007490633 0.65 (0.48, 0.89) 7.60% 1.01 1.27
DHX40 1 0.006401593 1.44 (1.11, 1.88) 7.10% 1.01 1.25
DHX40 1 0.006401593 1.44 (1.11, 1.88) 7.10% 1.01 1.25
DLEC1 -1 0.007441555 0.57 (0.37, 0.86) 7.60% 1.01 1.27
DLEC1 -1 0.007441555 0.57 (0.37, 0.86) 7.60% 1.01 1.27
DMXL2 1 0.006523881 1.39 (1.10, 1.77) 7.10% 1.01 1.25
DMXL2 1 0.006523881 1.39 (1.10, 1.77) 7.10% 1.01 1.25
DMXL2 1 0.006523881 1.39 (1.10, 1.77) 7.10% 1.01 1.25
DNAJC12 -1 0.008733264 0.61 (0.42, 0.88) 8.20% 1.01 1.27
DNAJC12 -1 0.008733264 0.61 (0.42, 0.88) 8.20% 1.01 1.27
DUS2L 1 0.006904869 1.58 (1.13, 2.21) 7.30% 1.01 1.26
ECT2 1 0.006333315 1.61 (1.14, 2.27) 7.00% 1.01 1.26
EIF2AK1 1 0.006304207 1.58 (1.14, 2.19) 7.00% 1.01 1.26
EIF2AK1 1 0.006304207 1.58 (1.14, 2.19) 7.00% 1.01 1.26
ELP3 -1 0.008530309 0.59 (0.40, 0.87) 8.10% 1.01 1.27
EML4 1 0.00939952 1.49 (1.10, 2.00) 8.50% 1.01 1.25
EML4 1 0.00939952 1.49 (1.10, 2.00) 8.50% 1.01 1.25
EMP3 -1 0.009949959 0.61 (0.42, 0.89) 8.80% 1.01 1.26
EXT1 1 0.008271434 1.54 (1.12, 2.12) 8.00% 1.01 1.25
EZR 1 0.006750056 1.45 (1.11, 1.91) 7.20% 1.01 1.25
EZR 1 0.006750056 1.45 (1.11, 1.91) 7.20% 1.01 1.25
FAF2 1 0.008604571 1.62 (1.13, 2.33) 8.10% 1.01 1.25
FAM179B -1 0.007462783 0.57 (0.38, 0.86) 7.60% 1.01 1.27
FAM20A 1 0.008860107 1.62 (1.13, 2.32) 8.30% 1.01 1.25
FAM20A 1 0.008860107 1.62 (1.13, 2.32) 8.30% 1.01 1.25
FAM3C 1 0.006674997 1.57 (1.13, 2.18) 7.10% 1.01 1.26
FAM3C 1 0.006674997 1.57 (1.13, 2.18) 7.10% 1.01 1.26
FAM5C 1 0.007019078 1.54 (1.13, 2.11) 7.30% 1.01 1.26
FAM66A -1 0.007271558 0.69 (0.53, 0.91) 7.50% 1.01 1.26
FAM71E1 -1 0.006859843 0.65 (047, 0.89) 7.20% 1.01 1.28
FANCI 1 0.006580511 1.50 (1.12, 2.01) 7.10% 1.01 1.26
FANCI 1 0.006580511 1.50 (1.12, 2.01) 7.10% 1.01 1.26
FBXL13 -1 0.007857688 0.65 (0.47, 0.89) 7.80% 1.01 1.27
FBXL13 -1 0.007857688 0.65 (0.47, 0.89) 7.80% 1.01 1.27
FBXL3 -1 0.006493504 0.58 (0.40, 0.86) 7.10% 1.01 1.28
FBXW7 1 0.006175921 1.49 (1.12, 1.99) 6.90% 1.01 1.26
FBXW7 1 0.006175921 1.49 (1.12, 1.99) 6.90% 1.01 1.26
FBXW7 1 0.006175921 1.49 (1.12, 1.99) 6.90% 1.01 1.26
FHAD1 -1 0.008426078 0.71 (0.54, 0.91) 8.10% 1.01 1.26
FIGF 1 0.009002018 1.69 (1.14, 2.50) 8.30% 1.01 1.25
FLII -1 0.008128059 0.61 (0.43, 0.88) 7.90% 1.01 1.27
FLI34503 1 0.006440243 1.52 (1.12, 2.05) 7.10% 1.01 1.26
FSD1L -1 0.009083561 0.66 (0.49, 0.90) 8.40% 1.01 1.26
FSD1L -1 0.009083561 0.66 (0.49, 0.90) 8.40% 1.01 1.26
FSD1L -1 0.009083561 0.66 (0.49, 0.90) 8.40% 1.01 1.26
FST -1 0.006099071 0.66 (0.48, 0.89) 6.90% 1.01 1.28
FST -1 0.006099071 0.66 (0.48, 0.89) 6.90% 1.01 1.28
FXN -1 0.00959081 0.63 (0.44, 0.89) 8.60% 1.01 1.26
FXN -1 0.00959081 0.63 (0.44, 0.89) 8.60% 1.01 1.26
FXN -1 0.00959081 0.63 (0.44, 0.89) 8.60% 1.01 1.26
GABRG2 1 0.00801239 1.48 (1.11, 1.97) 7.90% 1.01 1.25
GABRG2 1 0.00801239 1.48 (1.11, 1.97) 7.90% 1.01 1.25
GABRG2 1 0.00801239 1.48 (1.11, 1.97) 7.90% 1.01 1.25
GFPT1 1 0.006343975 1.56 (1.13, 2.14) 7.00% 1.01 1.26
GGT8P 1 0.00992679 1.62 (1.12, 2.33) 8.80% 1.01 1.24
GKN1 1 0.007050806 1.47 (1.11, 1.95) 7.30% 1.01 1.25
GLRX5 -1 0.008313892 0.65 (0.47, 0.89) 8.00% 1.01 1.27
GPR68 -1 0.009262259 0.62 (0.43, 0.89) 8.50% 1.01 1.27
GPR68 -1 0.009262259 0.62 (0.43, 0.89) 8.50% 1.01 1.27
GPS2 -1 0.007595274 0.66 (0.49, 0.90) 7.70% 1.01 1.27
GREB1L -1 0.007839939 0.62 (0.43, 0.88) 7.80% 1.01 1.27
GRPEL1 -1 0.006700841 0.62 (0.44, 0.88) 7.10% 1.01 1.28
GSTM4 -1 0.005934056 0.71 (0.56, 0.91) 6.80% 1.01 1.26
GSTM4 -1 0.005934056 0.71 (0.56, 0.91) 6.80% 1.01 1.26
GSTM4 -1 0.005934056 0.71 (0.56, 0.91) 6.80% 1.01 1.26
GTF21RD2 -1 0.006754304 0.60 (0.41, 0.87) 7.20% 1.01 1.28
HCN1 -1 0.009201866 0.58 (0.38, 0.87) 8.50% 1.01 1.26
HEATR6 1 0.009234691 1.43 (1.09, 1.87) 8.50% 1.01 1.24
HEBP1 -1 0.007381555 0.55 (0.35, 0.85) 7.60% 1.01 1.27
HEBP2 1 0.009915175 1.57 (1.11, 2.21) 8.80% 1.01 1.25
HERPUD1 1 0.008338896 1.48 (1.11, 1.98) 8.00% 1.01 1.25
HERPUD1 1 0.008338896 1.48 (1.11, 1.98) 8.00% 1.01 1.25
HERPUD1 1 0.008338896 1.48 (1.11, 1.98) 8.00% 1.01 1.25
HEXA -1 0.006684966 0.59 (0.40, 0.86) 7.10% 1.01 1.28
HNRNPA2B1 1 0.006193844 1.35 (1.09, 1.68) 6.90% 1.01 1.24
HNRNPA2B1 1 0.006193844 1.35 (1.09, 1.68) 6.90% 1.01 1.24
HSPA1L -1 0.009960713 0.66 (0.48, 0.91) 8.80% 1.01 1.26
IFT27 -1 0.008743864 0.65 (0.47, 0.90) 8.20% 1.01 1.27
IFT27 -1 0.008743864 0.65 (0.47, 0.90) 8.20% 1.01 1.27
IFT27 -1 0.008743864 0.65 (0.47, 0.90) 8.20% 1.01 1.27
IFT27 -1 0.008743864 0.65 (0.47, 0.90) 8.20% 1.01 1.27
IGF2R 1 0.009756773 1.63 (1.13, 2.37) 8.70% 1.01 1.24
IL1A 1 0.009440424 1.69 (1.14, 2.52) 8.50% 1.01 1.24
IL20RB 1 0.006998603 1.58 (1.13, 2.21) 7.30% 1.01 1.26
IQCC -1 0.006678534 0.66 (0.48, 0.89) 7.10% 1.01 1.28
IQCC -1 0.006678534 0.66 (0.48, 0.89) 7.10% 1.01 1.28
IQCF5 1 0.007048357 1.29 (1.07, 1.55) 7.30% 1.01 1.21
IQCG 1 0.00660325 1.25 (1.06, 1.48) 7.10% 1.01 1.2
IQCG 1 0.00660325 1.25 (1.06, 1.48) 7.10% 1.01 1.2
ITCH 1 0.007636272 1.69 (1.15, 2.47) 7.70% 1.01 1.25
ITFG1 1 0.006426544 1.46 (1.11, 1.91) 7.10% 1.01 1.26
JHDMID 1 0.006479536 1.57 (1.14, 2.18) 7.10% 1.01 1.26
KCNK13 -1 0.007077097 0.52 (0.32, 0.84) 7.40% 1.01 1.26
KCNMB3 -1 0.006827703 0.78 (0.65, 0.93) 7.20% 1.01 1.22
KCNMB3 -1 0.006827703 0.78 (0.65, 0.93) 7.20% 1.01 1.22
KCNMB3 -1 0.006827703 0.78 (0.65, 0.93) 7.20% 1.01 1.22
KCNMB3 -1 0.006827703 0.78 (0.65, 0.93) 7.20% 1.01 1.22
KCNMB3 -1 0.006827703 0.78 (0.65, 0.93) 7.20% 1.01 1.22
KCNMB3 -1 0.006827703 0.78 (0.65, 0.93) 7.20% 1.01 1.22
KDM4D -1 0.008522948 0.61 (0.43, 0.88) 8.10% 1.01 1.27
KIAA0753 -1 0.007526058 0.56 (0.36, 0.86) 7.70% 1.01 1.27
KIAA1024 1 0.006800873 1.56 (1.13, 2.16) 7.20% 1.01 1.26
KIF13B -1 0.010103096 0.58 (0.39, 0.88) 8.90% 1.01 1.26
KIF20B 1 0.006596402 1.65 (1.15, 2.36) 7.10% 1.01 1.26
KITLG -1 0.00932099 0.58 (0.39, 0.87) 8.50% 1.01 1.26
KITLG -1 0.00932099 0.58 (0.39, 0.87) 8.50% 1.01 1.26
KLHDC1 -1 0.006587563 0.63 (0.45, 0.88) 7.10% 1.01 1.28
KRTCAP2 1 0.009481883 1.58 (1.12, 2.23) 8.60% 1.01 1.25
LCN2 1 0.007623799 1.54 (1.12, 2.13) 7.70% 1.01 1.26
LGSN 1 0.00714657 1.52 (1.12, 2.07) 7.40% 1.01 1.26
LGSN 1 0.00714657 1.52 (1.12, 2.07) 7.40% 1.01 1.26
LHX1 1 0.007831619 1.48 (1.11, 1.98) 7.80% 1.01 1.25
LIMA1 -1 0.008443232 0.60 (0.42, 0.88) 8.10% 1.01 1.27
LIMA1 -1 0.008443232 0.60 (0.42, 0.88) 8.10% 1.01 1.27
LIMA1 -1 0.008443232 0.60 (0.42, 0.88) 8.10% 1.01 1.27
LMAN2L -1 0.009248927 0.63 (0.45, 0.89) 8.50% 1.01 1.27
LMAN2L -1 0.009248927 0.63 (0.45, 0.89) 8.50% 1.01 1.27
LMAN2L -1 0.009248927 0.63 (0.45, 0.89) 8.50% 1.01 1.27
LMAN2L -1 0.009248927 0.63 (0.45, 0.89) 8.50% 1.01 1.27
LMAN2L -1 0.009248927 0.63 (0.45, 0.89) 8.50% 1.01 1.27
LMAN2L -1 0.009248927 0.63 (0.45, 0.89) 8.50% 1.01 1.27
LOC100188947 -1 0.00851099 0.61 (0.42, 0.88) 8.10% 1.01 1.27
LOC100288842 -1 0.00809771 0.63 (0.45, 0.89) 7.90% 1.01 1.27
LOC100379224 -1 0.009205722 0.64 (0.46, 0.90) 8.50% 1.01 1.27
LOC338799 -1 0.007972298 0.55 (0.35, 0.86) 7.90% 1.01 1.27
LOC440335 -1 0.00981157 0.63 (0.44, 0.89) 8.70% 1.01 1.26
LOC440335 -1 0.00981157 0.63 (0.44, 0.89) 8.70% 1.01 1.26
LOC440335 -1 0.00981157 0.63 (0.44, 0.89) 8.70% 1.01 1.26
LOC57653 -1 0.009455291 0.66 (0.48, 0.90) 8.60% 1.01 1.26
LOC57653 -1 0.009455291 0.66 (0.48, 0.90) 8.60% 1.01 1.26
LOC57653 -1 0.009455291 0.66 (0.48, 0.90) 8.60% 1.01 1.26
LOC595101 -1 0.006518385 0.58 (0.39, 0.86) 7.10% 1.01 1.28
LOC643037 1 0.009129291 1.46 (1.10, 1.93) 8.40% 1.01 1.24
LOC729375 -1 0.009550732 0.65 (0.47, 0.90) 8.60% 1.01 1.26
LOC729668 1 0.008925516 1.54 (1.11, 2.12) 8.30% 1.01 1.25
LRPPRC 1 0.009760881 1.55 (1.11, 2.17) 8.70% 1.01 1.25
LRRC28 1 0.009655452 1.58 (1.12, 2.23) 8.60% 1.01 1.25
LRRC42 -1 0.006569663 0.60 (0.42, 0.87) 7.10% 1.01 1.28
LRRC4C -1 0.007662013 0.56 (0.37, 0.86) 7.70% 1.01 1.27
LSS 1 0.00963785 1.74 (1.14, 2.65) 8.60% 1.01 1.24
LSS 1 0.00963785 1.74 (1.14, 2.65) 8.60% 1.01 1.24
LSS 1 0.00963785 1.74 (1.14, 2.65) 8.60% 1.01 1.24
LSS 1 0.00963785 1.74 (1.14, 2.65) 8.60% 1.01 1.24
LYPD6 -1 0.006710307 0.68 (0.52, 0.90) 7.20% 1.01 1.27
LYPD6 -1 0.006710307 0.68 (0.52, 0.90) 7.20% 1.01 1.27
LYZL6 1 0.008275122 1.50 (1.11, 2.02) 8.00% 1.01 1.25
LYZL6 1 0.008275122 1.50 (1.11, 2.02) 8.00% 1.01 1.25
LZTFL1 -1 0.009526935 0.65 (0.47, 0.90) 8.60% 1.01 1.26
MAN2B2 -1 0.008606344 0.61 (0.42, 0.88) 8.10% 1.01 1.27
MAP2K7 -1 0.006674321 0.59 (0.41, 0.86) 7.10% 1.01 1.28
MAPK13 -1 0.007291857 0.66 (0.48, 0.89) 7.50% 1.01 1.27
MAT2A 1 0.009104483 1.60 (1.12, 2.27) 8.40% 1.01 1.25
MCF2 1 0.007384553 1.58 (1.13, 2.20) 7.60% 1.01 1.26
MCF2 1 0.007384553 1.58 (1.13, 2.20) 7.60% 1.01 1.26
MCF2 1 0.007384553 1.58 (1.13, 2.20) 7.60% 1.01 1.26
MCF2 1 0.007384553 1.58 (1.13, 2.20) 7.60% 1.01 1.26
MCF2 1 0.007384553 1.58 (1.13, 2.20) 7.60% 1.01 1.26
MCF2 1 0.007384553 1.58 (1.13, 2.20) 7.60% 1.01 1.26
MCM10 1 0.008326599 1.78 (1.16, 2.73) 8.00% 1.01 1.24
MCM10 1 0.008326599 1.78 (1.16, 2.73) 8.00% 1.01 1.24
ME1 1 0.00963294 1.57 (1.12, 2.21) 8.60% 1.01 1.25
MGC87042 1 0.009587863 1.43 (1.09, 1.88) 8.60% 1.01 1.24
MGC87042 1 0.009587863 1.43 (1.09, 1.88) 8.60% 1.01 1.24
MGRN1 -1 0.008635109 0.54 (0.34, 0.86) 8.10% 1.01 1.26
MGRN1 -1 0.008635109 0.54 (0.34, 0.86) 8.10% 1.01 1.26
MGRN1 -1 0.008635109 0.54 (0.34, 0.86) 8.10% 1.01 1.26
MGRN1 -1 0.008635109 0.54 (0.34, 0.86) 8.10% 1.01 1.26
MINK1 -1 0.0100436 0.66 (0.48, 0.91) 8.80% 1.01 1.26
MINK1 -1 0.0100436 0.66 (0.48, 0.91) 8.80% 1.01 1.26
MINK1 -1 0.0100436 0.66 (0.48, 0.91) 8.80% 1.01 1.26
MINK1 -1 0.0100436 0.66 (0.48, 0.91) 8.80% 1.01 1.26
MLLT1 -1 0.006613376 0.57 (0.38, 0.86) 7.10% 1.01 1.28
MR1 -1 0.008382286 0.58 (0.39, 0.87) 8.10% 1.01 1.27
MR1 -1 0.008382286 0.58 (0.39, 0.87) 8.10% 1.01 1.27
MR1 -1 0.008382286 0.58 (0.39, 0.87) 8.10% 1.01 1.27
MR1 -1 0.008382286 0.58 (0.39, 0.87) 8.10% 1.01 1.27
MST4 1 0.010303281 1.70 (1.13, 2.54) 8.90% 1.01 1.24
MST4 1 0.010303281 1.70 (1.13, 2.54) 8.90% 1.01 1.24
MST4 1 0.010303281 1.70 (1.13, 2.54) 8.90% 1.01 1.24
MTMR9LP -1 0.007633717 0.60 (0.41, 0.87) 7.70% 1.01 1.27
MTRF1 -1 0.008816635 0.67 (0.50, 0.91) 8.20% 1.01 1.26
MTRR 1 0.007604837 1.45 (1.10, 1.90) 7.70% 1.01 1.25
MTRR 1 0.007604837 1.45 (1.10, 1.90) 7.70% 1.01 1.25
MVD 1 0.008760469 1.53 (1.11, 2.09) 8.20% 1.01 1.25
MYBPHL -1 0.006565434 0.69 (0.53, 0.90) 7.10% 1.01 1.27
MYH3 -1 0.009625687 0.59 (0.40, 0.88) 8.60% 1.01 1.26
MYO1F -1 0.007103603 0.64 (0.47, 0.89) 7.40% 1.01 1.27
MZT2B -1 0.009962642 0.61 (0.41, 0.89) 8.80% 1.01 1.26
NAGPA -1 0.009376889 0.65 (0.47, 0.90) 8.50% 1.01 1.26
NAT15 -1 0.006663053 0.56 (0.37, 0.85) 7.10% 1.01 1.28
NAT15 -1 0.006663053 0.56 (0.37, 0.85) 7.10% 1.01 1.28
NAT15 -1 0.006663053 0.56 (0.37, 0.85) 7.10% 1.01 1.28
NCAPH 1 0.008056556 1.81 (1.17, 2.80) 7.90% 1.01 1.24
NCOA3 1 0.007667051 1.43 (1.10, 1.86) 7.70% 1.01 1.25
NCOA3 1 0.007667051 1.43 (1.10, 1.86) 7.70% 1.01 1.25
NCOA3 1 0.007667051 1.43 (1.10, 1.86) 7.70% 1.01 1.25
NCOA3 1 0.007667051 1.43 (1.10, 1.86) 7.70% 1.01 1.25
NCRNA00160 -1 0.008094623 0.64 (0.45, 0.89) 7.90% 1.01 1.27
NCRNA00200 1 0.005171237 1.32 (1.09, 1.61) 6.30% 1.01 1.23
NDUFS6 1 0.00974941 1.54 (1.11, 2.15) 8.70% 1.01 1.25
NECAP1 -1 0.007788839 0.63 (0.45, 0.89) 7.80% 1.01 1.27
NECAP1 -1 0.007788839 0.63 (0.45, 0.89) 7.80% 1.01 1.27
NEK10 -1 0.008430987 0.59 (0.39, 0.87) 8.10% 1.01 1.27
NFIB 1 0.00819163 1.68 (1.14, 2.46) 8.00% 1.01 1.25
NFIB 1 0.00819163 1.68 (1.14, 2.46) 8.00% 1.01 1.25
NFIB 1 0.00819163 1.68 (1.14, 2.46) 8.00% 1.01 1.25
NME2 1 0.008082262 1.49 (1.11, 2.01) 7.90% 1.01 1.25
NME2 1 0.008082262 1.49 (1.11, 2.01) 7.90% 1.01 1.25
NME2 1 0.008082262 1.49 (1.11, 2.01) 7.90% 1.01 1.25
NME2 1 0.008082262 1.49 (1.11, 2.01) 7.90% 1.01 1.25
NME2 1 0.008082262 1.49 (1.11, 2.01) 7.90% 1.01 1.25
NOL11 1 0.00717401 1.48 (1.11, 1.98) 7.40% 1.01 1.25
NOMO2 -1 0.009847368 0.70 (0.54, 0.92) 8.70% 1.01 1.25
NOMO2 -1 0.009847368 0.70 (0.54, 0.92) 8.70% 1.01 1.25
NOSTRIN -1 0.008395695 0.61 (0.43, 0.88) 8.10% 1.01 1.27
NOSTRIN -1 0.008395695 0.61 (0.43, 0.88) 8.10% 1.01 1.27
NOSTRIN -1 0.008395695 0.61 (0.43, 0.88) 8.10% 1.01 1.27
NOSTRIN -1 0.008395695 0.61 (0.43, 0.88) 8.10% 1.01 1.27
NXNL2 -1 0.008196179 0.65 (0.47, 0.89) 8.00% 1.01 1.27
NXNL2 -1 0.008196179 0.65 (0.47, 0.89) 8.00% 1.01 1.27
NXPH4 1 0.009631141 1.73 (1.14, 2.63) 8.60% 1.01 1.24
OXR1 1 0.009643083 1.53 (1.11, 2.10) 8.60% 1.01 1.25
OXR1 1 0.009643083 1.53 (1.11, 2.10) 8.60% 1.01 1.25
OXR1 1 0.009643083 1.53 (1.11, 2.10) 8.60% 1.01 1.25
OXR1 1 0.009643083 1.53 (1.11, 2.10) 8.60% 1.01 1.25
OXR1 1 0.009643083 1.53 (1.11, 2.10) 8.60% 1.01 1.25
OXR1 1 0.009643083 1.53 (1.11, 2.10) 8.60% 1.01 1.25
PAQR7 -1 0.00769964 0.61 (0.43, 0.88) 7.70% 1.01 1.27
PCDHGA6 1 0.008575643 1.59 (1.12, 2.24) 8.10% 1.01 1.25
PCDHGA7 1 0.010164903 1.80 (1.15, 2.83) 8.90% 1.01 1.23
PCDHGB4 1 0.008741639 1.56 (1.12, 2.18) 8.20% 1.01 1.25
PDIA6 1 0.006612815 1.66 (1.15, 2.39) 7.10% 1.01 1.26
PECI -1 0.008942033 0.71 (0.55, 0.92) 8.30% 1.01 1.25
PECI -1 0.008942033 0.71 (0.55, 0.92) 8.30% 1.01 1.25
PECI -1 0.008942033 0.71 (0.55, 0.92) 8.30% 1.01 1.25
PECI -1 0.008942033 0.71 (0.55, 0.92) 8.30% 1.01 1.25
PGA3 1 0.007689689 1.29 (1.07, 1.55) 7.70% 1.01 1.21
PHF11 -1 0.008193688 0.62 (0.43, 0.88) 8.00% 1.01 1.27
PHF11 -1 0.008193688 0.62 (0.43, 0.88) 8.00% 1.01 1.27
PHTF1 -1 0.007951372 0.63 (0.44, 0.88) 7.90% 1.01 1.27
PIAS4 -1 0.008102516 0.62 (0.44, 0.88) 7.90% 1.01 1.27
PITX3 -1 0.007254858 0.64 (0.47, 0.89) 7.50% 1.01 1.27
PLEKHG1 1 0.00933219 1.67 (1.13, 2.45) 8.50% 1.01 1.25
POLR3K -1 0.00967405 0.65 (0.47, 0.90) 8.60% 1.01 1.26
POU6F1 -1 0.007157717 0.65 (0.48, 0.89) 7.40% 1.01 1.27
POU6F1 -1 0.007157717 0.65 (0.48, 0.89) 7.40% 1.01 1.27
PPP6R2 1 0.006788571 1.38 (1.09, 1.75) 7.20% 1.01 1.24
PRDX4 1 0.00907468 1.58 (1.12, 2.23) 8.40% 1.01 1.25
PRELID2 -1 0.007576831 0.63 (0.45, 0.88) 7.70% 1.01 1.27
PRELID2 -1 0.007576831 0.63 (0.45, 0.88) 7.70% 1.01 1.27
PRELID2 -1 0.007576831 0.63 (0.45, 0.88) 7.70% 1.01 1.27
PSME4 1 0.008102155 1.51 (1.11, 2.06) 7.90% 1.01 1.25
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PTGER3 -1 0.008081201 0.58 (0.39, 0.87) 7.90% 1.01 1.27
PYGO2 -1 0.007468171 0.71 (0.55, 0.91) 7.60% 1.01 1.26
RABEP1 -1 0.008329941 0.57 (0.37, 0.86) 8.00% 1.01 1.27
RABEP1 -1 0.008329941 0.57 (0.37, 0.86) 8.00% 1.01 1.27
RABGAP1L 1 0.006232014 1.54 (1.13, 2.10) 6.90% 1.01 1.26
RABGAP1L 1 0.006232014 1.54 (1.13, 2.10) 6.90% 1.01 1.26
RAD9A -1 0.009330391 0.65 (0.46, 0.90) 8.50% 1.01 1.27
RAGE -1 0.006700386 0.61 (0.42, 0.87) 7.10% 1.01 1.28
RAPGEF2 1 0.008912008 1.80 (1.16, 2.79) 8.30% 1.01 1.24
RASGEF1B 1 0.006561595 1.50 (1.12, 2.02) 7.10% 1.01 1.26
RCBTB1 -1 0.007874485 0.60 (0.41, 0.87) 7.80% 1.01 1.27
RFWD3 1 0.007383613 1.50 (1.12, 2.03) 7.60% 1.01 1.26
RGR 1 0.005959146 1.46 (1.12, 1.92) 6.80% 1.01 1.26
RGR 1 0.005959146 1.46 (1.12, 1.92) 6.80% 1.01 1.26
RGR 1 0.005959146 1.46 (1.12, 1.92) 6.80% 1.01 1.26
RGS14 -1 0.009804379 0.65 (0.46, 0.90) 8.70% 1.01 1.26
RHBDD3 1 0.009281818 1.97 (1.18, 3.28) 8.50% 1.01 1.22
RIPPLY1 1 0.010067371 1.60 (1.12, 2.30) 8.80% 1.01 1.24
RIPPLY1 1 0.010067371 1.60 (1.12, 2.30) 8.80% 1.01 1.24
RNASE11 1 0.007561084 1.36 (1.09, 1.71) 7.70% 1.01 1.24
RNF125 -1 0.006986535 0.65 (0.48, 0.89) 7.30% 1.01 1.27
RNF180 -1 0.00949659 0.64 (0.46, 0.90) 8.60% 1.01 1.26
RNF180 -1 0.00949659 0.64 (0.46, 0.90) 8.60% 1.01 1.26
RNF214 -1 0.005949891 0.69 (0.53, 0.90) 6.80% 1.01 1.27
RNF214 -1 0.005949891 0.69 (0.53, 0.90) 6.80% 1.01 1.27
RNF216L 1 0.006855698 1.79 (1.17, 2.73) 7.20% 1.01 1.25
RNF216L 1 0.006855698 1.79 (1.17, 2.73) 7.20% 1.01 1.25
RNF216L 1 0.006855698 1.79 (1.17, 2.73) 7.20% 1.01 1.25
RPH3A 1 0.007850074 1.42 (1.10, 1.85) 7.80% 1.01 1.25
RPH3A 1 0.007850074 1.42 (1.10, 1.85) 7.80% 1.01 1.25
RPL37 1 0.008922524 2.00 (1.19, 3.36) 8.30% 1.01 1.22
RPL3L 1 0.006219667 1.38 (1.10, 1.74) 6.90% 1.01 1.24
RPS27L -1 0.009737503 0.63 (0.45, 0.90) 8.70% 1.01 1.26
RPS8 1 0.008439438 1.88 (1.18, 3.01) 8.10% 1.01 1.24
RPUSD3 -1 0.008911008 0.61 (0.42, 0.88) 8.30% 1.01 1.27
RPUSD3 -1 0.008911008 0.61 (0.42, 0.88) 8.30% 1.01 1.27
RUSC2 -1 0.009594773 0.66 (0.49, 0.91) 8.60% 1.01 1.26
RUSC2 -1 0.009594773 0.66 (0.49, 0.91) 8.60% 1.01 1.26
S100A8 1 0.008623961 1.47 (1.10, 1.96) 8.10% 1.01 1.25
SCAPER 1 0.009790827 1.64 (1.13, 2.38) 8.70% 1.01 1.24
SCAPER 1 0.009790827 1.64 (1.13, 2.38) 8.70% 1.01 1.24
SCFD2 1 0.009357868 1.56 (1.12, 2.18) 8.50% 1.01 1.25
SCUBE3 -1 0.00648237 0.65 (0.47, 0.89) 7.10% 1.01 1.28
SEC24D 1 0.007226299 1.76 (1.17, 2.67) 7.50% 1.01 1.25
SH3RF2 -1 0.008949805 0.59 (0.40, 0.88) 8.30% 1.01 1.27
SIX2 1 0.009940046 1.43 (1.09, 1.89) 8.80% 1.01 1.24
SLC14A2 -1 0.00688137 0.49 (0.29, 0.82) 7.20% 1.01 1.26
SLC25A13 1 0.008049299 1.62 (1.13, 2.32) 7.90% 1.01 1.25
SLC25A13 1 0.008049299 1.62 (1.13, 2.32) 7.90% 1.01 1.25
SLC25A13 1 0.008049299 1.62 (1.13, 2.32) 7.90% 1.01 1.25
SLC25A24 -1 0.006618756 0.59 (0.40, 0.86) 7.10% 1.01 1.28
SLC25A24 -1 0.006618756 0.59 (0.40, 0.86) 7.10% 1.01 1.28
SLC6A15 1 0.007451471 1.56 (1.13, 2.17) 7.60% 1.01 1.26
SLC6A15 1 0.007451471 1.56 (1.13, 2.17) 7.60% 1.01 1.26
SLC6A15 1 0.007451471 1.56 (1.13, 2.17) 7.60% 1.01 1.26
SLC7A13 -1 0.009306511 0.62 (0.43, 0.89) 8.50% 1.01 1.27
SLURP1 1 0.008042738 1.34 (1.08, 1.65) 7.90% 1.01 1.23
SPAM1 1 0.007221968 1.55 (1.13, 2.14) 7.50% 1.01 1.26
SPAM1 1 0.007221968 1.55 (1.13, 2.14) 7.50% 1.01 1.26
SPAM1 1 0.007221968 1.55 (1.13, 2.14) 7.50% 1.01 1.26
SPAM1 1 0.007221968 1.55 (1.13, 2.14) 7.50% 1.01 1.26
SPAM1 1 0.007221968 1.55 (1.13, 2.14) 7.50% 1.01 1.26
SSBP1 1 0.008145394 1.52 (1.11, 2.07) 7.90% 1.01 1.25
STAM2 -1 0.007611313 0.54 (0.34, 0.85) 7.70% 1.01 1.27
STARD13 -1 0.007388965 0.48 (0.28, 0.82) 7.60% 1.01 1.25
STARD13 -1 0.007388965 0.48 (0.28, 0.82) 7.60% 1.01 1.25
STARD13 -1 0.007388965 0.48 (0.28, 0.82) 7.60% 1.01 1.25
STC2 -1 0.007653482 0.57 (0.38, 0.86) 7.70% 1.01 1.27
STIL 1 0.008856454 1.65 (1.13, 2.41) 8.30% 1.01 1.25
STIL 1 0.008856454 1.65 (1.13, 2.41) 8.30% 1.01 1.25
STK11 -1 0.00927752 0.59 (0.40, 0.88) 8.50% 1.01 1.26
STK32B -1 0.007770131 0.54 (0.34, 0.85) 7.80% 1.01 1.26
STOX1 -1 0.009373358 0.60 (0.41, 0.88) 8.50% 1.01 1.27
STOX1 -1 0.009373358 0.60 (0.41, 0.88) 8.50% 1.01 1.27
STOX1 -1 0.009373358 0.60 (0.41, 0.88) 8.50% 1.01 1.27
STOX1 -1 0.009373358 0.60 (0.41, 0.88) 8.50% 1.01 1.27
STOX1 -1 0.009373358 0.60 (0.41, 0.88) 8.50% 1.01 1.27
SURF2 -1 0.008281877 0.61 (0.43, 0.88) 8.00% 1.01 1.27
SYCN 1 0.009880133 1.46 (1.09, 1.94) 8.70% 1.01 1.24
TBC1D10B -1 0.007813488 0.63 (0.44, 0.88) 7.80% 1.01 1.27
TCTN1 -1 0.008791552 0.63 (0.44, 0.89) 8.20% 1.01 1.27
TCTN1 -1 0.008791552 0.63 (0.44, 0.89) 8.20% 1.01 1.27
TCTN1 -1 0.008791552 0.63 (0.44, 0.89) 8.20% 1.01 1.27
TCTN1 -1 0.008791552 0.63 (0.44, 0.89) 8.20% 1.01 1.27
TCTN1 -1 0.008791552 0.63 (0.44, 0.89) 8.20% 1.01 1.27
TEX9 -1 0.009763575 0.62 (0.43, 0.89) 8.70% 1.01 1.26
TFG 1 0.007007574 1.72 (1.16, 2.54) 7.30% 1.01 1.26
TFG 1 0.007007574 1.72 (1.16, 2.54) 7.30% 1.01 1.26
TFG 1 0.007007574 1.72 (1.16, 2.54) 7.30% 1.01 1.26
TFG 1 0.007007574 1.72 (1.16, 2.54) 7.30% 1.01 1.26
TLR7 -1 0.007037628 0.68 (0.51, 0.90) 7.30% 1.01 1.27
TM6SF1 -1 0.0077869 0.63 (0.44, 0.88) 7.80% 1.01 1.27
TM6SF1 -1 0.0077869 0.63 (0.44, 0.88) 7.80% 1.01 1.27
TMEM132A 1 0.007152656 1.73 (1.16, 2.57) 7.40% 1.01 1.25
TMEM132A 1 0.007152656 1.73 (1.16, 2.57) 7.40% 1.01 1.25
TMEM140 1 0.009060643 1.48 (1.10, 1.99) 8.40% 1.01 1.25
TMEM91 -1 0.00674262 0.64 (0.46, 0.88) 7.20% 1.01 1.28
TMEM91 -1 0.00674262 0.64 (0.46, 0.88) 7.20% 1.01 1.28
TMEM91 -1 0.00674262 0.64 (0.46, 0.88) 7.20% 1.01 1.28
TMEM91 -1 0.00674262 0.64 (0.46, 0.88) 7.20% 1.01 1.28
TMEM91 -1 0.00674262 0.64 (0.46, 0.88) 7.20% 1.01 1.28
TMEM91 -1 0.00674262 0.64 (0.46, 0.88) 7.20% 1.01 1.28
TMPRSS13 1 0.008747326 1.84 (1.17, 2.89) 8.20% 1.01 1.24
TMUB2 -1 0.008171294 0.63 (0.45, 0.89) 8.00% 1.01 1.27
TMUB2 -1 0.008171294 0.63 (0.45, 0.89) 8.00% 1.01 1.27
TMUB2 -1 0.008171294 0.63 (0.45, 0.89) 8.00% 1.01 1.27
TNFRSF21 1 0.008234578 1.48 (1.11, 1.99) 8.00% 1.01 1.25
TNIP2 -1 0.008424446 0.60 (0.41, 0.88) 8.10% 1.01 1.27
TNIP2 -1 0.008424446 0.60 (0.41, 0.88) 8.10% 1.01 1.27
topORS -1 0.009571277 0.61 (0.42, 0.89) 8.60% 1.01 1.26
topORS -1 0.009571277 0.61 (0.42, 0.89) 8.60% 1.01 1.26
TPPP 1 0.006317198 1.57 (1.14, 2.18) 7.00% 1.01 1.26
TRAM1 1 0.010148341 1.56 (1.11, 2.20) 8.90% 1.01 1.24
TRIM35 -1 0.006782048 0.59 (0.40, 0.86) 7.20% 1.01 1.28
TRIM45 -1 0.009288628 0.55 (0.36, 0.86) 8.50% 1.01 1.26
TRIM45 -1 0.009288628 0.55 (0.36, 0.86) 8.50% 1.01 1.26
TRIM66 -1 0.006237676 0.63 (0.45, 0.88) 6.90% 1.01 1.28
TRPC4AP 1 0.007218558 1.63 (1.14, 2.32) 7.50% 1.01 1.26
TRPC4AP 1 0.007218558 1.63 (1.14, 2.32) 7.50% 1.01 1.26
TRPC7 1 0.010038406 1.63 (1.12, 2.36) 8.80% 1.01 1.24
TRPC7 1 0.010038406 1.63 (1.12, 2.36) 8.80% 1.01 1.24
TRPC7 1 0.010038406 1.63 (1.12, 2.36) 8.80% 1.01 1.24
TSC1 -1 0.008687639 0.58 (0.39, 0.87) 8.20% 1.01 1.27
TSC1 -1 0.008687639 0.58 (0.39, 0.87) 8.20% 1.01 1.27
TSC1 -1 0.008687639 0.58 (0.39, 0.87) 8.20% 1.01 1.27
TSGA10 -1 0.009624267 0.63 (0.44, 0.89) 8.60% 1.01 1.26
TSGA10 -1 0.009624267 0.63 (0.44, 0.89) 8.60% 1.01 1.26
TSPYL2 -1 0.008608205 0.61 (0.42, 0.88) 8.10% 1.01 1.27
TTC12 -1 0.00902816 0.53 (0.33, 0.86) 8.30% 1.01 1.26
TTC31 -1 0.008773497 0.65 (0.47, 0.90) 8.20% 1.01 1.27
TTC31 -1 0.008773497 0.65 (0.47, 0.90) 8.20% 1.01 1.27
TTC8 -1 0.0075677 0.64 (0.46, 0.89) 7.70% 1.01 1.27
TTC8 -1 0.0075677 0.64 (0.46, 0.89) 7.70% 1.01 1.27
TTC8 -1 0.0075677 0.64 (0.46, 0.89) 7.70% 1.01 1.27
UBA7 -1 0.008940825 0.61 (0.42, 0.88) 8.30% 1.01 1.27
UBR1 1 0.009723514 1.35 (1.08, 1.70) 8.70% 1.01 1.23
UCHL5 1 0.009364974 1.62 (1.13, 2.32) 8.50% 1.01 1.25
UCHL5 1 0.009364974 1.62 (1.13, 2.32) 8.50% 1.01 1.25
UCHL5 1 0.009364974 1.62 (1.13, 2.32) 8.50% 1.01 1.25
UCHL5 1 0.009364974 1.62 (1.13, 2.32) 8.50% 1.01 1.25
UFD1L 1 0.010119718 1.59 (1.12, 2.26) 8.90% 1.01 1.24
UFD1L 1 0.010119718 1.59 (1.12, 2.26) 8.90% 1.01 1.24
ULBP1 1 0.008659691 1.50 (1.11, 2.03) 8.20% 1.01 1.25
VDAC2 1 0.007637438 1.47 (1.11, 1.95) 7.70% 1.01 1.25
VDAC2 1 0.007637438 1.47 (1.11, 1.95) 7.70% 1.01 1.25
VDAC2 1 0.007637438 1.47 (1.11, 1.95) 7.70% 1.01 1.25
VDAC2 1 0.007637438 1.47 (1.11, 1.95) 7.70% 1.01 1.25
VPS13B 1 0.007972288 1.58 (1.13, 2.21) 7.90% 1.01 1.25
VPS13B 1 0.007972288 1.58 (1.13, 2.21) 7.90% 1.01 1.25
VPS13B 1 0.007972288 1.58 (1.13, 2.21) 7.90% 1.01 1.25
VPS13B 1 0.007972288 1.58 (1.13, 2.21) 7.90% 1.01 1.25
VPS24 -1 0.009864489 0.69 (0.52, 0.92) 8.70% 1.01 1.26
VPS24 -1 0.009864489 0.69 (0.52, 0.92) 8.70% 1.01 1.26
VPS24 -1 0.009864489 0.69 (0.52, 0.92) 8.70% 1.01 1.26
VPS24 -1 0.009864489 0.69 (0.52, 0.92) 8.70% 1.01 1.26
VPS37B 1 0.007784747 1.54 (1.12, 2.11) 7.80% 1.01 1.25
WDR67 1 0.007371765 1.70 (1.15, 2.49) 7.60% 1.01 1.25
WDR67 1 0.007371765 1.70 (1.15, 2.49) 7.60% 1.01 1.25
WDR75 -1 0.007896105 0.49 (0.29, 0.83) 7.80% 1.01 1.25
WDTC1 -1 0.008530846 0.63 (0.45, 0.89) 8.10% 1.01 1.27
XPOT 1 0.010160158 1.58 (1.11, 2.24) 8.90% 1.01 1.24
YEATS2 1 0.007348357 1.58 (1.13, 2.22) 7.60% 1.01 1.26
ZC3H18 1 0.007722884 1.66 (1.14, 2.41) 7.70% 1.01 1.25
ZCWPW1 -1 0.008302062 0.57 (0.37, 0.86) 8.00% 1.01 1.27
ZGPAT 1 0.008586682 1.47 (1.10, 1.96) 8.10% 1.01 1.25
ZGPAT 1 0.008586682 1.47 (1.10, 1.96) 8.10% 1.01 1.25
ZGPAT 1 0.008586682 1.47 (1.10, 1.96) 8.10% 1.01 1.25
ZGPAT 1 0.008586682 1.47 (1.10, 1.96) 8.10% 1.01 1.25
ZGPAT 1 0.008586682 1.47 (1.10, 1.96) 8.10% 1.01 1.25
ZNF189 -1 0.006959976 0.58 (0.39, 0.86) 7.30% 1.01 1.27
ZNF189 -1 0.006959976 0.58 (0.39, 0.86) 7.30% 1.01 1.27
ZNF425 -1 0.009534005 0.65 (0.47, 0.90) 8.60% 1.01 1.26
ZNF490 -1 0.006800138 0.57 (0.38, 0.86) 7.20% 1.01 1.27
ZNF528 -1 0.008402995 0.62 (0.43, 0.88) 8.10% 1.01 1.27
ZNF578 -1 0.00702429 0.61 (0.43, 0.88) 7.30% 1.01 1.28
ZNF695 1 0.009425745 1.87 (1.17, 2.99) 8.50% 1.01 1.23
ZNF71 -1 0.006488217 0.67 (0.50, 0.89) 7.10% 1.01 1.27
ZNF791 -1 0.006897515 0.60 (0.42, 0.87) 7.30% 1.01 1.28
ZNF813 -1 0.009651252 0.69 (0.52, 0.91) 8.60% 1.01 1.26
ZZEF1 -1 0.007161028 0.59 (0.41, 0.87) 7.40% 1.01 1.28
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ABI1 1 0.011314556 1.53 (1.10, 2.12) 9.40% 1 1.24
ADCY4 -1 0.012746837 0.60 (0.40, 0.90) 9.90% 1 1.25
ADCY4 -1 0.012746837 0.60 (0.40, 0.90) 9.90% 1 1.25
ADCY4 -1 0.012746837 0.60 (0.40, 0.90) 9.90% 1 1.25
AGBL2 -1 0.012159989 0.69 (0.52, 0.92) 9.70% 1 1.25
AKAP13 1 0.010556574 1.48 (1.10, 2.01) 9.00% 1 1.24
AKAP13 1 0.010556574 1.48 (1.10, 2.01) 9.00% 1 1.24
AKAP13 1 0.010556574 1.48 (1.10, 2.01) 9.00% 1 1.24
AKR1A1 1 0.010860471 1.41 (1.08, 1.83) 9.20% 1 1.23
AKR1A1 1 0.010860471 1.41 (1.08, 1.83) 9.20% 1 1.23
ALDH1B1 -1 0.011726926 0.63 (0.44, 0.90) 9.50% 1 1.26
AMBN 1 0.011422064 1.45 (1.09, 1.94) 9.40% 1 1.24
AMTN 1 0.010260119 1.39 (1.08, 1.79) 8.90% 1 1.23
ANKRD30BP2 1 0.010303181 1.48 (1.10, 2.00) 8.90% 1 1.24
ARFGAP1 1 0.011829858 1.47 (1.09, 1.99) 9.60% 1 1.24
ARFGAP1 1 0.011829858 1.47 (1.09, 1.99) 9.60% 1 1.24
ARMC1 1 0.01157055 1.46 (1.09, 1.95) 9.50% 1 1.24
ARPP21 -1 0.011971679 0.56 (0.35, 0.88) 9.60% 1 1.25
ARPP21 -1 0.011971679 0.56 (0.35, 0.88) 9.60% 1 1.25
ARPP21 -1 0.011971679 0.56 (0.35, 0.88) 9.60% 1 1.25
ARPP21 -1 0.011971679 0.56 (0.35, 0.88) 9.60% 1 1.25
ARSD -1 0.011023269 0.65 (0.47, 0.91) 9.20% 1 1.26
ARSD -1 0.011023269 0.65 (0.47, 0.91) 9.20% 1 1.26
ATP11B 1 0.011169252 1.56 (1.11, 2.20) 9.30% 1 1.24
BCKDHA -1 0.010291527 0.67 (0.49, 0.91) 8.90% 1 1.26
BCKDHA -1 0.010291527 0.67 (0.49, 0.91) 8.90% 1 1.26
BRIP1 1 0.012952368 1.55 (1.10, 2.19) 10.00% 1 1.24
C11orf74 -1 0.010770379 0.66 (0.48, 0.91) 9.10% 1 1.26
C14orf23 1 0.011832502 1.39 (1.08, 1.80) 9.60% 1 1.23
C14orf23 1 0.011832502 1.39 (1.08, 1.80) 9.60% 1 1.23
C16orf5 -1 0.010242171 0.66 (0.48, 0.91) 8.90% 1 1.26
C16orf5 -1 0.010242171 0.66 (0.48, 0.91) 8.90% 1 1.26
C16orf5 -1 0.010242171 0.66 (0.48, 0.91) 8.90% 1 1.26
C16orf5 -1 0.010242171 0.66 (0.48, 0.91) 8.90% 1 1.26
C17orf97 -1 0.012338083 0.60 (0.40, 0.89) 9.80% 1 1.25
C18orf55 -1 0.011092298 0.68 (0.50, 0.91) 9.30% 1 1.26
Clorf124 1 0.012304896 1.61 (1.11, 2.33) 9.80% 1 1.24
C1orf124 1 0.012304896 1.61 (1.11, 2.33) 9.80% 1 1.24
C20orf30 1 0.011038247 1.55 (1.11, 2.17) 9.20% 1 1.24
C20orf30 1 0.011038247 1.55 (1.11, 2.17) 9.20% 1 1.24
C20orf30 1 0.011038247 1.55 (1.11, 2.17) 9.20% 1 1.24
C20orf30 1 0.011038247 1.55 (1.11, 2.17) 9.20% 1 1.24
C20orf96 -1 0.010956191 0.65 (0.46, 0.90) 9.20% 1 1.26
C22orf26 -1 0.011951339 0.68 (0.50, 0.92) 9.60% 1 1.25
C3orf24 1 0.011566363 1.65 (1.12, 2.44) 9.50% 1 1.24
C3orf24 1 0.011566363 1.65 (1.12, 2.44) 9.50% 1 1.24
C4orf21 1 0.012027146 1.57 (1.10, 2.24) 9.60% 1 1.24
C5orf38 -1 0.012871615 0.63 (0.44, 0.91) 10.00% 1 1.25
C9orf117 -1 0.012155809 0.66 (0.48, 0.91) 9.70% 1 1.25
C9orf68 -1 0.011881699 0.64 (0.45, 0.91) 9.60% 1 1.26
CAPG -1 0.01139945 0.64 (0.45, 0.90) 9.40% 1 1.26
CASP14 1 0.011468521 1.45 (1.09, 1.94) 9.40% 1 1.24
CBX7 -1 0.010411793 0.64 (0.46, 0.90) 8.90% 1 1.26
CCDC11 -1 0.01124832 0.62 (0.42, 0.90) 9.30% 1 1.26
CD2BP2 -1 0.012203297 0.66 (0.48, 0.91) 9.70% 1 1.25
CD2BP2 -1 0.012203297 0.66 (0.48, 0.91) 9.70% 1 1.25
CDC25C 1 0.012973395 2.13 (1.17, 3.88) 10.00% 1 1.2
CDC25C 1 0.012973395 2.13 (1.17, 3.88) 10.00% 1 1.2
CDCA2 1 0.01062877 1.77 (1.14, 2.73) 9.00% 1 1.23
CHEK2 1 0.010238312 1.55 (1.11, 2.17) 8.90% 1 1.24
CHEK2 1 0.010238312 1.55 (1.11, 2.17) 8.90% 1 1.24
CHEK2 1 0.010238312 1.55 (1.11, 2.17) 8.90% 1 1.24
CHMP2A -1 0.011849205 0.69 (0.52, 0.92) 9.60% 1 1.25
CHMP2A -1 0.011849205 0.69 (0.52, 0.92) 9.60% 1 1.25
CIZ1 -1 0.011264428 0.64 (0.45, 0.90) 9.30% 1 1.26
CIZ1 -1 0.011264428 0.64 (0.45, 0.90) 9.30% 1 1.26
CIZ1 -1 0.011264428 0.64 (0.45, 0.90) 9.30% 1 1.26
CIZ1 -1 0.011264428 0.64 (0.45, 0.90) 9.30% 1 1.26
CIZ1 -1 0.011264428 0.64 (0.45, 0.90) 9.30% 1 1.26
CLEC6A 1 0.011311521 1.54 (1.10, 2.14) 9.40% 1 1.24
COL6A4P1 1 0.011152024 1.74 (1.13, 2.66) 9.30% 1 1.23
CPT2 -1 0.011138461 0.71 (0.55, 0.93) 9.30% 1 1.25
CYHR1 1 0.010619769 1.71 (1.13, 2.59) 9.00% 1 1.24
CYHR1 1 0.010619769 1.71 (1.13, 2.59) 9.00% 1 1.24
CYHR1 1 0.010619769 1.71 (1.13, 2.59) 9.00% 1 1.24
CYTH2 -1 0.010385083 0.61 (0.41, 0.89) 8.90% 1 1.26
CYTH2 -1 0.010385083 0.61 (0.41, 0.89) 8.90% 1 1.26
DDX47 -1 0.010917905 0.59 (0.40, 0.89) 9.20% 1 1.26
DDX47 -1 0.010917905 0.59 (0.40, 0.89) 9.20% 1 1.26
DEFB123 1 0.010229146 1.42 (1.09, 1.85) 8.90% 1 1.24
DIAPH1 1 0.012626509 1.59 (1.10, 2.28) 9.90% 1 1.24
DIAPH1 1 0.012626509 1.59 (1.10, 2.28) 9.90% 1 1.24
DIAPH2 1 0.012938831 1.64 (1.11, 2.41) 10.00% 1 1.23
DIAPH2 1 0.012938831 1.64 (1.11, 2.41) 10.00% 1 1.23
DIAPH3 1 0.011764308 1.73 (1.13, 2.65) 9.60% 1 1.23
DIAPH3 1 0.011764308 1.73 (1.13, 2.65) 9.60% 1 1.23
DIXDC1 -1 0.012908259 0.59 (0.39, 0.90) 10.00% 1 1.25
DIXDC1 -1 0.012908259 0.59 (0.39, 0.90) 10.00% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DMKN -1 0.011852194 0.69 (0.52, 0.92) 9.60% 1 1.25
DNALI1 -1 0.011877008 0.64 (0.45, 0.91) 9.60% 1 1.26
DPCD -1 0.012550805 0.65 (0.47, 0.91) 9.90% 1 1.25
DSCR8 1 0.010278294 1.47 (1.09, 1.97) 8.90% 1 1.24
DSCR8 1 0.010278294 1.47 (1.09, 1.97) 8.90% 1 1.24
DSCR8 1 0.010278294 1.47 (1.09, 1.97) 8.90% 1 1.24
DSCR8 1 0.010278294 1.47 (1.09, 1.97) 8.90% 1 1.24
DSCR8 1 0.010278294 1.47 (1.09, 1.97) 8.90% 1 1.24
DYNC1I2 -1 0.011091334 0.66 (0.48, 0.91) 9.30% 1 1.26
E2F1 1 0.012893985 1.55 (1.10, 2.18) 10.00% 1 1.24
EEF2K -1 0.012968682 0.54 (0.33, 0.88) 10.00% 1 1.24
EIF3H 1 0.011777481 1.47 (1.09, 1.99) 9.60% 1 1.24
ENO3 -1 0.012599193 0.71 (0.55, 0.93) 9.90% 1 1.24
ENO3 -1 0.012599193 0.71 (0.55, 0.93) 9.90% 1 1.24
ENO3 -1 0.012599193 0.71 (0.55, 0.93) 9.90% 1 1.24
EPX -1 0.012837554 0.67 (0.49, 0.92) 10.00% 1 1.25
EVL -1 0.011561201 0.54 (0.34, 0.87) 9.50% 1 1.25
FAM115A -1 0.010185752 0.69 (0.52, 0.92) 8.90% 1 1.26
FAM120A -1 0.011120887 0.59 (0.39, 0.89) 9.30% 1 1.26
FAM126A 1 0.012480024 1.92 (1.15, 3.20) 9.80% 1 1.21
FAM170A 1 0.011370873 1.46 (1.09, 1.97) 9.40% 1 1.24
FAM170A 1 0.011370873 1.46 (1.09, 1.97) 9.40% 1 1.24
FGB 1 0.012651414 1.36 (1.07, 1.73) 9.90% 1 1.22
FGB 1 0.012651414 1.36 (1.07, 1.73) 9.90% 1 1.22
FMNL3 -1 0.010449305 0.68 (0.51, 0.91) 9.00% 1 1.26
FMNL3 -1 0.010449305 0.68 (0.51, 0.91) 9.00% 1 1.26
GJA1 -1 0.010395278 0.61 (0.42, 0.89) 8.90% 1 1.26
GJA5 -1 0.011769561 0.66 (0.48, 0.91) 9.60% 1 1.26
GJA5 -1 0.011769561 0.66 (0.48, 0.91) 9.60% 1 1.26
GMFB -1 0.012184114 0.64 (0.45, 0.91) 9.70% 1 1.26
GPR180 1 0.011018759 1.78 (1.14, 2.79) 9.20% 1 1.23
GUCY2E 1 0.011410591 1.53 (1.10, 2.13) 9.40% 1 1.24
HOMER1 1 0.011336137 1.65 (1.12, 2.42) 9.40% 1 1.24
HOOK2 -1 0.011600713 0.67 (0.49, 0.92) 9.50% 1 1.25
HOOK2 -1 0.011600713 0.67 (0.49, 0.92) 9.50% 1 1.25
HOXA11 1 0.012018331 1.45 (1.09, 1.94) 9.60% 1 1.24
HSD11B1 1 0.010395781 1.46 (1.09, 1.94) 8.90% 1 1.24
H5D11B1 1 0.010395781 1.46 (1.09, 1.94) 8.90% 1 1.24
HSPA12B -1 0.012610444 0.61 (0.41, 0.90) 9.90% 1 1.25
HSPA12B -1 0.012610444 0.61 (0.41, 0.90) 9.90% 1 1.25
HSPG2 -1 0.010853095 0.61 (0.42, 0.89) 9.20% 1 1.26
HUWE1 1 0.011791679 1.59 (1.11, 2.29) 9.60% 1 1.24
HYAL2 -1 0.010655266 0.70 (0.54, 0.92) 9.00% 1 1.25
HYAL2 -1 0.010655266 0.70 (0.54, 0.92) 9.00% 1 1.25
IKBKAP -1 0.011093127 0.59 (0.40, 0.89) 9.30% 1 1.26
IKBKB -1 0.011775833 0.61 (0.42, 0.90) 9.60% 1 1.26
IKBKB -1 0.011775833 0.61 (0.42, 0.90) 9.60% 1 1.26
IKBKB -1 0.011775833 0.61 (0.42, 0.90) 9.60% 1 1.26
IKBKB -1 0.011775833 0.61 (0.42, 0.90) 9.60% 1 1.26
IKBKB -1 0.011775833 0.61 (0.42, 0.90) 9.60% 1 1.26
IKBKB -1 0.011775833 0.61 (0.42, 0.90) 9.60% 1 1.26
IKBKB -1 0.011775833 0.61 (0.42, 0.90) 9.60% 1 1.26
IL17C 1 0.010547784 1.50 (1.10, 2.04) 9.00% 1 1.24
ILF2 1 0.012045497 1.59 (1.11, 2.28) 9.60% 1 1.24
ITPRIP 1 0.010966603 1.63 (1.12, 2.36) 9.20% 1 1.24
KIAA0528 -1 0.0115925 0.64 (0.46, 0.91) 9.50% 1 1.26
KIAA1644 -1 0.010636853 0.65 (0.47, 0.91) 9.00% 1 1.26
KIF1C -1 0.0120162 0.67 (0.49, 0.91) 9.60% 1 1.25
KRT6C 1 0.012814231 1.38 (1.07, 1.79) 10.00% 1 1.23
LGMN 1 0.011416167 1.45 (1.09, 1.94) 9.40% 1 1.24
LGMN 1 0.011416167 1.45 (1.09, 1.94) 9.40% 1 1.24
LINGO1 1 0.012057057 1.70 (1.12, 2.56) 9.60% 1 1.23
LIX1 1 0.01111679 1.59 (1.11, 2.28) 9.30% 1 1.24
LOC100129931 -1 0.011472246 0.65 (0.46, 0.91) 9.40% 1 1.26
LOC100233209 1 0.012607821 1.43 (1.08, 1.90) 9.90% 1 1.23
LOC144776 1 0.012325145 1.38 (1.07, 1.79) 9.80% 1 1.23
LOC283761 1 0.011585471 1.57 (1.11, 2.24) 9.50% 1 1.24
LOC283761 1 0.011585471 1.57 (1.11, 2.24) 9.50% 1 1.24
LOC283761 1 0.011585471 1.57 (1.11, 2.24) 9.50% 1 1.24
LOC283761 1 0.011585471 1.57 (1.11, 2.24) 9.50% 1 1.24
LOC400043 -1 0.011245964 0.65 (0.47, 0.91) 9.30% 1 1.26
LOC91316 1 0.011446822 1.67 (1.12, 2.48) 9.40% 1 1.24
LOXL3 -1 0.012709255 0.65 (0.46, 0.91) 9.90% 1 1.25
LRGUK -1 0.010254375 0.65 (0.47, 0.90) 8.90% 1 1.26
LRPAP1 -1 0.011640785 0.60 (0.40, 0.89) 9.50% 1 1.26
LRRC23 -1 0.011607799 0.64 (0.45, 0.90) 9.50% 1 1.26
LRRC23 -1 0.011607799 0.64 (0.45, 0.90) 9.50% 1 1.26
LRRC23 -1 0.011607799 0.64 (0.45, 0.90) 9.50% 1 1.26
LRRC56 -1 0.010591983 0.68 (0.51, 0.92) 9.00% 1 1.26
LRTOMT -1 0.010400431 0.59 (0.40, 0.88) 8.90% 1 1.26
LRTOMT -1 0.010400431 0.59 (0.40, 0.88) 8.90% 1 1.26
LRTOMT -1 0.010400431 0.59 (0.40, 0.88) 8.90% 1 1.26
LRTOMT -1 0.010400431 0.59 (0.40, 0.88) 8.90% 1 1.26
LRTOMT -1 0.010400431 0.59 (0.40, 0.88) 8.90% 1 1.26
LRTOMT -1 0.010400431 0.59 (0.40, 0.88) 8.90% 1 1.26
LYRM1 -1 0.012839377 0.59 (0.38, 0.89) 10.00% 1 1.25
LYRM1 -1 0.012839377 0.59 (0.38, 0.89) 10.00% 1 1.25
LYRM1 -1 0.012839377 0.59 (0.38, 0.89) 10.00% 1 1.25
MAML1 1 0.012398823 1.60 (1.11, 2.31) 9.80% 1 1.24
MAP3K1 -1 0.012373459 0.60 (0.40, 0.90) 9.80% 1 1.25
MAPK14 1 0.012704887 1.45 (1.08, 1.94) 9.90% 1 1.23
MAPK14 1 0.012704887 1.45 (1.08, 1.94) 9.90% 1 1.23
MAPK14 1 0.012704887 1.45 (1.08, 1.94) 9.90% 1 1.23
MAPK14 1 0.012704887 1.45 (1.08, 1.94) 9.90% 1 1.23
MDH1B -1 0.012649336 0.68 (0.51, 0.92) 9.90% 1 1.25
MEIS1 1 0.012898017 1.69 (1.12, 2.55) 10.00% 1 1.23
MEIS3 -1 0.012545351 0.63 (0.44, 0.91) 9.90% 1 1.25
MEIS3 -1 0.012545351 0.63 (0.44, 0.91) 9.90% 1 1.25
MORN1 -1 0.011397709 0.63 (0.45, 0.90) 9.40% 1 1.26
MPHOSPH9 1 0.012594163 1.53 (1.10, 2.15) 9.90% 1 1.24
MPZL1 1 0.012035119 1.49 (1.09, 2.04) 9.60% 1 1.24
MPZL1 1 0.012035119 1.49 (1.09, 2.04) 9.60% 1 1.24
MPZL1 1 0.012035119 1.49 (1.09, 2.04) 9.60% 1 1.24
MRPL34 1 0.012406647 1.51 (1.09, 2.08) 9.80% 1 1.24
MSTO1 1 0.012937941 1.59 (1.10, 2.29) 10.00% 1 1.23
MYLK2 1 0.010890821 1.66 (1.12, 2.45) 9.20% 1 1.24
MYO7A 1 0.012737066 1.56 (1.10, 2.22) 9.90% 1 1.24
MYO7A 1 0.012737066 1.56 (1.10, 2.22) 9.90% 1 1.24
MYO7A 1 0.012737066 1.56 (1.10, 2.22) 9.90% 1 1.24
MYOG 1 0.011353552 1.36 (1.07, 1.72) 9.40% 1 1.23
NAA15 1 0.012422722 1.54 (1.10, 2.16) 9.80% 1 1.24
NBAS 1 0.012672103 1.55 (1.10, 2.19) 9.90% 1 1.24
NBPF3 -1 0.012664759 0.70 (0.52, 0.93) 9.90% 1 1.25
NDUFB6 -1 0.012109776 0.66 (0.48, 0.91) 9.70% 1 1.25
NDUFB6 -1 0.012109776 0.66 (0.48, 0.91) 9.70% 1 1.25
NDUFB6 -1 0.012109776 0.66 (0.48, 0.91) 9.70% 1 1.25
NFE2L1 -1 0.010751476 0.65 (0.47, 0.91) 9.10% 1 1.26
NOL10 1 0.011705945 1.59 (1.11, 2.28) 9.50% 1 1.24
NPHS2 -1 0.011756253 0.58 (0.38, 0.89) 9.60% 1 1.25
NPLOC4 1 0.011913565 1.61 (1.11, 2.35) 9.60% 1 1.24
NUDT21 1 0.011032838 1.60 (1.11, 2.30) 9.20% 1 1.24
NUP188 -1 0.011639171 0.55 (0.34, 0.87) 9.50% 1 1.25
OTOL1 1 0.012763111 1.39 (1.07, 1.81) 9.90% 1 1.23
PARP3 -1 0.01013124 0.68 (0.50, 0.91) 8.90% 1 1.26
PARP3 -1 0.01013124 0.68 (0.50, 0.91) 8.90% 1 1.26
PCDH11Y 1 0.012243822 1.46 (1.09, 1.97) 9.70% 1 1.24
PCDH11Y 1 0.012243822 1.46 (1.09, 1.97) 9.70% 1 1.24
PCDH11Y 1 0.012243822 1.46 (1.09, 1.97) 9.70% 1 1.24
PDE2A 1 0.010557993 1.43 (1.09, 1.88) 9.00% 1 1.24
PDE2A 1 0.010557993 1.43 (1.09, 1.88) 9.00% 1 1.24
PDE2A 1 0.010557993 1.43 (1.09, 1.88) 9.00% 1 1.24
PDE2A 1 0.010557993 1.43 (1.09, 1.88) 9.00% 1 1.24
PDE4A -1 0.01282959 0.66 (0.48, 0.92) 10.00% 1 1.25
PDE4A -1 0.01282959 0.66 (0.48, 0.92) 10.00% 1 1.25
PDE4A -1 0.01282959 0.66 (0.48, 0.92) 10.00% 1 1.25
PDE4A -1 0.01282959 0.66 (0.48, 0.92) 10.00% 1 1.25
PERP 1 0.012898142 1.49 (1.09, 2.04) 10.00% 1 1.24
PHGR1 -1 0.010645275 0.68 (0.50, 0.91) 9.00% 1 1.26
PHLDB1 -1 0.010487792 0.62 (0.43, 0.90) 9.00% 1 1.26
PHLDB1 -1 0.010487792 0.62 (0.43, 0.90) 9.00% 1 1.26
PHLDB1 -1 0.010487792 0.62 (0.43, 0.90) 9.00% 1 1.26
PIGL -1 0.012014368 0.68 (0.51, 0.92) 9.60% 1 1.25
PLA2G7 1 0.010739931 1.45 (1.09, 1.92) 9.10% 1 1.24
PLA2G7 1 0.010739931 1.45 (1.09, 1.92) 9.10% 1 1.24
PLEKHM2 -1 0.010229479 0.64 (0.46, 0.90) 8.90% 1 1.26
POPDC2 -1 0.011856189 0.66 (0.47, 0.91) 9.60% 1 1.26
PPM1B 1 0.011847581 1.59 (1.11, 2.29) 9.60% 1 1.24
PPM1B 1 0.011847581 1.59 (1.11, 2.29) 9.60% 1 1.24
PPM1B 1 0.011847581 1.59 (1.11, 2.29) 9.60% 1 1.24
PPM1B 1 0.011847581 1.59 (1.11, 2.29) 9.60% 1 1.24
PPM1B 1 0.011847581 1.59 (1.11, 2.29) 9.60% 1 1.24
PPP1R14C 1 0.010609549 1.69 (1.13, 2.54) 9.00% 1 1.24
PPP3R1 1 0.011797778 1.48 (1.09, 2.00) 9.60% 1 1.24
PPP6R3 1 0.01182462 1.46 (1.09, 1.96) 9.60% 1 1.24
PPP6R3 1 0.01182462 1.46 (1.09, 1.96) 9.60% 1 1.24
PPP6R3 1 0.01182462 1.46 (1.09, 1.96) 9.60% 1 1.24
PPP6R3 1 0.01182462 1.46 (1.09, 1.96) 9.60% 1 1.24
PPP6R3 1 0.01182462 1.46 (1.09, 1.96) 9.60% 1 1.24
PPP6R3 1 0.01182462 1.46 (1.09, 1.96) 9.60% 1 1.24
PRAME 1 0.012015796 1.56 (1.10, 2.20) 9.60% 1 1.24
PRAME 1 0.012015796 1.56 (1.10, 2.20) 9.60% 1 1.24
PRAME 1 0.012015796 1.56 (1.10, 2.20) 9.60% 1 1.24
PRAME 1 0.012015796 1.56 (1.10, 2.20) 9.60% 1 1.24
PRAME 1 0.012015796 1.56 (1.10, 2.20) 9.60% 1 1.24
PRDM1 1 0.010864619 1.56 (1.11, 2.21) 9.20% 1 1.24
PRDM1 1 0.010864619 1.56 (1.11, 2.21) 9.20% 1 1.24
PRIM2 1 0.01189465 1.53 (1.10, 2.13) 9.60% 1 1.24
PSMD11 1 0.012123119 1.56 (1.10, 2.21) 9.70% 1 1.24
PTPRT -1 0.012542322 0.60 (0.40, 0.90) 9.90% 1 1.25
PTPRT -1 0.012542322 0.60 (0.40, 0.90) 9.90% 1 1.25
QPRT 1 0.012915155 1.66 (1.11, 2.49) 10.00% 1 1.23
RACGAP1 1 0.012817548 1.63 (1.11, 2.40) 10.00% 1 1.23
RACGAP1 1 0.012817548 1.63 (1.11, 2.40) 10.00% 1 1.23
RACGAP1 1 0.012817548 1.63 (1.11, 2.40) 10.00% 1 1.23
RAMP2 -1 0.011709734 0.68 (0.50, 0.92) 9.50% 1 1.25
RARRES3 -1 0.012940159 0.54 (0.33, 0.88) 10.00% 1 1.24
RASGRF1 1 0.011225453 1.57 (1.11, 2.23) 9.30% 1 1.24
RASGRF1 1 0.011225453 1.57 (1.11, 2.23) 9.30% 1 1.24
RASGRF1 1 0.011225453 1.57 (1.11, 2.23) 9.30% 1 1.24
RBM45 -1 0.01057111 0.67 (0.49, 0.91) 9.00% 1 1.26
REPS1 1 0.010521625 1.55 (1.11, 2.16) 9.00% 1 1.24
REPS1 1 0.010521625 1.55 (1.11, 2.16) 9.00% 1 1.24
RFC4 1 0.010308541 1.53 (1.11, 2.11) 8.90% 1 1.24
RFC4 1 0.010308541 1.53 (1.11, 2.11) 8.90% 1 1.24
RHOXF1 -1 0.012326771 0.66 (0.48, 0.92) 9.80% 1 1.25
RNF126 -1 0.010822836 0.66 (0.48, 0.91) 9.10% 1 1.26
RNMTL1 -1 0.012150331 0.61 (0.41, 0.90) 9.70% 1 1.25
RSPO1 -1 0.010347188 0.61 (0.41, 0.89) 8.90% 1 1.26
SARS -1 0.011466736 0.61 (0.42, 0.90) 9.40% 1 1.26
SARS -1 0.011466736 0.61 (0.42, 0.90) 9.40% 1 1.26
SARS -1 0.011466736 0.61 (0.42, 0.90) 9.40% 1 1.26
SAT1 1 0.012394064 1.48 (1.09, 2.02) 9.80% 1 1.24
SAT1 1 0.012394064 1.48 (1.09, 2.02) 9.80% 1 1.24
SATB2 1 0.011161894 1.72 (1.13, 2.61) 9.30% 1 1.23
SATB2 1 0.011161894 1.72 (1.13, 2.61) 9.30% 1 1.23
SATB2 1 0.011161894 1.72 (1.13, 2.61) 9.30% 1 1.23
SCARF1 -1 0.012672823 0.61 (0.41, 0.90) 9.90% 1 1.25
SCARF1 -1 0.012672823 0.61 (0.41, 0.90) 9.90% 1 1.25
SCARF1 -1 0.012672823 0.61 (0.41, 0.90) 9.90% 1 1.25
SCARF1 -1 0.012672823 0.61 (0.41, 0.90) 9.90% 1 1.25
SCARF1 -1 0.012672823 0.61 (0.41, 0.90) 9.90% 1 1.25
SERPINI1 -1 0.012995951 0.60 (0.40, 0.90) 10.00% 1 1.25
SERPINI1 -1 0.012995951 0.60 (0.40, 0.90) 10.00% 1 1.25
SGSM2 -1 0.012351408 0.61 (0.41, 0.90) 9.80% 1 1.25
SGSM2 -1 0.012351408 0.61 (0.41, 0.90) 9.80% 1 1.25
SHF -1 0.010407548 0.64 (0.46, 0.90) 8.90% 1 1.26
SIRT3 -1 0.010395406 0.66 (0.48, 0.91) 8.90% 1 1.26
SIRT3 -1 0.010395406 0.66 (0.48, 0.91) 8.90% 1 1.26
SLC25A45 -1 0.01047703 0.67 (0.49, 0.91) 9.00% 1 1.26
SLC25A45 -1 0.01047703 0.67 (0.49, 0.91) 9.00% 1 1.26
SLC2A1 1 0.012060656 1.50 (1.09, 2.06) 9.60% 1 1.24
SLC2A8 -1 0.012758716 0.59 (0.39, 0.89) 9.90% 1 1.25
SLC3OA3 1 0.012074545 1.47 (1.09, 1.98) 9.60% 1 1.24
SMG6 -1 0.011386009 0.56 (0.36, 0.88) 9.40% 1 1.25
SMG6 -1 0.011386009 0.56 (0.36, 0.88) 9.40% 1 1.25
SOCS4 -1 0.012820451 0.63 (0.44, 0.91) 10.00% 1 1.25
SOCS4 -1 0.012820451 0.63 (0.44, 0.91) 10.00% 1 1.25
SPANXN2 1 0.010765906 1.37 (1.08, 1.74) 9.10% 1 1.23
SPATA5L1 1 0.011141111 1.51 (1.10, 2.07) 9.30% 1 1.24
SPATA5L1 1 0.011141111 1.51 (1.10, 2.07) 9.30% 1 1.24
TCERG1 1 0.012536518 1.66 (1.12, 2.48) 9.90% 1 1.23
TCERG1 1 0.012536518 1.66 (1.12, 2.48) 9.90% 1 1.23
TMEM108 -1 0.010602477 0.58 (0.38, 0.88) 9.00% 1 1.26
TMEM108 -1 0.010602477 0.58 (0.38, 0.88) 9.00% 1 1.26
TMOD4 -1 0.010546039 0.66 (0.48, 0.91) 9.00% 1 1.26
TRAK1 -1 0.012552903 0.57 (0.37, 0.89) 9.90% 1 1.25
TRAK1 -1 0.012552903 0.57 (0.37, 0.89) 9.90% 1 1.25
TRAPPC6A -1 0.012887833 0.72 (0.56, 0.93) 10.00% 1 1.24
TRPC6 -1 0.011288328 0.54 (0.34, 0.87) 9.40% 1 1.25
TTC13 1 0.011432765 1.76 (1.14, 2.72) 9.40% 1 1.23
TTC13 1 0.011432765 1.76 (1.14, 2.72) 9.40% 1 1.23
TTLL2 1 0.010400094 1.41 (1.08, 1.84) 8.90% 1 1.24
UBLCP1 1 0.010665655 1.72 (1.13, 2.62) 9.00% 1 1.24
VAT1 -1 0.011909359 0.69 (0.52, 0.92) 9.60% 1 1.25
VWA5A -1 0.012389498 0.63 (0.44, 0.91) 9.80% 1 1.25
VWA5A -1 0.012389498 0.63 (0.44, 0.91) 9.80% 1 1.25
VWA5A -1 0.012389498 0.63 (0.44, 0.91) 9.80% 1 1.25
WASF3 1 0.011210635 1.68 (1.13, 2.52) 9.30% 1 1.24
WDR65 -1 0.010288387 0.67 (0.49, 0.91) 8.90% 1 1.26
WDR65 -1 0.010288387 0.67 (0.49, 0.91) 8.90% 1 1.26
WDR65 -1 0.010288387 0.67 (0.49, 0.91) 8.90% 1 1.26
WDR65 -1 0.010288387 0.67 (0.49, 0.91) 8.90% 1 1.26
WDR65 -1 0.010288387 0.67 (0.49, 0.91) 8.90% 1 1.26
ZNF217 1 0.011799956 1.62 (1.11, 2.35) 9.60% 1 1.24
ZNF223 -1 0.010393203 0.74 (0.58, 0.93) 8.90% 1 1.24
ZNF263 -1 0.010124367 0.68 (0.51, 0.91) 8.90% 1 1.26
ZNF384 -1 0.012231707 0.52 (0.32, 0.87) 9.70% 1 1.24
ZNF384 -1 0.012231707 0.52 (0.32, 0.87) 9.70% 1 1.24
ZNF384 -1 0.012231707 0.52 (0.32, 0.87) 9.70% 1 1.24
ZNF384 -1 0.012231707 0.52 (0.32, 0.87) 9.70% 1 1.24
ZNF384 -1 0.012231707 0.52 (0.32, 0.87) 9.70% 1 1.24
ZNF384 -1 0.012231707 0.52 (0.32, 0.87) 9.70% 1 1.24
ZNF384 -1 0.012231707 0.52 (0.32, 0.87) 9.70% 1 1.24
ZNF568 -1 0.010974016 0.65 (0.47, 0.91) 9.20% 1 1.26
ZNF594 -1 0.010316068 0.64 (0.45, 0.90) 8.90% 1 1.26
ZNF630 -1 0.011504134 0.71 (0.54, 0.93) 9.40% 1 1.25
ZNF630 -1 0.011504134 0.71 (0.54, 0.93) 9.40% 1 1.25
ZNF630 -1 0.011504134 0.71 (0.54, 0.93) 9.40% 1 1.25
ZNF716 1 0.010708479 1.34 (1.07, 1.68) 9.10% 1 1.22
ZNF763 -1 0.010793188 0.64 (0.45, 0.90) 9.10% 1 1.26
ZPBP2 1 0.010005183 144 (1.09, 1.90) 8.80% 1 1.24
ZPBP2 1 0.010005183 1.44 (1.09, 1.90) 8.80% 1 1.24
Table 4. LincRNAs Identified as Associated with Breast Cancer Recurrence in 136 Breast Cancer Patients
LincRNA Chr start End Direction of Association (1 = Higher Expression Means Higher Risk) Standardized Hazard Ratio Estimate (95% Confidence Interval) Maximum Lower Bound Std HR @ 10% FDR Regression-to-the-Mean-Corrected Std HR
Khalil-787 15 49013058 49023258 1 6.10E-07 2.76 (1.85, 4.11) 0.1% 1.20 1.33
Khalil-2019 7 20876450 21120000 1 1.48E-08 1.75 (1.44, 2.12) <0.1% 1.18 1.41
Khalil-748 14 95988347 96000872 -1 2.87E-06 0.39 (0.26, 0.58) 0.2% 1.18 1.30
Khalil-1961 6 138901082 139020207 1 1.14E-05 2.01 (1.47, 2.74) 0.6% 1.10 1.31
Khalil-1464 3 171491881 171537606 1 6.38E-05 1.58 (1.26, 1.98) 2.0% 1.04 1.29
Khalil-769 14 102051822 102062397 1 6.34E-05 1.54 (1.25, 1.91) 2.0% 1.04 1.28
Khalil-1542 4 26809677 26850102 -1 6.86E-05 0.55 (0.41, 0.74) 2.0% 1.04 1.28
Khalil-966 18 74178337 74202937 -1 1.15E-04 0.54 (0.39, 0.74) 2.6% 1.04 1.26
Khalil-1867 6 29238046 29248321 1 8.71E-05 1.53 (1.24,1.90) 2.2% 1.04 1.28
Khalil-828 16 11294824 11305774 -1 1.97E-04 0.54 (0.39, 0.75) 3.7% 1.04 1.25
Khalil-1661 5 6829550 6853100 1 2.31E-04 1.99 (1.38, 2.88) 4.0% 1.04 1.24
Khalil-1697 5 55567468 55766893 -1 1.82E-04 0.49 (0.34, 0.71) 3.7% 1.04 1.24
Khalil-584 13 33888375 33923550 -1 2.72E-04 0.42 (0.27, 0.67) 4.3% 1.04 1.20
Khalil-96 1 119551052 119563877 -1 3.19E-04 0.57 (0.42, 0.77) 4.7% 1.03 1.24
Khalil-1797 5 147328132 147409407 1 3.51E-04 1.58 (1.23, 2.04) 4.8% 1.02 1.25
Khalil-933 18 42263052 42278652 -1 5.25E-04 0.48 (0.32, 0.73) 6.4% 1.02 1.21
Khalil-352 11 27594974 27650174 -1 4.49E-04 0.67 (0.54, 0.84) 5.8% 1.02 1.24
Khalil-207 1 239382227 239451677 1 6.35E-04 1.59 (1.22, 2.08) 7.3% 1.01 1.24
Khalil-2153 8 20826745 20929495 -1 7.42E-04 0.54 (0.38, 0.77) 8.0% 1.01 1.22
Khalil-1788 5 139092141 139092141 1 8.51E-04 1.63 (1.22, 2.16) 8.1% 1.01 1.23
Khalil-640 13 76462324 76475024 1 8.62E-D4 1.76 (1.26, 2.46) 8.1% 1.01 1.22
Khalil-2253 8 111747974 111813899 1 8.55E-04 1.37 (1.14, 1.65) 8.1% 1.01 1.22
Khalil-139 1 192885227 192945802 1 1.09E-03 2.00 (1.32, 3.02) 9.7% 1.00 1.20
Table 5. Intergenic Region Locations Identified as Associated with Risk of Breast Cancer Recurrence in 136 Breast Cancer Patients
Region Chromosome Start Stop Direction of Association (1 = Higher Expression Means Higher Risk) Standardized Hazard Ratio Estimate (95% Confidence Interval) Maximum Lower Bound Std HR @ 10% FDR Regression-to-the-Mean-Corrected Std HR
1 chr10 37,544,879 37,547,649 -1 0.00020 0.51 (0.36, 0.73) 1.9% 1.06 1.43
1 chr10 37,619,993 37,623,136 -1 0.00021 0.52 (036, 0.73) 1.9% 1.06 1.43
1 chr10 37,568,808 37,569,830 -1 0.00021 0.53 (0.38, 0.74) 1.9% 1.06 1.43
1 chr10 37,564,164 37,565,625 -1 0.00030 0.52 (0.37, 0.74) 1.9% 1.06 1.42
1 chr10 37,568,381 37,568,752 -1 0.00035 0.53 (0.38, 0.75) 1.9% 1.06 1.41
1 chr10 37,565,983 37,566,523 -1 0.00041 0.53 (0.37, 0.75) 1.9% 1.06 1.41
1 chr10 37,565,659 37,565,893 -1 0.00038 0.54 (039, 0.76) 1.9% 1.06 1.41
1 chr10 37,566,868 37,567,570 -1 0.00047 0.54 (0.38, 0.76) 1.9% 1.06 1.41
1 chr10 37,536,807 37,542,809 -1 0.00046 0.54 (0.38, 0.76) 1.9% 1.06 1.41
1 chr10 37,543,796 37,544,843 -1 0.00042 0.56 (0.40, 0.77) 1.9% 1.06 1.41
1 chr10 37,561,599 37,562,256 -1 0.00045 0.55 (0.39, 0.77) 1.9% 1.06 1.40
1 chr10 37,683,049 37,685,772 -1 0.00045 0.55 (0.39, 0.77) 1.9% 1.06 1.40
1 chr10 37,556,000 37,560,492 -1 0.00049 0.54 (0.38, 0.76) 1.9% 1.06 1.40
1 chr10 37,575,273 37,575,491 -1 0.00048 0.54 (0.38, 0.76) 1.9% 1.06 1.40
1 chr10 37,524,962 37,527,301 -1 0.00048 0.54 (0.39, 0.76) 1.9% 1.06 1.40
1 chr10 37,576,187 37,605,418 -1 0.00050 0.54 (0.38, 0.76) 1.9% 1.06 1.40
1 chr10 37,571,872 37,573,979 -1 0.00052 0.53 (0.37, 0.76) 1.9% 1.06 1.40
1 chr10 37,698,051 37,701,722 -1 0.00047 0.56 (0.41, 0.78) 1.9% 1.06 1.40
1 chr10 37,672,851 37,673,126 -1 0.00058 0.51 (0.35, 0.75) 1.9% 1.06 1.40
1 chr10 37,562,687 37,562,938 -1 0.00058 0.53 (0.37, 0.76) 1.9% 1.06 1.40
1 chr10 37,527,343 37,532,088 -1 0.00058 0.54 (0.38, 0.77) 1.9% L06 1.40
1 chr10 37,560,679 37,560,951 -1 0.00059 0.54 (0.37, 0.76) 1.9% 1.06 1.40
1 chr10 37,570,039 37,571,493 -1 0.00057 0.55 (0.39, 0.77) 1.9% 1.06 1.40
1 chr10 37,575,935 37,576,119 -1 0.00059 0.54 (0.38, 0.77) 1.9% 1.06 1.40
1 chr10 37,609,308 37,613,953 -1 0.00064 0.54 (0.38, 0.77) 2.0% 1.06 1.40
1 chr10 37,547,787 37,555,941 -1 0.00064 0.54 (0.38, 0.77) 2.0% 1.06 1.40
1 chr10 37,571,633 37,571,823 -1 0.00065 0.55 (0.39, 0.77) 2.0% 1.06 1.39
1 chr10 37,667,401 37,672,780 -1 0.00068 0.55 (0.39, 0.78) 2.0% 1.06 1.39
1 chr10 37,696,906 37,697,533 -1 0.00073 0.52 (0.36, 0.76) 2.0% 1.06 1.39
1 chr10 37,574,016 37,574,684 -1 0.00067 0.56 (0.40, 0.78) 2.0% 1.06 1.39
1 chr10 37,567,627 37,568,328 -1 0.00072 0.56 (0.41, 0.79) 2.0% 1.06 1.39
1 chr10 37,693,467 37,695,809 -1 0.00077 0.56 (0.40, 0.79) 2.1% 1.06 1.39
1 chr10 37,654,871 37,660,982 -1 0.00082 0.56 (0.40, 0.79) 2.2% 1.06 1.39
1 chr10 37,661,152 37,667,368 -1 0.00089 0.55 (0.39, 0.78) 2.2% 1.06 1.39
1 chr10 37,532,337 37,536,539 -1 0.00082 0.57 (0.41, 0.79) 2.2% 1.06 1.38
1 chr10 37,562,300 37,562,581 -1 0.00094 0.56 (0.39, 0.79) 2.2% 1.06 1.38
1 chr10 37,624,793 37,626,867 -1 0.00098 0.55 (0.39, 0.79) 2.2% 1.06 1.38
1 chr10 37,639,567 37,654,034 -1 0.00088 0.57 (0.41, 0.80) 2.2% 1.06 1.38
1 chr10 37,561,214 37,561,565 -1 0.00103 0.55 (0.39, 0.79) 2.2% 1.06 1.38
1 chr10 37,673,162 37,677,786 -1 0.00088 0.59 (0.43, 0.80) 2.2% 1.06 1.38
1 chr10 37,701,753 37,702,125 -1 0.00115 0.54 (0.37, 0.78) 2.3% 1.06 1.38
1 chr10 37,626,921 37,629,035 -1 0.00105 0.57 (0.41, 0.80) 2.2% 1.06 1.38
1 chr10 37,695,882 37,696,129 -1 0.00118 0.54 (0.37, 0.78) 2.4% 1.06 1.38
1 chr10 37,654,201 37,654,768 -1 0.00103 0.58 (0.42, 0.80) 2.2% 1.06 1.38
1 chr10 37,685,838 37,687,256 -1 0.00109 0.57 (0.41, 0.80) 2.3% 1.06 1.38
1 chr10 37,732,968 37,734,110 -1 0.00127 0.55 (0.38, 0.79) 2.4% 1.06 1.38
1 chr10 37,563,652 37,564,121 -1 0.00123 0.57 (0.41, 0.80) 2.4% 1.06 1.37
1 chr10 37,614,131 37,619,802 -1 0.00126 0.57 (0.40, 0.80) 2.4% 1.06 1.37
1 chr10 37,566,588 37,566,765 -1 0.00141 0.56 (0.39, 0.80) 2.5% 1.06 1.37
1 chr10 37,632,316 37,633,017 -1 0.00136 0.58 (0.41, 0.81) 2.4% 1.06 1.37
1 chr10 37,633,094 37,639,262 -1 0.00142 0.58 (0.42, 0.81) 2.5% 1.05 1.37
1 chr10 37,689,902 37,693,366 -1 0.00147 0.58 (0.42, 0.81) 2.5% 1.05 1.37
1 chr10 37,623,556 37,624,754 -1 0.00169 0.57 (0.40, 0.81) 2.8% 1.05 1.36
1 chr10 37,707,161 37,714,709 -1 0.00176 0.58 (0.41, 0.81) 2.9% 1.05 1.36
1 chr10 37,687,488 37,689,827 -1 0.00172 0.59 (0.42, 0.82) 2.9% 1.05 1.36
1 chr10 37,629,082 37,632,280 -1 0.00199 0.59 (0.42, 0.82) 3.2% 1.05 1.36
1 chr10 37,575,553 37,575,759 -1 0.00198 0.59 (0.42, 0.82) 3.2% 1.05 1.36
1 chr10 37,677,954 37,682,763 -1 0.00205 0.60 (0.43, 0.83) 3.3% 1.04 1.35
1 chr10 37,563,315 37,563,610 -1 0.00232 0.58 (0.40, 0.82) 3.5% 1.04 1.35
1 chr10 37,575,794 37,575,896 -1 0.00253 0.54 (0.36, 0.81) 3.7% 1.04 1.35
1 chr10 37,542,848 37,543,623 -1 0.00229 0.59 (0.42, 0.83) 3.5% 1.04 1.35
1 chr10 37,561,067 37,561,175 -1 0.00270 0.56 (0.38, 0.82) 3.8% 1.04 1.35
1 chr10 37,734,169 37,740,911 -1 0.00233 0.61 (0.44, 0.84) 3.5% 1.04 1.35
1 chr10 37,702,517 37,707,119 -1 0.00275 0.61 (0.44, 0.84) 3.8% 1.04 1.34
1 chr10 37,605,587 37,609,120 -1 0.00273 0.61 (0.44, 0.84) 3.8% 1.04 1.34
1 chr10 37,562,986 37,563,198 -1 0.00356 0.60 (0.43, 0.85) 4.6% 1.03 1.34
1 chr10 37,740,954 37,745,137 -1 0.00387 0.60 (0.43, 0.85) 4.8% 1.03 1.34
1 chr10 37,716,056 37,717,321 -1 0.00393 0.61 (0.44, 0.86) 4.9% 1.03 1.33
1 chr10 37,639,364 37,639,473 -1 0.00470 0.58 (0.40, 0.85) 5.4% 1.03 1.33
1 chr10 37,728,632 37,731,719 -1 0.00487 0.61 (0.43, 0.86) 5.4% 1.03 1.33
1 chr10 37,717,419 37,728,598 -1 0.00478 0.62 (0.45, 0.87) 5.4% 1.03 1.33
1 chr10 37,731,776 37,732,927 -1 0.00530 0.60 (0.42, 0.86) 5.7% 1.02 1.33
1 chr10 37,747,085 37,748,228 -1 0.00712 0.60 (0.42, 0.87) 6.9% 1.02 1.32
1 chr10 37,714,745 37,715,803 -1 0.00867 0.62 (0.43, 0.89) 7.7% 1.01 1.31
1 chr10 37,696,547 37,696,778 -1 0.01035 0.58 (0.38, 0.88) 8.6% 1.01 1.30
1 chr10 37,750,435 37,752,430 -1 0.01125 0.61 (0.42, 0.89) 9.1% 1.00 1.30
1 chr10 37,745,221 37,746,267 -1 0.01313 0.60 (0.40, 0.90) 9.8% 1.00 1.29
1 chr10 37,697,835 37,697,938 -1 0.01311 0.58 (0.38, 0.89) 9.8% 1.00 1.29
2 chr13 33,913,029 33,915,362 -1 0.00000 0.53 (0.41, 0.69) 0.1% 1.11 1.53
2 chr13 33,895,486 33,899,980 -1 0.00010 0.45 (0.30, 0.67) 1.7% 1.07 1.45
2 chr13 33,861,025 33,870,309 -1 0.00025 0.43 (0.28, 0.68) 1.9% 1.06 1.42
2 chr13 33,885,431 33,895,429 -1 0.00025 0.43 (0.21, 0.68) 1.9% 1.06 1.42
2 chr13 33,905,649 33,907,334 -1 0.00038 0.46 (0.30, 0.70) 1.9% 1.06 1.41
2 chr13 33,875,986 33,880,221 -1 0.00053 0.47 (0.31, 0.72) 1.9% 1.06 1.40
3 chr14 100,492,181 100,494,055 -1 0.00003 0.54 (0.41, 0.72) 0.8% 1.07 1.47
3 chr14 100,490,070 100,492,136 -1 0.00046 0.61 (0.46, 0.80) 1.9% 1.06 1.39
3 chr14 100,488,826 100,489,839 -1 0.00125 0.54 (0.37, 0.78) 2.4% 1.06 1.38
3 chr14 100,452,553 100,453,714 -1 0.00131 0.57 (0.40, 0.80) 2.4% 1.06 1.37
3 chr14 100,480,756 100,482,681 -1 0.00114 0.64 (0.48, 0.84) 2.3% 1.05 1.36
3 chr14 100,513,361 100,516,723 -1 0.00211 0.56 (0.38, 0.81) 3.3% 1.05 1.36
3 chr14 100,522,353 100,526,500 -1 0.00327 0.56 (0.38, 0.82) 4.3% 1.04 1.34
3 chr14 100,494,916 100,500,335 -1 0.00433 0.54 (0.35, 0.82) 5.3% 1.03 1.33
3 chr14 100,482,810 100,488,781 -1 0.00449 0.56 (0.37, 0.83) 5.3% 1.03 1.33
3 chr14 100,500,384 100,505,674 -1 0.00474 0.56 (037, 0.84) 5.4% 1.03 1.33
3 chr14 100,505,745 100,509,590 -1 0.00578 0.59 (0.41, 0.86) 6.0% 1.02 1.32
3 chr14 100,510,107 100,513,108 -1 0.00732 0.59 (0.40, 0.87) 6.9% 1.01 1.32
3 chr14 100,494,179 100,494,879 -1 0.00731 0.63 (0.45, 0.88) 6.9% 1.01 1.31
3 chr14 100,466,798 100,467,228 -1 0.00706 0.68 (0.51, 0.90) 6.9% 1.01 1.30
3 chr14 100,509,621 100,510,070 -1 0.01210 0.65 (0.47, 0.91) 9.5% 1.00 1.29
4 chr15 50,998,590 50,999,355 1 0.00000 1.46 (1.27, 1.67) 0.0% 1.11 1.36
4 chr15 50,995,854 50,996,481 1 0.00163 1.56 (1.18, 2.05) 2.8% 1.05 1.25
5 chr15 71,427,690 71,430,497 -1 0.00459 0.62 (0.44, 0.86) 5.4% 1.03 1.33
5 chr15 71,423,356 71,427,046 -1 0.00474 0.64 (0.47, 0.87) 5.4% 1.02 1.32
5 chr15 71,420,670 71,423,120 -1 0.00938 0.63 (0.45, 0.89) 8.1% 1.01 1.30
6 chr17 42,098,064 42,100,474 -1 0.00003 0.46 (0.32, 0.66) 0.8% 1.07 1.49
6 chr17 42,097,068 42,097,990 -1 0.00003 0.50 (0.36, 0.70) 0.8% 1.07 1.48
6 chr17 42,095,337 42,097,009 -1 0.00007 0.51 (0.36, 0.71) 1.4% 1.07 1.46
6 chr17 42,093,032 42,094,287 -1 0.00105 0.62 (0.47, 0.82) 2.2% 1.06 1.37
7 chr19 15,685,213 15,685,925 -1 0.00126 0.63 (0.47, 0.83) 2.4% 1.05 1.36
7 chr19 15,686,036 15,688,801 -1 0.00136 0.65 (0.49, 0.84) 2.4% 1.05 1.35
7 chr19 15,681,763 15,685,139 -1 0.00292 0.66 (0.51, 0.87) 3.9% 1.03 1.33
8 chr2 162,136,055 162,136,356 1 0.00049 1.67 (1.25, 2.24) 1.9% 1.06 1.28
8 chr2 162,135,070 162,135,249 1 0.00086 1.61 (1.22, 2.12) 2.2% 1.06 1.26
9 chr5 34,201,715 34,201,852 1 0.00323 1.91 (1.24, 2.94) 4.3% 1.04 1.19
9 chr5 34,170,829 34,170,949 1 0.00430 1.91 (1.22, 2.97) 5.3% 1.03 1.18
10 chr6 72,099,739 72,107,969 -1 0.00250 0.52 (0.34, 0.80) 3.7% 1.04 1.35
10 chr6 72,092,048 72,099,685 -1 0.00447 0.57 (0.39, 0.84) 5.3% 1.03 1.33
10 chr6 72,082,646 72,084,661 -1 0.00514 0.64 (0.47, 0.87) 5.6% 1.02 1.32
10 chr6 72,090,253 72,091,283 -1 0.01000 0.57 (0.37, 0.87) 8.5% 1.01 1.30
11 chr6 151,715,844 151,717,137 1 0.00002 1.51 (1.25, 1.83) 0.8% 1.07 1.33
11 chr6 151,717,215 151,718,164 1 0.00782 1.59 (1.13, 2.23) 7.2% 1.01 1.19
12 chr7 149,668,770 149,669,327 -1 0.00090 0.60 (0.44, 0.81) 2.2% 1.06 1.38
12 chr7 149,925,596 149,925,704 -1 0.00327 0.60 (0.43, 0.84) 4.3% 1.03 1.34
12 chr7 149,699,811 149,700,117 -1 0.00689 0.64 (0.47, 0.89) 6.8% 1.02 1.31
13 chr8 12,401,386 12,401,654 -1 0.00022 0.64 (0.51, 0.81) 1.9% 1.06 1.38
13 chr8 12,432,626 12,433,347 -1 0.00238 0.60 (0.43, 0.83) 3.5% 1.04 1.35
13 chr8 12,403,417 12,403,612 -1 0.00522 0.62 (0.45, 0.87) 5.6% 1.02 1.32
14 chr9 134,279,738 134,284,311 -1 0.00095 0.54 (0.38, 0.78) 2.2% 1.06 1.38
14 chr9 134,271,924 134,274,441 -1 0.00137 0.56 (0.40, 0.80) 2.4% 1.06 1.37
14 chr9 134,291,733 134,295,852 -1 0.00826 0.62 (0.43, 0.88) 7.5% 1.01 1.31
15 chrX 93,652,357 93,666,290 -1 0.00619 0.62 (0.44, 0.87) 6.3% 1.02 1.32
15 chrX 93,688,784 93,693,228 -1 0.00613 0.63 (0.45, 0.88) 6.3% 1.02 1.32
15 chrX 93,669,788 93,672,149 -1 0.00674 0.61 (0.43, 0.87) 6.8% 1.02 1.32
15 chrX 93,666,349 93,667,298 -1 0.01336 0.59 (0.39, 0.90) 10.0% 1.00 1.29
chrX 93,717,247 93,720,845 -1 0.00466 0.61 (0.44, 0.86) 5.4% 1.03 1.33
chrX 93,725,918 93,737,489 -1 0.00522 0.62 (0.44, 0.87) 5.6% 1.02 1.32
chrX 93,751,305 93,757,302 -1 0.00855 0.64 (0.45, 0.89) 7.7% 1.01 1.31
chrX 93,748,573 93,749,757 -1 0.01008 0.63 (0.44, 0.89) 8.5% 1.01 1.30
chrX 93,746,612 93,748,536 -1 0.01154 0.63 (0.45, 0.90) 9.1% 1.00 1.30
17 chrX 93,772,799 93,777,937 -1 0.00940 0.63 (0.44, 0.89) 8.1% 1.01 1.30
17 chrX 93,778,121 93,784,508 -1 0.01142 0.65 (0.47, 0.91) 9.1% 1.00 1.29
18 chrX 93,824,387 93,825,877 -1 0.00564 0.61 (0.43, 0.86) 5.9% 1.02 1.32
18 chrX 93,830,179 93,833,764 -1 0.00623 0.61 (0.43, 0.87) 6.3% 1.02 1.32
19 chr4 14,787,521 14,788,354 -1 0.00032 0.57 (0.41, 0.77) 1.9% 1.06 1.41
20 chr3 27,150,797 27,152,817 -1 0.00057 0.51 (0.35, 0.75) 1.9% 1.06 1.40
21 chr16 30,875,605 30,875,752 -1 0.00037 0.60 (0.45, 0.79) 1.9% 1.06 1.40
22 chr4 39,536,187 39,536,524 -1 0.00018 0.63 (0.49, 0.80) 1.9% 1.06 1.40
23 chr14 81,726,879 81,729,708 -1 0.00094 0.52 (0.36, 0.77) 2.2% 1.06 1.39
24 chrll 781,048 781,371 -1 0.00062 0.61 (0.46, 0.81) 2.0% 1.06 1.38
25 chr12 57,793,185 57,793,823 1 0.00042 1.49 (1.19, 1.86) 1.9% 1.06 1.28
26 chr8 81,525,870 81,526,021 1 0.00237 1.70 (1.21, 2.38) 3.5% 1.04 1.23
27 chr4 74,877,348 74,877,549 1 0.00276 1.69 (1.20, 2.37) 3.8% 1.04 1.22
28 chrl 36,798,999 36,802,115 -1 0.00305 0.60 (0.43, 0.84) 4.2% 1.04 1.34
29 chr19 12,378,905 12,380,075 -1 0.00340 0.58 (0.41, 0.84) 4.4% 1.03 1.34
30 chr21 9,837,324 9,837,442 1 0.00270 1.50 (1.15, 1.95) 3.8% 1.03 1.23
31 chr3 123,210,205 123,211,948 1 0.00339 1.72 (1.20, 2.48) 4.4% 1.03 1.21
32 chr8 12,054,779 12,054,926 -1 0.00359 0.59 (0.41, 0.84) 4.6% 1.03 1.34
33 chrll 63,336,814 63,339,112 -1 0.00382 0.62 (0.45, 0.86) 4.8% 1.03 1.33
34 chr6 36,575,163 36,576,155 -1 0.00332 0.72 (0.58, 0.90) 4.4% 1.03 1.29
35 chr14 38,291,258 38,299,693 -1 0.00440 0.65 (0.49, 0.88) 5.3% 1.03 1.32
36 chr1 168,218,748 168,220,325 1 0.00439 1.55 (1.15, 2.09) 5.3% 1.03 1.21
37 chr3 112,414,798 112,415,017 1 0.00494 1.80 (1.20, 2.71) 5.4% 1.03 1.19
38 chr10 133,732,921 133,733,113 -1 0.00553 0.64 (0.46, 0.88) 5.8% 1.02 1.32
39 chr3 195,671,271 195,671,479 1 0.00550 1.55 (1.14, 2.11) 5.8% 1.02 1.21
40 chr5 180,678,078 180,680,053 1 0.00682 1.65 (1.15, 2.38) 6.8% 1.02 1.19
41 chr10 29,738,073 29,738,359 -1 0.00621 0.71 (0.55, 0.91) 6.3% 1.02 1.29
42 chr2 91,816,094 91,819,627 -1 0.00735 0.63 (0.44, 0.88) 6.9% 1.01 1.31
43 chr15 39,777,520 39,813,177 -1 0.00738 0.63 (0.45, 0.88) 6.9% 1.01 1.31
44 chr16 21,527,242 21,527,480 -1 0.00715 0.68 (0.51, 0.90) 6.9% 1.01 1.30
45 chrl 222,906,688 222,910,172 1 0.00738 1.55 (1.13, 2.15) 6.9% 1.01 1.19
46 chr20 3,074,943 3,075,062 1 0.00770 1.67 (1.15, 2.43) 7.2% 1.01 1.18
47 chr15 50,653,452 50,656,894 1 0.00787 1.49 (1.11, 1.99) 7.2% 1.01 1.20
48 chr11 8,681,526 8,687,251 -1 0.00851 0.61 (0.42, 0.88) 7.7% 1.01 1.31
49 chr18 14,274,671 14,274,823 -1 0.00912 0.59 (0.39, 0.88) 7.9% 1.01 1.31
50 chr7 94,189,030 94,190,366 -1 0.00943 0.60 (0.41, 0.88) 8.1% 1.01 1.31
51 chr19 56,149,766 56,151,179 -1 0.00958 0.59 (0.39, 0.88) 8.1% 1.01 1.31
52 chr19 22,021,429 22,024,672 -1 0.00909 0.65 (0.47, 0.90) 7.9% 1.01 1.30
53 chr10 42,398,467 42,398,655 1 0.00822 1.37 (1.08, 1.73) 7.5% 1.01 1.19
54 chr1 15,936,663 15,936,819 1 0.00905 1.53 (1.11, 2.10) 7.9% 1.01 1.19
55 chr19 57,811,563 57,811,715 1 0.00906 1.61 (1.13, 2.29) 7.9% 1.01 1.18
56 chrX 115,108,909 115,109,012 1 0.01070 1.63 (1.12, 2.38) 8.9% 1.01 1.17
57 chr10 38,637,965 38,638,108 -1 0.01097 0.63 (0.44, 0.90) 8.9% 1.00 1.30
58 chr7 76,741,733 76,741,898 -1 0.01084 0.65 (0.47, 0.91) 8.9% 1.00 1.30
59 chr2 96,492,560 96,493,149 -1 0.01096 0.68 (0.50, 0.91) 8.9% 1.00 1.29
60 chr6 26,130,873 26,132,970 1 0.01081 1.58 (1.11, 2.25) 8.9% 1.00 1.18
61 chr16 25,271,035 25,272,071 -1 0.01152 0.61 (0.42, 0.90) 9.1% 1.00 1.30
62 chr5 10,435,961 10,438,476 1 0.01152 1.81 (1.14, 2.86) 9.1% 1.00 1.15
63 chr16 31,465,709 31,467,707 -1 0.01273 0.59 (0.39, 0.89) 9.8% 1.00 1.30
64 chr9 33,018,805 33,020,959 -1 0.01273 0.55 (0.35, 0.88) 9.8% 1.00 1.29
65 chr17 3,710,044 3,712,797 -1 0.01240 0.67 (0.48, 0.92) 9.7% 1.00 1.29
66 chr1 121,484,124 121,485,310 1 0.01262 1.56 (1.10, 2.21) 9.8% 1.00 1.17
67 chr17 41,379,297 41,379,450 -1 0.01286 0.68 (0.51, 0.92) 9.8% 1.00 1.28
68 chr6 138,982,087 138,982,527 1 0.01300 1.73 (1.12, 2.67) 9.8% 1.00 1.15
69 chr1 11,968,187 11,968,792 1 0.01310 1.78 (1.13, 2.81) 9.8% 1.00 1.14
TRPS1 NM_014112 C3orf18 NM_001171743 LRRC49 NM_001199018
SHROOM3 NM_020859 C3orf18 NM_001171740 CYBASC3 NM_001161452
GREB1L NM_001142966 C3orf18 NM_001171741 CYBASC3 NM_153611
MICA NR_036523 C3orf15 NM_033364 CYBASC3 NM_001161454
MICA NM_182924 DIS3L NM_001143688 CLINT1 NM_014666
MICA NR_036523 DIS3L NM_152383 CLINT1 NM_001195556
MICA NR_036523 DIS3L NM_133375 CLINT1 NM_001195555
MICA NR_036523 PSMD8 NM_002812 CLCA2 NM_006536
MICA NM_000247 B4GALT5 NM_004776 RPRD1A NM_018170
MICA NM_000247 ARPC1B NM_905720 TSPAN10 NM_031945
MICA NM_014632 SLC26A5 NM_001167962 BCL2 NM_000657
MICA NR_036523 SLC26A5 NM_206884 BCL2 NM_001040668
MICA NM_000247 SLC26A5 NM_206883 BCL2 NM_004049
MICA NR_036524 SLC26A5 NM_198999 BCL2 NM_001199864
MICA NR_036524 SLC26A5 NM_206885 BCL2 NM_138621
MICA NM_033386 ZNF837 NM_138466 BCL2 NM_020396
MICA NM_001122731 ZNF837 NM_001129730 BCL2 NM_138639
MICA NM_153206 BEND5 NM_024603 BCL2 NM_138723
MICA NM_022765 LOC100128675 NR_024561 BCL2 NM_001191
MICA NM_001136004 LOC100128675 NR_024562 BCL2 NM_138722
MICA NM0_01098526 GRTP1 NM_024719 BCL2 NM_ 006538
MICA NM_032867 AP1M1 NM_032493 BCL2 NM_001010922
MICA NM_001159291 AP1M1 NM_001130524 BCL2 NM_030766
MICA NM_000247 RTN4RL2 NM_178570 BCL2 NM_138578
MICA NR_036524 MAGI1 NM_001033057 BCL2 NM_001114735
MICA NR_036524 MAGI1 NM_015520 BCL2 NM_ 207002
MICA NM_015241 MAGI1 NM_004742 BCL2 NM_015367
MICA NM_001177519 ENPP5 NM_021572 BCL2 NM_004050
MICA NM_001177519 BZRAP1 NM_0004758 BCL2 NM_001199839
MICA NM_001177519 BZRAP1 NM_024418 BCL2 NM_000633
MICA NM_000247 DDB1 NM_001923 BBS5 NM_152384
MICA NM_001177519 NEDD4L NM_001144966 LOC100128640 NR_028389
MICA NM_001177519 NEDD4L NM_001144969 CAMK2G NM_172171
MICA NR_036524 NEDD4L NM_001144965 CAMK2G NM_172169
PIP4K2B NM_003559 NEDD4L NM_001144967 CAMK2G NM_172173
CWC25 NM_017748 NEDD4L NM_001144971 CAMK2G NM_172170
SLITRK2 NM_001144009 NEDD4L NM_001144964 CAMK2G NM_001222
SLITRK2 NM_001144005 NEDD4L NM_015277 TSPAN14 NM_030927
SLITRK2 NM_001144008 NEDD4L NM_001144968 TSPAN14 NM_001128309
SLITRK2 NM_001144010 NEDD4L NM_001144970 RWDD3 NM_015485
SLITRK2 NM_001144006 TMEM56 NM_152487 RWDD3 NM_001128142
SLITRK2 NM_001144003 TMEM56 NM_001199691 RWDD3 NM_001199691
SLITRK2 NM_001144004 TMEM56 NM_001199679 RWDD3 NR_037643
SLITRK2 NM_032539 LRRC49 NM_017691 RWDD3 NM_001199682
C3orf18 NM_016210 LRRC49 NM_001199017 TRAK1 NM_001042646
TRAK1 NM_014965 EML2 NR_034098 MTR NM_000254
LOC730668 NR_027240 EML2 NM_012155 MTR NM_002454
ZNF621 NM_198484 EML2 NR_002794 MTR NM_001190470
ZNF621 NM_001098414 LAPTM4B NM_018407 MTR NM_001190472
PELI3 NM_001098510 SLC38A2 NM_018976 MTR NM_001190452
PELI3 NM_145065 SCARNA15 NR_003011 MTR NM_001190489
NCOA3 NM_001174088 MID2 NM_133457 MTR NM_001190478
NCOA3 NM_001174087 MID2 NM_052817 MTR NM_019041
NCOA3 NM_181659 MID2 NM_012216 MTR NM_001190487
NCOA3 NM_006534 SLC26A8 NM_052961 MTR NM_001190706
PSMB3 NM_002795 SLC26A8 NM_ 138718 MTR NM_001190708
ZNF763 NM_001012753 SLC26A8 NM_001193476 MTR NM_001190702
CHDH NM_018397 NKAPP1 NR_027131 WBSCR27 NM_152559
SUSD4 NM_001037175 CLN5 NM_006493 LOC100130093 NR_024485
SUSD4 NM_017992 TLR5 NM_003268 LOC100130093 NR_024486
DNAH14 NM_144989 NPY5R NM_006174 FGFRL1 NM_021923
DNAH14 NM_001373 LOC402778 NM_001170820 FGFRL1 NM_001004358
DNAH14 NM_001145154 RPL14 NM_032111 FGFRL1 NM_001004356
KRT4 NM_182497 RPL14 NM_003973 TSNAXIP1 NM_018430
KRT4 NR_033415 RPL14 NM_001034996 BAIAP3 NM_003933
KRT4 NM_002272 C6orf155 NR_026807 BAIAP3 NM_001199099
STK3 NM_015690 ABCA3 NM_001089 BAIAP3 NM_001199097
STK3 NM_001112724 LOC723809 NR_027374 BAIAP3 NM_001199096
STK3 NM_018401 EPB49 NM_001114139 BAIAP3 NM_001199098
STK3 NM_006281 EPB49 NM_001114138 TSC1 NM_001162427
STK3 NM_173575 EPB49 NM_001114137 TSC1 NM_000368
STK3 NM_015000 EPB49 NM_001978 TSC1 NM_001162426
STK3 NM_007271 EPB49 NM_001114136 LDLRAD3 NM_174902
STK3 NM_031414 EPB49 NM_001114135 NPY1R NM_000909
STK3 NM_013233 PLEKHA7 NM_175058 IKBIP NM_153687
STK3 NM_080836 RNU6ATAC NR_023344 IKBIP NM_201613
STK3 NM_030906 LAMC2 NM_005562 IKBIP NM_201612
STK3 NM_145001 LAMC2 NM_018891 WDR67 NM_145647
STK3 NM_001122833 MST1 NR_927504 WDR67 NM_001145088
STK3 NM_032944 MST1 NM_002447 HMGCR NM_000859
CCDC24 NM_152499 MST1 NM_020998 HMGCR NM_001130996
IQCH NM_001031715 MST1 NR_002729 ZNF415 NM_001136038
IQCH NM_022784 GSTM2 NM_001142368 ZNF415 NM_001164309
NCRNA00173 NR_027346 GSTM2 NR_002932 ZNF415 NR_028343
NCRNA00173 NR_027345 GSTM2 NM_000848 ZNF415 NM_018355
GTPBP10 NM_001042717 ZNF337 NM_015655 LMX1B NM_001174147
GTPBP10 NM_033107 MTR NM_024010 LMX1B NM_001174146
EML2 NM_001193268 MTR NM_001190476 LMX1B NM_002316
EML2 NM_001193269 MTR NM_001114184 RBBP8 NM_203292
EML2 NM_024807 MTR NM_004294 RBBP8 NM_203291
RBBP8 NM_002894 PSD NM_002779 PTPN18 NM_001142370
SORBS2 NM_001145673 PSD NM_184231 PTPN18 NM_014369
SORBS2 NM_021069 PSD NM_015310 ENTPD8 NM_198585
SORBS2 NM_003603 PSD NM_032289 ENTPD8 NM_001033113
SORBS2 NM_001145674 PSD NM_012217 MTFR1 NM_014637
SORBS2 NM_001145675 PSD NM_012455 MTFR1 NM_001145839
SORBS2 NM_001145672 FAM201A NR_027294 MTFR1 NM_001145838
SORBS2 NM_001145670 C9orf156 NM_016481 APC2 NM_013366
SORBS2 NM_001145671 LOC644759 NR_033737 APC2 NR_030717
LASP1 NM_001142273 PPP1R9A NM_001166161 APC2 NM_005883
LASP1 NM_001142274 PPP1R9A NM_001166163 PSD NM_016453
LASP1 NM_006148 PPP1R9A NM_001166162 PSD NM_206909
LASP1 NM_015282 PPP1R9A NM_017650 ARMCX6 NM_019007
PLCB3 NM_000932 PPP1R9A NM_001166160 ARMCX6 NR_033669
PLCB3 NM_001184883 LRRN2 NM_006338 ARMCX6 NR_033670
CKAP4 NM_006825 LRRN2 NM_201630 ARMCX6 NM_001184768
RPPH1 NR_002312 OGFRL1 NM_024576 ARMCX6 NM_001009584
SCARNA16 NR_003013 OGDHL NM_001143997
MFSD2A NM_032793 OGDHL NM_001143996
MFSD2A NM_001136493 OGDHL NM_018245
ICA1 NM_138468 G6PD NM_000402
ICA1 NM_001136020 G6PD NM_001042351
ICA1 NM_153206 TMSB10 NM_021103
ICA1 NM_001098526 VASP NM_003370
ICA1 NM_004968 SEC23A NM_006364
ICA1 NM_178231 TMEM86A NM_153347
ICA1 NM_022307 ZNF774 NM_001004309
OPLAH NM_017570 CLIC6 NM_053277
C2orf55 NM_207362 ATL1 NM_080661
ZNF48 NM_052852 ATL1 NM_181598
ZNF48 NM_901007101 ATL1 NM_001127713
ZNF48 NM_153034 ATL1 NM_015915
ZNF48 NM_144684 ATL1 NM_152716
ZNF48 NM_001007169 ATL1 NM_001012980
ZNF48 NM_133464 ATL1 NM_032558
ZNF48 NM_031486 C3orf23 NM_173826
ZNF48 NR_026693 C3orf23 NM_001029840
ZNF48 NM_145312 C3orf23 NM_001029839
ZNF48 NM_152652 CHKB NM_005198
APC2 NM_003083 CHKB NR_027928

Claims (10)

  1. A method of predicting a likelihood of survival for at least 3 years without recurrence of breast cancer in a breast cancer patient, comprising:
    determining a level of the breast cancer prognostic biomarker kinesin family member 1B (KIF1B) in a breast cancer tumor sample obtained from the patient,
    normalizing the level of the breast cancer prognostic biomarker KIF1B to obtain a normalized level of KIF1B; and
    predicting a likelihood of survival for at least 3 years without recurrence of breast cancer of said patient,
    wherein an increased normalized level of the breast cancer prognostic biomarker KIF 1 B compared with the amount found in a cancer tissue reference set is negatively correlated with an increased likelihood of survival for at least 3 years without recurrence of breast cancer.
  2. A method of predicting a likelihood of survival for at least 3 years without recurrence of breast cancer in a breast cancer patient, comprising:
    determining levels of at least three RNA transcripts, or expression products thereof, in a breast cancer tumor sample obtained from said patient, wherein the at least three RNA transcripts, or expression products thereof, are selected from ENO1, IDH2, TMSB10, PGK1, and G6PD,
    normalizing the levels of the at least three RNA transcripts, or expression products thereof, to obtain normalized expression levels of the at least three RNA transcripts or expression products thereof, and
    predicting a likelihood of survival for at least 3 years without recurrence of breast
    cancer of said patient using the normalized expression levels, wherein increased normalized expression levels compared with the amount found in a cancer tissue reference set are negatively correlated with an increased likelihood of survival for at least 3 years without recurrence of breast cancer.
  3. The method of claim 2, wherein the levels of at least IDH2, PGK1, and G6PD are determined.
  4. The method of claim 2, wherein the levels of ENO1, IDH2, TMSB10, PGK1, and G6PD are determined.
  5. A method of predicting a likelihood of survival for at least 3 years without recurrence of breast cancer in a breast cancer patient, comprising:
    determining levels of at least five RNA transcripts, or expression product thereof,
    in a breast cancer tumor sample obtained from said patient, wherein the at least five RNA transcripts, or expression products thereof, are selected from PGD,
    TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENOI, PGK1, IDH2, AC02, and FBP1,
    normalizing the levels of the at least five RNA transcripts, or expression products thereof, to obtain normalized expression levels of the at least five RNA transcripts or expression products thereof, and
    predicting a likelihood of survival for at least 3 years without recurrence of breast
    cancer of said patient using the normalized expression levels, wherein increased normalized expression levels of PGD, TKT, TALDO 1, G6PD, GP 1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, and AC02 compared with the amount found in a cancer tissue reference set are negatively correlated with an increased likelihood of survival for at least 3 years without recurrence of breast cancer, and increased normalized expression level of FBP 1 is positively correlated with an increased likelihood of survival for at least 3 years without recurrence of breast cancer.
  6. The method of claim 5, wherein the levels of PGD, TKT, TALDO1, G6PD, GP1, SLC1A5, SLC7A5, OGDH, SUCLG1, ENO1, PGK1, IDH2, ACO2, and FBP1 are determined.
  7. The method of any one of claims 1-6, wherein the level is determined by whole transcriptome sequencing, reverse transcription polymerase chain reaction (RT - PCR), or array.
  8. The method of any one of claims 1-7, wherein the breast cancer tumor sample is a fixed, wax-embedded tissue sample.
  9. The method of any one of claims 1-8, wherein the breast cancer tumor sample is a fine needle biopsy sample.
  10. The method of any one of claims 1-9, further comprising creating a report based on the level of the one or more RNA transcripts, or an expression product thereof.
HK15101891.1A 2011-11-08 2012-11-02 Method of predicting breast cancer prognosis HK1201329B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161557238P 2011-11-08 2011-11-08
US201161557238P 2011-11-08
US201261597426P 2012-02-10 2012-02-10
US201261597426P 2012-02-10
PCT/US2012/063313 WO2013070521A1 (en) 2011-11-08 2012-11-02 Method of predicting breast cancer prognosis

Publications (2)

Publication Number Publication Date
HK1201329A1 HK1201329A1 (en) 2015-08-28
HK1201329B true HK1201329B (en) 2018-10-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP2776830B1 (en) Method of predicting breast cancer prognosis
US12534763B2 (en) Systems and methods of diagnosing idiopathic pulmonary fibrosis
EP3179393B1 (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
EP2715348B1 (en) Molecular diagnostic test for cancer
EP3147373A1 (en) Method for using gene expression to determine prognosis of prostate cancer
EP2641977A1 (en) Tests to predict responsiveness of cancer patients to chemotherapy treatment options
EP3556867A1 (en) Methods to predict clinical outcome of cancer
AU2012261820A1 (en) Molecular diagnostic test for cancer
US20200105367A1 (en) Methods of Incorporation of Transcript Chromosomal Locus Information for Identification of Biomarkers of Disease Recurrence Risk
EP3194621A1 (en) A method of predicting risk of recurrence of cancer
WO2014130617A1 (en) Method of predicting breast cancer prognosis
HK1201329B (en) Method of predicting breast cancer prognosis
WO2014130444A1 (en) Method of predicting breast cancer prognosis
HK40107615A (en) Methods to predict clinical outcome of cancer
HK40035898A (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
HK40014990A (en) Methods to predict clinical outcome of cancer
HK40043378A (en) Methods to predict clinical outcome of cancer
HK1235085A1 (en) Method for using gene expression to determine prognosis of prostate cancer
HK1237068A1 (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
HK1237068B (en) Gene expression profile algorithm and test for determining prognosis of prostate cancer
HK1189915A (en) Tests to predict responsiveness of cancer patients to chemotherapy treatment options
HK1212395B (en) Method for using gene expression to determine prognosis of prostate cancer
HK1189914A (en) Tests to predict responsiveness of cancer patients to chemotherapy treatment options
HK1185921A (en) Tests to predict responsiveness of cancer patients to chemotherapy treatment options